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Depletion of stratospheric ozone and changes in lifestyles have led to increased 
concern about the harmful effects of ultraviolet radiation (UVR). Exposure to UVR 
has been shown to induce both local and systemic suppression of immune responses 
initiated through the skin. The mechanism of dysregulation of immune responses 
following UV exposure is complex, and is initiated by chromophores. One such 
chromophore is urocanic acid (UCA), which is isomerised from the trans- to the 
cis -isoform by UVR, in the epidermis. The primary antigen presenting cell (APC) of 
the skin, the Langerhans cell (LC), plays a critical role in cutaneous immune 
responses. UVR alters LC frequency within the irradiated epidermis, and also exerts 
effects on the mature form of LC, the dendritic cells (DC), within lymph nodes 
draining irradiated sites. These changes appear to be concurrent with an alteration in T 
cell cytokine profiles. UVR suppresses immune responses which are normally 
characterised by Thl -like cytokine profiles, possibly by immune deviation to Th2 -like 
cytokine profiles. 
The contact hypersensitivity (CH) response is commonly used to demonstrate 
cutaneous immunity. A model of CH in C3H/HeN mice was established. This model 
was utilised to examine the effects of local UVB irradiation before induction of contact 
sensitisation. Cytokine profiles within lymph nodes draining the site of elicitation of 
CH, or the site of contact sensitisation were investigated. Results suggest that UVB 
has no effect on cytokine production during the sensitisation phase of CH, but that it 
downregulates Thl -like cytokine production upon elicitation of CH. 
Effects of UVR and UCA application were examined in relation to LC 
frequency within the epidermis. UVA1 (340- 400nm) irradiation, or trans -UCA 
application, did not alter the LC numbers within the exposed site. UVB (280- 315nm) 
irradiation and cis -UCA application depleted LC, and timecourses for LC depletion 
were established for both treatments. Injection of antibodies against either IL -1ß or 
xx 
TNF -a before UVB irradiation or cis -UCA treatment completely abrogated their 
effects on LC numbers. Thus, the UVB- mediated reduction of LC is dependent on the 
cytokines IL-1P and TNF -a. Despite reports that UVA1 irradiation protects mice from 
subsequent immunosuppression by UVB exposure, UVA1 irradiation did not affect 
the decrease in LC numbers induced by UVB. 
Despite the differences in effects on LC frequency, both UVA1 and UVB 
induced an accumulation of DC within lymph nodes draining the site of irradiation. 
For both irradiation regimens, the accumulation of DC was dependent on IL -113. This 
was identified by injecting neutralising IL-1f3 antibodies before irradiation, which 
inhibited the accumulation of DC within draining lymph nodes following irradiation. 
Similar experiments indicated that accumulation of DC following UVB irradiation, but 
not following UVA1 irradiation, was also dependent upon TNF -a. 
Induction of cytokines within irradiated skin was examined. UVB exposure 
increased the expression of IL -10 and TNF -a proteins at the irradiated site. Attempts 
to identify the source of these cytokines were inconclusive, as both keratinocyte 
(PAM -212) and melanocyte (B 16) cell lines failed to secrete these cytokines following 
UVB irradiation. Intracellular stores of TNF -a decreased as the dose of radiation 
increased. The technique of reverse transcription -polymerase chain reaction 
(RT -PCR) was established to examine expression of cytokine mRNA in irradiated 
skin. Following UVB irradiation, TNF -a mRNA was upregulated and there was 
induction of IL -10 mRNA. UVA1 irradiation did not result in such changes. There 
were also differences in the timecourse of IL -1 ß mRNA upregulation. IL -113 mRNA 
expression peaked transiently 4h after UVB irradiation. Following UVA1 irradiation, 





1.1. Environmental ultraviolet radiation 
Ultraviolet radiation (UVR) is commonly subdivided into three categories, 
depending on wavelength; UVC (200 -280 nm), UVB (280 -315 nm) and UVA (UVA2; 
315 -340 nm, UVAl; 340 -400 nm). Of the solar radiation that reaches Earth, 9% is in 
UV waveband. Ozone in the stratosphere effectively filters out all the UVC and much 
of the UVB wavelengths, whilst wavelengths above 320 nm pass through relatively 
unhindered. Around 1000 -fold more UVA reaches the Earth's surface in comparison 
with UVB. Between 1970 and 1987, a substantial decrease in the protective ozone 
layer occurred (Frederick and Snell, 1988; Kerr, 1988), and steps such as the Vienna 
Convention, Montreal Protocol, and Copenhagen Amendments are being taken to 
redress the situation. 
While reductions in ozone have been most publicised over the polar caps, 
measurements in more populated regions also suggest a pattern of decline. Indeed, 
radiative transfer analyses of satellite based 03 measurements between 1979 and 1992 
have shown that surface UVB increased substantially at all latitudes except the tropics, 
if other factors such as cloud cover and local pollutant levels remained constant 
(Madronich and de Gruijl, 1992). 
Hawaii is the most UV- intense location on the planet, with the lowest ozone 
thickness values ever recorded outwith the Antarctic region (Bergmanson and Sheldon, 
1997). Relative to values in the 1970s, by 1998 surface UV radiation had increased 
7% at Northern hemisphere mid- latitudes in Winter/ Spring and around 4% in 
Summer/ Autumn, and about 6% at Southern hemisphere mid- latitudes on a 
year -round basis. In the polar regions, increases were 130 and 22% in Antarctic and 
Arctic springs respectively (Madronich et al 1998). Biologically damaging radiation at 
Palmer Station (64 °S) was found to be comparable or even exceed the maximum 
summer values of San Diego (32°N) (Madronich et al 1998). A study conducted in 
Glasgow revealed that there was an increase in UVB between 1995 and 1996. This 
was not due to clearer local conditions, as UVA levels were comparable on the days 
studied (Moseley and Mackie, 1997). Long -term predictions are that there will be a 
slow recovery (decline in UVB) to pre -ozone depletion levels over the next 50 years. 
The amount of UVB reaching the Earth's surface in specific regions is dependent 
on other factors, such as weather conditions and the degree of pollution. UV 
measurements are routinely higher (by ground base data) in the less industrialised and 
less densely populated Southern hemisphere (Madronich et al 1998). After volcanic 
eruptions, ozone depleting aerosols are injected into the stratosphere and a delicate 
balance is struck between ozone depletion and increased reflective properties due to 
these particles. Estimates of the biologically effective UVR at the land surface after the 
El Chichon (1982) and Mount Pinatubo (1991) eruptions suggested that levels 
increased, as the effect of ozone depletion outweighed that of increased UV scattering 
( Vogelmann et al 1992). 
UVR plays an important role in environmental considerations outwith direct 
effects on health. The cyanobacteria that play a key role in maintaining an ecological 
balance are dramatically affected by UV. Not only are cyanobacteria primary sources 
of the marine food web, but they are also important biofertilisers. Exposure of three 
cyanobacteria species (Nostoc, Anabena and Scytonema) to UVB corresponding to a 
20% increase in its environmental flux has drastic effects on biomass production, 
photosynthetic rate and nitrogen fixation (Babu et al 1998). 
Although most UVR that people experience is derived from sunlight, particularly 
with increased UVB due to ozone depletion, exposure can occur via other sources. 
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These include both cosmetic and medical use of sunlamps. Industrial UV exposure 
can also occur, as is the case with welding arcs or tungsten halogen lamps. 
UV exposure can mediate alterations of immune responses. This chapter will 
describe generally cells of the skin, and immune responses activated by antigen 
exposure in the cutaneous environment. It will then detail the mediators involved in 
translating UVR into an effective modulator of such responses. Current understanding 
of the UV- induced alterations in cells of the immune system will be outlined. Effects 
at a cellular level will bestudied, including the involvement of cytokines. The effect of 
UV irradiation on disease states will be summarised, and finally, potential mechanisms 
to reduce UV- mediated immune suppression will be discussed. Although the 
experiments conducted in this thesis are entirely based in mice, within this introduction 
there will be an emphasis on UV effects on human systems. A general discussion will 
provide comparison of the results discussed herein with those found by previous 
studies on mice. 
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1.2. Skin physiology 
The skin is the largest tissue of the body, providing a relatively impermeable 
barrier to the external environment. Skin is made up from two distinct layers; the 
dermis and the epidermis. The dermis is the thickest and deepest layer, comprised of 
connective tissue with a network of capillaries and lymphatics. The dermis is overlaid 
by the epidermis, with the majority of cells being keratinocytes at different stages of 
terminal differentiation. The epidermis also contains melanocytes and Langerhans cells 
(LC). Finally, the stratum corneum is the 'dead' layer on the epidermal surface, 
comprised of dead cells and molecules sloughing off the body. 
1.2.1. Cells of the skin immune system 
The skin is readily accessible to infectious organisms. Like the gut and 
respiratory tract, the skin has its own associated immune system. The skin- associated 
lymphoid tissue (SALT) (Streilein, 1993) was recognised because lymphoid 
malignancies which showed cutaneous tropism were always T cell derived, and a 
population of 'passenger leukocytes' within the skin was identified. 
Keratinocytes comprise around 90% of epidermal cells. When adjacent to the 
basement membrane they are predominantly proliferating stem cells. As they mature, 
keratinocytes move through the suprabasal membrane toward the stratum corneum. 
Keratinocytes are capable of secreting cytokines and expressing MHC class II 
molecules. Mast cells are resident within the skin, and as described later (see section 
1.3.6), have an important role in merging innate and specific, adaptive immune 
responses. Langerhans cells (LC) also play a key role, as the cells resident in the 
epidermis with the ability to initiate specific immune reponses upon presentation of 
antigen to T cells within DLN (described in section 1.3.1). 
The cells involved in immune responses within the skin are detailed in table 1.1. 
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Innate 
resident recruited recirculating 
Monocytes Natural killer 
Endothelial cells Granulocytes - cells 
Mast cells basophils Dendritic cells 
Tissue eosinophils 
macrophages neutrophils 
(Melanocytes) Mast cells 
Epitheloid cells 
Keratinocytes 
Adaptive T cells T cells T cells 
Langerhans cells B cells 
Dendritic cells 
Table 1.1. Innate and adaptive cells of the skin immune system (adapted from Bos et 
al 1997). 
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1.3. Cells of the immune response 
1.3.1. Langerhans cells 
The primary antigen presenting cell (APC) in the epidermis are LC, which form 
a semi- continuous network comprising around 3% of epidermal cells. They are 
defined by their dendritic morphology, unique organelles named Birbeck granules 
within the cytosol, and membrane expression of ATPase, class II MHC, and CD 1 a 
(humans). 
LC act as sentinel cells within the epidermis and are important in initiating 
cutaneous immune responses (Toews et al 1980). In the course of a normal cutaneous 
immune response, LC internalise and process antigen, with changes in cytokine 
production by keratinocytes and LC themselves leading to their migration to the 
draining lymph node (DLN). During migration via the afferent lymphatics, LC 
mature, as revealed by the altered expression of various adhesion and costimulatory 
molecules. Once in the paracortical region of the lymph node, where they are known 
as dendritic cells (DC), they present antigenic peptides to specific T cells, which are 
stimulated to proliferate and produce a particular cytokine profile. 
It was first observed that application of a contact sensitiser to a body site 
deficient in LC, such as the hamster cheek pouch or mouse tail skin, led not to contact 
sensitisation, but rather to a specific unresponsiveness upon later challenge with that 
sensitiser. This observation suggested a key role for LC in presentation of antigens 
encountered through the skin. In guinea pigs, application of a contact sensitiser 
(DNCB) caused LC numbers, as assessed by ATPase, to drop in the first 24h. 
ATPase density reached its lowest level by 24h, with fewer dendritic processes and 
rounding of cells. Morphology and density slowly recovered to normal levels by 96h 
(Hanua et al 1989). Loss of ATPase activity correlated with an "activated" state, and 
application of a second contact sensitiser 24h after the first resulted in tolerance to the 
second. 
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The key migratory signals are believed to be provided in an autocrine fashion 
by interleukin (IL)-113, and in a paracrine fashion by tumour necrosis factor (TNF) -a 
(Wang et al 1999; Kimber et al 1998). LC express only the type 2 (p75) TNF -a 
receptor (TNFR2; CD 120b), and mice deficient in expression of TNFR2 have 
significantly impaired LC migration (Wang et al 1997). Blocking of TNF -a activity by 
neutralising antibodies revealed that TNF -a acts early in the response, as injection of 
antibodies prior to contact sensitisation, but not 18h after, inhibited contact 
sensitisation and the subsequent contact hypersensitivity (CH) response upon 
challenge (Cumberbatch and Kimber, 1995). IL-113 is produced solely by LC within 
the murine epidermis. Topical exposure of mice to chemical allergens stimulates 
increased production of IL- l ß by LC (Enk and Katz, 1992a). Intradermal injection of 
this cytokine stimulates LC migration, at a slower rate than TNF -a injection 
(Cumberbatch et al 1997b). It is therefore postulated that IL -10 acts as the initial signal 
to induce TNF -a production and release from keratinocytes, and also delivers an 
autocrine signal for LC migration (Kimber et al 1998). 
Although freshly prepared or 12h- cultured LC actively present antigen to 
primed T cells, they are weak or inactive at stimulating a primary allogeneic 
proliferation response, with a 12- to 16 -fold lower stimulatory capacity compared with 
72h LC. In contrast, 72h -cultured LC are extremely active stimulators of primary 
responses. Fresh LC do not initiate the formation of cell aggregates, in spite of their 
ability to present antigen in some assays. Cultured LC and splenic DC do induce 
clustering of lymphocytes. Freshly isolated LC lack the ability to cluster with T cells 
by an antigen- independent pathway, whereas mature LC can initiate clustering by an 
antigen- independent mechanism. LC cultured for 72h have functions that fully 
resemble those of lymphoid DC (Inaba et al 1986). The surface density of Ia 
molecules increases 4 -fold during culture. This maturation can be seen in serum free 
cultures, indicating that factors responsible for maturation are not limited to, or 
present, in serum. Cell free medium from keratinocyte cultures do not alter 
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maturation, indicating that keratinocytes are not solely responsible for maturation either 
(Picut et al 1988). 
1.3.2. Dermal dendritic cells 
The classification of dermal DC comprise a diverse number of cell types that 
exhibit dendritic morphology, including monocytic/ macrophagic cells, fibroblasts, 
dermal APC and stromal cells. Due to the wide variety of cells forming this 
population, definitive cell markers are limited and often not exclusive. In humans, 
most dermal DC are factor XIII +, a molecule involved in wound repair, CD 1 a +, CD 1 b+ 
and CDIc+ (Bergstresser et al 1995) and sometimes MHC class II+ (Braverman and 
Keh -Yen, 1992). A human LC -like dermal APC has been identified, expressing the 
LC- associated markers MHC class II, CD45 and CD1a, but also markers not 
expressed by LC (CD lb, CD1 lb, and factor XIII). This unique population comprises 
approximately 2.7% of total dermal cells. 
In mice, similar dermal DC populations can be found, with 2.5% dermal cells 
being la +. Ia+ DC, present in the perivascular region of the mouse dermis, when 
hapten -derivatised, are capable of inducing CH in naive mice (Tse and Cooper, 1990). 
There also exists a population of Thy -1 +, Iá cells, exhibiting a dendritic morphology, 
within the murine epidermis. It has been suggested that the relative frequency of these 
cells to LC influence the intensity of CH (Bigby et al 1987). Adoptive transfer of 
hapten -derivatised Thy -1+ DC specifically downregulate contact sensitisation (Sullivan 
et al 1986). 
1.3.3. Monocyte /macrophage cells 
Monocytes leave the circulation by binding to the endothelial leukocyte adhesion 
molecule (ELAM) -1 (now known as E- selectin; CD62E). This is induced on the 
vascular endothelium in the proximity of a UV- irradiated site, or after injection with 
purified protein derivative (PPD) which elicits delayed type hypersensititvity (DTH) 
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(Norris et al 1991). ELAM -1 is first detectable at 6 hours, and maximally at 24 hours, 
in both cases. Infiltration by macrophages into the treated site has a similar time - 
course. By three days however, ELAM -1 is more strongly expressed in DTH sites 
than in UV- exposed skin. This difference may be due to local cytokine activity. Thus, 
following UV, ELAM -1 could act by recruiting antigen presenting macrophages to 
temporarily replace the LC which had migrated from the skin. Other adhesion 
molecules induced by intradermal injection of PPD to elicit DTH, such as vascular cell 
adhesion molecule (VCAM) -1 and intercellular adhesion molecule (ICAM) -1, are 
unaltered in UV- exposed skin (Norris et al 1991). 
Investigation of epidermal cell suspensions, derived from skin which had been 
subjected to erythemagenic UVB each day for 4 days, showed a doubling in numbers 
of CD36+ macrophages compared with unirradiated controls (Hurks et al 1997). This 
increase correlated with recovery, and enhancement, of mixed epidermal cell 
lymphocyte reaction (MECLR) responses (Hurks et al 1997; Cooper et al 1985). 
MECLR is used as a measure of immunostimulatory activity; epidermal cells act as 
stimulators to induce proliferation of allogeneic peripheral blood responder cells. In 
situ immunohistochemistry and flow cytometric analyses of cell supensions revealed 
that UVR induced not only infiltration of CD36+ monocyte /macrophage cells into the 
epidermis, but also expansion of the dermal macrophage subset, which is 
phenotypically identical (Meunier et al 1995). 
1.3.4. CD4+ T cells (and cytokine dichotomy) 
The cytokine microenvironment in which an antigen is encountered determines 
the type of immune response initiated against it. CD4+ T cells are commonly divided 
into Thl- and Th2 -type subsets, as determined by the cytokine profiles they produce. 
Evidence for these profiles is strong in the mouse, where immune responses can be 
driven by repeated antigenic stimulation to levels at which clear and distinct cytokine 
profiles can be determined (Mosmann et al 1991; Mosmann and Sad, 1996). There is 
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evidence for Thl- and Th2 -type cytokine profiles in humans, particularly in long -lived 
disease states such as malaria, but under experimental conditions polarisation is usually 
weaker due to fewer exposures to antigen (Romagnani, 1991; Romagnani, 1997). 
Evidence for subsets is also available from in vitro manipulations to produce T cell 
lines. Thl -like cytokines include IL -12 (although not produced by T cells themselves) 
and TN-y i.e. those promoting cell- mediated immune responses (Trinchieri, 1993). 
Th2 -like profiles promote humoral immune responses, and include IL -4, IL -5 and 
IL -10. Cytokines of both subsets can interact with and inhibit the function and 
activation of cells from the opposite subset (see fig. 1.1), thereby promoting 
outgrowth of their own subset. For instance, IFN -y can inhibit the proliferation of 
Th2 cells, and IL -10 can block cytokine synthesis by Thl cells. IL -4 has dominant 
effects over those of IL -12 (Hsieh et al 1993). 
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CD4+ T helper cell subsets 





Antibody mediated responses 
1 
IL-2 / \ IL-4 / \ 
(IL-12) / \ IL-5 
IFN-y lo 0- - - -I IL-10 
Figure 1.1. The subsets of CD4* T cells, the cytokines they produce and the cross -regulatory 
mechanisms they use. 
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1.3.5. CD8+ T cells 
CD8+ T cells, also known as cytotoxic T lymphocytes (CTL), are class I 
MHC- restricted cells. Upon activation CD8+ T cells kill infected or abnormal cells by 
either of two mechanisms. These are a secretory lytic pathway or a nonsecretory lytic 
pathway (Berke, 1995). The first of these involves binding to an appropriate target, 
activation of a Cat + -dependent degranulation, with release of perforin and granymes to 
cause lysis of the target cell. The second, nonsecretory mechanism involves induction 
of apoptosis in the target, following cross -linking of apoptosis inducing cell- surface 
molecules on the target, such as Fas (CD95). 
Recent investigations are showing that CD8+ T cells can be subdivided into 
distinct subgroups on the basis of their cytokine production (Mosmann and Sad, 
1996). Similar to CD4+ T cells, cytokines secreted by CD8+ T cells are also important 
in directing immune responses. 
1.3.6. Contact hypersensitivity 
Allergic contact dermatitis is a common ailment, characterised by an eczematous 
reaction at the site of contact with a specific sensitiser. CH responses are reactions to 
small, structurally simple haptens. There are nearly 3000 chemical agents which can 
result in allergic contact dermatitis and common sensitisers include nickel in jewellery, 
compounds in plants, and many industrially relevant compounds. The sensitisers 
alone are generally incapable of generating an immune response, but react with 
proteins in the skin to create immunologically relevant hapten -derivatised proteins. 
These can be presented by APC, primarily LC, inducing their migration to the lymph 
node(s) draining the site of encounter. The CH response only occurs in individuals 
who have been sensitised to the chemical allergen by previous exposure. Around 
1 -2% of the general population have some form of contact sensitivity. 
CH is widely used to elicit and examine immune responses in the skin of 
experimental animals. As alluded to above, CH responses can be divided into two 
12 
phases. The first of these is the sensitisation (afferent) phase. During contact 
sensitisation, hapten -carrier complexes are taken up by LC in the epidermis, carried to 
the DLN and presented to specific T cells, as shown in fig. 1.2. In the lymph node, 
the hapten conjugate is presented on MHC molecules to antigen -specific T cells, 
inducing their proliferation and differentiation into an effector population. This T cell 
population then leaves the lymph node and circulates to the site of sensitisation via the 
blood. The T cells extravasate into the skin with the aid of adhesion molecules on the 
epithelium, and promote an inflammatory reaction. 
Upon rechallenge with the specific contact sensitiser (elicitation), T cells can be 
activated in situ, so that the reaction occurs at a quicker rate (see fig. 1.3). 
Additionally, circulating T cells generated during the sensitisation phase can migrate 
into the site of contact and release cytokines, leading to infiltration of more cells into 
the area and a measurable inflammation. The majority of contact sensitisers elicit an 
immune response characterised by a Thl -like cytokine profile during both phases of 
the reaction ( Kimber and Dearman, 1997). CD4 gene targeted mice (CD4-) 
demonstrate hyporesponsiveness in CH (Fujisawa et al 1996). 
Destruction of afferent lymphatics draining the exposed skin prevents contact 
sensitisation taking place. Congenitally athymic (nude) mice do not show a 
lymphoproliferative response to oxazolone (Ox) and contact sensitisation does not 
develop. The degree of DLNC proliferation to the sensitiser correlates with the level of 
sensitisation and the severity of elicitation. Indeed, the local lymph node assay is able 
to identify at least moderate and strong skin allergens (Kimber, 1992; Kimber et al 
1990b). Antigenic competition in CH is associated with, and probably a consequence 
of, a depressed primary proliferative response to the second chemical (Kimber et al 
1990a). Therefore, modulation of the primary response may directly affect the degree 
of sensitisation, and the magnitude of response upon challenge. 
In the secondary, elicitation, phase, classical 24- to 48h CH skin reactions are 
preceded by an early swelling reaction that peaks 2h after challenge. The ability to 
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initiate this early event is T cell dependent (van Loveren et al 1983), and also relies on 
release of serotonin (Gershon et al 1975) and participation of mast cells (van Loveren 
et al 1983; Askenase et al 1983). Pharmacological agents that blocked the activity of 
serotonin not only inhibited the early phase of the CH response upon elicitation, but 
also the late stage. This only occurred when serotonin was blocked at the time of 
challenge but not later, indicating that serotonin is not involved in the late component 
(van Loveren and Askensase, 1984). The early CH response is easily compressed, 
indicating that it is an oedematous response. The late response is more robust, 
indicating that it is a cellular infiltrate (van Loveren et al 1984b). 
Two functionally distinct, antigen specific T cells populations mediate the 
different components of CH elicitation. The T cell population responsible for the early 
reaction is induced within 24h of sensitisation. Another population mediates the late 
24 -48h swelling reaction, with the cells being induced 3 -4 days after sensitisation, and 
requiring much more antigen for immunisation (van Loveren et al 1984a). 
It is thought that antigen specific T cells activate mast cells to release serotonin. 
Serotonin then opens gaps between adjacent epithelial cells and allows extravasation of 
more T cells into the site, which in turn release chemokines and attract mononuclear 
cells. However, CH responses could be elicited in mast -cell deficient mice by some 
groups (Galli and Hammel, 1984; Thomas and Schrader, 1983), questioning the 
contribution of these cells in serotonin release. Local injection of serotonin alone could 
initiate CH. When serotonin was injected into the ears of mice that had been 
intravenously injected with only late- acting CH T cells (i.e. T cells involved in the late 
component of ear swelling), a 2h ear swelling could be measured (Ptak et al 1991). It 
was postulated that only a small number of mast cells may be required to initiate the 
response, as mast cells are still around 1% of normal numbers in mast -cell deficient 
mice. More recent data suggest that there may be redundancy in the source of 
serotonin, and platelets may also contribute (Geba et al 1996). 
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Complement may play a role in elicitation and development of the CH response. 
Complement -depleting cobra venom and antibodies against the C5 component inhibited 
CH responses. Locally increased macrophage chemotactic activity was lost from skin 
extracts of mice depleted of complement, as was the late elaboration of IFN -y (Tsuji et 
al 1997). It is thought that C5 attracts macrophages into the site of elicitation, with 
subsequent attraction of circulating T cells, and IFN -y production at the site producing 
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Figure 1.2. The sensitisation phase of contact hypersensitivity. The contact sensitiser forms a hapten- 
carrier complex in the epidermis. Langerhans cells internalise the antigen and migrate via the afferent 
lymphatics to the paracortical region of the draining lymph node, where, as dendritic cells, they 
















Figure 1.3. Elicitation phase of contact hypersensitivity. Antigen presenting cells (Langerhans cells) 
carrying the hapten -carrier complex (1) migrate from the epidermis into the dermis, where they 
present antigenic peptides to CD4+ memory T cells (2). Activated CD4+ T cells release pro - 
inflammatory cytokines (eg. IFN -y) (3), which activate keratinocytes to release other pro -infammatory 
cytokines (4). Non -antigen specific CD4+ T cells are attracted to the site (5), along with activated 
macrophages (6). The reaction is downregulated thereafter (taken from National Radiological 
Protection Board, NRPB- R297). 
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1.3.7. Delayed type hypersensitivity 
Delayed type hypersensitivity (DTH) is similar to CH but is initiated by more 
complex protein antigen. The protein is internalised by APC, processed and presented 
on MHC molecules to specific T cells in the DLN. 
In experiments by van Loveren, classical 24- to 48h DTH responses to 
lymphoma cells were preceded by an early swelling reaction that peaked 2h after 
injection of lymphoma cells into mouse footpads. As in CH, the late response of 
DTH appeared at 18h, peaked at 24h, then declined, after challenge. The T cell 
population responsible for the early reaction was induced between 12 and 24h after 
immunisation, whereas cells which mediated the 24 -48h swelling reaction were 
induced 3 -4 days after immunisation (van Loveren et al 1983). 
As with CH responses, serotonin release is required for elicitation of DTH 
responses. Mice treated with reserpine before challenge did not exhibit either the early 
or late components of ear swelling. Depletion of T cells from DLNC from immunised 
donor animals, to be used in adoptive transfer experiments, removed the potential to 
initiate either component in recipient mice. The early, but not the late, swelling could 
be induced in mice that received serum from immunised mice (Vandebriel et al 1989). 
The serum factors involved were therefore dependent on T cells for production, and 
were found to be mast cell arming T cell factor (MCTF) and specific macrophage 
arming factor (SMAF). These factors were produced early in the immune response, 
becoming detectable in serum 2 -3 days after immunisation (Vandebriel et al 1989). 
MCTF and SMAF `arm' their respective cell types to recognise specific antigen. C5 
dependent mechanisms also operate in sites of DTH elicitation (Tsuji et al 1997). 
1.3.8. General immunological tolerance 
Tolerance is generally associated with abnormal antigen presentation, failing to 
activate APC to release cytokines (Weigle and Romball, 1997). "Split tolerance" can 
develop, where, by preferential Th subset activation, the `incorrect' arm of the immune 
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response is activated due to alterations in the cytokine milieu. The use of adjuvants can 
also lead to preferential subset activation, with Complete Freund's Adjuvant (CFA) 
inducing a Thl -like profile, whereas Incomplete Freund's Adjuvant (IFA) induces Th2 
cells (Mauri et al 1996; Forsthuber et al 1996). Similarly, a Th2 profile can be 
achieved by targeting of autoantigens to B cells (Weigle and Romball, 1997). The 
ability of lipopolysaccharide (LPS), TNF -a and IL -1 to interfere with tolerance 
suggests a role for pro -inflammatory (Th1 -like) cytokines. 
Both B cells and DC have been strongly implicated in tolerance induction in 
vivo. Mice deficient in B cells can still become tolerant in both Thl and Th2 
compartments to the peptide and superantigen, human IgG. In the human IgG 
tolerance model, tolerance induction may be correlated to the manner in which APC 
prepare the antigen. Aggregated human IgG is aggressively degraded, processed to 
peptides, and activates the APC to produce IL -1 and other cytokines. Monomeric 
human IgG remains basically intact, and fails to induce cytokine production. 
Alongside cytokines, costimulatory molecules appear to play a key role in 
tolerance. Blocking of B7 -CD28 interaction has been suggested as a tolerance 
inducing mechanism. However, in vitro upregulation of B7 expression on B cells 
does not convert a tolerogenic to an immunogenic signal. 
Investigation of suppressor T cell -cell interactions by Lowy and colleagues 
revealed I -J- encoded determinants to be restrictive elements (Lowy et al 1983). 
Depletion of I -J+ cells with specific monoclonal antibody and complement before 
immunisation with azobenzenearsonate -coupled APC removed the APC required for 
Ts but not CTL induction. Granstein and collegues found tolerance inducing cells in 
the high density, hapten -coupled epidermal cell (HD -EC) fraction (Granstein et al 
1987), with the property confined to the adherent population. After UVB, electron 
microscopy of this HD -EC population revealed two cell types - keratinocytes and 
macrophage -like cells. Pretreatment of recipient mice with cyclophosphamide 
abolished the ability to induce Ts formation upon HD -EC transfer. Further 
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experiments indicated that the epidermal cells that activate suppressor T cells were 
high- density, la +, I -J restricted, glass adherent and UVR resistant, as well as 
cyclophosphamide sensitive (Granstein et al 1987). 
1.4. UV and chromophores in the skin 
UVR has been shown to have immunosuppressive effects, with the greatest 
effect within the UVB spectrum (280 -315 nm). Ex vivo experiments indicated that 
these wavelengths penetrate only as far as the epidermis (see fig 1.4), where it is 
thought that initiation of immunosuppressive effects occurs. More recent data from 
irradiation of human skin with monochromatic light in vivo indicates that wavelengths 
as short as 300 nm can penetrate as far as dermal cells (Young et al 1998). Within the 
epidermis, chromophores for UV- radiation include trans -urocanic acid (UCA) (Norval 
et al 1989b; Noonan and De Fabo, 1992), found within the stratum corneum, and 
DNA (Applegate et al 1989). Upon exposure to UVB, one and/or other of these 
chromophores appears to initiate a cytokine cascade, leading to suppression of T cell 
mediated immune responses, such as DTH and CH. 
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Figure 1.4. Penetration of human skin by UVR. Shorter wavelengths are absorbed in the epidermis, 
whilst longer wavelengths (UVA) can penetrate as far as the dermis (taken from National Radiological 
Protection Board, NRPB- R297). 
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1.4.1. Urocanic acid 
One of the major chromophores for UVR within the epidermis is UCA. UCA is 
formed by the action of the enzyme histidine ammonia -lyase during keratinisation. It is 
found naturally as the trans -isomer within the stratum corneum and is a major absorber 
of UV in the skin. Upon UVR, trans -UCA isomerises to cis -UCA in a dose - 
dependent fashion until a photostationary state is reached when approximately equal 
quantities of the two isomers are present. It then takes around two weeks for cis -UCA 
to return to a baseline level. Broad -band UVB is more potent in formation of cis -UCA 
in mouse skin than narrow -band UVB (Gibbs et al 1993). In Caucasian skin the 
photoisomerisation of UCA occurs between 305 -341 nm (i.e. in both the UVB and 
UVA wavebands) (Kammeyer et al 1995; Gibbs et al 1997) and has a maximum 
efficiency at 290 -310 nm in vitro (Gibbs et al 1997). This red shift between 
isomerisation in vitro and that in vivo may be due to the 10 to 12 nm red shift in the 
absorption of UCA in association with stratum corneum proteins (Jones et al 1996). 
Untreated murine flank skin contains around 5 µg /cm2 UCA, with 4% in the cis 
isoform (0.2 µg/cm2) (Norval et al 1988). A 500 kJ /m2 dose of UVA1 led to UCA 
isomerisation, with 17% in the cis isoform in C3H/HeN mice (El -Ghorr and Norval, 
1999). UVA lamps have also been shown to cause isomerisation of UCA in BALB /c 
mouse skin (Webber et al 1997). Significantly elevated levels of cis -UCA were found 
after as little as 100 J /m2 UVB (broadband, TL -12 bulbs), with over 40% formation 
after a 1000 J /m2 exposure. Narrow -band UVB (from a TL -01 bulb) was 5 -10 fold 
less efficient compared to the broad -band UVB source, with a dose of 10 kJ /m2 TL -01 
needed to reach 40% cis -UCA formation (El -Ghorr and Norval, 1999). 
The rate of cis -UCA formation can be reduced by topical application of 
sunscreens. Formation rate is reduced with increasing sun protection factor (SPF), 
and only broad -spectrum, highly protective sunscreens offer protection after multiple 
exposures (Krien and Moyal, 1994). There is a three -fold greater amount of cis -UCA 
in the sunburned stratum corneum than in normal skin. Cis -UCA can be formed in 
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human skin with common exposures (1 and 0.5 minimum erythemal dose (MED)) 
over a broad spectrum range of UVB and UVA, up to at least 363 nm (Kammeyer et al 
1995). The photoisomerisation rate decreased as wavelength increased, with the 
dosage of UVA1 needed to reach the photostationary point much higher than that with 
UVA2 (Mohammad et al 1999). A theoretical approach to estimate the distribution of 
cis -UCA after irradiation indicated that cis -UCA may diffuse into the deeper layers of 
the epidermis at a rate of 10- 17m2 /s (Krien and Moyal, 1994). The percentage of 
cis -UCA in suction blister fluid 24 hours after 3 MED of either UVB or UVA1 
(340 -400 nm) is increased over that found in fluid from unirradiated skin (Skov et al 
1998a). Analysis revealed that cis -UCA was maintained for several weeks following 
irradiation (Gilmour et al 1993b), in the dermis or near the dermo -epidermal junction 
(Norval et al 1995). UCA was transiently detectable in the serum of individuals given 
a single suberythemal dose of UVB, reaching a maximum at 24h after exposure. UCA 
has been detected in urine 5 -7h after 1 -1.5 MED total body exposure (Norval et al 
1995). 
There is a large inter -individual variation in UCA concentrations but little 
difference between body sites within one person (Kavanagh et al 1995; de Fine 
Olivarius et al 1997b). No correlation between the total UCA concentration and skin 
type, degree of pigmentation, MED or stratum corneum thickness was found 
(Kavanagh et al 1995; de Fine Olivarius et al 1997b). A study of seasonal variation in 
UCA isomers in human skin has revealed that the total UCA content was lower in the 
summer months in all 6 body sites tested, of which some were normally exposed and 
others not exposed to sun (de Fine Olivarius et al 1997a). The percentage of cis -UCA 
was close to the maximum obtainable during the summer months, except in the 
unexposed buttocks, and it decreased to below 7% in the winter months in all body 
sites apart from the forehead. A recent study of patients who had been treated for basal 
cell carcinoma and malignant melanoma concluded that there was no difference in the 
absolute amount of UCA isomers in the skin of the two cancer groups and normal 
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controls (de Fine Olivarius et al 1998). Irradiating these subjects with a single test UV 
dose resulted in a relatively higher production of cis -UCA in both cancer groups 
compared with the controls. The significance of this change, if any, is not known at 
present. 
UCA was regarded initially as a potential natural sunscreen, but tests to 
evaluate its SPF have shown that this is not the case. Addition of trans -UCA to human 
skin in amounts around 200 times greater that those occurring naturally afforded a SPF 
of only 1.58 (de Fine Olivarius et al 1996). Rodent experiments have suggested that 
cis -UCA can initiate at least some of the events leading to immunosuppression 
(reviewed in Norval et al 1989b; Norval et al 1995), and the pioneering work of De 
Fabo and Noonan showed that CH suppression has a similar action spectrum to the 
absorption spectrum of UCA (De Fabo and Noonan, 1983; De Fabo et al 1983). 
Evidence to corroborate this view in human subjects is not easy. Cis -UCA has been 
shown to suppress human natural killer (NK) cell activity in a dose -dependent manner 
in vitro, while trans -UCA has little effect (Gilmour et al 1993a). However no 
correlation was found between the percentage of cis -UCA in the skin and the 
suppression in NK cell activity induced by narrowband UVB therapy of individuals 
with psoriasis (Guckian et al 1995). If human epidermal cells were treated with 
cis -UCA in vitro before testing their activity as stimulator cells in a MECLR, a 20% 
suppression resulted (Hurks et al 1997a). The downregulation was increased to 27% 
by incubation of the epidermal cells with cis -UCA for 3 -6 days before testing. 
Trans -UCA had no such effect. In addition cis -UCA did not alter a mixed lymphocyte 
reaction (MLR) if present throughout the culture period (Hurks et al 1997a). Thus, a 
partial downregulation in human epidermal antigen presenting activity could be 
attributed to cis -UCA. A further potential in vivo mechanism of action of cis -UCA 
includes the stimulation of prostaglandin E2. This has been reported in vitro from 
human peripheral blood monocytes (Hart et al 1993) and keratinocytes (Jaksic et al 
1995). 
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Chronic exposure of mice with either broad -band and narrow -band UVB 
sources resulted in trans- to cis -UCA conversion. The percentage of cis -UCA began 
to return to normal levels after 4 weeks of chronic narrow -band UVB (3000 Jim', 3 
times per week), despite continued exposure (El -Ghorr et al 1995). CH was 
suppressed only in mice that had received broad -band UVB, thereby questioning the 
correlation between cis -UCA and CH outcome, after continued irradiation (El -Ghorr et 
al 1995). In contrast, systemic suppression of CH could not be seen in mice 
genetically deficient in histidase, and therefore skin UCA ( <10% normal), upon a 
single UVB exposure, whereas suppression in wild -type mice was dose -responsive 
and comparable to that seen previously in BALB /c mice (De Fabo et al 1983). 
Histidase deficient mice exhibited a normal CH response to TNCB. 
Incubation of epidermal cells in cis -, but not trans -UCA, completely inhibited 
antigen presentation in a spindle -cell tumour antigen system. Neither histamine 
antagonists nor indomethacin, which inhibit prostaglandins, reversed cis -UCA effects. 
An effect could also be seen on secondary immune responses. Pre -incubation with 
cis -UCA, but not trans -UCA, prior to injecting antigen pulsed epidermal cells into the 
footpads of immune mice, inhibited the DTH response upon challenge (Beissert et al 
1997). These data indicate that cis -UCA may be an important regulator of LC antigen 
presenting ability in tumour immune responses, and therefore in photocarcinogenesis. 
Intraperitoneal injection of cis -UCA for 7 consecutive days, starting on the day 
of transplantation, was able to prolong the survival of allogeneic MHC disparate skin 
grafts in mice (Gruner et al 1992). C3H mice were transplanted with C57B1/6 skin 
and cis -UCA prevented rejection in a dose -dependent manner. Trans -UCA had no 
protective effect. Furthermore, cis -UCA injection delayed the onset of acute 
graft- versus -host disease and prevented the lethal disease in 30% of animals (Griner et 
al 1992). Trans -UCA did not significantly delay onset of graft- versus -host disease. 
However, if C3H mice that had previously rejected allografts were given skin from the 
same donor strain 4 weeks later, and the recipients were treated with cis -UCA as 
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before, grafts were rejected. This indicates that tolerance was not induced by cis -UCA 
in this system 
Splenic DC were obtained from mice injected intravenously with 50 -200µg 
cis- or trans -UCA, and pulsed with DNP6 Ova. It was found that splenic dendritic 
cells (DC) from cis -UCA injected mice had significantly impaired APC function 
(assessed as the proliferative response of T cells derived from mice immune to DNP6 
Ova), whereas those from trans -UCA injected mice had normal APC ability. This was 
despite the DC having the same Ia expression (Noonan et al 1988). Mixtures of DC 
from cis -UCA treated mice with normal DC did not impair APC function, and direct 
addition of cis -UCA to in vitro proliferation assays was without effect. Addition of 
indomethacin, to inhibit prostaglandin synthesis, did not have any effect (Noonan et al 
1988). This may indicate that essential mediators of immune suppression are not 
available once cells are removed from the mice. 
Addition of a methyl group to position 2 of the imidazole ring of UCA abrogates 
the immunosuppressive effects of cis -UCA. The side arm may be altered significantly 
(by reduction, or even replacement) with no loss of activity (Norval et al 1989a). 
Thus, the 5- membered ring is necessary for immunosuppressive activity, perhaps by 
fitting into a receptor site. 
1.4.2. DNA damage 
As is the case with cis -UCA, rodent models suggest that DNA damage is a 
critical event in UV- induced immunosuppression (reviewed in Vink et al 1996b). 
Cells of the South American opossum, Monodelphis domesticus, contain an enzyme 
that confers the ability to repair UVR- induced pyridimine dimers in DNA by a process 
known as photoreactivation. In photoreactivation, cyclobutane dimers between 
adjacent pyridimines on the same DNA strand are repaired in situ by splitting of the 
dimers. This process is mediated by an enzyme activated by visible (photoreactivating) 
light in marsupial cells. Exposure of opossums to UVB before contact sensitisation 
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suppressed CH responses. Extraction of DNA from UV- irradiated skin samples 
indicated that there was significant induction of pyridimine dimers by 
immunosuppressive doses of UVB (Applegate et al 1989). If UVB was followed by 
exposure to photoreactivating light, CH responses were restored to levels comparable 
to those of unirradiated opossums. Analysis of skin samples from opossums which 
were exposed to photoreactivating light showed that 86% of the pyridimine dimers had 
been removed. 
Vink and colleagues identified cells with cyclobutyl pyridimine dimers within the 
epidermis, the dermis, and DLN of irradiated sites in mouse skin (Vink et al 1996a). 
When mice were sensitised through irradiated sites with the contact sensitiser FITC, 
Ia+ cells bearing FITC and containing dimers could be detected in DLN. Such cells 
from mice sensitised 3d after UVB exposure exhibited reduced APC function in vivo. 
This was demonstrated by injecting DLNC into the footpads of syngeneic mice, then 
challenging these recipients with FITC 5d later. DLNC from unirradiated, 
FITC -sensitised mice were capable of inducing CH in recipients upon challenge. Mice 
immunised with DLNC from mice which had been sensitised 3d after irradiation had 
significantly reduced CH responses. Liposomes incorporating T4 endonuclease V 
(T4N5) accelerate the repair of pyridimine dimers. APC function was completely 
restored in mice which received T4N5 immediately after irradiation, but only if the 
liposomes were applied to the exposed site (Vink et al 1996a). Further experiments by 
this group examined the effect of repair of cyclobutyl pyridimine dimers within DLNC 
from irradiated, contact sensitised mice in vitro. When DC enriched from the DLNC 
population of irradiated mice were injected into syngeneic recipient mice, the CH 
response was suppressed compared with that elicited in mice which received DC from 
unirradiated mice. DNA damage was repaired in DC from irradiated mice in vitro, by 
incubating cells with liposomes containing a photolyase, which underwent 
photoreactivation in visible light. Injection of DC incubated with photolyase restored 
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CH responses to levels comparable to those achieved by transfer of DC from 
unirradiated mice (Vink et al 1997). 
Kremer and colleagues exposed normal human skin to UVB doses ex vivo. 
UVB induced DNA damage could be demonstrated, and damage increased with 
increasing UVB dose. In contrast to studies in mice, DNA damage within the LC did 
not lead to a functional impairment to stimulate T cells, as irradiation did not decrease 
the capacity of LC to induce T cell proliferation on a per cell basis (Kremer et al 1997). 
Kripke and colleagues demonstrated that injecting supernatants from irradiated 
PAM -212 cells into mice suppressed the DTH response to alloantigen. Incubation of 
PAM -212 cells with T4N5 liposomes following UVB irradiation removed the 
suppressive activity of supernatants (Nishigori et al 1996a). Application of T4N5 
liposomes to mouse skin immediately after UVB irradiation decreased the number of 
cyclobutane pyridimine dimers in the epidermis. Additionally, suppression of CH 
responses by UVB exposure was abrogated in T4N5 treated mice (Kripke et al 1992). 
However, the suppression of CH responses by UVB was not completely reversed by 
T4N5 liposomes. This group proposed that DNA damage would induce the release of 
immunoregulatory cytokines (Kripke et al 1992). They showed that supernatants from 
irradiated PAM -212 cells can suppress DTH responses when injected intravenously 
into mice. Immunoperoxidase staining of irradiated PAM -212 cells revealed induction 
of IL -10 following irradiation. Incubation of PAM -212 cells with T4N5 reduced the 
induction of IL -10, thereby supporting their earlier hypothesis. Application of T4N5 
liposomes to murine skin in vivo reduced the induction of IL -10 within the epidermis 
and serum following UVB exposure (Nishigori et al 1996b). Interestingly, IFN -7 
production by T cells stimulated by DC from irradiated mice was impaired. However, 
if DC from irradiated mice were incubated with photolyase in vitro before stimulating 
T cells, IFN-y production was restored (Vink et al 1997). 
Encapsulating the restriction endonuclease HindIII in liposomes allows induction 
of DNA strand breaks in vivo and in vitro. Topical application of such liposomes to 
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murine skin impaired the induction of CH responses initiated at either local or distant 
sites. HindIII induced production of TNF -a in the epidermis of mice, and TNF -a and 
IL -10 production by keratinocytes in vitro (O'Connor et al 1996). HindIII induced 
DNA strand breaks therefore mimic the effect of UVB irradiation. APC function was 
impaired in mice treated with HindIII liposomes. Interestingly, HindIII liposomes 
suppressed the DTH response to Candida albicans, and this was abrogated by 
antibodies against IL -10 (Nishigori et al 1996a). 
Evidence to support the role of DNA damage in initiation of immunosuppressive 
mechanisms is limited in human subjects. Hurks et al (1995) showed that the in vitro 
action spectrum for the suppression in the MECLR is associated with UV- induced 
DNA damage. Recently this study was extended to investigate the action spectra at 4 
wavelengths for the induction of thymine dimers, which represent the largest subclass 
of cyclobutyl pyrimidine dimers, and the suppression in the MECLR following in situ 
irradiation of small pieces of human skin (Hurks et al 1997b). The 2 action spectra 
had close similarities with a high sensitivity at 254, 297 and 302 nm, then a steep 
decline to 312 nm. However with such large gaps in the wavelengths studied and no 
information regarding UVA wavelengths, more information is required. 
Young and colleagues investigated the depths to which monochromatic light 
could penetrate and induce DNA damage within human skin. Human volunteers were 
irradiated in vivo, and thymine dimers identified in punch biopsies with a monoclonal 
antibody. DNA dimer formation was independent of epidermal layer studied, when 
light ranging from 300 to 360 nm was utilised. There was poor transmission to the 
basal epidermal layer of wavelengths between 280 and 300 nm. Dimers were 
detectable within dermal nuclei when wavelengths as short as 300 nm were used 
(Young et al 1998). This contrasts with findings from ex vivo studies, and indicates 
that there is significant transmission of UVB wavebands through the skin. 
Repair of pyridimine dimers does not fully restore CH responses in mice (Kripke 
et al 1992), indicating that although DNA damage appears to be important, it is not 
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wholly responsible for UV- induced immunosuppression. This is supported by the fact 
that humans have the capacity to rapidly repair cyclobutane pyridimine dimers by a 
photoreactive enzyme (Sutherland et al 1980), but can still be immunosuppressed upon 
UV irradiation. 
1.4.3. Other chromophores 
UV can activate the transcriptional factors AP -1 and NF-KB. NF-KB is located 
in the cytoplasm, in association with the inhibitory molecule, KB. Upon activation 
IKB is split from NF-KB, and NF-KB can migrate into the nucleus and initiate gene 
transcription. It is hard to envisage that UVB can by -pass cytoplasmic NF-KB and 
only activate it secondary to DNA damage (reviewed in (Schwarz, 1998). Studies by 
Devary and colleagues involved UVC irradiation of enucleated cells. It was 
demonstrated that NF-KB could be activated in these cells upon irradiation, indicating 
that a nuclear signal is not a requirement for NF-KB activation following UV exposure 
(Devary et al 1993; Simon et al 1994). UV can activate genes by intracellular 
signalling pathways, which are triggered by effects on the cell membrane. 
Application of a- tocopherol, the most biologically active form of the antioxidant 
vitamin E, to mouse skin before irradiation with solar- simulated UVR completely 
reversed UV- induced suppression of CH and migration of LC (Yuen and Halliday, 
1997). It was postulated that scavenging of UVR- induced lipid peroxidases and 
reactive oxygen may have inhibited loss of cell membrane integrity. 
When sensory nerves were depleted from mice by injecting with the neurotoxin 
capsaicin before 4 weeks of age, UV irradiation of the mice at a later time did not lead 
to suppression of CH responses. When mice were injected with calcitonin gene - 
related peptide antagonist, CH responses were similarly restored in UV- irradiated mice 
(Garssen et al 1998). This implies that sensory neuropeptides are involved in 
UV- mediated immune suppression. 
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PUVA induces monofunctional adducts and cross -links in DNA, as opposed to 
the cyclobutyl pyridimine dimers induced by UVB irradiation. The cytotoxic action of 
UVA is dependent upon reactive oxygen species. In human skin, possible 
endogenous chromophores for generating reactive oxygen species may come from the 
circulation. Flavins are thought to play a role in photo- induced skin injury, and UVA 
irradiation of riboflavin produces singlet oxygen, superoxide anions, and triplet -state 
riboflavin radicals (Sato et al 1995). The latter of these mediators are immediately 
quenched in human skin. If H202 is produced, damage can occur at sites other than 
the generation site, due to the long -lived nature of the molecule. 
UVB irradiation of PAM -212 cells inhibits induction of interferon regulatory 
factor -1 (IRF -1) mRNA expression in response to stimulation by IFN -7 (Aragane et al 
1997). It is also recognised that UV induces clustering and internalisation of the cell 
surface receptors for TNF -a and IL -1 (Rosette and Karin, 1996). UVB appears to 
trigger the CD95 (Fas) pathway, by directly activating the CD95 receptor (Aragane et 
al 1998) and thereby resulting in apoptosis of the target cell. 
1.5. Effects of UVB on APC 
It is apparent that disruption of LC could be a fundamental component of 
UV- mediated immunosuppression, either by incorrect, inappropriate or inefficient 
antigen presentation. Alternatively, depletion or apoptosis of LC could lead to antigen 
presentation by another cell type. Two important signals involved in initiating 
migration of LC from the epidermis are IL-1p and TNF -a (Cumberbatch et al 1997a; 
Kimber et al 1998), and the role of these cytokines in UV irradiated sites is discussed 
later, in sections 1.9.1 and 1.9.7 respectively. 
Several studies have examined LC numbers and morphology within human skin 
following UV exposure (Yoshikawa et al 1990; Skov et al 1998b). 
Photochemotherapy is the combined use of chemicals, such as psoralen, and UV in 
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treatment of skin ailments. The presence of psoralen in the skin, whether it is applied 
locally or given systemically, enhances the pigmentary response of the skin to UVR. 
UVA exposure in combination with psoralen application (PUVA) for skin conditions 
such as psoriasis altered LC morphology after a single exposure, with loss of fine 
dendritic processes (Friedmann, 1981). Repeated exposures led to a progressive 
reduction in numbers, to 10% after 7 treatments. By this time, the remaining cells 
were elongated with coarse dendrites. LC were detectable in, or under, the basal layer, 
suggesting migration out of the epidermis, or the preferential survival of cells 
positioned deeper in the skin. An Australian study showed that UV acts differently on 
LC of people of different racial origins (Hollis and Scheibner, 1988). Whereas LC 
were depleted by apoptosis in the darker skin of Aboriginal or Asian Australians, cells 
in those of Celtic descent died due to membrane disruption and organelle damage 
(Hollis and Scheibner, 1988). Absolute numbers were less drastically reduced in 
blacks, and returned to normal levels more quickly. 
The effect of low -dose, long -term UVB (300 -500 J /m2 initially, three times 
weekly for four weeks) on the function of LC was investigated in skin blisters/biopsies 
from healthy volunteers, and showed a marked suppression of the MECLR (Van Praag 
et al 1994). The reduction in MECLR was not paralleled by changes in LC numbers or 
in HLA class II expression. Furthermore, the LC appeared ultrastructurally normal 
(Van Praag et al 1994). It is unlikely that low -dose UVB alters these cells at a 
phenotypic or structural level, but could alter membrane motility (Kobata et al 1993), 
thereby decreasing the efficiency of antigen presentation, or of antigen internalisation 
and processing. 
Further in vitro investigations of human LC function showed a UVB 
dose -dependent decrease of T cell proliferation in the MECLR (Rattis et al 1995). 
Responses by both CD4+ and CD8+ T cells were inhibited by UVB- treated LC. 
Supernatants from irradiated cells did not inhibit the proliferation induced by 
unirradiated control LC, suggesting that immunosuppression is not mediated by 
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soluble factors, as indicated by murine models (Rivas and Ullrich, 1992; Rivas and 
Ullrich, 1994). Addition of IL -1 a, IL-lß or IL -2 did not reverse the defective LC 
function (Rattis et al 1995). Phenotypic analysis indicated that UVB did not alter 
levels of expression or the percentage of cells displaying HLA -DR. However, 
cultured LC were less sensitive to UVB- exposure than fresh cells. Cultured LC 
express higher levels of the costimulatory molecules, ICAM -1 (CD54), B7 and 
leukocyte function- associated antigen (LFA) -3. UVB may therefore exert an 
immunosuppressive effect by preventing accessory function development, a 
phenomenon seen with blood DC (Young et al 1993). Again, this could be related to 
cytoskeletal damage (Zamansky and Chou, 1987), and/or decreased mobility of 
surface antigens (Kobata et al 1993). 
Epidermal cells obtained from suction blisters of human skin after exposure in 
vivo to varying doses of UV exhibited altered capacities to stimulate T cells. 
Epidermal cells were pulsed with purified antigen, either immediately or 24h following 
UV- treatment, and their ability to induce T cell proliferation assessed. A dose - 
dependent reduction of activating ability was found (Austad and Braathan, 1985), and 
could be mimicked by pretreatment of epidermal cells to deplete HLA -DR+ cells. As 
LC are the only DR+ cells resident in normal human epidermis, it is likely that changes 
in these cells account for these observations. Cell death was limited to DR- 
keratinocytes, and was not related to the responses obtained (Austad and Braathan, 
1985). 
UV also causes changes in intercellular signalling. In vitro stimulation by 
epidermal cells obtained from both UV- exposed and normal control skin induces a 
greater than 1000 -fold increase in mRNA for the T cell growth factor IL -2, in 
allogeneic CD4+ T cells. However, the mRNA for the IL -2 receptor a -chain (IL -2Ra, 
CD25) was upregulated only upon stimulation by normal, unirradiated epidermal cells 
(Stevens et al 1995). At the protein level, CD25 expression on T cells was increased 
within 48h of incubation with normal epidermal cells, but was not altered by 
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incubation with irradiated epidermal cells. Treatment with antibodies to transforming 
growth factor (TGF) -3 restored the ability of the UV- exposed epidermal cells to 
upregulate CD25. Thus, the altered immune response after UV- exposure seems to be 
due in part to TGF -ß released by epidermal cells post -UV, initiating an altered early 
CD4+ T cell gene expression, which is characterised by the deficient IL -2Ra 
expression (Stevens et al 1995). Furthermore, T cells stimulated by UV- exposed 
epidermal cells have altered growth factor utilisation and cytokine production patterns 
(Stevens et al 1998). T cells cultured with control epidermal cells utilise IL -2, IL -7 
and IL -15 for growth, and produce predominantly IFN -y. Those stimulated with 
UV- exposed epidermal cells use IL -4 for growth, and more cells produce IL -4 and/or 
IL -5 compared to controls. 
Noonan and collegues showed that short UV wavelengths led to a loss of 
ATPase staining dendrites and a decrease in total epidermal LC 24h later, in BALB /c 
mice, in a dose -dependent fashion (Noonan et al 1984). Doses of 270 or 290 nm UV 
used to deplete LC were insufficient to suppress the CH response, although higher 
doses could. Conversely, a dose of 320 nm UV that caused 50% suppression of CH 
did not deplete LC, nor did it affect LC morphology (Noonan et al 1984). Chronic 
UVA exposure (10 kJ /m2, 3 times per week for 4 weeks) reduced ATPase+ and Ia+ 
cells in murine epidermis (Aubin et al 1991). 
When DLNC excised from a contact sensitised mouse were injected into a 
syngeneic recipient, the recipient mouse was able to elicit a full CH response upon its 
first exposure to the contact sensitiser. However, if DLNC were tranferred from a 
donor mouse exposed to UVB 4 days before sensitisation, a specific tolerance was 
generated in the recipient (Tang et al 1992). This observation suggests that UVB 
affects CH at the level of the APC originating in the skin. Analysis of the DLNC 
surprisingly revealed that more were FITC (the contact sensitiser)+ in UVB- pretreated 
animals, and that the fluorescence intensity was no different from sensitised only 
animals. A higher proportion of the DLNC from the UVB- irradiated mice were 
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Mac -1 +, F4/80 +, with few containing Birbeck granules, indicating that UVB changes 
the APC type. 
1.6. UV radiation and hypersensitivity responses 
Several studies have indicated that UV irradiation of human subjects generally 
leads to the downregulation of CH and DTH responses, both of which are considered 
as important measures of T cell function. Mork and Austad (1992) reported that 70% 
of patients with allergic chronic dermatitis in their hands could be treated successfully 
with suberythemal UVB, and the situation was maintained if UVB was given once 
weekly thereafter. Similarly exposure to suberythemal UVB 4 times weekly over a 3 
week period was sufficient to suppress the CH response to nickel in nickel- sensitive 
individuals (Sjovall and Christensen, 1986). This effect was limited to the UVB 
wavelengths as UVA did not alter the patch -test scores. In contrast, Tie et al (1995) 
found that subjects, sensitised through normal skin and challenged via UVB- exposed 
skin, exhibited enhanced CH. 
Using carefully graded doses of sensitiser (DNCB), Friedmann et al (1989) 
showed that therapy with both broadband UVB and PUVA (psoralen plus UVA) 
induced impairment of CH in about 70% of patients with psoriasis. The sensitiser was 
applied approximately halfway through the therapy and the elicitation occurred 4 weeks 
after the cessation of therapy. Subjects who were not sensitised successfully during 
treatment were re- sensitised at a later date, and no evidence for tolerance was obtained 
in either the UVB or the PUVA group. 
Following exposure of a small area of skin to 144 mJ /cm2 UVB on each of 4 
consecutive days, a protocol which reduces LC numbers in the epidermis from 565 to 
17 per mm2, 40% of volunteers demonstrated suppressed CH responses to DNCB 
applied epicutaneously at the site of exposure, followed by challenge at a distant 
unirradiated site (Yoshikawa et al 1990). In agreement with mouse studies (Streilein 
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and Bergstresser, 1988), these subjects were designated as UVB- susceptible (UVB -S) 
and the others, in whom the extent of the CH response was unaltered by the UV 
exposure, were termed UVB -resistant (UVB -R). Skov et al (1998b) reported that 
56% of human subjects exhibited suppressed CH responses following 3 MED UVB 
and sensitisation on the irradiated site. Tolerance was not induced in the unresponsive 
individuals. Interestingly, tests to assess LC (CD 1a+HLA -DR +) and macrophage 
(CD 1 a HLA -DR+) numbers and the ability of epidermal cells to activate autologous 
T cells following irradiation revealed no differences between the UVB- susceptible and 
resistant individuals. Thus susceptibility to UVB cannot be correlated easily with these 
local changes in epidermal APC populations or functions. 
The clear division into UVB -S and UVB -R has not been confirmed in all studies. 
Cooper et al (1992) reported that almost all subjects had reduced ability to respond to 
DNCB if the sensitiser was applied to the irradiated site. The downregulation was 
dose dependent to some extent as the lowest exposure used (0.75 MED of UVB daily 
for 4 days to a small area of skin) induced non -responsiveness in 68% of individuals 
while the highest (2 MED of UVB daily for 4 days) induced non -responsiveness in 
95% of individuals. The most susceptible people exhibited tolerance to DNCB on 
repeated challenge with the sensitiser. There was a rather modest suppression in CH if 
the DNCB was applied at a distant unirradiated site after 4 MED UVB was given as a 
single dose. There may be a wavelength dependence in the local immunosuppressive 
effect as exposure to UVA did not alter the induction of CH in any subject (Skov et al 
1997). Another study has demonstrated that solar- simulated UV exposure, 
corresponding to 3 MED, followed by sensitisation on the irradiated site led to 
suppressed CH responses in 50% of subjects (Serre et al 1997). However, in 
contrast, Kelly et al (1993) found that solar simulated radiation was highly 
immunosuppressive in everyone tested. A single exposure of a small area of skin to 3 
MED was followed by sensitisation with DNCB on the irradiated site and 
diphenylcyclopropenone on a distant site, and elicitation with both sensitisers occurred 
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3 weeks later. The CH response was completely suppressed locally in 100% of 
individuals and systemically in 83% of individuals. A dose of radiation of this 
magnitude is of biological relevance as it would be experienced within one hour at 
noon in the summer in the United Kingdom. 
It is difficult at this time to draw firm conclusions from these rather disparate 
observations. However, it is clear that, in all studies, at least a proportion of human 
subjects exhibit suppressed CH if the sensitiser is applied to the irradiated site. The 
effect is more marked if small quantities of sensitiser are used. UV- induced tolerance 
and systemic immunosuppression are not consistently observed, and the contribution 
of different wavelengths within the UV spectrum is uncertain at present. Studies in 
rodents provide more consistent data. 
Streilein and Bergstresser found that UVB exposure, with 600 J /m' on four 
consecutive days, before contact sensitisation of different mouse strains, led to 
different outcomes upon elicitation of the CH response (Streilein and Bergstresser, 
1988). Some mouse strains exhibited CH responses which were unaltered in 
comparison with unirradiated counterparts, and were designated as UVB -R. Examples 
of the UVB -R strains which this group discovered are A/J and BALB /c mice. In other 
strains, such as C3H/HeN and C57B1/6 strain mice, the CH response was significantly 
downregulated by irradiating prior to sensitisation, and these were designated as 
UVB -S. Experiments conducted in one set of F1 hybrids derived from 2 UVB -S 
parental strains displayed the UVB -R trait, suggesting gene complementation, and also 
that more than one gene locus was invovled. 
The CH response to DNFB was suppressed in mice irradiated with 720 J /m2 
UVB and contact sensitised throught the same site 6h later. This was to a similar 
extent as the suppression observed in mice sensitised 72h after irradiation. Partial 
tolerance could be displayed, as resensitising of mice did not restore the CH response 
(Hammerberg et al 1996). This only occurred when mice were sensitised at the site of 
UVB exposure, and not if sensitised at a distant site. Mice sensitised 6h after a single 
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720 J /m2 UVB exposure exhibited tolerance, and maximum tolerance could be 
observed in mice sensitised 48h after irradiation. 
Garssen and coworkers irradiated mice and then sensitised the mice with either 
picryl chloride or Ox on the non -UV- exposed abdomen. In mice which were irradiated 
with UVB before sensitisation, 70 -80% suppression of CH responses was observed 
upon challenge on the UV- protected ears (Garssen et al 1999). Both the early and late 
phases of CH are impaired in mice irradiated before contact sensitisation (Sontag et al 
1994). 
Most experiments have focussed on the effects of UVB before contact 
sensitisation. In experiments by Polla and colleagues, local exposure of the sites of 
elicitation (ears) of CH in mice exposed to UVB for 4 days prior to challenge actually 
enhanced the CH response, in both C3H/HeJ and A/J strain mice. PUVA had no 
effect on the CH response if given at this stage. The enhancement was due to a local, 
not systemic, effect of UVB (Polla et al 1986). 
Like CH responses, DTH responses of mice can be inhibited by UV exposure. 
In mice which were irradiated with UVB before infection with HSV, the DTH 
response elicited by injecting viral antigens into the ears later was reduced from the 
DTH response elicited in animals which were not irradiated (Howie et al 1986). 
UVAl exposure inhibited the response to HSV antigens, although less efficiently than 
a broad -band UVB irradiation (El -Ghorr and Norval, 1999). The DTH response to 
Mycobacterium bovis can also be suppressed by exposure of mice to UVB before, 
during or after infection (Jeevan and Kripke, 1989). Similarly, mice given a single 
UVB exposure before or after immunisation with Candida albicans exhibited a 
depressed DTH response against this pathogen (Denkins et al 1989). 
38 
1.7. UV and T cells 
While aspects of T cell immunity have been outlined above in the context of 
hypersensitivity responses (see section 1.5), the effects of UV on T cell numbers are 
worthy of consideration. Changes in circulating T cell subsets as a result of exposure 
are controversial and, indeed, it is possible that such modulations are only transient. 
Thus, for example, Gilmour et al (1993b) found no significant changes in the 
percentages of blood CD3 +, CD4+ or CD8+ cells during and after broadband UVB 
phototherapy or PUVA. In contrast, exposure of people to the midday sun for 1 hour 
per day for 12 days during the Spring in Sydney, Australia, led to a small but 
significant decrease in the number of peripheral T cells (Hersey et al 1983). 
Circulating CD4+ T cell numbers declined markedly while CD8+ T cells increased. The 
reduction in the CD4:CD8 ratio was not completely restored, even 2 weeks 
post- exposure. The decrease in peripheral CD4+ T cells might be accounted for by 
migration into irradiated sites. 
Limited studies have examined T cell subsets in UV- exposed skin. Biopsies 
showed an initial decrease, or depletion, of intraepidermal T cells within 2 days of a 
single erythemal UV dose of solar simulated light (Di Nuzzo et al 1996). Dermal 
T cells increased by 24 hours and were maximal at 48 hours. One week after the 
irradiation, the migration into the epidermis of CD3+ T cells, expressing CD4 but not 
CD8, could be detected. These cells were almost exclusively of the memory 
phenotype (CD45RO +), and lacked expression of the activation markers HLA -DR, 
VLA -1 and IL -2R (Di Nuzzo et al 1998). Thus the cutaneous CD4:CD8 ratio may be 
increased following UV exposure. The time course of the T cell infiltration into the 
epidermis and dermis was UV dose -dependent. One explanation for the initial loss of 
cutaneous T cells may be phototoxicity. It has been shown that T cells are 
hypersensitive to UV compared with keratinocytes (Teunissen et al 1993), monocytes 
(Kremer et al 1995) or B cells (Deeg et al 1989). 
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1.8. UVB- induced immunological tolerance 
UV radiation results in an inability to respond at later times to haptens 
encountered through irradiated skin shortly after exposure. This occurs in UVB -S 
mice, whereas UVB -R strains can raise a significant CH response upon challenge. 
Similar traits have been correlated to skin cancers in humans. It has been revealed that 
92% of skin cancer patients fall into the UVB -S category (Yoshikawa et al 1990), and 
therefore UVB- induced suppression of CH may act as a risk factor /indicator for skin 
cancers. However it should be noted that the proportion of blacks with the UVB -S 
trait is similar to the proportion in Caucasians, despite black populations having a 
significantly lower incidence of skin cancer (Vermeer et al 1991). This may perhaps 
be attributed to the protective effects of melanin preventing significant DNA damage. 
Alongside the inability to respond to recall antigens, specific suppressor cells are 
generated. These can be demonstrated by adoptive transfer experiments, involving 
transfer of spleen cells from irradiated, immunised mice to naive recipients. Recipients 
fail to respond to the hapten upon challenge despite never having encountered it 
themselves. 
1.9. UV and NK cells 
Natural killer (NK) cells are non MHC- restricted cytotoxic cells which are part of 
the innate immune system, important in the recognition and lysis of both 
virally- infected cells and tumour cells (Trinchieri, 1989). There is an inverse 
correlation between the expression of surface MHC class I molecules on target cells 
and their susceptibility to NK cell- mediated lysis (Kane, 1992). NK cells also play a 
role in the directing of immune responses via the release of cytokines such as IFN -y 
(Trinchieri et al 1984). 
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UVR causes a dose -dependent inhibition of NK cell activity (Weitzen and 
Bonavida, 1984; Toda et al 1986). In vitro exposure demonstrated that NK activity 
and lymphocyte proliferation, in response to mitogen, were inhibited to the same 
extent. Both effects were suppressed maximally at 260 nm, consistent with nucleic 
acid acting as the main chromphore (Schater et al 1983), although there is also 
evidence for the involvement of UCA (Gilmour et al 1993a). The dose required for 
50% inhibition of NK cell activity at 300 nm was only 3 mJ /cm2, equivalent to about 
12 minutes of midday exposure to the sun in a temperate climate during summer. 
Although these experiments were conducted in vitro which would eliminate the 
absorptive properties of the skin, it is likely that environmental UV exposure might be 
sufficient to inhibit NK cell function (Weitzen and Bonavida, 1984; Schater et al 
1983). As UV penetration through skin layers, assessed by thymine dimer formation, 
shows a very small decline of 2.5% per cell layer at 300 nm (Chadwick et al 1995), at 
this wavelength the amount of radiation required to inhibit NK cell activity is within 
that reaching the dermis and capillaries. Also it has been calculated that, when the 
greater proportion of UVA in solar radiation and its greater penetration into the skin are 
taken into account, UVA may have an equivalent immunosuppressive effect as that of 
UVB on NK cell activity (Hersey et al 1993). 
In vivo studies utilising solarium exposure as a source of UV have concluded 
that NK cell function is reduced during the course of tanning (Hersey et al 1983). This 
suppression was particularly significant 2 weeks after the last treatment. Circulating 
NK cell numbers were also decreased, although the correlation between the numbers 
and function was not absolute. Measurement of NK cell activity after various UV 
therapies, used for the treatment of psoriasis, showed depression during and 4 weeks 
after the irradiation course (Gilmour et al 1993a). The precise timing and extent of the 
downregulation varied between the groups (PUVA, broadband UVB, narrowband 
UVB) and may be related to dose. No change in circulating NK cell numbers was 
reported (Gilmour et al 1993a). 
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UVR does not prevent NK cells recognising and binding to their target cells but 
acts at the apoptotic or lytic stage. NK cells, exposed to UVB in vitro, were induced 
to spontaneously release cytotoxic factors, detectable within 30 minutes of exposure 
(Weitzen and Bonavida, 1984). In agreement with this is the observation that 
superoxide dismutase (SOD), an antioxidant which scavenges superoxide anions, 
reversed the UV- induced suppression in NK cell activity (Toda et al 1986). IL -2 also 
reversed the suppression and acted synergistically with SOD. Thus UV may induce 
NK cells to produce reactive oxygen species, resulting in a less efficient killing of 
target cells. 
In association with a decrease in NK cell activity, a similar decrease in 
NK- associated cytokines might be expected as a result of UVR. As NK cells are a 
potent, although not the only source of IFN -' (Hosoi et al 1993), UV could bias the 
systemic immune system away from cellular immune responses. Induction of 
suppressive monocytic /macrophagic cells, T cells and their related cytokines, as well 
as prostaglandin release, could then play a role in exacerbating the downregulation in 
NK cell activity. 
1.10. UVR and its effects on cytokine production 
1.10.1. Interleukin (IL) -1 
IL -1 is a proinflammatory cytokine synthesised in 2 isoforms (IL-la and IL-1p) 
encoded by different genes (D'Eustachio et al 1987). IL -1 can stimulate prostaglandin 
synthesis by many cell types (Pentland and Mahoney, 1990), and is a significant 
mediator in induction of fever (Long et al 1990) and acute inflammatory responses 
(McIntyre et al 1991). 
IL -1ß plays a vital role in CH responses. Shornick and colleagues engineered an 
1L-lß deficient mouse, and used these mice to demonstrate the importance of IL-lß in 
contact sensitisation. Sensitisation of wild -type mice with a range of concentrations of 
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TNCB led to a dose -dependent swelling of the footpad upon challenge, which was 
maximal when a sensitising concentration of 0.1% TNCB was used. No footpad 
swelling could be measured in IL-113 deficient mice upon challenge, following 
sensitisation with this dose ( Shornick et al 1996), and a concentration of 1% TNCB 
was needed to achieve a response equivalent to that induced by 0.1% TNCB wild -type 
mice. Injection of IL-113 into IL-10 deficient mice immediately before contact 
sensitisation resulted in a dose -dependent restoration of responsive to challenge. 
When DLNC from wild -type mice contact sensitised with 0.1% TNCB were incubated 
with haptenated spleen cells in vitro, antigen specific proliferation could be detected. 
When DLNC from IL-1p deficient mice contact sensitised with 0.1% TNCB were 
incubated with haptenated spleen cells, there was no antigen specific proliferation 
(Shornick et al 1996). 
Cumberbatch and colleagues have revealed that IL -113 is vital for initiating LC 
migration from the epidermis, and subsequent accumulation of DC within DLN. 
Intradermal injection with 50ng IL -113 led to LC migration, with a 15% reduction 
within 2h. DC numbers began to increase in DLN 4h after IL-113 injection 
(Cumberbatch et al 1997c). Intraperitoneal injection of anti -IL -113 antibodies resulted 
in a 61% inhibition of Ox- induced increases in DC within DLN. Anti-IL-1f3 could also 
inhibit LC migration from the epidermis and accumulation of DC induced by TNF -a 
injection. It was deduced that IL -113 acts in concert with TNF -a, as injection of mice 
with antibodies against TNF -a prevented the LC migration and accumulation of DC 
induced by IL-1f3 injection (Cumberbatch et al 1997a). 
Enk and Katz identified enhanced expression of TNF -a, IL -10, IL-la and even 
IL-113 mRNA, in epidermal cell suspensions prepared 4h after injection of 1L-113 in vivo 
(Enk et al 1993a). Supernatants of highly enriched cultured LC displayed IL -1 
activities. Cell mixing experiments to investigate the role of contaminating 
keratinocytes showed that IL -la was predominantly derived from keratinocytes. PCR 
revealed that IL-1[3 transcripts were limited to LC (Schreiber et al 1992). 
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Interestingly, induction of apoptosis of mononuclear phagocytes in vitro leads to 
a rapid release of IL-113 (Long et al 1990). Apoptosis is a known phenomenon 
following UVB irradiation of cells (Kitajima et al 1996; Aragane et al 1998; Schwarz et 
al 1995). IL -1 was shown to be present in the stratum corneum of normal human 
skin, but not in the basal layer. After UVB exposure, IL -1 appeared in the basal cell 
layer, and was increased in the more exterior regions (Oxholm et al 1988). Together 
with this increase in IL -1, IL -1 receptor antagonist (IL -lra) was increased markedly 
following 2 -3 MED of UV (Hirao et al 1996). IL -lra is reportedly induced during 
keratinocyte differentiation, a known effect of UVR or sun -exposure (Matsui et al 
1996). The ratio of IL- lra:IL -la in sun -exposed skin was over 100, an excess 
sufficient to block IL-la-induced biological responses (Hirao et al 1996). In 
unexposed skin, the ratio was around 8, which is too low to block activity. Therefore, 
although UV stimulates an increase in IL -1 levels, with the concomitantly greater rise 
in IL -lra, UV may actually inhibit the activities of IL -la and suppress an inflammatory 
response. The adhesion molecule VCAM -1 is known to be upregulated on endothelial 
cells by IL -1, but is unaltered by UV- exposure (Norris et at 1991). 
1.10.2. Interleukin (IL) -6 
IL -1 is a potent inducer of IL -6, a cytokine which is detectable in serum 1 -3 
hours after 2 -4 MED whole -body UV- exposure of human subjects (Kirnbauer et at 
1989; Urbanski et al 1990). IL -6 has a wide range of effects, including fever 
induction and the synthesis of acute phase proteins. Like IL -1, it is known to be 
produced by keratinocytes and LC. Although initially regarded as a pro -inflammatory 
cytokine, recent evidence suggests a significant anti -inflammatory, and even an 
immunomodulatory, role for IL -6. It can elicit the release of adrenocorticotropic 
hormone from the central nervous system, increasing synthesis of glucocorticoids in 
the adrenal gland (Tilg et at 1997). In turn, these suppress IL -1 and TNF -a synthesis. 
It is also suggested that IL -6 induces the soluble form of the TNF receptor, p55 (Tilg 
44 
et al 1997). Elevations in IL -6 correlate well with UV- induced fever courses, and 
precede increases in acute phase proteins, such as C- reactive protein (Urbanski et al 
1990). IL -6 induced C- reactive protein promotes synthesis of 5 -10 fold greater 
quantities of IL -lra compared with IL -113 from peripheral blood mononuclear cells 
(Tilg et al 1997). Antibodies to IL -6 inhibit this in a dose -dependent manner. 
Irradiation of long -term cultured epidermal cells shows that IL -6 production is 
attributable to UVB wavelengths, with UVA having no effect (Kirnbauer et al 1989). 
Whether IL -6 production is mediated directly by UVB, and/or via IL -1 or other 
mediators in vivo is unresolved. 
1.10.3. Interleukin (IL) -10 
One of the major immunoregulatory cytokines involved in the balance of an 
immune response is IL -10. This was first recognised in murine Th2 -cell lines, and has 
been shown to have an inhibitory effect on Thl -like cells (Fiorentino et al 1992). By 
inhibiting the growth and cytokine production of Thl -like cells, IL -10 promotes a 
Th2 -like cytokine profile within localised areas. IL -10 is produced by many cell types, 
including T lymphocytes, of both helper (Ullrich, 1995) and cytotoxic (Romagnani, 
1997) subsets, monocyte /macrophages (Kang et al 1994), B cells, mast cells, 
keratinocytes (Ullrich, 1994) and melanocytes (Teunissen et al 1997). 
IL -10 in delayed type and contact hypersensitivities 
Intraperitoneal injection of IL -10 blocks both phases of DTH. Similarly, the 
effector phase of CH can be blocked by IL -10, although IL -10 injection does not block 
the induction phase of CH (Schwarz et al 1994). Blocking of the effector phase of CH 
by IL -10 is not dose -dependent, and only occurs if IL -10 is administered at least 12h 
before hapten challenge, implying indirect activity of IL -10 on other mediators. 
Sensitisation with contact allergens induces IL -10 mRNA in murine epidermal cells, 
detectable at 4h and maximal by 12h (Enk and Katz, 1992b). This quickly diminishes 
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to 50% by 18h, and background levels at 24h, after painting (Ferguson et al 1994). 
IL -10 injection decreases the inflammatory cell infiltrate, and decreases edema at the 
dermis compared to mice with a normal CH response (Kondo et al 1994). IL -10 
application also suppresses the IFN -y mRNA upregulation normally seen in CH 
(Kondo et al 1994). IL -10 gene targeted mice (IL -10T) mice mount an exaggerated 
CH response, increased in both magnitude and duration of response (Berg et al 1995). 
Ear swelling was maintained 4 days after challenge in IL-10T mice, and epidermal 
pustules were larger and more frequent than in WT mice. In many areas these pustules 
became confluent and formed serocellular crusts on the surface of IL-10T mouse ears. 
These results clearly implicate IL -10 in control of CH responses within the skin. 
Normal mice exhibit suppressed DTH responses after UVB- irradiation, whereas 
in IL -10T mice, a full DTH response is restored (Teunissen et al 1994). Investigation 
of serum from irradiated wild -type mice shows an IL -10 peak 4 days after a single 
UVB- exposure, coinciding with optimum immunosuppression. Evidence for the 
downregulatory role of IL -10 in DTH is provided by intraperitoneal injection of the 
cytokine prior to either the sensitisation or elicitation phase. Injection leads to blocking 
of both events (Schwarz et al 1994). 
The primary source of IL -10 following UVB -irradiation is yet to be determined, 
although many cell types have been suggested. Potential candidates include 
keratinocytes and melanocytes, which are located in the epidermis, and infiltrating 
monocytic /macrophagic cells, which are induced following UVB- exposure. Other 
candidates may be Th2 -like cells, primed in draining lymph nodes by LC migrating 
from UVB -irradiated skin. 
IL -10 effects on antigen presentation 
IL -10 does not act directly on Thl -like cells to inhibit their activity (Enk et al 
1993b; de Waal Malefyt et al 1992). Pretreating LC with IL -10 causes loss of antigen 
presenting function for Thl -like cells, failing to promote proliferation and inducing 
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clonal anergy (Enk et al 1993b). IL -2 and IFN -y mRNA levels are decreased to 
around 50% that of untreated cells. Antigen presentation for Th2 cells is unaffected. 
If cells are cultured for 2 -4 days prior to treatment with IL -10, inhibition is reduced. 
This suggests that IL -10 affects maturation of one or more of the costimulatory 
molecules expressed on cultured LC, but not on freshly isolated cells (Enk et al 
1993b). The effect is not on class II MHC expression or cell viability. B7 mRNA 
levels are normally upregulated on cultured LC, but remain constant after IL -10 
pretreatment. Lack of B7 expression is associated with clonal anergy (Gimmi et al 
1993). 
When macrophages are used as APC, the Thl/Th2 balance is similarly affected. 
However, these effects are mediated by different mechanisms. Upon culture with 
IL -10, macrophage HLA -DR/DP and HLA -DQ expression is strongly downregulated, 
and the upregulation usually induced by IFN -y and/or IL -4 is inhibited. IL -10 alters 
macrophage appearance in culture, causing rounding -up and decreased adherence. 
This could prevent further antigen presentation, and possibly act as a migratory trigger 
in vivo (Ferguson et al 1994). IL -10 also has an autoregulatory role on macrophages, 
downregulating its own mRNA expression. Whilst suppressing production of 
inflammatory cytokines, it enhances production of the anti -inflammatory IL -1 receptor 
antagonist (IL- lra). 
The antigen -presenting capacity of B cells is upregulated by IL -10, with an 
increase in class II MHC expresion (Enk et al 1993b). Splenic B cells do not inhibit 
Thl -like cell proliferation (de Waal Malefyt et al 1992). IL -10 also acts as a B cell 
growth factor (Enk et al 1993b). The significance of this in relation to UV- induced 
immunosuppression may be minimal however, as the skin is relatively deficient in 
B cells. IL -10 can be found in sera after UV exposure, but only with doses over 10 
MED (Beissert et al 1996; Rivas and Ullrich, 1994). 
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IL -10 and UVB- induced immunosuppression 
With the apparent deviation toward a Th2 -like cytokine response following UVB 
exposure, it is natural to hypothesise a central role for IL -10 in UVB- induced 
immunosuppression. IL -10 exhibits antagonistic effects towards IFN -7, inducing 
downregulation of MHC class II expression, and therefore antigen presentation, on 
macrophages (Moore et al 1993). It suppresses cytokine synthesis when Thl T cell 
clones, or NK cells, are activated by IL -2 and accessory cells in an antigen non- 
specific manner. Furthermore, whilst downregulating inflammatory cytokines 
(Howard and O'Garra, 1992), IL -10 can upregulate IL -lra expression and secretion 
(Cassatella et al 1994). IL -10 could thereby play a key role in the production of 
"split- tolerance ". 
There is strong evidence for a role for IL -10 mediating immune suppression in 
the mouse following UVB exposure, especially for the participation of 
keratinocyte -derived IL -10 (Rivas and Ullrich, 1994). Human studies present a less 
clear picture, with some groups finding both keratinocyte -derived IL -10 mRNA and 
secreted protein (Enk and Katz, 1992b; Grewe et al 1995), some finding mRNA 
without protein secretion (Kang et al 1994), and others finding neither mRNA (Ried et 
al 1994; Teunissen et al 1994) nor protein (Teunissen et al 1997; Jackson et al 1996). 
After exposure of small areas of human skin sites to 3 MED UVB or UVAl, 
Skov et al found that IL -10 protein was slightly increased in suction blister fluid taken 
24 hours later. This increase is only significant following UVB irradiation (Skov et al 
1998a). Kang et al (1994) argue that IL -10 within UV- exposed human skin is secreted 
from infiltrating CD11b+ macrophages rather than resident CD1 lb- keratinocytes. LC 
and UV- induced macrophages respond differently to inflammatory stimuli (Shibaki et 
al 1995). The infiltrating macrophages preferentially activate suppressor CD4+ T cells 
(Shibaki et al 1995), and secrete high levels of IL -10. UV- induced macrophages could 
thereby favour development of Th2 -like suppressor cells. Although keratinocytes 
synthesize small amounts of IL -10 mRNA, the protein may remain inside the cells. 
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Teunissen et al (1997) performed exhaustive studies on normal human keratinocytes 
from 40 donors and were unable to detect any IL -10 mRNA or protein following UVB 
irradiation. Examination of two human cell lines (A341, HaCaT) gave similar results. 
IL -10 mRNA within melanocytes was detected, without protein secretion. Therefore 
the positive findings from other groups (Enk and Katz, 1992b; Grewe et al 1995) may 
be due to melanocyte contamination. Teunissen and colleagues (1997) also performed 
whole body irradiations (1.5 MED), and were unable to detect alterations in serum 
IL-10 levels outwith the 24 hour biphasic temporal pattern of controls. It is difficult to 
reconcile this result with a major role for macrophage -derived IL -10 in systemic 
immunosuppression in human subjects. 
Potential sources of IL -10 after UV exposure 
Keratinocytes - IL -10 production by human keratinocytes is currently a 
contentious issue (Jackson et al 1996; Grewe et al 1996). Ried et al (1994) could not 
detect IL -10 gene expression in human keratinocytes, and could not induce expression 
with various stimuli (IL -113, IL -6, IL -8, TNFa, IFN -y, TPA, retinoic acid, osmotic 
stress or UV- radiation). However, IL -10 mRNA is detectable in the epidermis in 
human Th2 -like skin diseases, such as Sezary Syndrome, and following tape- stripping 
(Nickoloff et al 1994). IL -10 was predominantly identified throughout all levels of the 
epidermis, within the cytoplasm of keratinocytes, with accentuation on their 
membranes in upper level cells. IL -10 cannot be seen in keratinocytes of normal or 
psoriatic (Thl -like) skin (Nickoloff et al 1994). 
IL -10 production by murine keratinocytes is generally accepted. Depletion 
studies have shown keratinocytes to be the main source of IL -10 mRNA after 
sensitisation with contact allergens (Enk and Katz, 1992b). The murine keratinocyte 
cell -line, PAM -212, constitutively expresses IL -10 mRNA, with increased protein 
secretion upon stimulation (Teunissen et al 1997). In keratinocyte cultures derived 
from BALB /c, C57B1/6, and Swiss mice, IL -10 is detectable by ELISA. Upregulation 
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of IL -10 mRNA in keratinocytes has also been shown to occur late in the induction 
phase of murine CH (Enk and Katz, 1995), again suggesting an immunomodulatory 
role. 
Melanocytes - Teunissen et al (1997) argue that IL -10 mRNA found within 
human epidermal cell preparations is due to contamination by melanocytes. Using 
limiting dilutions to obtain pure cultures of keratinocytes (identified as cytokeratin 
positive) and melanocytes (NKI -beteb positive), followed by RNA extraction at 24h or 
48h after phorbol myristate acid (PMA), IFN -y or UVB stimulation, IL -10 mRNA 
was only detectable in melanocyte cultures. This was not translated to detectable levels 
of protein however. 
Monocyte /macrophages - One of the major events in a DTH or CH response is 
induction of a cellular infiltrate into the responsive area. This infiltration also occurs 
24 -48h after UVB- exposure. When epidermal cells are separated on the basis of 
CD1 lb expression, macrophages (CD1 1b+), induced to infiltrate by UVB, have 
reproducibly 200 -400 fold higher IL -10 mRNA content relative to keratinocytes 
(CD1 lb-) (Kang et al 1994). Production and secretion of IL -10 protein is undetectable 
until 48h after irradiation, and is closely related to macrophage infiltration. Flow 
cytometric analysis of the macrophage population shows 19% have a greater capacity 
to retain cell -associated IL -10, and these may be representative of a highly activated 
subpopulation. Human monocytes are strong producers of IL -10, dependent upon the 
stimuli (de Waal Malefyt et al 1992). 
T cells - After UVB -irradiation the ratio of CD4 +CD8+ cells within the skin is 
increased. This occurs after a delay of around 2 days, at which point migration of 
CD4+ T cells into the site is detectable. As IL -10 is inhibitory towards APC function 
for Thl -like cells , but not Th2 -like cells (Ferguson et al 1994), a positive feedback 
loop may be established in irradiated skin whereby IL -10 causes an increase in 
50 
Th2 -like cells, and further generation of IL -10. 
1.10.4. Interleukin (IL) -12 
IL -12 is implicated in polarisation of immune responses towards a Thl -like 
cytokine response (Trinchieri, 1994; Openshaw et al 1995), by inducing IFN -y 
production (Gately et al 1991) and by enhancing NK and CTL reponses (Locksley, 
1993). IL -12 is formed by the covalent linkage of p35 and p40 subunits to produce a 
biologically active heterodimeric p70 molecule. The p40 subunit is produced in 10- to 
100- fold excess of p35, but evidence for increased secretion is lacking. When 
recombinant p40 was injected into mice, an antagonist activity was observed (Mattner 
et al 1993), and a recently produced IL -12 p40 transgenic mouse (in which circulating 
p40 is detectable) has diminished type 1 cytokine responses (Yoshimoto et al 1998). 
The primary sources of IL -12 are APC such as monocytes, macrophages, 
neutrophils, DC and B cells (Trinchieri, 1993). IL -12 leads to IFN -y production, 
which in turn potentiates APC functions and increases IL -12 production by a positive 
feedback mechanism. The major biological activity of IL -12 is on NK and T cells 
(Locksley, 1993), increasing cytokine production, proliferation and cytotoxicity. 
IL -12 is regarded as the key cytokine in directing cell- mediated immune responses, via 
generation of Thl cells (Trinchieri, 1993). However, in p40 transgenic mice, DTH 
responses were suppressed and there was skewing towards Th2 -like cytokine profiles 
in response to antigen. IFN -y was decreased, whereas IL -4 and IL -10 were increased, 
versus control littermates (Yoshimoto et al 1998). 
IL -12 is essential during the sensitisation and elicitation phases of CH. Injection 
of anti -IL -12 prior to sensitisation of mice with DNFB led to a suppressed response 
upon challenge, via generation of a tolerant state ( Riemann et al 1996). Anti -IL -12 
treatment before elicitation of CH to DNFB also leads to a suppressed inflammatory 
response ( Riemann et al 1996). 
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Regulation of IL -12 is central to UV- induced immunosuppression. There is 
evidence for this in mouse models. Administration of IL -12 4h after a single 15 kJ/m2 
dose of UVB blocked the suppression of DTH and CH observed in UV- irradiated 
mice, in a dose -dependent manner (Schmitt et al 1995). Intraperitoneal injection of 
IL -12 21h after the last of 4 daily, 1000 J /m2 UVB exposures also prevented 
suppression of CH upon elicitation (Schwarz et al 1996). Administration of IL -12 
prevented the induction of suppressor T cells in both series of experiments. Adoptive 
transfer of spleen cells from UV- irradiated mice treated with IL -12 had no effect on the 
immune response of recipient mice (Schmitt et al 1995; Schwarz et al 1996). Depletion 
studies identified CD8 +, rather than CD4 +, T cells, as the cells responsible for 
transferring suppression to recipient mice (Schwarz et al 1998). 
IL -12 p35 chain mRNA is expressed constitutively by human keratinocytes, and 
upon contact sensitisation, p40 mRNA is rapidly expressed (Muller et al 1994a). 
IL -12 protein is detectable in concentrated epidermal cell supernatants, and is readily 
detectable in keratinocyte cell line supernatants following stimulation with phorbol -12, 
13- dibutyrate (Aragane et al 1994). Anti -IL -12 treatment of haptenated human 
epidermal cells causes a 50% reduction in allogeneic T cell proliferation assays (Muller 
et al 1994a). UVB irradiation of human peripheral blood monocytes before using them 
in APC dependent T cell stimulation assays, resulted in a selective inhibition of antigen 
presentation to established human Thl clones (Kremer et al 1996). While proliferation 
and IFN -y production by Th 1 clones was inhibited in a dose -dependent manner, 
normal proliferative activity and cytokine production were maintained in Th2 clones. 
Perhaps most interestingly, while the proliferative responses of Th0 clones were 
normal, there was a preferential suppression of IFN -y production, skewing cytokine 
profiles towards those of Th2 clones (Kremer et al 1996). These studies indicate the 
way that resident dermal and/or infiltrating macrophages may behave at irradiated sites. 
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1.10.5. Interleukin (IL) -15 
IL -15 has the ability to stimulate growth of both CD4+ and CD8+ T cell subsets 
(Grabstein et al 1994), to generate lymphokine- activated killer cells (Burton et al 1994; 
Bamford et al 1994) and to act as a chemokine for T cells (Wilkinson and Liew, 1995). 
Conflicting data have been reported regarding IL -15 after UV exposure. 
Mohamadzadeh et al (1995) found that IL -15 mRNA was constitutively 
expressed in the human dermis, but was absent in the epidermis. Upon UV- exposure, 
IL -15 mRNA was enhanced in dermal sheets and induced in the epidermis. 
Expression was traced to HLA -DR- cells, predominantly keratinocytes, but not to 
HLA -DR+ cells, probably LC. Immunoblot analysis revealed that IL -15 protein 
secretion in cultured keratinocytes was enhanced by UVB. In contrast, Blauvelt et al 
(1996) detected constitutive IL -15 mRNA expression in freshly isolated human 
keratinocytes and LC, and this was downregulated by UVB exposure in a dose- and 
time -dependent manner. 
One important difference between the experimental protocols used by these 
groups is that Mohamadzadeh et al (1995) irradiated intact epidermal and dermal 
sheets, whereas Blauvelt and colleagues (1996) irradiated after segregation of cell 
types. Doses of 200 J /m2 UVB were found to be toxic in vitro, but gave optimal IL -15 
mRNA expression in situ. This may imply that IL -15 expression is under the control 
of other intercellular UV- inducible factors found within the skin, but which cannot act 
in culture. It should be noted that IL -15 mRNA appears to be regulated at 
post -transcriptional levels (Tagaya et al 1996), and is not necessarily related to protein 
secretion. 
Macrophages can also produce IL -15 (Carson et al 1994), and if recruited locally 
as a result of UV irradiation, could be another source of this cytokine. IL -15 could 
play an important role in regulating the local cytokine microenvironment at 
UV- exposed sites, aiding the outgrowth of suppressor T cells. 
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1.10.6. Interleukin (IL) -18 
IL -18 is one of the most recently discovered cytokines. As its original name, 
IFN -y inducing factor (IGIF) suggests, IL -18 is implicated in the bias of immune 
responses towards the Thl -like arm (Takeda et al 1998), promoting cell- mediated 
immune responses and facilitating CH. IL -18 stimulation results in increased IFN -y 
production by antigen -stimulated T cell lines, but has no effect on IL -4 or IL -10 
production, in both murine (Kohno et al 1997) and human (Micaleff et al 1996) 
systems. NK cell cytotoxicity is also enhanced (Micaleff et al 1996; Ushio et al 1996). 
Cellular sources of IL -18 include activated macrophages and Kupffer cells (Ushio et al 
1996), and murine keratinocytes (Stoll et al 1997). IL -18 mRNA is upregulated early 
in the response to contact allergens (Stoll et al 1997), implicating it in directing CH 
development. The findings that the human IL -18 amino acid sequence includes an 
IL -1 signature -like sequence (Kohno et al 1997), that the IL -113 converting enzyme 
(ICE) cleaves an IL -18 precursor (Gu et al 1997), and that IL -18 signals through IL -1 
receptor -associated kinase (IRAK) (Robinson et at 1997), suggest that IL -18 is under 
similar control to 1L-113 and may have expression resembling that of IL -113. Whilst 
IL -18 enhances T cell proliferation, this can be blocked by treatment with neutralising 
anti -IL -2 monoclonal antibodies (at least at low IL -18 concentrations (Micaleff et al 
1996)), so that its activity may be sensitive to changes in both IL -2 and IL -2Ra 
(CD25) expression. The upregulation of CD25 mRNA in CD4+ T cells is not induced 
by irradiated epidermal cells (Stevens et al 1995). 
1.10.7. Tumour necrosis factor (TNF) -a 
TNF -a is a trimeric, pro -inflammatory cytokine. The TNF -a gene is 
polymorphic, containing 5 micro- satellite regions, induction is mostly mediated by a 
K3 binding site for NF -KB, and is also regulated at the transcriptional level, 
predominantly by a UA -rich sequence in the 3' -UTR, controlling mRNA turnover 
(Rink and Kirchner, 1996). Synthesis of TNF -a can be blocked by phosphodiesterase 
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inhibitors, corticosteroids, co -3 polyunsaturated fatty acids and IL -10 (Eigler et al 
1997). 
LPS treatment induces monocytes to produce many pro -inflammatory cytokines, 
including TNF -a. Monocytes then produce IL -10 8 -24h later, and this is dependent 
on TNF -a (Wanidworanun and Strober, 1993). IFN -y and/or IL -4 inhibit the TNF -a 
induced IL -10 increase in monocytes. 
Arguably the most important effects of TNF -a are on LC. TNF -a is needed to 
keep LC alive in culture, whereas without keratinocyte- derived cytokines the cells 
rapidly involute and die. TNF -a does not have any effects on the maturational state of 
the cells, and freshly isolated epidermal cells express TNF -a mRNA (Koch et al 
1990). Cumberbatch and colleagues showed that TNF -a is implicated in migration of 
LC from the epidermis and accumulation of DC within DLN. Intradermal injection of 
TNF -a resulted in a decrease in LC numbers in the epidermis (Cumberbatch et al 
1997a), and in a dose- and time -dependent accumulation of DC (Cumberbatch and 
Kimber, 1992). Furthermore, treatment of mice with antibodies to neutralise TNF -a 
inhibited the number of DC in DLN measured 18h after contact sensitisation with Ox 
or FITC (Cumberbatch and Kimber, 1995). The efficiency of skin sensitisation was 
similarly reduced, with impaired CH responses in anti -TNF -a treated mice compared 
to mice treated with control serum. These effects were only detected when TNF -a was 
inhibited at the time of sensitisation, as injection of anti -TNF -a 18h after contact 
sensitisation was without effect (Cumberbatch and Kimber, 1995). As mentioned in 
section 1.9.1, LC require signals from both IL -113 and TNF -a to initiate migration 
(Cumberbatch et al 1997a). Examining the kinetics and interaction of the two signals, 
it would appear that the TNF -a signal is secondary to IL -113 signalling (Cumberbatch et 
al 1997a; Kimber et al 1998). In experiments by Moodycliffe and colleagues, 
broad -band UVB induced accumulation DC within the DLN of irradiated mice, and 
suppressed the CH response to Ox. When mice were injected with neutralising 
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antibodies to TNF -a before irradiation, the accumulation of DC was abrogated and the 
CH response was restored (Moodycliffe et al 1994). 
Studies in mouse models suggest that susceptibility to UVB- induced 
immunosuppression is partly controlled by the Tnf locus (Yoshikawa and Streilein, 
1990). Induction of TNF -a could lead to altered, or diminished, antigen presentation, 
via LC depletion from the epidermis. Injection of anti -TNF -a can block the 
UV- induced suppression of CH responses, but has no effect on DTH responses to 
spleen cells (Rivas and Ullrich, 1994). 
TNF -a is strongly implicated in the inflammatory response to UVB- exposure. 
Skov et al (1998a) found that irradiating human skin with 3 MED of UVB led to a 
rapid increase in TNF -a protein in suction blister fluid, which was maximal at 6 hours 
following exposure. Interestingly, exposure to 3 MED UVA1 (340 -400 nm) resulted 
in a slight decrease in TNF -a at 6 hours (Skov et al 1998a). 
Conflicting data have been reported on the role of UVB- induced TNF -a in the 
upregulation of E- selectin. Strickland et al (1997) found E- selectin expression on 
dermal blood vessels proximal to the exposed site by 4 hours, before TNF -a could be 
detected. Walsh (Walsh, 1995) studied the "sunburn" response, finding that mast cells 
degranulated upon exposure to 3 MED, releasing stores of intracellular TNF -a, which 
in turn led to E- selectin and ICAM -1 expression on cutaneous endothelium by 2 hours. 
Keratinocytes contributed minimally to this effect, which could be blocked with the 
mast cell inhibitor, disodium cromoglycate (Walsh, 1995). TNF -a is further 
implicated in sunburn cell formation by in vitro studies, as antibodies against TNF -a 
reduced UV- induced apoptosis in human keratinocytes, although not completely 
(Schwarz et al 1995). 
UVB exposure (200 J /m2) stimulated a similar quantity of TNF -a from cultured 
human dermal fibroblasts as IL -la. However, the two treatments synergised to give a 
30 -40 fold increase in TNF -a, mirrored by mRNA expression (Fujisawa et al 1997). 
As UVB is capable of inducing IL -la directly, and as incident UVB can penetrate to 
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the dermis, a TNF -a cascade could be initiated in this site (Fujisawa et al 1997). In 
vitro studies using a human keratinocyte cell line showed that blockade of IL -la 
activities with monoclonal antibodies also resulted in a partial inhibition of TNF -a 
release, supporting an autocrine role for IL -la in TNF -a release (Corsini et al 1995). 
Antioxidants have a similar effect in inducing TNF -a secretion (Corsini et al 1995). 
DNA damage is implicated in TNF -a gene expression following UVB- exposure 
(Kitibel et al 1998). Cis -UCA, even above physiological levels, could not augment 
phorbol 12- myristate 13- acetate (TPA) induced synthesis of either TNF -a mRNA or 
protein in keratinocytes (Redondo et al 1996). Interestingly, UVB mimicks the TNF -a 
induced modulation of the p55 TNF surface receptor on keratinocytes, and mRNA 
expression, via a TNF -a mediated autocrine regulatory pathway (Trefzer et al 1993). 
1.11. UV and skin cancer 
Skin cancers are commonly divided into 3 distinct categories; basal cell 
carcinoma, squamous cell carcinoma and malignant melanoma. Although the first 2 
have a low mortality rate, they are important conditions due to the resultant morbidity 
and cosmetic deformities, and represent 90% of all skin cancers. In addition, a study 
of non -melanoma skin cancer incidence in the Glasgow area indicated that basal cell 
carcinomas are under -recorded by 31% and squamous cell carcinomas by 43% (Lucke 
et al 1997). Risk factors for basal cell carcinoma include increasing age, red/blonde 
hair and fair skin (Lin and Carter, 1986). Outdoor occupations and a family history 
are àlso implicated (Hogan et al 1989). There is an increased risk of a basal cell 
carcinoma patient developing squamous cell carcinoma (Karagas, 1994) and malignant 
melanoma. The link between these associations is thought to be UVR, as UV is 
regarded as a major etiological factor in these cancers. 
UVB appears to be the most important environmental factor in skin cancer 
pathogenesis (Streilein et al 1994a), and approximately 90% of the estimated 
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900,000 - 1,200,000 new cases of non -melanoma skin cancers (squamous and basal 
cell carcinoma) in the USA each year are attributed to it (Buckman et al 1998). There 
is a global trend of increasing skin cancer incidence. Currently, each year in Belgium 
there are 15- 20,000 basal cell or spinal cell epitheliomas being diagnosed (Autier, 
1998). The incidence of basal cell carcinoma increased 11% between 1985 and 1990 
in Australia (Marks, 1995), with similar increases reported in Great Britain (Ko et al 
1994) and The Netherlands (Coebergh et al 1991). Estimates suggest that for every 
2.5% decrease in ozone levels, such as that seen over Northern hemisphere 
mid -latitudes, human skin cancer rates will increase by 10 %. 
The 1985 Vienna Convention introduced a framework for international 
restrictions on use of ozone depleting substances. Estimates of the effectiveness of 
these measures have been calculated. Extrapolating to the year 2100 using a 'no 
restrictions' scenario or the Montreal Protocol scenario, large increases in skin cancer 
incidence are predicted (4- and 2 -fold respectively). Under the stricter Copenhagen 
Amendments, in which ozone reaches its minimum levels in 2000, increases in skin 
cancer incidence are predicted to reach a peak 60 years later of 10% (Slaper et al 1996). 
The United States Environmental Protection Agency (EPA) report that cutaneous 
malignant melanoma already has one of the fastest growing incidence rates of all 
cancers in the USA, with case numbers doubling over the last 20 years (Streilein et al 
1994a). NASA studies in Puerto Rico have shown that, calculating from their lowest 
values in 1978 and 1991, the age- adjusted incidence of melanoma has increased 528% 
and 200% in males and females respectively in 13 years (Matta et al 1998). Studies on 
the Norwegian population show that holidays abroad are now having a detectable 
effect on melanoma incidence (Bentham and Aase, 1996). In Canada, predictions are 
that melanoma will become a much larger burden on its health care system in the early 
part of the 21st century (MacNeill et al 1995). 
Experiments by Kripke and colleagues in the 1970s demonstrated that 
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UVB- induced skin tumours are highly immunogenic when transplanted into syngeneic 
mice (Fisher and Kripke, 1977; Kripke et al 1979). When the same tumours were 
transplanted into UVB -irradiated mice there was no rejection, and this indicated that 
UVB must induce some form of immunomodulation to prevent tumour rejection. 
Daily irradiation with UVR filtered beneath 315 nm (2.5 x 105 J /m2) induced 
murine tumours with 50% probability of tumour development (T50) after 68 weeks of 
irradiation. Tumours included SCC, poorly differrentiated (spindle cell) tumours and 
benign papillomas. Irradiation with UVA/B (FS40, 2.394 x 104 J /m2) 3 times per 
week resulted in a T50 of 23 weeks. This shows that UVA is carcinogenic in haired 
mice, although less so than UVB (Strickland, 1986). 
As mentioned in section 1.7, when human subjects with a history of skin 
cancer are assessed for immune function following UVB, the vast majority show 
depressed CH responses to DNCB, with half of these appearing to be tolerant to 
rechallenge at unirradiated sites (Yoshikawa et al 1990). Therefore, humans can be 
classified as UVB -susceptible (UVB -S) or UVB- resistant (UVB -R). These putative 
traits have been linked to the Tnfa and Lps loci in mice (Yoshikawa and Streilein, 
1990; Streilein and Bergstresser, 1988). This has recently been narrowed to withina 
190kb region on the Bat5 and H -2D segment of mouse chromosome 17 
(Handel- Fernandez et al 1999). The UVB -S trait applies to 30 -40% of the Caucasian 
population, but increases to over 90% in skin cancer patients, indicating UVB -S may 
be a risk factor for skin cancer (Yoshikawa et al 1990). Intriguingly, blacks, who 
have a far lower incidence of skin cancer, also carry the UVB -S trait at a frequency of 
around 40% (Vermeer et al 1991). 
1.12. Other human diseases 
The eyes are dramatically affected by over -exposure to UV. Ocular damage from 
UV exposure includes effects on the cornea, lens, iris, and associated epithelial and 
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conjunctival tissues (Longstreth et al 1998). Photokeratosis, also known as 
snowblindness, is common in outdoor recreationists. There is significant evidence 
suggesting a correlation between UV exposure and conjunctival pterygium, climatic 
droplet keratopathy and cataracts (Bergmanson and Sheldon, 1997), and it is likely that 
ocular melanoma and other cornea/conjunctival condtions (eg. pinguecula) will 
increase as ozone decreases. Recent quantitative risk assessments developed for 
cataract idicate that, under the Montreal Adjustments, cataract incidence will peak at 
just under 3 new cases per 100,000 (Longstreth et al 1998). 
Many mouse models indicate that UVB can alter immune responses to viruses, 
bacteria and parasites (reviewed in (Halliday and Norval, 1997). For ethical and 
pratical reasons, less is known about UV- mediated effects on human diseases. 
With the effect of UV on T helper cell subsets, exposure could have important 
consequences in T cell mediated diseases in humans. UVB could be of particular 
relevence in human immunodeficiency virus (HIV) patients, where sunlight could 
accelerate acquired immunodeficiency syndrome (AIDS) progression (Vincek, 1995; 
Wallace and Lasker, 1992). UV could act by facilitating viral replication and 
accumulation of stable mRNA (Valerie et al 1988), and/or by inducing a Thl to Th2 
switch, a factor implicated in disease exacerbation (Clerici and Shearer, 1993). 
In herpes simplex virus (HSV), one of the factors inducing recrudescence and 
the appearance of cold -sores is exposure to sunlight. HSV- specific 
lymphoproliferation was markedly reduced (39.8- 93.8 %) 3 days after whole -body, 1 
MED exposure, and remained suppressed for at least a further week (Miura et al 
1994). This was associated with increased levels of TGF -ß (IL -10 was unaltered), 
secondary to IL -6 induction, in HSV -stimulated peripheral blood leukocyte cultures. 
The association between UVB- induced immune dysregulation and development of 
recurrent HSV lesions was incomplete, implying that UVB contributes to, but is not 
directly responsible for, HSV reactivation. 
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The immune response to intracellular bacteria could also be altered by UVB. In 
experiments using the lepromin reaction, a cell- mediated immune response to antigens 
of Mycobacterium leprae, 27 of 29 cases showed a reduced reaction in locally 
irradiated sites, by at least 20 %. Irradiation decreased lymphocyte infiltration, 
particularly CD4+ T cells, in and around the induced granuloma (Cestari et al 1995). 
As the granulomatous response limits or suppresses infection, it thus follows that 
UVB could exacerbate the clinical situation. 
Damian and colleagues investigated the effect of UV exposure on the DTH 
response to tuberculin protein purified derivative in Mantoux test positive volunteers. 
The Mantoux induced erythema was suppressed in skin irradiated with solar simulated 
radiation, but not in unirradiated sites (Damian et al 1998). Interestingly, when 
individuals were chronically irradiated over 4 -5 weeks, the suppression, although 
significant, was not as large as that achieved by a short course of UV exposure. 
Erythemagenic UVR is also toxic in the autoimmune disease systemic lupus 
erythematosus (SLE) (McGrath et al 1994; Dov Golan et al 1992). This phenomenon 
may be due to further suppression of already reduced cell- mediated immunity 
(Horwitz, 1972). Tissue damage occurs, and may be due to TNF -a production. 
Suppression of NK cells and perturbed regulation of immunoglobulin production 
could also exacerbate the disease. Enhanced binding of autoantibodies to the cell 
membrane of UV- irradiated keratinocytes may perpetuate tissue damage (Dov Golan et 
al 1992). 
1.13. Sunscreens 
As sunscreens prevent classical sunburn ie. erythema, it would be anticipated 
that they would also protect against UV- induced immunosuppression. The easiest way 
to reduce UCA photoisomerisation is to decrease the intensity of incident light, and the 
rate of cis -UCA formation is reduced by topical application of sunscreens (Krien and 
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Moyal, 1994). This is limited to broad -spectrum (ie. filtering out both UVB and 
UVA), highly protective sunscreens however. Cis -UCA formation is inversely related 
to the SPF, with protection against isomerisation exceeding the SPF values by a factor 
of greater than 10. After multiple exposures the protective effect of classical UVB 
filters is lost, with only those blocking both UVA and UVB retaining activity against 
photoisomerisation (Krien and Moyal, 1994). Thus, sunscreens which prevent 
sunburn may protect against at least one mechanism (cis -UCA) of 
immunosuppression, with the degree of protection determined by the nature of the 
sunscreen. 
Attempts to develop systems to assess the immune protection factor of 
sunscreens, in comparison with their SPF have resulted in much discussion 
(Davenport et al 1998; Gasparro, 1998; Wolf and Kripke, 1998; Chu et al 1998). 
Davenport et al.used breast tissue explants as a source of epidermal cells for use in 
MECLR experiments, finding that the reduction in the elicited response was prevented 
by application of various sunscreens (Davenport et al 1998). The degree of protection 
is debatable, and may not exceed the SPF (Wolf and Kripke, 1998). 
Application of a high protection sunscreen (SPF 29) was found to prevent the 
UVB- induced suppression of both the primary allergic reaction, and CH elicitation, to 
DNCB (Whitmore and Morison, 1995). Broad -spectrum sunscreens stopped the 
immunosuppression of CH to a recall antigen (nickel) when applied before solar - 
simulated irradiation (suberythemal, once a day for five days). There was only a slight 
protective effect afforded by a narrow -band sunscreen (Damian et al 1997). 
Application of sunscreens prevented infiltration of CD36+ macrophages into 
irradiated sites when an erythemagenic, 4 day UVB exposure protocol was used 
(Hurks et al 1997). The influx of these cells is closely correlated with modulation of 
MECLR responses. However, when a suberythemagenic, 4 week protocol was 
employed, suppression of MECLR was not altered by sunscreen application (Hurks et 
al 1997). 
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Multiple, low -dose exposures to UV in solariums decreased both NK cell 
function and numbers (Hersey et al 1983), a phenomenon which was not prevented by 
sunscreen application (Hersey et al 1987). The sunscreens used in these studies did 
not block UVA- wavelengths. Other immunologic properties, such as immunoglobulin 
production, measured in pokeweed mitogen- stimulated cultures of B and T cells, and 
DTH, remained depressed (Hersey et al 1987). A decrease in the circulating CD4:CD8 
ratio, with a rise in percentage of CD8+ cells still occurred. 
As prevention of UV- induced immunosuppression appears dependent on the 
nature of the sunscreens, caution regarding their use must exercised. Protection 
against visible damage such as erythema could encourage longer exposure, unwittingly 
enhancing damage to the immune system. Behaviour regarding sunscreen application 
is also vitally important. Physical sunscreens are more difficult to apply than chemical 
sunscreens, with the result that often less is applied (Diffey and Grice, 1997). Studies 
show both types of sunscreen are commonly used at volumes below those at which the 
commercial SPF is calculated (Stenberg and Larko, 1985; Diffey and Grice, 1997). 
1.14. Diet 
Various food components, including flavonoids (Middleton and Kandaswami, 
1992), green tea polyphenols, silymarin, and pyridoxine, can influence the immune 
system, and when they are either fed or topically applied to irradiated mice, skin cancer 
incidence (Birt et al 1997; Gensler et al 1996), pyridimine dimer formation (Chatterjee 
et al 1996), and immune suppression (Reeve et al 1995; Katiyar et al 1995) are 
reduced. Pyridoxine- supplemented feed also reduces the suppression of CH after 
cis -UCA painting in mice (Reeve et al 1995). 
There is more circumstantial evidence for the influence of dietary components in 
UV- induced immunosuppression in humans. Melanoma patients have decreased levels 
of selenium in their sera, compared with healthy individuals (Reinhold et al 1989). 
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Selenium is important in inducing free radical scavenging systems, and it is postulated 
that decreased levels increase susceptibility to various cancers (Clark, 1985). Topical 
L- selenomethionine application leads to an increased MED (Burke et al 1992). 
Rafferty et al (1998) have shown recently that sodium selenite and selenomethionine 
supplementation protect human keratinocytes and melanocytes in vitro from 
UVB- induced cell death. It has been hypothesised that an antioxidant -rich diet will 
protect against UV- induced free radical formation within the skin and subsequent cell 
membrane damage. During the course of a 3 -6 months diet including fish -oil 
supplements, rich in w -3 fatty acids, the MED rose progressively for each volunteer, 
but decreased within 10 weeks of termination (Rhodes et al 1994). The total fatty acid 
content within the epidermis rose from 1.8% to 24.2 %, and was accompanied by 
thiobarbituric acid reactive substances (TBARS), indicating lipid peroxidation in 
irradiated skin. Thus, w -3 fatty acids decrease UVB- erythemal sensitivity but increase 
susceptibility of the skin to lipid peroxidation (Rhodes et al 1994). In another fish -oil 
supplementation study, MED was again shown to increase, with a concomitant 
decrease in PGE2 levels (Rhodes et al 1995). Reduced PGE2 may be due to w -3 fatty 
acid interference at more than one step. The w-3 fatty acids may compete with the 
more common w-6 fatty acids for metabolism of cyclo -oxygenase, or for release from 
cell membranes by phospholipases. It is also suggested that w-3 fatty acids can act as 
an oxidisable buffer, reducing free radical damage to more essential structures. 
Another anti -oxidant, vitamin E, offers partial protection against the 
UVA- induced decrease in the ability of human LC to present antigen (Clement- Lacroix 
et al 1996). These data imply, but do not confirm, a role for oxidative stress in the 
immunosuppressive effects of UVA. 
In one single -diet study, it was found that f3-carotene prevented UV- induced 
suppression of DTH (measured by a Multitest CMI kit, incorporating seven different 
test antigens), after 10 weeks compared to that in volunteers fed a placebo diet (Fuller 
et al 1992). 
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The following chapters will detail UV mediated effects on a variety of immune 
parameters. Firstly, the suppression of CH responses by UVB will be examined. 
Alterations induced within DLN of irradiated mice during both contact sensitisation and 
elicitation of CH will be addressed. The effects of UV radiation on LC within the 
epidermis, and subsequent changes in DC frequency within DLN will be reported. 
Finally, the molecular signals involved in altering immune paramaters within the skin 




Materials and Methods 
2.1. General 
2.1.1 - Mice. 
Female C3H/HeN (H -2k) and BALB /c (H -2") mice aged 6 -10 weeks were 
obtained from the specific pathogen -free animal breeding facility at the Medical 
Microbiology Transgenic Unit, University of Edinburgh. Male mice were used for 
some PCR experiments. Mice were maintained in rooms with UV filtered lighting, 
and were age matched to within 2 weeks in individual experiments. 
2.1.2 - Growth medium and supplements. 
RPMI -1640 (Flow Laboratories, Irvine, UK) was supplemented with 100 
Iu/ml penicillin, 200 mg /ml streptomycin, 2 mM L- glutamine, 100 µg /m1 gentamicin, 
10 µg /ml fungizone, 25 mM HEPES buffer (Gibco BRL, Paisley, UK) and 10% 
heat -inactivated foetal calf serum (FCS; Gibco BRL), designated RPMI -FCS 
throughout. 
2.1.3 - Cells. 
PAM -212 (BALB /c strain mice- derived keratinocyte cell line (Yuspa et al 
1980)) and B 16 cells (C57B1/6 melanoma- derived (Kreider and Schmoyer, 1975)) 
(both obtained from Dr. R McKenzie, Department of Dermatology, University of 
Edinburgh) were cultured in RPMI -FCS. Vero cells for HSV assays were also 
cultured in RPMI -FCS. Cells were harvested using 0.1% trysin/ 0.04% versene 
solution. 
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Epidermal cells were prepared from mouse ears. Ears were collected and 
floated dorsal side down on 0.76% tetrasodium ethylenediamine tetraacetic acid 
(EDTA; Sigma) in PBS, pH 7.2 for 2 hours, at 37 °C. Ears were rinsed by passaging 
through PBS three times, and epidermal sheets removed with a scalpel blade. Single 
cell suspensions of were prepared by rubbing epidermal sheets through a steel gauze 
(J. Staniar and Co., Manchester, UK), before washing by centrifugation at 1000 rpm 
in RPMI -FCS. 
2.1.4 - UV sources and exposures. 
Mice were shaved on the back with electric clippers at least 24h before 
irradiating. Mice were irradiated under two Philips TL- 20W/12 bulbs with an output 
range of 270 -350 nm, peak 305 nm, emitting 80 mW /cm2 (see fig. 2.1; Philips, 
Eindhoven, The Netherlands). The output of this source was determined using a 
filtered photodiode meter, calibrated against measurements made with a UV- visible 
spectroradiometer (model 742, Optronic Laboratories) across the spectral range 
250- 400 nm (Dr. N Gibbs, Photobiology Unit, University of Dundee). The tube to 
target distance was 16 cm. Control mice were shaved and/or anaethetised where 
appropriate, but not irradiated. One MED for C31-1/HeN mice under these conditions 
was 1500 J /m2. 
For studies examining the effects of narrow -band UVB exposure, a single 
TL01 lamp (Philips) was used. This lamp emitted predominantly at 311 -312 nm, and 
the total irradiance was 200 µW /cm2 (see fig. 2.1). One MED for C3H/HeN mice was 
10,600 J /m2 of TL01. 
UVA1 exposure was from a Dr. Hoenle Bluelight lamp, emitting 38.5 W /m2 
(see fig. 2.1). Contaminating UVB was filtered out by shielding mice with a 1cm 
depth of cation X (provided by Dr. F de Gruijl, Utrecht) in distilled water, at a 
concentration of 0.1 mg /ml, in a perspex tray. Mice were anaethetised with 
67 
Hypnorm/Hypnovel in these experiments due to the length of exposure. One MED for 
C3H/HeN mice was 500,000 J /m2 of UVAl. 
2.1.5 - UV irradiation of cells. 
Cells were monolayered in flat -bottomed 24 -well plates (Iwaki, Japan) 
overnight, then rinsed with PBS. Cells were overlaid with 150 µl phenol -red free PBS 
and irradiated. PBS was removed and the cells incubated in a 1 ml volume of 
RPMI -FCS. 
2.1.6 - UV irradiation of mice. 
Mice were contained in a perspex box, with a maximum of four per irradiation 
to reduce sheltering by littermates. In experiments where ears were protected from 
UV- exposure, mice were shaved on the dorsum with electric clippers at least 24h 
before irradiating, and their heads covered with paper towels during irradiation. Due 
to the length of exposure needed for 500 kJ /m2 UVA1, mice were anaethetised by 
intraperitoneal injection of 150 µl sterile distilled water containing 1.67 mg /ml 
Hypnorm (Janssen Pharmaceutical, Oxford, UK) and 0.83 mg /ml Hypnovel (Roche, 
Welwyn Garden City, UK). Control mice for UVA1 experiments were anaethetised, 
but not irradiated. Mice were carefully spread out in a perspex box during irradiation 
to reduce sheltering by littermates. Mice were limited to 4 per box for UVB 
irradiation, but were not anaesthetised. 
2.1.7 - Urocanic acid isomers. 
Trans -urocanic acid (trans -UCA; 4- imidazoleacrylic acid) was purchased from 
Sigma Chemical Co. (Poole, UK). Cis -UCA was prepared by thin layer 
chromatography after UV irradiation as described previously (Norval et al 1989a), by 
Dr. J Crosby, University of Bristol. Imidazole -4(5)- methylidene malonic acid 
(IMMA) and methylated imidazole -4(5)- methylidene malonic acid (MeIMMA) were a 
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gift from Dr. H Morrison, Dept. Chemistry, Purdue University. The chemical 
structures of these molecules are shown in fig. 4.1. These substances were dissolved 
in the vehicle DMSO:ethanol (1:9), and were dropped onto mouse ears which had been 
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Figure 2.1. The spectral outputs of the UV lamps used during these studies. The outputs of the TL -01 
(broad -band) UVB lamp (dotted line), and the TL -12 (narrow -band) UVB lamp (solid line), are shown 
in the left panel. The right panel shows the output of the Dr. Hoenle Bluelight (UVA1) lamp, with 
cation X filtration (solid line) or without filtering (dotted line). 
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2.2. Immune responses. 
Contact hypersensitivity. 
2.2.1 - Contact sensitisers. 
4- ethoxymethylene -2- phenyl -2- oxazolin -5 -one (oxazolone; Ox) and 
1- chloro -2, 4- dinitrobenzene (DNCB) and were purchased from Sigma. Contact 
sensitisers were dissolved to the desired concentration in 4:1 acetone:olive oil (AOO). 
2.2.2 - Measurement of contact hypersensitivity responses. 
Groups of 6 -8 C3H/HeN mice were shaved on their backs two days prior to 
experimental procedures. At the start of each experimental timecourse, mice were 
anaethetised, ears covered and the shaved dorsum exposed to doses of UVB as 
described in individual experiments. On day 0, 50 µl of contact sensitiser in 
acetone:olive oil (AOO, 4:1) was dropped onto the irradiated area, at sensitising 
concentrations. Sensitising concentration was 1% Ox, and was titrated for DNCB as 
described in section 2.3.2. Positive control mice were sensitised but not irradiated, 
and negative control mice were neither irradiated nor sensitised. Mice were tailmarked 
10 days later, their ears measured with an engineer's micrometer (Draper Precision 
Instruments, Japan) as shown in fig. 2.2, and 20 µl of contact sensitiser diluted in 
AOO (4:1) to challenge concentration applied to the dorsum of each ear, of all mice. 
Challenge concentration was 0.25% Ox. A challenge concentration of 1% was used in 
initial DNCB CH elicitation experiments, and was altered between 0.4 %, 0.75% and 
1% for further experiments, as described in sections 2.3.4 and 2.3.5. Ears were 
remeasured 24h later. In some experiments, the challenge was repeated on days 11 
and 12, with ear thickness monitored at 24h intervals. All ear measurements were 
carried out under blinded conditions. The degree of contact hypersensitivity was 
assessed as the function of the challenge- induced increase in ear thickness, with the 
mean incremental ear swelling and standard error of the mean (SEM) calculated for 
each group. 
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The percentage suppression was calculated according to the formula :- 
suppression = 100 - 100 (increase in experimental- increase in negative control) 
(increase in positive control - increase in negative control) 
2.2.3 - Proliferative responses of draining lymph node cells following 
contact sensitisation. 
Female C3H/HeN mice were irradiated on the shaved back with 2 MED (2880 
J /m2) UVB (TL- 20W/12) on two consecutive days. One day after the last irradiation, 
mice were separated into groups of 5 animals, and contact sensitised. Two groups had 
25 µl of 1% Ox (Sigma) dropped on each ear, whilst another received 25 µl vehicle 
(AOO). Control groups contained unirradiated mice. Auricular lymph nodes were 
collected, pooled and single cell suspensions of lymph node cells (LNC) were obtained 
by rubbing lymph nodes through a steel gauze (J. Staniar and Co.), then washed by 
centrifugation at 1000 rpm in RPMI -FCS. Cells were resuspended in RPMI -FCS, 
viable cells counted in trypan blue and 2 x 106 viable cells added to wells in a 96 -well 
round -bottom culture plate (Iwaki) in a 200 µl volume. Cells were radioactively pulsed 
by adding 2 µCi 3H- thymidine to each well over a 24h period. Cells were harvested 
onto filter mats and the radiation incorporated measured on a scintillation counter 
(Canberra Packard, Zurich, Switzerland). 
2.2.4 - Cytokine production by draining lymph node cells. 
C3H/HeN mice were contact sensitised as described in section 2.2.2. Three 
days following contact sensitisation, draining auricular lymph nodes were removed. 
Alternatively, mice had CH responses elicited and DLN removed 3 days after the initial 
challenge (ie. on day 13 after contat sensitisation). Single cell suspensions were 
prepared by rubbing through a metal gauze (J. Staniar and Co.) and washed by 
centrifugation at 1000rpm in RPMI -FCS. Cells were seeded at 1 x 10' per ml in 
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24 -well culture plates (Iwaki). Supernatants were removed at intervals up to 120h, 
and frozen at -70 °C until assayed for cytokine content (mouse IL -10 and IL -12 ELISA, 
BioSource International (details in section 2.3.3); mouse IL -10, IFN -y and IL -12 
ELISA, AstraZeneca). 
Delayed type hypersensitivity. 
2.2.5 - Herpes simplex virus. 
Type 1 herpes simplex virus (HSV -1) which was a plaque -purified isolate from 
a clinical case (Howie et al 1986), was passaged in vitro in Vero cells at a multiplicity 
of infection of 0.2 pfu/cell. The titre of stock virus was determined by plaque assay 
(see section 2.2.6), and the virus stored at -70 °C. Killed virus was prepared by 
irradiating thin films of sonicated viral stocks with approximately 300 mJ /cm2 UVB. 
2.2.6 - Determination of viral titre by plaque assay. 
Plaque assays for infectious HSV were performed using monolayers of Vero 
cells in flat -bottomed 96 -well plates (Nunclon, Roskilde, Denmark). 1 x 105 cells per 
well were monlayered overnight. Following sonication of the stock, HSV was added 
to each well in serial dilutions and allowed to adhere to the cells for 1 hour, before 
overlaying with 0.25% Seaplaque agarose in the culture medium. After 2 days 
incubation with HSV at 37 °C, cells were fixed in formol saline and stained with 10% 
Giemsa. Plaques were counted by low power light microscopy, and the titre calculated 
at 2 x 10' pfu/ml. 
2.2.7 - Measurement of delayed type hypersensitivity responses. 
Groups of 8 C3H/HeN mice were used for delayed type hypersensitivity 
studies. Mice were irradiated with 1500 J /m2 UVB 3 days before infection with HSV. 
Another group of mice were injected subctaneously with 100 µg cis -UCA 5h before 
infection. Mice receiving anti -IL -10 (provided by Dr. SE Ullrich, Dept. Immunology, 
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University of Texas, Houston; clone. SXC -1) were injected intraperitoneally with 100 
µg anti -IL -10 4h after UVB or cis -UCA exposure, with control mice injected with 
0.1% BSA. In experiments investigating the effect of UCA analogues on DTH 
responses, analogues were injected subcutaneously 5h before infection. 
To infect mice, 5 x 105 plaque forming units of live HSV in 100111 PBS were 
injected subcutaneously. Positive control mice were infected but not irradiated, and 
negative control mice were neither infected nor irradiated. Ten days later, mice were 
individually tail -marked, their ears measured with an engineer's micrometer (Draper 
Precision Instruments) as shown in fig. 2.2, and 2 x 105 killed HSV diluted in 10 µl 
PBS injected into the pinnae of each ear. Mice were killed 24h later, and ears 
remeasured. All ear measurements were carried out under blinded conditions. The 
degree of delayed type hypersensitivity was assessed by the challenge- induced increase 
in ear thickness during this 24h period, with the mean incremental ear swelling and 
SEM calculated for each group. 
The percentage suppression was calculated according to the formula :- 
% suppression = 100 - 100 (increase in experimental- increase in negative control) 
(increase in positive control - increase in negative control) 
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Figure 2.2. Measurement of mouse ear thickness with a micrometer. This was used to assess the 
inflammation induced by elicitation of CH or DTH responses (reproduced from K Halliday, Ph.D 
thesis, University of Edinburgh). 
75 
2.3. Effects at a cellular level 
2.3.1 - Quantitative cytokine analyses in skin samples. 
Skin samples (approximately 0.5 cm') were cut from the shaved back of C3H 
mice and weighed. These were finely chopped, removed to 1m1 RPMI -FCS and snap 
frozen. Samples were thawed and homogenised using an Ultra -Turrex T8 hand -held 
homogeniser (IKA Laboratories, Stafen, Germany), snap frozen again, thawed and 
sonicated for 10s. Any skin remaining was removed by centrifuging at 3000 rpm for 5 
mins, and the supernatant collected for cytokine analysis by ELISA (details in section 
2.3.3). 
2.3.2 - Preparation of cell lysates. 
Cells were treated as described in section 2.1.5. Cells were lysed by adding 2 
mis of ice -cold triple- detergent lysis buffer. Triple- detergent lysis buffer comprised 50 
mM Tris HC1 (pH 8.0), 150 mM NaC1, 0.02% sodium azide and 1% NP -40 (all 
Sigma), with 100 gg /ml phenylmethyl sulfonylfluoride, 1 µg /ml aprotonin and 0.5% 
sodium deoxycholate (all Sigma) added just before use. Lysates removed 30s after 
adding the lysis buffer were stored at -70 °C until the cytokine content was assayed by 
ELISA (see section 2.3.3). 
2.3.3 - Enzyme Linked ImmunoSorbent Assays (ELISA). 
ELISA were conducted for IL -10, IL -12 and TNF -a using Cytoscreen 
Immunoassay kits (BioSource International, Camarillo, CA), according to the 
manufacturer's instructions. Briefly, for each assay a standard curve was created by 
addition of standards to a row of wells (standards ranged from 0 -200 pg /ml IL -10, 
0 -500 pg /ml IL -12 and 0 -1250 pg /ml TNF -a). Initial steps involved coating plates 
with standards and samples. For IL -12 assay, 100 µl standards were added to wells. 
Samples were diluted 1/2 with diluent buffer, and 100111 added to wells. A 50 µl 
volume of biotinylated anti -IL -12 was then added to all wells except a chromagen 
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blank control. For TNF -a assay, 50 µl of standards and samples were added to each 
well, followed by 50 gl of biotinylated anti -TNF -a, except a chromagen blank control. 
Plates were incubated at room temperature for 2h before washing 4 times with wash 
buffer. For IL -10 assay, 100 41 of standards and samples were added to wells and 
incubated for 90 mins at 37 °C, before washing 4 times with wash buffer. Biotinylated 
anti -IL -10 was then added to all wells except a chromagen blank for a further 45 mins 
at 37 °C, before washing. As a second step in all assays, streptavidin -HRP was added 
to all wells except the chromagen blanks, and the plates incubated for a further 30 mins 
at room temperature (45 mins at 37 °C for IL -10). Plates were washed and 100 µl 
stabilized chromagen added to each well for 15 -30 mins in the dark, before addition of 
100 µl stop solution. Absorbance at 450 nm of each well was read on a plate reader 
(MR 700 Plate Reader, Dynatech) blanked against the chromagen blank (consisting of 
stabilized chromagen and stop solution only). The standard curve was constructed and 
all sample concentrations calculated from this. Samples reading over the highest 
standard were diluted with standard diluent and re- analysed, with this additional 
dilution accounted for in the final calculation. IFN -y, and some IL -10 and IL -12, 
assays were conducted using in -house ELISA developed by Dr. RJ Dearman, 
AstraZeneca Central Toxicology Laboratory. 
2.3.4 - Immunoperoxidase staining of skin sections. 
Skin sections were frozen in cryomatrix (Life Sciences International, Runcorn, 
UK) then cut on a cryostat. Sections were placed on microscope slides and fixed in 
2% paraformaldehyde. Slides were stored at 4 °C until staining. To stain, slides were 
allowed to heat to room temperature, and covered with methanol including 3% 
hydrogen peroxide (H2O2) for 30 minutes, before washing twice with PBS. Slides 
were overlaid with 20% normal rabbit serum in PBS for 20 minutes, and washed twice 
with PBS. Primary antibody (anti- IL -10, clone JES -2A5, Harlan Seralab, 
Loughborough, UK; anti -CD54 (ICAM -1), clone KAT -1, Serotec, Oxford, UK; 
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anti -Ia [MHC class II]; clone YE2 /36HLK [rat IgG2a], Serotec; anti -IgG2a negative 
control, clone LO- DNP -16, Serotec) was diluted appropriately in PBS containing 3% 
bovine serum albumin (BSA), and overlaid overnight at room temperature. Slides 
were again washed twice with PBS, and overlaid with secondary antibody 
(biotinylated rabbit anti -rat IgG (H +L), Vector Laboratories, Peterborough, UK) 
diluted 1 /100 in PBS containing 3% BSA, for 30 minutes. Slides were washed twice 
with PBS, and HRP- avidin (Vector Laboratories) diluted 1 /100 in PBS containing 3% 
BSA added for 30 minutes. Slides were again washed in PBS, and developed by 
addition of diaminobenzidene (DAB; Sigma) for 5 -10 minutes. Finally, slides were 
washed with PBS then water, allowed to dry, and mounted in DPX under a glass 
cover slip. Slides were stored at 4 °C before examination. 
Lymph node cells or splenocytes from untreated mice were used as positive 
controls. Tissues were collected and single -cell suspensions prepared. Cells were 
then cytospun and stored at 4 °C until stained. 
2.3.5 - Immunoperoxidase staining of cells. 
PAM -212 or B16 cells were seeded at 1 x 106 cells /chamber on 2- chamber 
slides, and allowed to adhere overnight. Cells were then irradiated in the presence of 
150 pl phenol -red free PBS, which was then replaced with 1 ml RPMI -FCS. At the 
end of the experimental timecourse, cells were fixed in 2% paraformaldehyde before 
staining for IL -10 as described in section 2.3.4. 
2.3.6 - Expression of ICAM -1 on PAM -212 cells. 
PAM -212 cells were suspended in RPMI -FCS, 5 x 105 cells per well seeded in 
24 -well plates (Iwaki), and allowed to adhere overnight. Cells were then cultured in 
fresh RPMI -FCS, supplemented with varying concentrations of cis -UCA, trans -UCA 
or histamine, or combinations thereof, along with varying concentrations of TNF -u 
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(Genzyme). After 24 hours, cells were harvested by chemical (trypsin/ versene), or 
mechanical (scraping), removal from the plate, prior to washing by centrifugation in 
PBS. Cells were incubated with 100 pl of primary monoclonal antibody (1 /100 
dilution in PBS) (rat anti -mouse ICAM -1, and rat IgG2a anti -mouse negative control; 
both Serotec) on ice for 45 mins. PAM -212 were washed and incubated with 100 pl 
secondary detecting antibody (goat anti -rat IgG F(ab)2 FITC- conjugate; Serotec) at a 
1 /100 dilution, on ice for 45 minutes. Finally, cells were fixed in formol saline and 
analysed by EPICS (Coulter). 
Positive controls included LPS- stimulated peritoneal macrophages and DC 
from the draining lymph nodes of contact sensitised mice. Peritoneal macrophages 
were obtained from peritoneal lavage of mice with RPMI -FCS. Cells were washed by 
centrifugation at 1000 rpm for 5 mins, and viable cells resuspended at 5 x 105 cells /ml 
in RPMI -FCS. Cells were stimulated overnight with 5 pg /ml LPS. DC were 
identified in lymph node cell single -cell suspensions by their large size and high 
granularity. Negative controls, demonstrating non -specific staining, were typically set 
at 1 %. 
2.4. Effects on Langerhans cells and dendritic cells. 
2.4.1 - Preparation of epidermal sheets. 
Mice were exposed to UVB or UVA1 as detailed in section 2.1.6, or were 
painted with trans- or cis -UCA as detailed in section 2.1.7. In experiments examining 
the neutralizing effects of anti -TNF -a (20 µg) or anti -IL -113 (20 µg) (both goat 
anti -mouse antibodies, R &D Systems, Abingdon, UK), the antibodies were injected 
intraperitoneally in a 100 pl volume 2 hours before irradiation or UCA painting. 
Control mice were injected with the same volume of normal goat serum as a control. 
In experiments examining the effect of TNF -a (Genzyme, Cambridge, MA), 1000 U 
TNF -a was injected intradermally in a 20 pl volume 30 mins before irradiation. 
Control mice were injected with the same volume of 0.1% BSA as a control. Mouse 
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ears were collected into PBS and kept on ice prior to splitting with forceps. The ears 
were floated dorsal side down on 0.76% tetrasodium ethylenediamine tetraacetic acid 
(EDTA; Sigma) in PBS, pH 7.2 for 2 hours, at 37 °C. Ears were rinsed by passaging 
through PBS three times, and epidermal sheets removed with a scalpel blade. 
2.4.2 - ATPase staining of epidermal sheets. 
Epidermal sheets were stained for adenine triphosphatase (ATPase) using 
adenine diphosphate (ADP) as a substrate (Chaker et al 1984). Epidermal sheets were 
fixed by floating in sodium cacodylate /formaldehyde buffer (6.85% sucrose, 1.6% 
sodium cacodylate, 0.1% formaldehyde in distilled water) for 1 hour at 4 °C, before 
rinsing in PBS. Sheets were stained by adding to ADP -lead [0.12% MgSO4, 5% 
D- glucose, 0.06% ADP (Sigma) in Tris /mal buffer (3.025% Tris buffer salt, 2.9% 
maleic acid, 1% NaOH; pH 7.3):distilled water, 2:3] for 70 mins at 37 °C, prior to 
rinsing four times in Tris /mal buffer:distilled water, 2:3. Sheets were developed at 
room temperature by a 20 minute incubation in 2% ammoniumpolysulphide, and 
washed with water. Finally, epidermal sheets were mounted in 50% glycerol under a 
glass cover slip. Slides were stored at 4 °C before examination, and the number of 
ATPase+ cells counted in 10 fields per epidermal sheet (1 field = 0.1 mm2), with a 
minimum of 4 sheets per group. 
2.4.3 - Ia staining of epidermal sheets. 
Epidermal sheets were fixed in prechilled acetone for 20 mins at -20 °C. 
Following fixation, sheets were washed three times in PBS and placed in tissue culture 
plates for incubation with antibody solutions. Primary antibody (anti -Ia [MHC class 
II]; clone YE2 /36HLK [rat IgG2a], Serotec; anti -IgG2a negative control, clone 
LO- DNP -16, Serotec) diluted 1 /100 in 0.1% bovine serum albumin (BSA)/PBS was 
added and incubated for 30 mins at room temperature. 
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For fluorescent development, epidermal sheets were washed in three changes 
of PBS and secondary antibody (fluorescein isothiocyanate (FITC)- conjugated F(ab')2 
goat anti -rat IgG, clone STAR69, Serotec) diluted 1 /100) in 0.1% BSA/PBS added. 
Sheets were incubated in the dark for a further 30 mins at room temperature. Antibody 
solution was discarded and tissue washed in PBS. Epidermal sheets were then 
mounted on microscope slides in glyceroUsaline (9:1), using forceps to tease tissue, 
and kept in the dark at 4 °C before examination by fluorescence microscopy. 
Concanavilin A (ConA) stimulated splenocytes were used as positive controls. 
For immunoperoxidase development, endogenous peroxidase activity was 
blocked by a 30 min incubation with 3% H202 in PBS prior to addition of primary 
antibody. Epidermal sheets were washed in three changes of PBS and secondary 
antibody (biotinylated anti -rat IgG (H +L), Vector Laboratories, Peterborough, UK) 
diluted 1 /100 in PBS containing 0.1% BSA, for 30 minutes. Slides were washed 
twice with PBS, and HRP- avidin (Vector Laboratories) diluted 1 /100 in PBS 
containing 0.1% BSA added for 30 minutes. Slides were again washed in PBS, and 
developed by addition of DAB (Sigma) for 5 -10 minutes. Finally, sheets were washed 
with PBS then water and mounted in DPX under a glass cover slip. Slides were 
stored at 4 °C before examination. 
Positive controls for both procedures consisted of either DLNC or spleen cells 
which were cytospun onto microscope slides. Slides were stained for MHC class II 
expression in the same manner as epidermal sheets. 
2.4.4 - Dendritic cell enrichment. 
The method of Macatonia and collegues (Macatonia, 1986) was followed to 
enrich DC populations from auricular lymph nodes following a variety of treatments. 
In experiments examining the effect of TNF -a (1000 U) (Genzyme), TNF -a was 
injected intradermally in a 20µ1 volume 4h before DLN collection. Control mice (12 
per group) were injected with the same volume of 0.1% BSA as a control. In 
81 
experiments examining the neutralizing effects of anti -TNF -a (20 µg) or anti -IL -113 (20 
µg) (both goat anti -mouse antibodies, R &D Systems, Abingdon, UK), the antibodies 
were injected intraperitoneally in a 100 µl volume 2 hours before irradiation. Control 
mice were injected with the same volume of normal goat serum as a control. Single 
cell suspensions were prepared by rubbing lymph nodes through a 200 -mesh steel 
gauze (J. Staniar and Co.). Cells were washed by centrifugation at 1000 rpm in 
RPMI -FCS and resuspended in 8 ml RPMI -FCS. The cell suspension was gently 
underlaid with 2 ml 13.5% w/v metrizamide (Nygaard, Oslo, Norway) diluted in 
RPMI -FCS, and centrifuged at 600 g for 20 mins at room temperature. A DC enriched 
population was removed from the resultant interface (shown in fig. 2.3) and washed 
twice in RPMI -FCS. The pellet was resuspended in a minimal volume of RPMI -FCS, 
and DC counted by morphologic analysis by light microscopy. The enriched 
population typically comprised 60 -85% DC of total cells counted. 
Q 
Figure 2.3. The DC interface after centrifugation on a 14.5% Metrizamide gradient. The band 
contains a DC- enriched population (reproduced from A Moodycliffe, Ph.D thesis, University of 
Edinburgh). 
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2.5. Polvmerase chain reaction (PCR). 
2.5.1 - RNA isolation. 
RNA was isolated from tissue samples using the SV total RNA isolation 
system (Promega, Madison, WI), according to the manufacturer's instructions. 
Mouse ears or samples of shaved back skin were weighed, removed into 1 ml SV 
RNA lysis buffer and homogenised. Alternatively, 5 x 105 cultured cells were 
trypsinised and washed, and the cell pellet resuspended in SV RNA lysis buffer. A 
175 pl volume of lysate was removed to a microcentrifuge tube and 350 pl SV RNA 
dilution buffer added. The tube was heated to 70 °C for 3 mins, then centrifuged at 
12,000 rpm for 10 mins. The lysate was removed to a clean tube and 200 µl 95% 
ethanol added to it. This mixture was transferred to a spin basket, centrifuged onto a 
membrane (12,000 rpm, 1 min) and the eluate discarded. SV RNA wash solution was 
added to the spin basket, which was again centrifuged and the eluate discarded. 
DNase incubation kit (40 pl yellow core buffer, 5 µ10.09M MnC12, 5 DNase I per 
reaction) was added to the spin basket membrane and incubated for 15 mins at room 
temperature. This reaction was stopped by addition of 200 pl SV DNase stop solution, 
and the spin basket centrifuged. The membrane was then washed consecutively by 
centrifugation with 600 pl and 250 pl SV RNA wash solution. Finally, 1000 
nuclease -free water was overlaid on the membrane and RNA collected from the 
membrane by centrifugation into a collection tube. The isolated RNA was stored at 
-20 °C. 
2.5.2 - Reverse transcription of RNA isolates. 
Purity and concentration of RNA isolates was determined by optical density. 
RNA was diluted in distilled water to concentration of 2 pg per 9 and denatured by 
heating to 65 °C for 2 mins, before quenching on ice. 11 µl of a reverse transcription 
(RT) mix was then added to each sample; 1 pl RNA guard (Pharmacia Biotech), 4µl 
1st strand buffer, 0.01 M dithiothreitol (DTT; GibcoBRL), 2 pg oligo dT(18), 200 units 
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Moloney murine leukemia virus reverse transcriptase (MMLV RT; GibcoBRL), 1111 
dNTPs (25 mM mix of dATP, dCTP, dGTP, dTTP; Pharmacia Biotech). Reverse 
transcription was allowed to occur by incubating at 37 °C for lh, and the reaction 
stopped by heating to 95 °C for 5 mins. 
Semi -quantitative PCR. 
2.5.3 - Primer labelling. 
Each primer was y[3211-dATP -end labelled in a 30111 reaction mix; 5 11M 
primer, 30 units T4 polynucleotide kinase (PNK), lx PNK buffer (both New England 
Biolab, Hitchin, Herts. ) and 0.08 mCi /ml y[32P] -dATP (ICN Pharmaceuticals). The 
mixture was incubated at 37 °C for 1h, before denaturing at 95 °C for 5 mins (Progene, 
Techne (Cambridge) Ltd, Cambridge). IL -113 and TNF -a primers were kindly 
supplied by Dr. R McKenzie (Department of Dermatology, University of Edinburgh), 
13- actin, IFN -y and IL -10 primers were purchased from Pharmacia Biotech. Primer 
sequences are detailed in table 2.1. 
2.5.4 - PCR amplifications. 
PCR was performed on 2111 RT- reaction in a PCR cocktail containing 0.08 
mM dNTP mix (Pharmacia Biotech); 0.5 units thermally stable "Red -hot" DNA 
polymerase (Advanced Biotechnologies, Leatherhead, Surrey, UK); lx PCR buffer 
(Advanced Biotechnologies). For each primer pair the optimum Mgt+ (MgC12; 
Advanced Biotechnologies) concentration of the final mix was determined to eliminate 
non -specific signals. To establish the optimum Mgt+ concentration, RT products were 
amplified with unlabelled primers, and resolved on 1.5% agarose gels with ethidium 
bromide. Products were visualised under UV- light. Reactions were overlaid with 
mineral oil (Sigma), and 'hot -started' (D'Aquila et al 1991), by preheating 
RT- reactions and PCR cocktail to 85 °C. Primers (Pharmacia Biotech) were added in a 
1.5 ill mix. Products were amplified at 95 °C for 1 min (denaturing), 65 °C for 1 min 
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(annealing) and 72 °C for 1 min (polymerisation). The optimum cycle numbers were 
determined for each primer set by plotting product accumulation against cycle number, 
following autoradiography (see section 2.5.5). 
2.5.5 - SDS -PAGE and autoradiography. 
Radioactive y[32P] -dATP -labelled PCR products were resolved by 12% 
SDS- polyacrylamide electrophoresis (SDS -PAGE) at 120 volts. Samples were run 
against a pUC digest DNA ladder (GibcoBRL). Gels were analysed by capturing with 
Grab -IT, then calculating raw volume of each band with GelWorks 1D Advanced 
(both programs from UltraViolet Products, Cambridge). 
2.6 - Statistics. 
Preliminary statistics were carried out by ANOVA. In examples where 


















































































































































































































































































































































































































































































































































The effect of UVB on cytokine profiles during CH responses 
in C3H/HeN mice 
3.1 Introduction 
Many groups have shown an apparent unresponsiveness or immunological 
tolerance to antigens encountered through UVB irradiated sites (Schwarz et al 1996; 
Hammerberg et al 1996; Dai and Streilein, 1997; Niizeki and Streilein, 1997). This 
tolerance may be mediated by a selective activation of Th2 cells above Thl cells. 
Contact hypersensitivity (CH) is a common and relatively well investigated 
immune response induced by chemical antigens encountered through the cutaneous 
microenvironment, as described in section 1.3.6. This chapter investigates 
UVB- mediated effects on the CH response and alterations in cytokine production by 
DLNC which may account for UVB- mediated immune suppression. As the induction 
phase of CH is usually characterised by a Th1 -like cytokine profile (Kimber and 
Dearman, 1997; Dearman et al 1996), it is postulated that UVB may alter this by 
enhancing Th2 -like cytokine production, or at least by downregulating Th1 -like 
cytokines. Multiple challenges with contact sensitiser were used to enhance any 
differences which were made by UVB pretreatment. Repeated antigenic exposure over 
a period of days is a means of skewing T cell responses to a greater extent, due to the 
negative cross -regulatory mechanisms both T helper subsets use (described in section 
1.3.4). A similar technique has been used previously to investigate cytokine 
production by DLNC during elicitation of a CH response (Dearman et al 1996). 
The elicitation phase of CH is also impaired in irradiated mice. As discussed 
earlier, the ear swelling response of CH occurs by early and late components (see 
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section 1.3.6). Investigations into the effects of UVB exposure on these components 
revealed that irradiation impairs both stages (Sontag et al 1994). 
The aims of this area of research were - 
A. to establish a CH protocol for the contact sensitiser DNCB, 
B. to examine the effect of local UVB exposure prior to sensitisation on the CH 
response, 
C. to examine cytokine profiles in DLN during the induction and elicitation phases of 
CH. 
It was hypothesised that UVB would reduce the CH response to DNCB if 
given prior to sensitisation, and that this would possibly be due to a preferential bias 
towards Th2 -like cytokine production by DLNC during at least one phase of the 
response. The first set of experiments served to establish a suitable CH regimen for 
study and examine effects of UVB on elicitation of this response, and the second 
investigates effects that UVB exerts during contact sensitisation. 
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RESULTS 
Establishing a CH protocol for DNCB and investigating cytokine 
profiles upon the elicitation phase of CH. 
3.2 Establishing a CH protocol for DNCB. 
A basic protocol giving a suitably large CH response was required. 
Preliminary experiments were conducted to establish the optimum sensitising dose of 
DNCB for CH responses in C3H/HeN strain mice. Mice were sensitised by painting 
5O0 of either 0.1 %, 1% or 2.5% DNCB on their shaved back -skin, and were 
challenged on their ears 10 days later with 2O111 1% DNCB (as described in section 
2.2.2). This challenge dose was chosen as it had been used previous studies to 
investigate cytokine profiles of DLNC (Dearman et al 1996). Control groups consisted 
of mice which were given vehicle (AOO) only at the sensitisation stage. Challenges 
were repeated on 3 consecutive days with 1% DNCB, and the increase in ear thickness 
measured. Repeated challenges were used to boost the response and to further polarise 
cytokine profiles which were to be investigated later. Negative control mice were 
challenged with AOO only. A sensitisation dose of 0.1% DNCB did not provoke a 
CH response above that of unsensitised mice which were given only vehicle at the time 
of sensitisation. There was an increasing irritant response with repeated challenges, as 
measured by ear swelling in unsensitised mice (vehicle group). The optimal 
sensitisation dose was found to be 1% DNCB. The CH responses after sensitisation 
with varying concentrations of DNCB are shown in fig. 3.1. 
3.3 Establishing an immunosuppressive UVB regimen for DNCB - 
induced CH. 
The next experiments were designed to investigate whether, and in what 
regimen, UVB could suppress the CH response to DNCB. UVB was given in 3 
different regimens; 1- A single 1440 J /m2 UVB exposure 3 days before contact 
sensitisation; 2- 2 x 960 J /m2 exposures on consecutive days before sensitisation; and 
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3- 3 x 960 J /m2 exposures on consecutive days before sensitisation. All regimens 
suppressed the CH response elicited by a 1% DNCB challenge. Suppression was 
observed after all challenges, and was calculated at 45.5 %, 62.1% and 53.0% for 
UVB regimens 1, 2 and 3 respectively, at 24h (calculated against the unsensitised, 
challenged group (veh), as described in section 2.2.2). The effects of the UVB 
regimens on the CH response can be seen in fig. 3.2. All UVB treatments caused a 
decreased CH response when compared with the positive control, and this was 
significant for regimens 2 and 3 at 48h. Therefore, repeated irradiations gave more 
marked suppression than a single exposure. 
3.4 CH responses elicited by repeated challenge with weaker 
concentrations are more suppressed by UVB. 
A protocol for UVB suppression of the CH response to DNCB was designed 
from the data obtained in sections 3.2 and 3.3. It was decided to use a regimen of 3 
daily irradiations with 1440 J /m2 UVB prior to contact sensitisation with 1% DNCB 1 
day after the last irradiation. Mice were challenged with 2Oµ10.4% DNCB 10 days 
later. A challenge dose of 0.4% was used to reduce the inflammatory response in mice 
due to challenges alone. This is shown in fig. 3.1, where repeated challenge of 
unsensitised mice with 1% DNCB (vehicle group) resulted in a large ear swelling by 
the end of the experiment. As can be seen in fig. 3.3, this new regimen suppressed the 
CH response at all times when repeated challenges with 0.4% DNCB were given, and 
the degree of suppression was maintained through to the end of the challenge regimen 
(21.4 and 47.9% suppession at 24h, 74.6 and 77.0% at 48h, and 67.4 and 63.1% at 
72h). 
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3.5 Cytokine profiles of DLNC after CH elicitation by multiple 
challenges. 
It was established above that the CH response to DNCB could be suppressed 
by UVB irradiation prior to contact sensitisation (section 3.4). To determine if the 
UVB- mediated suppression could be attributed to an altered cytokine profile, DLN 
were taken from mice which had been challenged repeatedly with DNCB (the same 
mice that exhibited depressed CH in fig. 3.3). Single cell suspensions of DLNC were 
prepared and cultured without any stimulus for up to 5 days, as described in section 
2.2.4. Supernatants were collected at various times and then stored for cytokine 
analysis by ELISA (described in section 2.3.3). As can be seen in fig. 3.4, mice 
which had been irradiated before contact sensitisation showed similar Th 1 -like (IL -12 
and IFN -y) cytokine profiles upon elicitation of CH to those of positive control 
animals. Two positive control groups were conducted to establish the degree of 
inter -group variation. However, IFN -y and IL -12 did not increase over the culture 
period, suggesting that cells may have been optimally activated before DLN collection. 
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Figure 3.1. The dose response for DNCB sensitisation of C3H/HeN mice. Mice (n= 6) were 
sensitised on shaved dorsal skin with either 50111 AOO or DNCB, at concentrations stated (w /v). Ten 
days later mice were challenged by application of 201111% DNCB to the dorsum of each ear (neg was 
challenged with 20µ1 AOO). Pre- and post -challenge measurements of ear thickness were made and the 
mean increase in ear thickness used as a measure of the CH response. Results are shown expressed as 
the mean increase in ear thickness for each group, ± SEM. Challenges were repeated at 24 and 48h 
after the initial challenge. 
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Figure 3.2. Immunosuppression of the CH response to DNCB by various UVB regimens. Mice 
(n= 6) were shaved on their back and irradiated with either 1440 J /m2 UVB 3 days before sensitisation, 
960 J /m2 on 3 consecutive days before sensitisation, or 960 J /m2 on 2 consecutive days before 
sensitisation. One day later mice were sensitised on shaved area with either 501.1l vehicle (AOO) or 
50µ1 1% DNCB. A further mice 201.2.1 
the dorsum of each ear. Pre- and post -challenge measurements of ear thickness were made and the 
mean increase in ear thickness used as a measure of the CH response. Results are expressed as the 
mean increase in ear thickness for each group, ± SEM. Challenges were repeated at 24 and 48h after 
the initial challenge. *= p< 0.05, vs. positive control. 





Figure 3.3. UVB can suppress the CH response to DNCB even if several challenges are given. Mice 
(n= 6) were shaved on their back and irradiated with 1440 mJ /m2 UVB on three consecutive days. 
One day later mice were sensitised on shaved area with either 501.1 AOO or 500 1% DNCB. Ten 
days later mice were challenged by application of 2Oµ10.4% DNCB to the dorsum of each ear. 
Pre- and post -challenge measurements of ear thickness were made and the mean increase in ear 
thickness used as a measure of the CH response, expressed as mean ± SEM. Challenges were 
repeated at 24 and 48h after the initial challenge. Significant differences between the positive, 








d 00 N VO N ch r` C1 










d' 00 N O N - N CT 
time of culture (h) 
Figure 3.4. Thl -like cytokine production by DLNC following elicitation of CH, with multiple 
challenges. C3H/HeN mice were irradiated with 1440 J /m2 UVB on their shaved backs on 3 
consecutive days. Mice were sensitised through the irradiated site with either 500 1% DNCB or 
A00 one day after the last irradiation. Similar groups were established with unirradiated control 
mice, with 2 positive control groups established to counter intra- experimental variation. CH was 
elicited 10 days later by dropping 2011l 0.4% DNCB onto the ears. This was repeated on day 11 and 
12. Auricular lymph nodes were removed on day 13 and single -cell suspensions prepared. Cells 
were seeded at 1 x 107 per ml in 24 -well culture plates. Supernatants were removed at intervals up 
to 120h, and frozen at -70 °C until assayed for IL -12 (left) and IFN -y (right) content (as described in 
section 2.3.3). 
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3.6 UVB- mediated suppression of CH elicited by a single challenge. 
As Th 1 cytokines appeared to be optimally secreted after multiple challenges 
with DNCB, it was decided to revert to experiments using a single challenge. If mice 
were given repeated irradiations with 1 MED UVB (1440 J /m2, for 3 consecutive days) 
prior to contact sensitisation, the CH response could be fully suppressed when a single 
challenge with either 0.4% or 0.75% DNCB was used (shown in fig. 3.5). The 
relative suppression in UVB exposed mice increased as challenge dose decreased. 
This was calculated at 100% suppression at all times with a 0.4% challenge, and 81% 
(24h), 69% (48h) and 74% (72h) suppression with a 0.75% challenge. 
3.7 Cytokine profiles of DLNC after CH elicitation by a single 
challenge. 
Contact sensitisation was established in groups of unirradiated or UVB 
irradiated mice. CH reponses were elicited by a single challenge 10 days after 
sensitisation, and DLN removed 3 days later to examine the effect of cytokine profiles. 
As shown in fig. 3.6, the CH response was significantly suppressed in the irradiated 
mice (completely at 48h, and by 56.1 or 51.2% at 72h, in comparison with control 
groups). Single cell suspensions of DLNC were prepared and cultured without any 
stimulus for up to 5 days, as described in section 2.2.4. Supernatants were collected 
at various times and then stored for cytokine analysis by ELISA (described in section 
2.3.3). Th 1 -like cytokines increased throughout the culture period, indicating that the 
cells were still stimulated 3 days after challenge, and that they had not been driven to 
optimal secretory patterns. As shown in fig. 3.7, cells from mice which had been 
irradiated (UVB group) were less able to secrete Thl -like cytokines (IFN -y and IL -12) 
than mice which were mounting an ordinary CH response (pos groups). As with the 
multiple challenge regimen, the Th2 -like cytokine under investigation, IL -10, was 
undetectable at all times (data not shown; IL -10 ELISA limit of detection was 100 
pg /ml, in this case). 
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Figure 3.5. UVB exposure induced suppression of the CH response to DNCB, regardless of 
challenge concentration. Mice (n= 6) were shaved on their back and irradiated with 1440 J /m2 UVB 
on three consecutive days. One day later mice were sensitised on the shaved area with either 501A 
vehicle (AOO) or 5041 1% DNCB. Ten days later mice were challenged by application of 204l 0.4% 
(top) or 0.75% (bottom) DNCB to the dorsum of each ear. Pre- and post -challenge measurements of 
ear thickness were made and the mean increase in ear thickness used as a measure of the CH 
response, expressed as mean ± SEM. Measurements were repeated at 24 and 48h after the initial 
challenge. Significant differences between the positive, unirradiated control groups and the 


























neg veh pos(1) pos(2) UVB 
Figure 16. UVB suppresses the CH response to DNCB after a single challenge. Mice (n= 8) were 
shaved on their back and irradiated with 1440 J /m2 UVB on three consecutive days. Mice were 
sensitised on shaved area with either 5O111 A00 or 5O0 1% DNCB on day O. Ten days later mice 
were challenged by application of 2Oµ10.4% DNCB to the dorsum of each ear. Negative (neg) 
control mice received A00 at both phases, whereas vehicle (veh) control mice were not sensitised 
but were challenged with DNCB. Two positive control groups were established to counter 
infra- experimental variation. Pre- and post -challenge measurements of ear thickness were made and 
the mean increase in ear thickness used as a measure of the CH response, expressed as mean ± SEM. 
Ear measurements were carried out at 48h (a) and 72h (b). Significant differences between the 
positive, unirradiated control groups and the irradiated group were determined by Student's t -test. 
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Figure 3.7. Thl -like cytokine production by DLNC following elicitation of CH, after a single 
challenge. C3H/HeN mice were irradiated with 1440J/m2 UVB on their shaved backs on 3 
consecutive days. Mice were sensitised through the irradiated site with either 5Oµ1 1% DNCB or 
A00 one day after the last irradiation. Similar groups were established with unirradiated control 
mice. CH was elicited 10 days later by dropping 2Oµ10.4% DNCB onto the ears. Auricular lymph 
nodes were removed on day 13 and single -cell suspensions prepared. Cells were seeded at 1 x 10' 
per ml in 24 -well culture plates. Supernatants were removed at intervals up to 120h, and frozen at 
-70 °C until assayed for IL -12 (left) and IFN -y (right) content (as described in section 2.3.3). 
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Investigating cytokine profiles upon induction of contact sensitisation. 
There appeared to be a reduction in Thl -like cytokine profiles during the 
elicitation phase of the CH response to DNCB (when a single challenge was used). 
The cytokine microenvironment in which an antigen is encountered for the first time is 
an important factor in determining the subsequent cytokine profile produced upon 
restimulation of the specific T cells generated. The in vitro cytokine profile of cultured 
DLNC following UVB irradiation, and contact sensitisation, in vivo, was therefore 
investigated. 
It was decided to investigate cytokine profiles during the contact sensitisation 
phase of CH using the contact sensitiser 4- ethoxymethylene -2- phenyl -2- oxazolin -5- 
one (oxazolone; Ox). Ox is a stronger inducer of TNF -a within the skin than DNCB 
(Holliday et al 1997), and causes a greater lymphoproliferative response and DC 
accumulation within DLN ( Kimber et al 1990c). The local lymph node assay, in 
which proliferation of DLNC following contact sensitisation is measured, can be used 
as an indicator of the strength of sensitiser (Kimber and Dearman, 1991; Kimber et al 
1990b). As such, Ox represents a stronger contact sensitiser than DNCB. 
A contact sensitisation protocol that had previously been used in our laboratory 
was adopted. This UVB exposure regimen was 2 daily 1440 J /m2 exposures before 
sensitising a day later and had been shown to result in 46% suppression of the elicited 
CH response (M.B. Lappin, Ph.D thesis, University of Edinburgh). This UVB 
exposure regimen was adapted to 2 daily exposures of 2880 J /m2 UVB. 
3.8 The effect of UVB on the proliferative response of DLNC 
after contact sensitisation with Ox. 
Mice were irradiated with 2 daily exposures of 2880 J /m2 UVB and sensitised 
with 1% Ox one day later. Positive control groups consisted of unirradiated mice 
which were contact sensitised. Positive control groups were performed in duplicate 
within individual experiments in order to examine infra- experimental variation. The 
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cellularity of auricular lymph nodes removed from Ox sensitised mice was greater than 
those from irradiated, Ox sensitised mice. DNCB induced only a slight increase in 
DLN weight and cellularity. UVB irradiation resulted in an increase in DLN weight, 
but not in cellularity (shown in fig. 3.8). The belief that Ox would represent a better 
contact sensitiser to study the primary (sensitisation) response was reinforced by the 
findings. 
In agreement with DLN cellularity, proliferative responses were reduced slightly 
by prior UVB irradiation in Ox sensitised mice (shown in fig. 3.9). Ox sensitisation 
resulted in a high proliferative response of DLNC, which was significantly suppressed 
by approximately 20% by UVB exposure (p= 0.012). In AOO treated (i.e. 
unsensitised) control mice, DLNC proliferation was slightly, but not significantly, 
increased following UVB irradiation. 
3.9 The effect of UVB on cytokine profiles of DLNC after CH 
sensitisation. 
Cytokine analysis showed that UVB radiation did not significantly alter the 
early (up to 36h) profiles of IL -12, IFN -y and IL -10, following the induction phase of 
contact sensitisation (figs. 3.10a, b and c, respectively). Importantly, the IL -12 
ELISA used in these experiments recognises both bioactive IL -12 (p70) and the free 
p40 subunit. IL -12 production was significantly increased (p= 0.028) in cells from 
UVB irradiated, contact sensitised mice compared with positive control (Ox) mice by 
48h. Levels remained greater in UVB irradiated mice compared with the Ox group 
after this time, but these differences were not significant (shown in fig. 3.10). There 
was also an increase in IFN -y by 96 and 120h of culture (shown in fig. 3.10), in 
supernatants from DLNC from UVB irradiated, contact sensitised mice compared with 
the Ox group. This increase was not significant. IL -10 was found in approximately 
15 -20% lower concentrations in cells from UVB, contact sensitised mice from 72h 
onwards (shown in fig. 3.10). This decrease was not significant at any time. 
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In UVB irradiated, unsensitised mice there was production of IL -12 from 
DLNC throughout the study (shown in fig. 3.10). Production was rapid in the first 
12h (similar to contact sensitised mice), and this led to detectable IFN -y by 48h 
(shown in fig. 3.10). IL -10 was not assayed in irradiated, unsensitised mice. 
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Figure 3.8. UVB irradiation leads to increased numbers of DLNC following induction of contact 
sensitisation. C3H/HeN mice were irradiated with 2880J/m2 UVB on 2 consecutive days. One day 
after the last irradiation, mice were contact sensitised. Mice were sensitised by applying either 25111 
1% Ox, 1% DNCB or A00 to their ears. Similar groups were established with unirradiated mice. 
Three days following contact sensitisation, auricular lymph nodes were removed and weighed. 
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Figure 3.9. Spontaneous proliferation of DLNC following induction of contact sensitisation. 
C3H/HeN mice were irradiated with 2880J/m2 UVB on 2 consecutive days. One day after the last 
irradiation, mice were contact sensitised, by applying either 254l 1% Ox or AOO to their ears. 
Similar groups were established with unirradiated control mice. Three days following contact 
sensitisation, auricular lymph nodes were removed, and single -cell suspensions prepared. Cells were 
seeded at 2 x 106 per 2004l in 96 -well round -bottom culture plates, and pulsed with 2pCi tritiated 
thymidine. Cells were harvested after 24h and the radiation incorporated measured. 3 individual 
experiments were performed and results are plotted as the average of the mean for individual 
experiments ± SEM, where 100% represents the proliferation induced by the group Ox (1) for each 
individual experiment (100% represents 3H- thymidine uptake cpm of 42,190, 70,776 and 80,774 for 
3 individual experiments). Values were normalised against these values due to variation in counts 
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Figure 3.10. Cytokine production by DLNC following induction of contact sensitisation. C3H/HeN 
mice were irradiated with 2880J/m2 UVB on 2 consecutive days. One day after the last irradiation, 
mice were contact sensitised. Mice were sensitised with either 250 1% Ox or AOO applied to the 
ears. Similar groups were established with unirradiated control mice. Three days following contact 
sensitisation, auricular lymph nodes were removed, and single -cell suspensions prepared. Cells were 
seeded at 1 x 107 per ml in 24 -well culture plates. Supernatants were removed at intervals up to 
120h, and frozen at -70 °C until assayed for cytokine content (as described in Mats and Meths, 
section 2.3.3). Results from individual experiments were normalised against the 72h value for Ox 
(1), and are represented as the mean ± SEM for at least 4 experiments (IL -10; 100% = 175.45 pg/ml, 
range; 168.5 - 182.4 pg/ml, IL -12; 100% = 6.62 pg/ml, range; 1.65 - 15.1 pg/ml, IFN -y; 


















' ' 48 72 96 






24 48 72 




In this chapter protocols to examine the CH response to DNCB, and 
suppression of this response by UVB were established (shown in fig. 3.1, and 
figs. 3.2 and 3.3 respectively). These systems were then utilised to examine the 
cytokine profiles of DLN during both induction of contact sensitisation and elicitation 
of the CH response. 
3.11 UVB and the induction of contact sensitisation 
The proliferative response of DLNC after contact sensitisation was suppressed 
if mice were exposed to UVB beforehand (fig. 3.6). The local lymph node assay is 
able to identify at least moderate and strong skin allergens (Kimber, 1992). On this 
basis it would be anticipated that the CH response in UVB irradiated mice would be 
reduced from that of unirradiated, contact sensitised mice. This was a regular feature 
during this series of experiments. UVB slightly increased DLN weight and cellularity 
in unsensitised mice (see fig. 3.8), and this may suggest that it acts in a manner similar 
to that of contact sensitisers. Of interest is the observation that antigenic competition in 
CH is associated with a depressed primary proliferative response to the second 
chemical (Kimber et al 1990a). Depressed proliferative responses are observed in 
these experiments (see fig. 3.9), and therefore, UVB may mimic antigenic 
competition. 
Saijo and colleagues irradiated C3H mice with either a single 2 kJ /m2 UVB 
exposure or 400 J /m2 daily for 4 days, before sensitisation with FITC. They then 
showed UVB -irradiated mice were immunosuppressed (Saijo et al 1996). This was 
identified by collecting DLNC 18h after FITC sensitisation and then culturing in vitro 
with primed T cells. DLNC, or FACS -sorted APC, from UVB -irradiated mice 
induced around 40% less proliferation than those from normal mice. 
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Chronic activation of both murine and human CD4+ T cells in the presence of 
IL -10 gives rise to T cells with low proliferative capacity (Groux et al 1997). 
However, UVB irradiation before contact sensitisation did not significantly alter IL -10 
or IFN -y secretion by DLNC compared with DLNC from unirradiated, contact 
sensitised mice (figs. 3.9 and 3.11 respectively). Exposure resulted in a significant 
increase in IL -12 production by 48h of culture, as can be seen in fig. 3.10. These data 
indicate that UVB irradiation may enhance synthesis of IL -12 by DLNC after contact 
sensitisation whilst having no effect on Th2 cytokine production. They therefore 
appear to contradict the initial hypothesis which was that, at the very least, Thl -like 
cytokines would be reduced in mice that had been UVB -irradiated. 
In experiments by DiIulio et al, the presence of IL -12 during the sensitisation 
phase of CH increased the magnitude and duration of the response (DiIulio et al 1996). 
Injection of anti -IL -12 before sensitisation resulted in a reduced ear swelling upon 
challenge ( Riemann et al 1996). Furthermore, Riemann and colleagues showed that 
when anti -IL -12 treated mice were rechallenged, the CH response remained minimal, 
suggesting that tolerance had been induced. Anti -IL -12 treatment after sensitisation but 
before challenge could also suppress CH (Riemann et al 1996). Anti -IL -12 injection 
before sensitisation inhibited UVB induced suppression of CH (Schwarz et al 1996). 
Injection of IL -12 into UVB treated mice (and sensitised through the same site) before 
challenge restored normal CH responses (Schwarz et al 1996). These observations 
indicate a role for IL -12 in both stages of CH, and strongly implicate it in UVB 
mediated immune suppression. 
Kremer and colleagues showed that UVB irradiation of monocytes impaired 
their ability to stimulate proliferation and lFN -y production of Th 1 cells, in a 
dose -dependent manner, whilst retaining normal APC function to Th2 cells (Kremer et 
al 1996). Th0 cell stimulation was also normal, but exhibited a preferential 
suppression of IFN -y production. This was related to decreased production of IL -12 
p70 protein. 
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Recent findings suggest that IL -12 p40 may actually regulate Thl responses. 
Mice transgenic for IL -12 p40 (the inducible subunit) have high serum levels of mainly 
monomers or p40 homodimers. Antigen induced cytokine production is skewed 
toward a Th2 profile, with decreased production of IFN -y and increased production of 
IL -4 and IL -10, suppressed DTH responses and increased susceptiblity to malarial 
infection (a Th2- mediated disease) (Yoshimoto et al 1998). 
The IL -12 ELISA used for analysis of DLNC supernatants measured both the 
IL -12 p40 subunit and the bioactive p70 heterodimer. It is possible that UVB 
increases IL -12 p40 production by DLNC, and skews immune responses by this 
antagonistic mechanism. However, IFN -y began to increase in supernatants from 
UVB -irradiated DLNC at late timepoints (see fig. 3.11), suggesting that the IL -12 
produced may have been biologically active. Interestingly, Schmitt et al observed 
increased IL -12 production by LNC from irradiated mice (Schmitt et al 1998). They 
irradiated mice then stimulated LNC in vitro in the presence of LPS. IL -12 production 
was increased in LNC from UVB -irradiated mice compared with LNC from 
non -irradiated mice, when measured by ELISA. Conversely, DC- enriched 
populations from the spleens of irradiated mice produced significantly less biologically 
active IL -12 than splenic DC from non -irradiated mice. Ullrich argues that secretion of 
IL -12 p40, which can bind IL -12 receptor, thereby interfering with IL -12 p70 
signalling, is a result of UV- induced cytokines acting on DC (Ullrich, 1999). This 
may explain UV- mediated suppression of Thl cells. Because IL -4, but not IL -12, is 
necessary for Th2 cell growth, Th2 cells would be unaffected in UV- irradiated mice. 
In experiments conducted by Saijo et al, T cells from naive, or FITC- sensitised 
mice, produced less IFN -y and IL -2 in response to 24h culture with APC from 
UV- irradiated mice than in response to APC from unirradiated mice (Saijo et al 1996). 
Th2 -like cytokines (IL -4 and IL -10) were not detectable unless supernatants were 
concentrated, and were not consistently produced. Culture with APC from 
UV- irradiated mice did not increase Th2 -like cytokine synthesis. 
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In experiments by Simon and colleagues, unirradiated BALB /c epidermal cells, 
LC, or splenic adherent cells, presented keyhole limpet hemocyanin (KLH) to both 
antigen specific Th 1 and Th2 cell lines. In vitro irradiation of epidermal cells and LC 
with 20 mJ /cm2 UVB led to loss of their ability to stimulate Th1 cell lines, but the cells 
retained APC function for Th2 cell lines. Irradiated splenic adherent cells lost APC 
function for both subsets (Simon et al 1990). This selective activation of Th2 cells 
was due to induction of clonal anergy in Th1 cells. Th1 cells were unable to respond 
to antigen presented by normal APC at later times (Simon et al 1991). This was not 
reliant on soluble factors, as supernatants from UVB- exposed LC or splenic adherent 
cells had no effect on Th 1 cell proliferation. 
IL -10 does not have any effects on anti -CD3 or alloantigen- induced 
LC- dependent T cell proliferation. Production of IL -2 and 1FN -y (but not IL -6) was 
reduced in these assays (Enk et al 1993b). IL -10 pretreated LC did not alter 
proliferative responses of Th2 -cell clones (D 10.G4), but these cells were unable to 
support proliferation of Thl -cell clones (AE7). Fresh or 1 day cultured LC were 
inhibitory toward Th 1 cells, but by day 2 or 3 of culture, LC were affected to a much 
lesser extent by IL -10 pretreatment (Enk et al 1993b). DC treated with IL -10 were 
capable of supporting proliferation of, and IFN -y secretion by, both CD4+ and CDS+ 
T cells in a mixed leukocyte response. In contrast, IL -10 markedly inhibited DC 
driven lFN -y production by purified CD4+ or CD8+ T cells. Under the same 
conditions, macrophage -dependent proliferation was strongly inhibited. IL -10 
inhibited DC induced production of lFN -y by Thl clones, and CD4+ and CD8+ T cells 
from unprimed mice (Macatonia et al 1993). These experiments suggest that it would 
have been beneficial to have purified DLNC into CD4+ and CD8+ T cell subsets, as this 
would have removed redundant signals between the cell types and may have made any 
preferential effects of UVB exposure easier to identify. 
It has been shown previously that lymphocytes from UVR exposed mice 
produce less IL -2 and IFN -y when activated in vitro by antigen or anti -CD3 (for 
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polyclonal T cell activation) (Araneo et al 1994). IL -4 secretion was consistently 
elevated in comparison to normal controls. Isotype analysis showed that specific 
antibodies to ovalbumin (the immunising antigen) was slightly reduced in all IgG 
subclasses, accompanied by an enhancement of IgA. 
Thomson and colleagues found that IFN -y was detectable in DLN 3 days after 
sensitisation with Ox, and this could be amplified by culturing the cells with anti -CD3 
antibodies (Thomson et al 1993). Treatment of mice with anti -IL -4 before sensitisation 
did not affect DLNC production of measured cytokines (IFN -y, IL -3, 
IL -4, GM -CSF) in vitro. Conversely, anti -TN-y caused a marked rise in IL -4, a 
lesser and more variable rise in IL -2, and a decrease in IFN -y, particularly by CD4+ 
cells. Despite these effects, anti -IFN -y did not significantly alter CH reponses to Ox. 
This suggests that IFN -y participates in, but is not wholly responsible for, the CH 
response. Anti -IL -4 did not alter CH outcome either, but it has been postulated that 
IL -4 may play a role in the effector, rather than the sensitisation, phase of CH (Gautam 
et al 1992). In agreement with this is the finding that IFN -y -/- mice can mount CH 
responses as well as wild -type (C57B1/6) mice (Reeve et al 1999). UVB and cis -UCA 
suppressed CH responses in both sets of mice (69% and 29% reduction in C57B1/6, 
79% and 27% in IFN -y-' respectively). Responses could be restored by injection of 
IFN -y. This suggests that IFN -y can antagonise the immunosuppressive action of 
cis -UCA (Reeve et al 1999). 
Boonstra and colleagues found that IFN -y production by purified splenic CD4+ 
T cells was reduced if mice were irradiated before spleen collection and CD4+ cell 
stimulation in vitro with anti -CD3 antibodies (Boonstra and van Oudenaren, 1998). 
They observed that polarization of both CD4+ T cell compartments was reduced, but 
that the Thl compartment was affected more severely than the Th2 compartment. 
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3.12 UVB and CH elicitation. 
Miyauchi and Horio used a similar system to the one used here (described in 
section 2.2.2) and showed that the degree of CH suppression mediated by UVB was 
increased as the challenge concentration of contact sensitiser decreased (Miyauchi and 
Horio, 1995). This finding is corroborated by the results in section 3.4. They also 
found that suppression was greater if UVB doses were divided i.e. 2 exposures of 500 
J /m2, as opposed to a single 1000 J /m2 exposure. This was observed in the series of 
experiments reported here, and is shown in fig. 3.2. 
Initial cytokine analysis experiments were conducted using DLNC from mice 
which had had multiple (3) challenges with DNCB. Multiple challenges were used to 
enhance any differences which were made by UVB pretreatment, thereby making them 
easier to identify. Repeated antigenic exposure is a means of skewing T cell responses 
to a greater extent, with a more defined cytokine profile emerging (Mosmann et al 
1991). However, it was found that in C3H mice, repeated elicitation of CH fully 
activated DLNC by 3 days. This was the time after primary elicitation that DLN were 
removed, and there did not appear to be any further cytokine production during the 
culture period (see fig. 3.4). Alterations in cytokine profiles were not apparent, and 
IL -10 could not be detected. A similar technique was used by Dearman and colleagues 
to investigate the cytokine profile of DLNC following a DNCB elicited CH response, 
in BALB /c mice (Dearman et al 1996). They could not detect IL -10 production in their 
experiments, but IFN -y was produced throughout the study. Interestingly, IFN -y 
levels detected after multiple challenges in BALB /c mice were similar to those found 
during investigation of DLNC cytokine profiles after a single challenge (see fig. 3.7). 
This may indicate that DNCB is a stronger contact sensitiser in C3H/HeN mice than in 
BALB /c mice. 
It has been demonstrated previously that repeated application of the contact 
sensitiser 2, 4, 6- trinitro- l- chlorobenzene (TNCB) results in a site -restricted shift in 
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the time course of antigen- specific responses, from a delayed to an early -type 
response. The cutaneous microenvironment at the time of antigen presentation to 
T cells during the elicitation phase, rather than the induction phase of CH, is 
responsible for this shift. This also extends to unrelated third -party antigens. 
Repeated (chronic) exposure to TNCB led to a situation where high constitutive IL -4 
mRNA levels were observed, and IL -10 mRNA was upregulated as early as 1 -3h later, 
in an antigen specific manner. These changes were also observed at the protein level. 
Acute exposure to TNCB increased mRNA expression of IL -2, IFN -y, and TGF -13. 
Chronic exposure elevated the mRNA expression for IL -4 and IL -10, with the 
immunoregulatory cytokines appearing to differentiate the regimens (Kitagaki et al 
1997). 
Reversion to a single challenge regimen allowed cytokine production to be 
detected, as shown by increases in IL -12 and IFN -y during culture (shown in fig. 
3.7). IL -12 was measured by an ELISA that recognises both natural IL -12 (p70) and 
the free p40 subunit. In these analyses, UVB irradiation before contact sensitisation 
appeared to change the cytokine profile to that of a primary response, as cytokine 
production by UVB treated DLNC was similar to that of negative control mice (no 
sensitisation, DNCB challenge). IL -10 was not detectable at any time during culture. 
These data tentatively support the hypothesis that UVB reduces Thl -like immune 
responses, but not by upregulation of Th2 -like responses (Saijo et al 1996). 
In a secondary immune response, T cells can encounter and be activated by 
antigen at the site of application, rather than in DLN as is the case in the primary 
response. When keratinocytes were used as accessory cells there was a specific defect 
in T cell IFN -y production, whereas IL -2 and IL -4 were induced at levels comparable 
to those seen when professional APC were used as accessories (Goodman et al 1994). 
This was not due to non -productive CD28 engagement, as stimulation of this pathway 
by monoclonal antibodies still did not induce IFN -y production in keratinocyte 
supported cultures. IL -2 was increased 10 -fold in these CD28- triggered cultures, 
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demonstrating a specific deficiency in IFN -y as opposed to a failure to respond to 
CD28 signalling. RT -PCR revealed that keratinocytes produced little or no mRNA for 
IL -12 p40 compared with professional APC, and addition of IL -12 to cultures restored 
IFN -y production. 
Noonan and colleagues reported that a single UV exposure suppressed the CH 
response to TNCB and DNFB (Noonan et al 1981). BALB /c mice had their ears 
covered and were irradiated on their shaved backs, then contact sensitised through the 
same site. A CH response was elicited by challenge on the ears 5 -7 days later. The 
degree of systemic immune suppression was proportional to the logo dose of 
irradiation, and exhibited a time delay before detection. Mice sensitised 1 day after UV 
treatment mounted normal CH responses upon elicitation, but if they were sensitised 
3 -15 days after irradiation, systemic CH was suppressed by around 70%. When 
normal mice were immunised with TNP- conjugated splenocytes from normal or UV 
exposed mice, a normal DTH response could be elicited by a later injection of 
TNP- conjugated splenocytes. UV- irradiated recipients could not be sensitised with 
splenocytes from UV- irradiated mice, although a time delay of 3 days was required to 
establish unresponsiveness (Noonan et al 1981). This indicates the blocking of 
sensitisation in UV- irradiated mice was due to defective antigen presentation. CH to 
DNFB can be impaired by intradermal injection with cis -UCA (200µg) into C3H/HeN, 
C3H/HeJ, C57B1/6 and BALB /c mice (Kurimoto and Streilein, 1992). 
3.13. Criticisms of experimental design and suggestions for further 
work 
The experiments described herein investigated the effects of UVB exposure on 
both induction of contact sensitisation and elicitation of CH responses. Whilst IL -10 
was detectable during the sensitisation phase, it was not detectable during elicitation. 
For this reason it would have been useful to have investigated another Th2 -like 
cytokine, such as IL -4. A recent investigation by Garssen and colleagues has 
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identified IL -4 in culture supernatants following in vitro stimulation of DLNC derived 
from contact sensitised mice. IL -4 production by these cells was unaltered if mice 
were UVB irradiated before sensitisation (Garssen et al 1999). 
It would also have been constructive to have investigated the cytokine profiles 
of purified CD4+ or CD8+ cells. As mentioned above, analysis of cytokine production 
by a mixed CD4+ or CD8+ cell population suggested that culture with IL -10 treated DC 
had no effect on cytokine profiles (Macatonia et al 1993). However, when cells were 
purified there was a clear differential effect on Thl- and Th2 -like cytokine production. 
Examination of purified CD4+ cells from spleens of irradiated mice showed a reduction 
in both Thl and Th2 -like cytokines investigated, but the effect was more severe on the 
Thl -like compartment (Boonstra and van Oudenaren, 1998). Masking effects may 
operate in DLN of UVB- irradiated mice, where induction of DC accumulation may 
lead to macrophage activation within the DLN. Macrophages may phagocytose 
apoptotic cells, leading to cytokine secretion by these macrophages and further 
complication of cytokine analysis when looking at the total DLNC population. 
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Chapter 4 
Alterations in LC numbers after UVA1, UVB, or UCA 
4.1 Introduction 
It is recognised that UVB can suppress cell- mediated immune responses 
(Fisher and Kripke, 1977; Kripke et al 1979; Noonan et al 1981). More recent 
investigations indicate that UVA1 (340 -400 nm) may also have such an effect 
(Clement- Lacroix et al 1996; El -Ghorr and Norval, 1999), although this area is 
controversial (Skov et al 1997; Reeve et al 1998). It has been shown, for example, 
that UVA1 at a dose of as small as 1000 J /m2 can suppress DTH responses in 
C3H/HeN mice (El -Ghorr and Norval, 1999). In contrast, there is evidence from the 
hairless mouse (Reeve et al 1998), and more recently from C57BL /6 mice (Reeve et al 
1999), that irradiation with total UVA (320 -400 nm) before UVB partially protects 
mice from UVB- induced immunosuppression of CH. One possible mechanism for 
this immune suppression is through effects on APC at irradiated sites. 
Cis -UCA may represent an important immunoregulatory tool, with potential 
application in a wide variety of situations. It has several facets that contribute to this. 
Firstly, cis -UCA is a small and naturally occurring molecule, so side -effects with 
regard to its use should be limited. While UVB phototherapy is used for skin 
conditions such as psoriasis, its use is limited by its erythemal side -effects. Cis -UCA 
is easily made in vitro from trans -UCA. Cis -UCA can be applied by a non -invasive 
regimen, in the form of an ointment or cream. Additionally, due to its size, the 
molecule can readily be manipulated to enhance its efficacy. However, the 
mechanisms by which cis -UCA mediates immune suppression remain unclear. The 
structures of cis- and trans -UCA are shown in fig. 4.1. 
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Imidazole-4(5)- methylidene malonic acid (IMMA) is a molecule which 
resembles both trans- and cis -UCA, and as such may be useful in determining 
immunomodulatory determinants on cis -UCA. IMMA has its imidazole and carboxyl 
functionalities permanently fixed in a configuration analogous to both trans- and 
cis -UCA (shown in fig. 4.1). Additionally, photoinactivation of bacteriophage 
single -stranded DNA is changed by a factor of 0.43 by IMMA, a value which is 
intermediate between the rate for trans -UCA (1.6) and cis -UCA (0.014) (Houghtaling 
et al 1996). Methylated IMMA (MeIMMA) is similar to IMMA but has a methyl group 
added to the 2- position of the imidazole ring (see fig. 4.1). 
It has been known for some time that irradiation with UVB results in a decrease 
of LC, as assessed by CD1a, MHC class II or ATPase expression, from the irradiated 
site in the epidermis. The following experiments were carried out to investigate 
whether cis -UCA or UVA1 were capable of depleting LC from murine epidermis, as 
both modalities modulate immune responses which can be initiated by APC at the site 
of exposure. 
The aims of these experiments were - 
A. To examine the effects of UCA analogues on DTH responses. 
B. To examine whether UVA1 could deplete LC when a given in a single, 
suberythemal dose. 
C. To examine wavelength interaction in regard to LC numbers. 
D. To examine and establish timecourses for LC depletion mediated by UVB and 
cis -UCA. 

















4.2. UCA analogues can suppress the DTH response to HSV -1. 
To establish an immunosuppressive dose of cis -UCA and to find out if the 
UCA analogues were immunosuppressive, cis -UCA and its analogues, IMMA and 
MeIMMA, were injected subcutaneously into mice 5h before infecting mice in the 
scruff of the neck with HSV -1. A DTH response was elicited 10 days later by 
injecting inactivated HSV -1 into the pinnae of the ear, and the increase in ear thickness 
measured 24h later (as described in section 2.2.7). Cis -UCA significantly suppressed 
the DTH response to HSV -1 by 40% when injected at a dose of 501.tg (p= 0.021 vs. 
positive control). MeIMMA and IMMA also significantly suppressed the response 
when 5014 of either analogue was injected before infection (by 69% and 77%; 
p= 0.029 and p= 0.028 vs. positive control, respectively) (see fig. 4.2). Further 
experiments indicated that the immune suppression mediated by cis -UCA was 
dose -dependent, and both IMMA and MeIMMA showed similar tendencies (as shown 
in fig. 4.3). Immune suppression by cis -UCA has previously been shown to be 
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Figure 4.2. UCA analogues can suppress the DTH response to HSV -l. Mice (n =8) were injected subcutaneously with 
501.4 IMMA, MeIMMA or cis -UCA and infected with 5 x 10' pfu HSV 5h later. DTH was elicited 10 days later by 
injecting 2 x 103 pfu inactivated HSV into the pinnae of each ear. Increases in ear thickness were measured 24 hours 
later. The mean increase in ear thickness was used as a measure of the DTH response. Results are expressed mean ± 
SEM. Positive control mice (pos) were injected with vehicle only before infecting, and negative control mice (neg) 
were not infected. Significant differences between the positive control (pos) and the analogue treated groups were 
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Figure 4.3. UCA analogues can suppress the DTH response to HSV -1. Mice (n =8) were injected 
subcutaneously with the analogue indicated and infected with 5 x 105 pfu HSV 5h later. DTH was 
elicited 10 days later by injecting 2 x 105 pfu inactivated HSV into the pinnae of each ear. Increases 
in ear thickness were measured 24h later. The mean increase in ear thickness was used as a measure 
of the DTH response. Results are expressed as percentage suppression for individual experiments, or 
mean of 2 experiments ± SD. 
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4.3. UVB causes LC depletion in the epidermis, but UVA1 does not. 
C3H/HeN mice were exposed to UVB or UVA1 radiation as described in 
section 2.1.6. One day after irradiation, ears were collected from these mice and 
epidermal sheets prepared. LC were identified by staining for ATPase activity, then 
counted. Irradiating with 1 MED (500 kJ /m2) UVA1 did not result in any change in 
LC numbers compared with control animals at 24h, as shown in fig 4.4. The 
morphology of the LC in UVA1 exposed epidermis was similar to that of unirradiated 
mice (data not shown). Exposure to 1 MED (1440 J /m2) UVB significantly depleted 
LC from murine epidermis by 24h. Furthermore, when a 1 MED UVA1 exposure was 
followed by 1 MED UVB exposure, LC were depleted to levels comparable to those 
achieved by UVB radiation alone. Painting a 20 gg dose of cis -UCA also resulted in 
significant LC depletion. In all cases of depletion, the remaining LC were rounded and 
had fewer dendritic processes than LC in their respective controls (data not shown). It 
was confirmed over a series of experiments that whilst a 1 MED dose of broad -band 
UVB depleted LC by 25 -30%, a 1 MED UVA1 exposure had no effect on LC 


























Figure 4.4. UVAL does not deplete LC numbers and does not confer protection from UVB- induced 
depletion. Mice were treated with 1 MED UVAL, 1 MED UVB, or 1 MED UVA1 followed 
immediately by 1 MED UVB. For the veh and cis -UCA groups, ears gently were tape- stripped 24h 
before painting with DMSO /eth or 201.tg cis -UCA. Ears collected 24h later. For UCA experimental 
groups, mice had their ears tape -stripped twice 24h before application of veh (DMSO /eth) or 
cis -UCA. Four epidermal sheets from each group were prepared and stained for ATPase activity. 
Results are shown as the mean ± SEM. Significant differences between the relevant control and the 
experimental groups were determined by Student's t -test. For UV treated groups, *= p< 0.05, 
vs. unirradiated, and for the cis -UCA group, *= p< 0.05, vs. vehicle. 
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Experiment unirradiated UVB % change UV A % change 
1 374 263 -29.7 ( *) 351 -6.1 
2 329 200 -39.2 ( *) 301 -8.5 
3 329 256 -22.2 ( *) 355 +7.9 
4 430 346 -19.5 ( *) 432 +0.5 
Table 4.1. UVB induces a reduction in LC, but UVA1 does not. Mice were either unirradiated, or 
received either 1 MED UVB or 1 MED UVA1. Ears were collected and stained for ATPase activity 
24h later. In individual experiments, 4 epidermal sheets were prepared each group. Results from 4 
individual experiments are shown as mean and percentage change from control values. *= p< 0.05, 
vs. control. 
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4.4. UVB- mediated LC depletion is dose -dependent. 
The next series of experiments investigated the dose of UVB required to 
deplete LC from irradiated epidermis. As shown in fig 4.5, a dose of as little as 0.5 
MED (750 J /m2) broad -band UVB was enough to alter the morphology and number of 
LC. The effect was dose -dependent, with increased LC depletion in epidermal sheets 
irradiated with 1 MED (1500 J /m2) broad -band UVB. A single MED (10,000 J /m2) 
exposure of narrow -band UVB (TL -01) depleted numbers to similar levels compared 
with the same dose of broad -band UVB, but there was not a significant reduction with 
a 0.5 MED TL -01 exposure. The effect on morphology was not as marked after 
narrow -band UVB (TL -01) as with broad -band UVB (m-12). UVA1 did not 
significantly deplete numbers, and again, if it preceded a 1 MED broad -band UVB 
exposure, did not confer protection against LC depletion. 
4.5. A timecourse for UVB effects on LC. 
Local and systemic immune suppression following UVB exposure exhibit 
different kinetics. Hammerberg et al (1996) examined the time needed between 
irradiation and contact sensitisation of C57BL /6 mice to establish suppression of CH. 
Suppression could be observed immediately, and up to 48h, after irradiation, if mice 
were sensitised through the irradiated site (local suppression). If mice were sensitised 
through unirradiated sites, a period of 3 days was required before systemic 
suppression was observable. The timecourse of ATPase+ cell depletion by UVB was 
therefore examined. Mice were exposed to UVB at various times before collecting 
their ears and staining all samples for ATPase activity at the same time. There was a 
highly significant drop in LC within 12h of exposure to 1 MED UVB. 24h after 
irradiation LC numbers were still depleted, although to a lesser extent. LC frequency 
exhibited a slow and steady recovery thereafter, which can be seen in 
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fig 4.6a. Numbers fell by as much as 45% by 12h, with 27% depletion at 24h. 
Examination at earlier times showed that LC were significantly depleted as early as 6h 
after UVB exposure (by 32 %), but that the peak in reduction was at 12h (see 
fig. 4.6b). 
4.6. An extended examination looking for UVA1 effects on LC. 
It was apparent that previous experiments using a standard 24h timepoint to 
investigate UVA1 effects on LC numbers may have missed the peak in alterations, 
either by looking after numbers had recovered, or by looking too early for any effects 
to have been mediated. LC frequency in UVA1 irradiated mouse epidermis was 
investigated at various times up to 96h after exposure. This can be seen in fig 4.7. A 
1 MED UVA1 exposure did reduce LC frequency, but this reduction was not 
significant at any of the times examined (maximum reduction was from 374 to 318.25 
per mm2 (15 %), at 48h; p= 0.17 vs. unirradiated Oh). The morphology of ATPase+ 
cells present in the epidermis was similar at all times, with long dendritic processes 
clearly visible (data not shown). 
4.7. A timecourse for cis -UCA mediated LC depletion from murine 
epidermis. 
Mouse ears were gently tape- stripped twice 24h before they were painted with 
UCA isomers (as described in section 2.1.7). Tapestripping did not alter LC numbers 
in the epidermis, as shown in fig. 4.4. Tapestripped and vehicle (DMSO /eth) painted 
ears had the same LC frequency as untreated, unirradiated ears. Preliminary 
experiments had established that 201.tg cis -UCA significantly depleted LC numbers by 
24h after painting on to mouse ears (shown in fig. 4.4). Examination of the 
timecourse for ATPase+ cell depletion following cis -UCA painting was then 
undertaken. UCA isomers were applied at various times before collecting the ears for 
ATPase staining. As shown in fig 4.8, maximal depletion of LC by cis -UCA occured 
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at 24h, and with a decrease from 374 to 260.75 ATPase+ cells/ mm2 (30.3 %). The 
timecourse was not extended beyond this time. Trans -UCA reduced LC numbers only 
slightly, and this decrease was not significant at any time (a maximum of 9.3% at 
24h). Cis -UCA induced LC migration therefore has a delayed timecourse in 
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Figure 4.5. UVB- induced alterations in LC numbers are dose -dependent. Mice were exposed to either 25 or 50 kJ /m' (I 
MED) narrow -band UVB (TL -01). 360, 720 or 14-40 Jim' (1 MED) broad -band UVB (l'L -12), 500 kJ /m'- (t MED) 
UVA I or 500 kJ /m' (I MED) UVA I followed immediately by 1440 J /m= (I MED) broad -band UVB (TL -12). Ears 
collected 24h later and 4 epidermal sheets from each group were prepared and stained for ATPase activity. Results are 
shown as the mean SEM. Significant differences between the normal control and the experimental groups were 
determined by Student's r -test. *= p< 0.05, and '= p< 0.01, vs. unirradiated. 
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Figure 4.6a and b. The timecourse for ATPase+ cells in murine epidermis following irradiation with 1 
MED of UVB (1440 J /m2). Mice were irradiated and ears collected at various times thereafter. Four 
epidermal sheets from each group were prepared and stained for ATPase activity. Results from 2 
separate experiments are shown, as the mean ± SEM for each timepoint, with Oh representing the 





Figure 4.7. The timecourse for ATPase* cells in murine epidermis following irradiation with 1 MED 
of UVAl (500 kJ /m2). Mice were irradiated as decsribed in section 2.1.6 and ears collected at various 
times thereafter. Four epidermal sheets from each group were prepared and stained for ATPase 
activity. Results are shown as the mean ± SEM for each timepoint, with Oh representing unirradiated 
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Figure 4.8. The timecourse for ATPasse cells in murine epidermis following painting with 2014 cis- or trues -UCA. 
Mice had their ears tape- stripped twice 24h before application of DMSO /eth or 20µg UCA isomers. Four epidermal 
sheets from each group were prepared and stained for ATPase activity. Results are shown as the mean t SEM. 
Significant differences between the DMSO /eth group and the experimental groups were determined by Student's t -test. 
= p< 0.05. vs. untreated. 
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4.8. Blocking TNF -a activity inhibits LC migration induced by either 
UVB or cis -UCA. 
There is evidence in humans that UVB irradiation induces TNF -a production in 
the epidermis, as assayed in suction blister fluid, but that UVA1 does not (Skov et al 
1998a). As TNF -a is important in LC migration (described in section 1.3.1), and both 
UVB and cis -UCA are capable of inducing migration, it was decided to investigate the 
role of TNF -a following treatment with either. Anti -TNF -a was injected 
intraperitoneally into mice 2h prior to irradiation with 1 MED UVB or painting with 
201.1g cis -UCA. Epidermal sheets were taken at 24h (for maximal cis -UCA depletion 
and still significant UVB depletion). UVB irradiation of mice injected with normal 
goat serum resulted in 32% and 41% depletion of LC from the epidermis, for 
experiments 1 and 2 respectively. UVB irradiated mice injected with anti -TNF -a did 
not have altered LC numbers, with the frequency being reduced by only 7% and 9% 
relative to respective controls (shown in fig 4.9a). Fig 4.9b shows that LC retained a 
normal appearance if animals were injected with anti -TNF -a before UVB irradiation. 
Similar results were obtained from mice injected with anti -TNF -a before painting their 
ears with cis -UCA (see figs. 4.10a and 4.10b). LC frequency was reduced by 20% 
and 15% respectively following painting with 20µg cis -UCA. If mice were treated 
with anti -TNF -a 2h before application of cis -UCA, reductions in LC frequency were 
completely abrogated. 
4.9. Exogenous TNF -a increases LC depletion mediated by UVB, and 
provides a signal which can promote LC depletion in UVA1 irradiated 
mice. 
TNF -a was injected into the pinnae of mouse ears 0.5h before collecting the 
ears for ATPase staining of the epidermis. Injection of TNF -a resulted in LC 
depletion in the epidermis of mice (a 22.4% decrease from 0.1% BSA injected mice). 
Mice which were irradiated with UVB exhibited a 19.6% decline in LC within the 
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epidermis 24h later, whilst UVA1 irradiation had no effect. Mice injected with TNF -a, 
and irradiated 24h earlier, had LC depletion to a similar degree as TNF -a injection 
alone. Mice irradiated with UVA1 and injected with TNF -a had a LC frequency of 
325.5 per mm2. UVB irradiated mice and injected later with TNF -a had LC at a 
frequency of 300 per mm2 (see fig. 4.11a). UVA1 alone, as expected, had no effect 
on LC frequency. It is possible that the dose of TNF -a used in these experiments 
(1000 U) masked any endogenous protein released as a result of irradiation. 
Importantly, this experiment shows that UVA1 irradiation does not lead to a signal that 
inhibits the action of TNF -a. Fig. 4.11b shows the morphology of the LC remaining 
in the epidermis. 
4.10. Blocking IL -1ß activity inhibits LC migration induced by either 
UVB or cis -UCA. 
Another important cytokine involved in LC migration is IL -113. When the 
effects of this cytokine were neutralised by injecting anti -IL -lß 2h before 
UVB- irradiation, LC numbers and morphology were restored to normal. This can be 
seen in fig. 4.12. In UVB iradiated mice injected with normal goat serum, LC 
frequency was reduced by 31% and 26% respectively. There was no depletion of LC 
in mice injected with anti- IL -10. As with anti -TNF -a injection, injection of anti -IL -113 
2h before cis -UCA painting also inhibited depletion of LC from the epidemis, and this 
can be seen in fig. 4.13. Cis -UCA painting resulted in migration of 22% and 29% of 
LC from the epidermis in experiments 1 and 2 respectively, and this migration was 















Figure 4.9a. The role of TNF -a in UVB- mediated LC depletion. Mice were injected with normal 
goat serum or 2014 anti -TNF -a 2h before 1 MED (1440 J /m2) UVB irradiation. Four epidermal 
sheets from each group were prepared and stained for ATPase activity. * *= p< 0.01 vs. control, and 




Figure 4.9b. Blocking TNF -a inhibits alterations in LC morphology induced by UVB irradiation. 
Mice were injected with normal goat serum (1), or anti -TNF -a (2), before irradiating with 1 MED 
UVB. The morphology of LC remaining within epidermal sheets 24h after irradiation are shown 
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Figure 4.10a. The role of TNF -a in cis -UCA- mediated LC depletion. Mice were injected with 
normal goat serum (solid bars) or 20µg anti -TNF -a (striped bars) 2h before ear painting 20µg of 
either UCA isomer. Four epidermal sheets from each group were prepared and stained for ATPase 




Figure 4.10b. Blocking TNF -a inhibits alterations in LC morphology induced by cis -UCA painting. 
Mice were injected with normal goat serum (1), or anti -TNF -a (2), before painting the ears with 201.1g 
cis -UCA. The morphology of LC remaining within epidermal sheets 24h after cis -UCA application 
are shown (both magnifications are x 250). 
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Figure 4.11a. TNF -a induces LC migration in UVA irradiated mice, and enhances UVB- mediated LC depletion. Mice 
were irradiated with 1 MED (1440 J /m2) UVB or 1 MED (500 kJ /m2) UVA1. Mice were injected with 1000 U TNF -a 
or 0.1% BSA 0.5h before ear collection (24h after UV exposure). Four epidermal sheets from each group were prepared 
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Figure 4.11b. Morphology of LC remaining in the epidermis following various treatments. Mice 
were untreated (1), injected with TNF -a (2), irradiated with 1 MED UVB (3) or irradiated with 1 
MED UVA1 (4). The morphology of LC remaining within epidermal sheets 24h after irradiation are 
shown (all magnifications are x 250). 
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Figure 4.12. The role of IL -1(3 in UVB- mediated LC depletion. Mice were injected with normal goat 
serum or 201..tg anti- IL -113 2h before 1 MED (1440 J /m2) UVB irradiation. Four epidermal sheets from 
each group were prepared and stained for ATPase activity. * *= p< 0.01, vs. unirradiated control, and 
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Figure 4.13. The role of IL -1(3 in cis -UCA- mediated LC depletion. Mice were injected with normal 
goat serum (solid bars) or 20µg anti- IL -1(3 (striped bars) 2h before ear painting 2014 of either UCA 
isomer. Four epidermal sheets from each group were prepared and stained for ATPase activity. 
Results are shown as the mean ± SEM, *= p< 0.05, and * *= p< 0.01, vs. DMSO. 
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4.11. LC staining on the basis of MHC class II expression. 
Anti -class II MHC antibodies were titrated using single -cell suspensions of 
LNC or splenocytes, which were cytospun onto microscope slides. These cells were 
used as positive controls throughout. Initial experiments used a fluorescent secondary 
antibody for development. Fluorescence was visualised under a UV light microscope. 
Alternatively, samples were stained using a biotinylated secondary antibody, and 
developed with avidin -HRP followed by DAB (described in section 2.4.3). Attempts 
to stain for MHC class II antigens in skin sections or epidermal sheets were 
unsuccessful. Levels of background staining were high and showed a 'brick' -like 
pattern. This indicates that the keratinocytes bound antibody, and LC were not readily 
identifiable because of this (data not shown). 
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4.12. DISCUSSION 
IMMA has its imidazole and carboxyl functionalities permanently fixed in a 
configuration analogous to both trans- and cis -UCA (Houghtaling et al 1996). IMMA 
was capable of suppressing the DTH response to HSV when it was injected 5h before 
infection, as described in section 4.2. Like cis -UCA, the immunosuppressive effects 
of IMMA appeared to be dose -dependent. 
Norval and collegues showed that addition of a methyl group to position 2 of 
the imidazole ring of UCA abrogated immunosuppressive effects of cis -UCA (Norval 
et al 1989a). The side arm could be altered significantly (by reduction, or even 
replacement) with no loss of activity. Thus, it appeared that the 5- membered ring was 
necessary for immunosuppressive activity, perhaps by fitting into a receptor site. 
MeIMMA resembles IMMA, with the only alteration being addition of a methyl group 
at the 2- position of the imidazole ring. It was therefore anticipated that this analogue of 
UCA would have no immunosuppressive properties. However, MeIMMA did 
suppress DTH responses (figs. 4.1 and 4.2), and this was to a similar extent to 
cis -UCA. 
LC possess a Mgr- or Cam- dependent plasma- membrane ecto- adenosine 
triphosphatase (ATPase), and this was the marker used to identify LC throughout these 
experiments. Staining for MHC class H expression was also attempted, but the level 
of binding to keratinocytes in C3H/HeN mouse ears and skin did not allow LC 
identification by this method. Regardless, ATPase staining has many advantages over 
MHC class II staining in UV- irradiated samples. It is well documented that UVB 
causes an inflammatory response, and one of the predominating cell types in this 
infiltrate are monocyte/ macrophage cells (Hammerberg et al 1996; Meunier et al 
1995). Although there is a time delay before the inflammatory cell infiltration 
following UVB irradiation, the infiltrating monocyte/ macrophage cells do express 
MHC class II, and may therefore complicate identification of LC. Hammerberg and 
colleagues reported that 24h after a 1.1 MED UVB exposure, infiltrating 
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monocyte/ macrophage cells represented 1.2% of the total dermal cell population 
(Hammerberg et al 1996). The peak in infiltrating cell numbers occured 48 -72h after 
irradiation. It was anticipated, and observed, that UVB- treatment would result in a 
loss of dendrites on LC, and this would have made distinction between small, rounded 
LC and infiltrating macrophages difficult. Additionally, there is evidence that MEC 
class II expression may also be induced on keratinocytes (Nickoloff and Turka, 1994; 
Basham et al 1985). In contrast, ATPase enzyme protects LC from permeabilization 
upon exposure to extracellular ATP, whereas keratinocytes and macrophages (J774) 
are susceptible (Girolomoni et al 1992). Loss of ATPase activity correlates with an 
"activated" state, and application of a second contact sensitiser 24h after the first 
resulted in tolerance to the second (Hanua et al 1989). Therefore, ATPase activity may 
represent the best, single marker for both LC and their capacity to initiate immune 
responses. 
Noonan et al. found that ATPase positive cells were reduced 24h after 
irradiating mice on the back with narrow -band UVB (270, 290, 320 nm) (Noonan et al 
1984). Irradiating with 270 or 290 nm UVB led to a loss of dendrites and a decrease 
in the total epidermal LC, in dose -dependent fashion. A dose of 320 nm UV that 
caused 50% systemic suppression of CH did not deplete LC. Previous experiments 
within this laboratory demonstrated that chronic broad -band UVB (TL -12) (1000 J /m2, 
3 times per week) reduced LC by greater than 50% after 2 weeks, but this could not be 
reduced further with more exposures (El -Ghorr et al 1995). Narrow -band UVB 
(TL -01, 3000 J /m2, 3 times per week) depleted LC by 20% after 2 weeks. This 
gradually increased to 40% with further exposures (for up to 6 weeks). In the series 
of experiments detailed in this chapter it has been consistently shown that a single 1440 
J /m2 broad -band UVB irradiation can reduce LC numbers present in murine epidermis 
24h later by around 30 %. The reduction in LC frequency mediated by broad -band 
UVB was dose -dependent, and the peak in LC depletion occurred 12h after irradiation. 
A single 10,000 J /m2 exposure to narrow -band UVB (TL -01) resulted in a 38% 
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reduction 24h later. Local suppression of CH is influenced by the timing of hapten 
application after UVB exposure. In a previous study, Miyauchi and Horio found the 
optimal time to induce maximal suppression correlated with the time of minimal 
ADPase+ cells after 1000 J /m2 (3 days) (Miyauchi and Horio, 1995). The lamp used 
for their study had an emission spectrum of 275 -375 nm, with peak at 305 nm, and 
therefore resembles the output of the Philips TL -12 used in these experiments. The 
timecourse reported by Miyauchi and Horio is in conflict with that described in section 
4.5. In the experiments shown here, LC numbers were not significantly depleted, and 
were returning to normal levels, by 3 days after UVB exposure. One potential reason 
for this difference may be the source of the epidermal sheets used. Whereas epidermal 
sheets were derived from ears for all experiments described in this chapter, Miyauchi 
and Horio used UVB irradiated abdominal skin. Therefore, whereas ears do not have 
to be treated before experimentation, abdominal skin has to be shaved to remove fur. 
Additionally, ears are subject to incidental UVR via natural and artificial light sources 
within animal housing facilities, whilst abdominal skin is protected by its fur and 
anatomical position. This may provide a reason for the difference in LC numbers 
found in these experiments, using epidermal sheets from ears, and those of other 
groups, using abdominal sheets (a mean of 380 against around 800 per mm2). 
Abdominal skin is unlikely to have been exposed to UVR except in the earliest stages 
of a mouse's life, and may therefore be more sensitive to its effects. Ears are 
commonly exposed to some radiation, and may adapt. As such, the ears would 
represent a better model for the types of UV exposure that humans receive. Although 
mice in each individual experiment were age matched, ages ranged from between 7 -11 
weeks old between experiments. This may account for the variation in mean ATPase+ 
cells between experiments, with LC frequency increasing with age. Interestingly, 
Miyauchi and Horio also showed that old mice (26 weeks) are less susceptible to 
UVB- induced immune suppression than young mice (11 weeks) (Miyauchi and Horio, 
1995), and this may suggest adaptive mechanisms over time. 
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In contrast to the results shown in this chapter, some groups have shown 
reductions in LC numbers by UVA radiation. However, the protocols of exposure are 
often different, and many studies are further complicated by the use of psoralen. For 
instance, Aubin et al. used continued UVA exposure (99.5% emitted energy between 
320 -400 nm, 10 kJ /m2, 3 times per week for 4 weeks) in conjunction with the 
psoralen, TMAP (Aubin et al 1991). This regimen led to a decrease in ATPase +, Ia+ 
and Thy -1+ cells in the exposed skin of C3H mice. CH induction at the treated site 
was reduced, and this was related to impaired APC function in DLN (as shown by 
adoptive transfer of DLNC from irradiated mice into unirradiated recipients). Chronic 
UVA exposure alone also reduced ATPase +, la +, Thy -l+ cells, but had no effect on 
immune function (Aubin et al 1991). This was also observed in BALB /c mice. 
Polychromatic UV light, composed of environmentally relevant wavelengths, 
was found to disrupt the cytoplasmic microtubule complex in a dose -dependent 
manner. This did not correlate with the cytotoxicity of the UV light used. UVC did 
not alter microtubules at doses as high as 100 J /m2, but microtubules were disrupted 
after 3000 J /m2 UVA exposure (Noonan et al 1984). No changes could be seen in the 
actin microfilaments which stretch across the length of control and irradiated cells. 
UVA (320 -400 nm) isomerises UCA (El -Ghorr and Norval, 1999) but may not 
lead to immune suppression. A simple additive effect of UVAl, UVA2, and UVA1 +2 
was seen for trans -UCA isomerisation (Webber et al 1997). This indicates that failure 
to produce immune suppression is not due to complex wavelength interaction and/or 
the presence of an in vivo endogenous photosensitiser of UCA photoisomerisation. 
Webber and colleagues postulated that other factors, such as UVA blocking of signals 
generated downstream of cis -UCA, may be involved. 
Trans- to cis -UCA conversion can be seen with both broad- and narrow -band 
UVB lamps (EI -Ghorr et al 1995). The percentage of cis -UCA started to return to 
normal levels after 4 weeks (3000 J /m2, 3 times per week) of narrow -band UVB 
exposure, despite continued exposure. CH was suppressed only in mice that had 
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received broad -band UVB, suggesting that there was no correlation between cis -UCA 
and the CH outcome (E1 -Ghorr et al 1995). 
In the experiments described here, cis -UCA was also capable of depleting LC, 
but took longer to do so than UVB (maximal depletion was 24h after painting). There 
are many possible reasons for this delayed action. One simple explanation may be 
that, although mice have the epidermis gently tape - stripped before painting, cis -UCA 
may require time to permeate into the epidermis in this artificial system. A theoretical 
approach to estimate the distribution of cis -UCA after irradiation indicates that it may 
diffuse into the deeper layers of the human epidermis at a rate of 10" 12m2 /s (Krien and 
Moyal, 1994). Cis -UCA is formed immediately in the stratum corneum following UV 
irradiation, and may be able to mediate effects more rapidly. In experiments by 
Kurimoto and Streilein, LC were rounded up and possessed fewer dendrites as early 
as 5h after an intradermal injection of 2001.ig cis -UCA (Kurimoto and Streilein, 1992). 
Cis -UCA (20µg) did not result in as much LC depletion as UVB irradiation (1440 
J /m2) (an average of 20.8 %, ranging from 15.1 to 28.7% in 6 experiments, as against 
around 30% following UVB), even though it was applied at the high -end of 
physiological dosage (20µg per mouse ear). Untreated murine flank skin contains 
around 51.1g/cm2 UCA, with 4% in the cis isoform (0.2µg/cm2) (Norval et al 1988). 
This may indicate that cis -UCA acts in concert with other UVB-induced 
pathways/ mechanisms. It is possible that cis -UCA acts in a synergistic manner with 
UV- induced DNA damage to stimulate LC migration. Blocking, or lack, of either 
cis -UCA or DNA damage have been shown to prevent UVB- induced immune 
suppression (El -Ghorr and Norval, 1995; De Fabo et al 1999; Kripke et al 1992; 
Sutherland et al 1980), suggesting that they are not mutually exclusive. This could 
also explain the disparity in timecourses, as either mechanism (DNA damage or 
cis -UCA) alone could be less effective and take longer to act than UVB irradiation, 
which would induce both simultaneously. 
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When cis -UCA (2001.tg) was injected intradermally into C3H/HeN, C3H/HeJ, 
C57B1/6 or BALB /c mice, CH to DNFB painted on to the injected site is impaired (by 
up to 68 %). Staining for Ia expression in the epidermis 5h later revealed that LC had 
lost their dendrites and were rounded up, with frequency reduced in all strains (by 
25% compared with positive controls) (Kurimoto and Streilein, 1992). This 
immunosuppressive effect could be partially restored (CH to 73 %, and LC to 90 %, of 
the positive controls) by intraperitoneal injection of anti -TNF -a antibodies 2h before 
cis -UCA treatment (Kurimoto and Streilein, 1992). These experiments indicate that if 
LC can be retained in the site to be sensitised, CH responses are normal. The 
experiments described in section 4.8 also show the dependency of cis -UCA mediated 
LC migration upon TNF -a. This dependency is further extended to IL-lß in section 
4.10. 
Cis -UCA, even above physiological levels, could not augment phorbol 
12- myristate 13- acetate (TPA) induced synthesis of either TNF -a mRNA or protein in 
long -term cultured human keratinocytes (Redondo et al 1996). Skov et al. (1998a) 
showed that irradiation of human volunteers with 3 MED UVB led to a rapid increase 
in TNF -a concentration within suction- blister fluid, which was maximal 6h after 
exposure. UVA1 caused a slight decrease in TNF -a, although both UV regimens led 
to a slight increase in cis -UCA. Therefore, if UVA1 cannot stimulate TNF -a release 
or production, it may not provide an essential signal for LC migration. As discussed 
in section 4.6, and above, LC numbers were not depleted by exposure of mice to 
500,000 J /m2 UVA1. UVB does induce TNF -a secretion, and this and IL-113 are vital 
in UVB- mediated LC migration. Both these cytokines were shown to be important in 
cis -UCA mediated LC migration also. 
Enk and Katz identified a causal relationship between production of IL-113 by 
epidermal LC and the induction of epicutaneous sensitisation, by injection of 11-1ß 
(Enk and Katz, 1995). Epidermal cell suspensions prepared 4h after IL -1ß injection, 
or application of TNCB, produced almost identical cytokine mRNA profiles. There 
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was enhanced expression of MHC class II, TNF -a, IL -10, IL -la and even IL -113 
itself. Addition of IL -113 to keratinocytes (derived by washing non -adherent cells from 
epidermal cell cultures) resulted in increased TNF -a and IL -10, with a less pronounced 
IL -1a increase (Enk and Katz, 1995). Lymphocytes from UVR exposed mice 
produced less IL -2 and IFN -y when activated in vitro by antigen or anti -CD3 
(polyclonal T cell activation). IL -4 secretion was consistently elevated in comparison 
to normal controls. A similar change could be induced when mice were treated with 
LPS or IL-113. The ability of IL-113 to alter cytokine secretion was not a direct effect, as 
addition of IL-113 to cultures of antigen -primed T cells did not alter cytokine patterns 
(Araneo et al 1994). 
UVB not only alters the frequency of LC in the epidermis, but also has effects 
on LC function. In experiments by Dittmar and colleagues, UVB irradiation inhibited 
upregulation of B7 molecules on human LC derived from suction blister roofs after 
irradiation. These LC could not activate naive resting T cells. In contrast, UVA1 
exposed LC did upregulate B7, and were capable of stimulating naive T cells (Dittmar 
et al 1999). Antibodies to CD28 restored the stimulatory capacity of UVB irradiated 
LC. Experiments by Simon et al. showed that unirradiated BALB /c epidermal cells, 
LC, or splenic adherent cells, but not Ia epidermal cells, presented keyhole limpet 
hemocyanin (KLH) to both antigen specific Thl and Th2 cell lines. Irradiated 
epidermal cells and LC lost their ability to stimulate Thl cell lines, but retain APC 
function to Th2 cell lines (Simon et al 1990). UVB reduced the total number of Ia+ 
epidermal cells, but did not reduce intensity of staining on positive cells. 
UVA- mediated damage to membranes, proteins, DNA or other cell targets is 
predominantly related to oxidative stress. Clement- Lacroix and colleagues found that 
the APC function of cultured LC (measured by MECLR) was dose -dependently 
reduced by direct UVA exposure, at doses up to 20 J /m2 (Clement- Lacroix et al 1996). 
Overnight incubation with the anti -oxidant vitamin E partially protected against this 
immunosuppression, and reduced the number of thiobarbituric acid reactive substances 
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(TBARS) released into the supernatant (indicating reduced oxidative damage). This 
suggests that UVA can alter APC functions partly via generation of reactive oxygen 
species. 
As mentioned above and in section 1.3.3, macrophages infiltrate the skin 
following UVB exposure. Meunier and colleagues identified the macrophages 
infiltrating human skin after sunburn (3 days after 4 MED FS40) as having the 
extended phenotype CD 1 a CD lc" CD 11b+ CD 11 c+ CD36+ FcyR1I+ DR +) (Meunier et al 
1995). They observed that after UVR there was expansion of bone -marrow derived 
DR+ cells in the perivasculature and sub -basement membrane zone of the papillary 
dermis. Despite an overall expansion of DR+ cells, the CDIa+ CD 1c+ CD36" LC -like 
dendritic APC subset of dermal DR+ cells was depleted, indicating that LC loss was 
not accounted for by accumualtion within the dermis. In contrast, there was a selective 
expansion of the dermal macrophage subset, which is phenotypically identical to the 
population that appears in the epidermis after UVR injury. These cells derived not 
only from transcapillary migration, but also from in situ proliferation of a dermal 
precursor (Meunier et al 1995). These cells are capable of migration to DLN, as 
phenotypic experiments investigating hapten carriage after UVB suggest that hapten is 
presented by macrophage -like cells, rather than LC (Tang et al 1992). 
This chapter has shown that UVA1, at least at a dose of 500 kJ /m2 (1 MED), 
cannot deplete LC from murine epidermis. UVB, both broad- and narrow -band, and 
cis -UCA, can mediate LC depletion. This effect is dose -dependent, and is mediated 
via the cytokines IL-113 and TNF -a. Blocking of either cytokine abrogated the effects 
of either UVB exposure or cis -UCA painting on LC. LC frequency is significantly 
reduced as early as 6h after UVB irradiation, but may take longer following cis -UCA 
application. 
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4.13. Criticisms of experimental design and suggestions for further 
work 
It would have been ideal in all of the experiments detailed above to have 
corroborated findings by use of another LC marker. This was attempted for MHC 
class II staining, but did not yield any results (described in section 4.11). 
In the experiments described herein, it has been shown that UVB and 
cis -UCA, but not UVA1, mediate migration, or at least depletion, of LC from murine 
epidermis. The timecourse of LC depletion was established for UVB and potential 
effects by UVA1 were examined up to 96h after exposure. Depletion following 
cis -UCA painting was found to be maximal in these experiments 24h later, but the 
timecourse was not extended beyond this point (see fig. 4.8). It cannot be discounted 
that LC numbers continue to decline after this time, and therefore would have been 
useful to have extended the timecourse of investigation following cis -UCA painting. 
This was not undertaken as it had been anticipated that the timecourse would have 
more closely resembled that for UVB (so that LC numbers would have been 
recovering by 24h), and it has been reported previously that LC were significantly 
depleted by 5h after cis -UCA injection (Kurimoto and Streilein, 1992). 
Further investigation of the immune suppression mediated by IMMA and 
MeIMMA would have been interesting. These were shown to have been equally, if 
not more, immunosuppressive than cis -UCA in the context of the DTH response to 
HSV -1 (described in section 4.2). This was not examined in the context of CH 
responses, or LC depletion. A dose -response for effects of cis -UCA and its analogues 
on LC depletion would have provided useful data. 
The interaction of UV wavelengths is an area of much current interest. From 
the data provided in this chapter, it is clear that irradiating C3H/HeN mice with 1 MED 
UVAI before 1 MED UVB does not alter the depletion of LC mediated by UVB alone. 
Reeve and colleagues showed that in the same series of experiments in which this 
regimen provided photoimmunoprotection (Reeve et al 1998), the reverse exposure 
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protocol, irradiating with 1 MED UVB before 1 MED UVAl, also provided 
photoimmunoprotection. Examination of the effects of such a protocol on LC numbers 




Alterations in the accumulation of DC in DLN 
following UVA1 and UVB 
5.1 Introduction 
Dendritic cells (DC) found in DLN are believed to be the mature form of 
epidermal LC. DC aggregate with T cells within the DLN and form clusters. Freshly 
isolated LC are not capable of doing this, as the cells need a period of around 3 days to 
acquire this ability (Inaba et al 1986). It has been proposed that following UVB 
irradiation the ability of DC to present antigen is impaired, due to an inability to form 
T cell clusters (Muller et al 1994b). Vink and colleagues showed that UV- induced 
DNA damage plays a role in this impairment. When DC from irradiated and contact 
sensitised mice were injected into syngeneic recipients, there was a failure to induce 
CH in recipients upon challenge. By incubating DC in the presence of liposomes 
containing T4 endonuclease V (T4N5) or a photolyase to remove pyridimine dimers, 
the ability of DC from irradiated mice to induce CH in recipients could be restored 
(Vink et al 1996a; Vink et al 1997). Experiments on the murine epidermal- derived DC 
line, XS52, indicate that UVB irradiation prepares DC to undergo apoptosis upon 
contact with T cells (Kitajima et al 1996). The XS52 cells remained susceptible to 
T cell- mediated apoptosis 16h after irradiation with even small doses of UVB. The 
APC capacity of XS52 cells, using CD4+ T cell clones as responders, was inhibited by 
greater than 50% by irradiation with 5 -10 mJ /cm2 UVB (Caceres -Dittmar et al 1995). 
Pretreatment with catalase prevented the UV- induced inhibition of APC function, 
whereas exposure to hydrogen peroxide mimicked the effects of UV, thereby 
indicating a role for reactive oxygen species in UV- induced alteration of DC APC 
ability. 
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There exists a correlation between the number of DC arriving in DLN 24h after 
contact sensitisation and the magnitude of the induced T cell proliferative response 
(Kimber et al 1990c). UVB has been shown previously to induce DC accumulation 
within DLN. UVB suppresses the antigen presenting ability of DC, as shown by the 
reduced proliferative responses induced by these cells. This is not due to a reduction 
in Ia expression (Moodycliffe et al 1992), but costimulatory molecules may be altered. 
The cytokines IL-113 and TNF -a are important in induction of LC migration 
from the epidermis, and subsequent DC accumulation in DLN. In previous 
experiments there was no detectable alteration in ATPase+ cell numbers following 
UVA1 irradiation (see chapter 4). There is evidence that UVB irradiation induces 
TNF -a production in the human epidermis, but that UVA1 does not (Skov et al 
1998a). These experiments were conducted to investigate whether UVA1 and UVB 
were capable of increasing DC numbers in DLN for the site of exposure. The 
contribution of both cytokines was investigated in relation to DC increases induced by 
UVR. 
The aims of these experiments were - 
A. To examine the effects of UVA1 and UVB on DC accumulation in lymph nodes 
draining the site of exposure. 




5.2. An exposure of 2 MED UVB results in accumulation of DC within 
DLN. 
It has been shown previously that irradiating mice with UVB leads to an 
increase in DC numbers within DLN (Moodycliffe et al 1994). Preliminary 
experiments were performed to establish the technique of DC enumeration and to 
corroborate this finding. C3H/HeN mice were exposed to 2 MED UVB (2880 J /m2). 
Auricular lymph nodes were removed 48h later, and single -cell suspensions were 
prepared from pooled samples. DC were enriched by centrifugation on a 14.5% 
metrizamide gradient, as described in section 2.4.4. There was a substantial increase 
in total DLNC following UVB exposure, from 8.42 x 106 cells per DLN in 
unirradiated mice to 11.58 x 106 cells per DLN in irradiated mice (see fig. 5.1). This 
increase in total cells was accompanied by an even greater increase in DC per DLN, 
from 2,330 DC per DLN in unirradiated mice to 13,540 following a 2 MED UVB 
exposure. 
5.3. Both UVA1 and UVB result in an accumulation of DC in DLN of 
irradiated sites. 
It was next examined whether lower doses of UVB were capable of increasing 
DC numbers, and whether an equivalent dose of UVA1, in terms of MED, had the 
same effect. Mice were irradiated with either 1 MED UVA1 (500 kJ /m2) or 1 MED 
UVB (1440 J /m2), as described in section 2.1.6. Auricular lymph nodes were 
collected 24h or 48h later. As shown in table 5.1, DC were increased by both UV 
regimens. There was an approximate doubling of DC numbers in the DLN by 24h 
after UVB or UVA1 irradiation, and this value was not substantially increased at 48h 
after a 1 MED exposure. Total DLN cellularity was increased by 41% after UVA1, 
and by 86% following UVB, irradiation. It has been reported previously that DC were 
maximally increased 48h after UVB -irradiation (Moodycliffe et al 1992), but this was 
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not apparent from these experiments. 
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UNIRR. 2 MED 
UVB 
Figure 5.1. UVB induces DC accumulation in DLN. Mice were given a single exposure of 2 MED 
UVB and auricular lymph nodes collected 48h later. Control mice were unirradiated. Single -cell 
suspensions were derived from auricular lymph nodes, and total cells counted (solid bars). DC were 
enriched on a 14.5% metrizamide gradient before counting (clear bars). 
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Experiment DC/resting LN U VB % change U V A 1 % change 
24h 
1 1067 2186 +105 1857 +74 
2 997 2136 +114 1929 +93 
3 992 2214 +123 3450 +248 
4 1923 4149 +116 3606 +88 
48h 
1 5160 9319 +81 13320 +158 
2 2800 9150 +227 4320 +54 
3 4180 6075 +45 4600 +10 
Table 5.1. UVA1 and UVB irradiation induce an accumulation of DC in DLN. Mice were given a 1 
MED exposure of either UVB or UVA1, and DLN collected 24h or 48h later. Control mice were 
unirradiated. DC were enriched on a 14.5% metrizamide gradient before counting. Results from 
several individual experiments are shown as the mean DC per DLN, and the percentage change from 
their respective control (unirradiated) mice, within individual experiments. 
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5.4. Blocking of TNF -a inhibits DC accumulation as a result of UVB 
irradiation, but has no effect on UVA1- induced accumulation. 
It was shown previously that intraperitoneal injection of anti -TNF -a could 
prevent the depletion of ATPase+ cells from the epidermis if given prior to UVB (see 
section 4.8). It was therefore of interest to examine whether injection of the same 
antibody could prevent DC accumulation in DLN. It can be seen in fig. 5.2 that in 
mice given anti - TNF -a, there was significant abrogation of the increase in DC as a 
result of UVB exposure. In experiment 1, UVB resulted in a 133% increase of DC 
within DLN over DC numbers found in unirradiated mice (2136 DC per DLN vs. 
997). In mice given anti -TNF -a, there was only a 9% increase in DC within DLN 
from UVB irradiated mice over DC numbers found in unirradiated mice (1257 DC per 
DLN vs. 1153). In a second experiment, UVB caused a 123% increase in DC within 
DLN, but this was reduced to a 36% increase in mice treated with anti -TNF -a. There 
was no significant difference in the numbers of DC per DLN from UVA1 exposed 
mice and those recovered from UVA 1 exposed mice treated with anti -TNF -a. In 
experiment 1, the increase in DC numbers induced by UVA1 alone was 93% (1929 
vs. 997 DC per DLN), and despite being reduced to a 45% increase in mice treated 
with anti -TNF -a, this was not significant. In a second experiment, UVA1 irradiation 
caused a 248% increase in DC within DLN, and this was only very slightly, and 
non -significantly, reduced by anti -TNF -a, to a 236% increase. 
5.5. Blocking of IL -113 inhibits DC accumulation as a result of either 
UVB or UVA1 irradiation. 
LC migration from the epidermis following UVB exposure was shown in 
section 4.10 to be dependent on IL -1 f3 as well as TNF -a. The effect of blocking IL-113 
by the use of specific antibodies was therefore examined. When anti -IL -113 was 
injected 2h prior to either UVA1 or UVB irradiation, subsequent accumulation of DC 
within the auricular lymph nodes was inhibited. These results are presented in 
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fig. 5.3. In mice which were injected with normal goat serum and were not irradiated, 
1067 DC per DLN were found. Injection with anti -1L -113 reduced this slightly, but not 
significantly. UVB irradiation of mice injected with normal goat serum increased DC 
numbers by 103% to 2186 per DLN, with injection of anti -IL -113 preventing this 
increase (1029 DC per DLN). UVAI irradiation of mice injected with normal goat 
serum increased DC numbers by 74% to 1857 per DLN, with injection of anti-IL-113 
similarly preventing this increase (929 DC per DLN). 
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Figure 5.2. Anti -TNF -a reduces DC accumulation following UVB, but not UVA!, irradiation. Mice 
were injected intraperitoneally with 2014 anti -TNF -a or normal goat serum 2h before irradiating. 
Mouse ears were given a single exposure of either 1 MED UVB or 1 MED UVA1, and DLN collected 
24h later. *= p< 0.05 and * *= p< 0.01, vs. unirradiated control, §= p< 0.05 and § §= p< 0.01, 
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Figure 5.3. Anti -IL -113 reduces DC accumulation following UVB and UVA1 irradiation. Mice were 
injected intraperitoneally with 201.tg anti- IL -113 or normal goat serum 2h before irradiating. Mouse 
ears were given a single exposure of either 1 MED UVB or 1 MED UVAl, and DLN collected 24h 
later. *= p< 0.05 and * *= p< 0.01, vs. control, §= p< 0.05 and § §= p< 0.01, vs. same treatment 
without antibody. 
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5.6. The effect of TNF -a on DC migration following UVB or UVA1 
exposure. 
Cumberbatch and Kimber showed that injection of TNF -a induces migration of 
LC from the epidermis (Cumberbatch et al 1997a) and an accumulation of DC within 
the DLN (Cumberbatch and Kimber, 1992). Alternatively, injection of antibodies 
against TNF -a can inhibit the frequency of DC within DLN of contact sensitised mice. 
Subsequent CH responses were also impaired in these mice (Cumberbatch and 
Kimber, 1995). Using the same methods, it has been shown that TNF -a is a critical 
factor in accumulation of DC within DLN of UVB irradiated mice (Moodycliffe et al 
1994). As it appears that TNF -a is not necessary for accumulation of DC within DLN 
following UVA1 irradiation (see section 5.4), it was anticipated that injection of 
TNF -a would enhance DC accumulation above that induced by UVA1 alone. 
Conversely, TNF -a was found to be critical in UVB- induced accumulation of DC, and 
it was anticipated that injection of this cytokine would have no marked effect on the 
number of DC within DLN. 
In these experiments, mice were irradiated 24h, and injected with TNF -a 4h, 
before collecting DLN. The results of this are shown in fig. 5.4. TNF -a injection 
caused a marked increase of DC numbers, up to 8060 DC per DLN from 1925 in 
unirradiated mice injected with 0.1% BSA. As expected, DC were increased in mice 
exposed to 1 MED UVB (by 116% to 4149) and in UVA1 irradiated mice (by 88% to 
3606). These levels of accumulation are in agreement with those reported earlier (see 
section 5.3). TNF -a injection into irradiated mice further increased the number of DC 
per DLN, to 8685 in UVB irradiated mice and to 9835 in UVA1 irradiated mice. 
Therefore, UVA1, but not UVB, irradiation, appears to augment the accumulation of 
DC in DLN of TNF -a injected mice. 
Mice exposed to 1 MED UVA1 followed immediately with 1 MED UVB 
exhibited DC accumulation (an increase of 98% over unirradiated control mice to 3806 
DC per DLN) (also shown in fig. 5.4). This increase was therefore comparable to 
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irradiation with either spectrum alone (UVB = 116% increase; UVA1 = 87% increase). 
This result can be interpreted in 2 ways. Firstly, UVA1 and UVB act on the same cells 
and therefore result in similar accumulation of DC, with the accumulation not being 
additive. Secondly, UVA1 exposure results in accumulation of one population of DC, 
and inhibits accumulation of another population of DC following UVB exposure. In 
conjunction with the data found following TNF -a injection, this experiment provides 
tentative evidence that UVA1 acts on a different DC population than UVB and TNF -a. 
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An increase in lymph node DC after UVA1 exposure could be detected (section 
5.3), but there was no reduction or alteration in ATPase+ cell numbers in the epidermis 
(section 4.2). Taken together, these data suggest that UVA1 may act on a cutaneous 
APC population other than LC. To investigate this possibility, it was decided to 
attempt to examine potential effects on dermal DC. Unfortunately, dermal DC in the 
mouse comprise a large number of cell types and without defined phenotypic markers. 
Therefore, macrophages infiltrating the skin after UV irradiation may be misinterpreted 
as dermal DC, as might LC migrating out of the epidermis. This infiltrate is maximal 
by 48 -72h after UVB irradiation (Meunier et al 1995). One technique to evade both 
these problems is to study cells which have migrated out of the ear during an ex vivo 
culture period, thereby removing the possibility of a macrophagic infiltrate. 
The rationale behind this approach was to use spontaneous migration of cells 
from split ear halves as a starting value, representing APC capacity. DC were 
identified by morphology under a light microscope. This technique has been used by 
Larsen and colleagues to obtain migratory cells from the dermis for functional studies 
(Larsen et al 1990). Subsequent treatment would reduce the number of LC within the 
ears and therefore reduce the number of DC recoverable by floating the ears on 
RPMI -FCS. 
For instance, it has been shown in chapter 4 that UVB irradiation results in 
migration of LC from the ear in vivo. If ears were taken at a time before macrophage 
infiltration could occur, there would be fewer DC within the ear, and therefore fewer 
recoverable DC following floating on RPMI -FCS. It was postulated that UVA1 would 
act on a cell population other than LC, also resulting in migration out of the ear in vivo. 
Therefore, UVA1 would similarly result in fewer cells available for migration into 
RPMI -FCS upon floating. Finally, if ears were irradiated with both UVB and UVAl, 
there would be migration of both cell populations in vivo. There would be an additive 
effect and therefore even fewer recoverable DC than with either irradiation protocol 
alone. This would provide at least circumstantial evidence for UVB and UVA1 acting 
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on different cell types in vivo. A schematic representation of this theory is shown in 
fig. 5.5. Experiments were conducted to establish the feasibility of such an approach. 
5.7. DC migration from ear halves is a quantifiable method and 
suitable for investigation of UVR effects. 
Preliminary experiments investigated whether DC could be recovered from 
RPMI -FCS. Ears were taken and split into halves, then floated on RPMI -FCS. 
Supernatants were collected and cells washed by centrifugation. Recovered cells were 
counted under light microscopy, and DC identified. DC were recoverable after 24h in 
numbers ranging from 4500 to 6000 cells per ear (data not shown). By 96h of culture 
RPMI -FCS became contaminated due to deterioration of the ear half and DC could not 
be recovered. 
The next series of experiments investigated whether it was possible to alter the 
number of recoverable DC. Mice were contact sensitised by applying 20 pl 1% Ox to 
both ear surfaces, the ears immediately removed and split into halves with forceps. 
Ear halves were then floated on RPMI -FCS for 24h, allowing for spontaneous 
migration of DC from ear halves. Medium was then removed, washed by 
centrifugation and DC counted by light microscopy. The number of cells recovered 
from the medium are shown in fig. 5.6. DC numbers were not significantly altered by 
this technique, presumably because cells were not allowed enough time migrate in 
vivo. When ears were left in vivo for 1 day following contact sensitisation before 
removal, DC numbers recovered by floating on tissue culture medium for a further 24h 
were reduced (see fig 5.6). This indicates that this system may be utilised as a 
quantitative measure of DC remaining in the ear various times after treatment. Due to 
time constraints, such experiments involving exposure to various UV regimens were 
not pursued. 
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1. In vivo treatment = 
unirradiated 





3. Spontaneously migrated cells recovered = 
UVA1 UVB, UVA1 
Q 
X X - B X - A X-C 
4. Cells migrated due to treatment = 
B A C 
If A = B = C, this would suggest A and B are the same cells. 
If C > A or B, this would suggest the cells are from different populations, 
but if C < A + B, this would suggest some of the cells are the same. 
Fig. 5.5. A schematic diagram to explain the theory for investigating DC which spontaneously 











Figure 5.6. There is a detectable reduction of DC recovered from RPMI -FCS if ears are left for 24h 
after contact sensitisation. Mouse ears were contact sensitised by dropping 25111 1% Ox or A00 on 
to both surfaces. Ears were removed either immediately (Oh) or 24h later (24h), and split into halves 




In agreement with previous studies (Moodycliffe et al 1992; Moodycliffe et al 
1994) there was an accumulation of DC within DLN following UVB irradiation (see 
sections 5.2 and 5.3). This effect was dependent on TNF -a and IL -lß, as 
neutralisation of either inhibited the DC increase. This is shown in figs. 5.3 and 5.4 
respectively. There was an unexpected increase in DC within DLN after UVA1 
exposure (described in section 5.3). This was to a similar degree as the accumulation 
induced by an equivalent dose of UVB (assessed by erythema). There are a number of 
potential APC within the dermis, and it is possible that the more penetrative abilities of 
UVA1 allow it to act on one or more of these cell types to induce their migration to 
DLN. Only antibodies to IL -lß, but not TNF -a, prevented DC accumulation after 
UVA1 (see sections 5.4 and 5.5). The most likely candidate as an APC to mediate 
UV- induced immune suppression is dermal DC. 
TNF -a was not necessary for accumulation of DC within DLN following 
UVA1 irradiation, as injection of neutralising antibodies into UVA1 irradiated mice did 
not prevent DC accumulation (see section 5.4). As such, it was investigated whether 
injection of TNF -a could augment the accumulation of DC within DLN of irradiated 
UVA1 alone. It is of interest that TNF -a injection into mice which had been exposed 
to UVB caused only a small increase in DC per DLN above that induced by TNF -a 
injection alone. This was from 8060 in unirradiated mice to 8685 in UVB irradiated 
(an increase of only 625 DC). This increase is probably due to 1 MED UVB not 
inducing secretion of maximal concentrations of TNF -a, so that injection of exogenous 
TNF -a may act on cells not affected by UVB to induce their migration and subsequent 
arrival in the DLN. The increase in UVA1 irradiated, TNF -a injected mice was 1775 
above that induced by TNF -a alone (see section 5.6). In comparison with unirradiated 
mice, UVA1 caused an 87% increase in DC per DLN from 1925 to 3606 (therefore 
1681 more DC per DLN). These values (a 1681 increase with UVA1 over control 
mice, and a 1775 increase over TNF -a injected mice) further strengthen the argument 
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that UVA1 may promote DC accumulation in DLN independently of TNF -a. 
Treatment of mice with 1 MED UVA1 followed immediately by 1 MED UVB did not 
result in DC numbers equivalent to addition of either irradiation protocol alone, but 
rather equivalent to only UVA1 exposure (see fig. 5.4). This may indicate that UVA1 
induces a signal within the skin which inhibits the action of the subsequent UVB 
exposure. 
The efficiency of CH sensitisation is impaired when contact sensitisers are 
applied to skin naturally deficient, or depleted, of LC. There is evidence that a second 
pathway of cutaneous antigen presentation exists. Ia+ DC, present in the perivascular 
region of the mouse dermis, when hapten -derivatised, are capable of inducing CH in 
naive mice (Tse and Cooper, 1990). Thus, if UVA1 depleted these cells, it may impair 
subsequent immune responses. 
Alternatively, there also exists a population of Thy -1 +, Iá cells, exhibiting a 
dendritic morphology, within the murine epidermis. It has been suggested that the 
ratio of these cells to LC influences the intensity of CH (Bigby et al 1987). Sullivan 
and colleagues showed that adoptive transfer of hapten -derivatised Thy -1+ DC 
specifically downregulated contact sensitisation (Sullivan et al 1986). If UVA1 could 
initiate migration of these cells to DLN, it may alter the ratio of respective APC and 
interfere with later immune responses. Chronic UVA (10 kJ /m2, 3 times per week for 
4 weeks) has been shown to reduce Thy -1+ cells from murine epidermis (Aubin et al 
1991). This would also provide a possible explanation as to why Reeve et al. (Reeve 
et al 1998; Reeve et al 1999), when using interacting UV wavelengths, observe 
immune protection. In their experiments CH responses in mice were not inhibited if 
the mice were irradiated with UVA before contact sensitisation, but were if mice 
received UVB before sensitisation. Furthermore, if mice were irradiated with UVA 
followed immediately by UVB, before contact sensitisation, CH responses elicted later 
were less suppressed than those in mice given only UVB. It could be that both subsets 
of cells (Thy -1 +, Iá, and LC) would appear in DLN around the same time. Further 
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studies have indicated that the immunoprotective activity of UVA in this system is due 
to the induction of heme oxygenase. This molecule protects tissues from oxidative 
stress. Heme oxygenase progressively increased in UVA irradiated skin, but when 
expression was blocked, the immunoprotective effect against UVB or cis -UCA was 
abrogated (Reeve and Tyrell, 1999). 
An inflammatory infiltrate, consisting of lymphocytes and macrophages, is 
localised around the vessels of the upper and mid dermis following UVA 1 exposure 
(Lavker and Kaidbey, 1997), indicating that a signal is induced deep in the skin. 
Young and colleagues identified that irradiation of human skin with monochromatic 
light of 300 nm results in DNA damage in dermal cells (Young et al 1998). Therefore, 
it seems unlikely that pyridimine dimers are involved in initiation of the signal. This 
signal is not dependent on TNF -a, as antibodies to neutralise this cytokine did not 
inhibit DC accumulation following UVA1 exposure. TNF -a is neither chemotactic nor 
chemokinetic for macrophages (Webb et al 1996), so blocking of activity may not alter 
this infiltrate, but possibly affect subsequent interactions or cytokine release. Blocking 
IL -lß may prohibit activation of infiltrating macrophages. Another possible reason for 
migration of these cells as opposed to LC may be differential effects on adhesion 
molecules which act to retain the cells in the dermis. LC express a6 integrin, whereas 
DC do not, and antibodies against a6 integrin inhibit Ox and TNF -a induced LC 
migration from the epidermis (Price et al 1997). TNF -a causes LC to round up in the 
epidermis of mice treated with antibodies against a6 integrin, but does not induce 
migration. Dermal DC may express different adhesion molecules than LC and may be 
more susceptible to IL -113, but not TNF -a, induced migration. 
Dermal macrophages are induced to proliferate and infiltrate the epidermis 
following UVB- induced injury. Meunier and colleagues (1995) recognised that, after 
exposing humans to a 4 MED UVB, there was an expansion of CD45 +DR+ 
(macrophage) cells around the vasculature. This change could be seen as early as 24h, 
and was maximal between 48 and 72h, after irradiation. Three days following 
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irradiation, the CD36+ macrophage subset represented 53.3% of dermal DR+ cells, 
whereas they represented 18.3% of this population in unexposed skin. Experiments 
by Tang and colleagues suggest that these cells are capable of migration to DLN, as 
phenotypic experiments investigating hapten carriage in mice after UVB irradiation 
indicate that hapten is presented by macrophage -like cells, rather than LC, in DLN of 
the irradiated mice. Whereas 49% of DLN DC had Birbeck granules in FITC 
sensitised mice, this fell to 11% in mice which had been irradiated before FITC 
sensitsation (Tang et al 1992). 
Moodycliffe et al. (1992) showed that UVB irradiation alone induced DC 
migration to DLN, and UVB prior to contact sensitisation at the same site enhanced 
migration. The percentage of DC bearing ETC and the quantity of FITC per cell was 
unaltered by UVB irradiation. Additionally, UVB did not alter Ia expression on 
FITC- bearing DC. Neither UCA isomer (even above physiological levels, 100 -200 
µg/mouse) had an effect on DC numbers in lymph nodes of sensitised or unsensitised 
mice (Moodycliffe et al 1992). 
UVB not only alters DC numbers, but can change the antigen presenting ability 
of DC. A UVB dose in excess of 1000 J /m2 inhibits the stimulation of primary T cell 
responses by DC from human blood to alloantigen by 60 -70% (Young et al 1993). 
The effect was 2- or 3 -fold greater on MLR than in polyclonal mitogenesis, using 
comparable DC numbers and UVB doses. Costimulatory molecules (B7, ICAM -1) 
were reduced in a dose -dependent manner, although cell viability was unaffected. 
Sufficient contacts to prime T cell responsiveness to IL -2 could be formed, although 
subsequent proliferation was severely impaired without supplemental lymphokines. 
T cell alloreactivity was preserved in the secondary response (Young et al 1993). 
In experiments by Noonan and colleagues, the APC function of splenic DC 
was tested after either a single 27 kJ /m2 UVB exposure or intravenous injection of 
50 -200µg cis- or trans -UCA per mouse. Splenic DC (65 -90% la +, 8 -11% FcR +, <2% 
Thy -1.2 +) were obtained by density centrifugation and pulsed with DNP6 ovalbumin, 
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then the proliferative response of T cells derived from mice immune to DNP6 
ovalbumin measured. Splenic DC from UVB- irradiated or cis -UCA treated mice had 
significantly impaired APC function, whereas those from trans -UCA mice had normal 
ability (Noonan et al 1988). This was despite the DC having the same Ia expression. 
Mixtures of DC from irradiated or cis -UCA treated mice with normal DC did not 
impair APC function. A time delay for the onset of defective APC function was 
required, as DC taken 3 days after irradiation had normal activity, whilst those taken 7 
days later were suppressive. Direct addition of cis -UCA to in vitro proliferation assays 
was without effect, nor did addition of indomethacin, to inhibit prostaglandins, have 
any effect. This may indicate that essential mediators are not available once cells are 
removed from UVB- exposed mice. 
An experimental protocol to investigate potential effects of UVA1 on cutaneous 
APC populations other than LC were established. The method of floating ear halves 
on RPMI -FCS is used to obtain migratory cells from the dermis, traditionally for 
functional studies. Larsen and colleagues discovered that the majority of migratory 
leukocytes were Ia+ LC, with the remainder comprised of Thy -1 +, CD3 +, CD4 ", CD8 -, 
dendritic epidermal cells and a small population of Iá , CD 11 a 18+ macrophages (Larsen 
et al 1990). The number of migratory cells was 8,000 -10,000 per ear per day, from 
C57B1/6 mouse ears. In the preliminary experiments reported here (section 5.7), cell 
recovery was 4500 -6000 per C3H/HeN mouse ear, within 24h of floating. As cells 
migrate spontaneously from ear halves upon floating, the rationale behind this 
experimental protocol was that a reduction in cell numbers recovered ex vivo, would 
indicate an earlier migration of cells in vivo. Recoverable cell numbers could be 
reduced by topical application of 1% Ox 24h before ear collection, but not if ears were 
removed immediately after contact sensitisation (see fig. 5.6). When assessed with 
data on LC migration, these observations suggest that contact sensitisation induced 
migration of cells from the ear within 24h. As the number of migratory cells was 
reduced at 24h, replenishment of LC or recruitment of other cells would appear not to 
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have occurred. Thus, the immunostimulatory capacity of the ear as a whole would be 
reduced. The theory behind tentative identification of different cell populations by this 
technique is explained in fig. 5.5. 
5 9. Criticisms of ex s erimental desi n and su s s estions for further 
work 
The experiments described in this chapter detail the role of IL-113 and TNF -a in 
UV- induced DC accumulation within DLN. As there appears to be a difference in 
dependency of these cytokines following UVB irradiation compared with UVA1, it 
was informative to perform additive experiments. Using both UV exposures, it could 
be determined whether the number of DC within DLN was increased by the same 
magnitude as the increase in UVB irradiated mice PLUS the increase in UVA1 
irradiated mice. Such an experiment was performed with a 1 MED UVA1 exposure 
followed immediately by 1 MED UVB. This result showed that DC accumulation was 
not the equivalent of DC accumulation induced by UVA1 plus DC accumulation by 
UVB. When assessed with DC accumulation following TNF -a injection, it can be 
argued that UVA1 may inhibit actions of subsequent UVB irradiation. Due to time 
constraints and the number of mice involved in such an experiment, the reverse 
exposure regimen i.e. UVB followed by UVA1, was not performed. It would be 
anticipated that such an experiment would give DC accumulation suggestive of an 
additive effect, as any blocking effects mediated by UVA1 would be delivered after 
UVB. 
Functional assays such as MLR would provide information on the 
immunostimulatory capacity of these apparently different DC populations. Experiments 
by Dittmar et al (1999) indicated that UVB irradiation prevents the upregulation of B7 
on LC, but that UVA1 does not. Lack of B7 expression is associated with clonal 
anergy (Gimmi et al 1993). Additionally, phenotypic analysis, by the use of 
monoclonal antibodies and EPICS, would provide important information on the 
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immunostimulatorY molecules expressed on the DC populations. Ia expression on DC 
accumulating in DLN following UVB does not appear to differ from that on normal 
DC, with both sets of cells presenting the same amount of FTTC after contact 
sensitisation (Moodycliffe et al 1992). 
Previous experiments by Moodycliffe and colleagues (1992) showed that the 
maximum accumulation of DC within DLN of irradiated mice occured 48h after 
exposure. Although this was not observed in these experiments, where the increase at 
24h was proportionally the same as that observed at 48h, it may be constructive to 
have investigated UVA1 induced accumulation over time. The hypothesis that UVA1 
can induce accumulation of a dermal DC population may be conducive to arrival of 
these DC in the DLN before epidermal LC. 
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Chapter 6 
Cytokine and ICAM -1 expression in the skin 
following UVB or UVA1 irradiation 
6.1 Introduction 
CH and DTH are Thl -like cytokine mediated immune responses, and as such, 
suppression may be mediated through an altered cytokine balance, leading to Th2 cell 
growth or activation. This may be in the form of altered antigen presentation, by way 
of an altered microenvironment, in which specific T cells are activated. The effects of 
UV exposure on LC and DC have already been discussed (see chapters 4 and 5 
respectively). This chapter will detail effects on cytokine and adhesion molecule 
(ICAM -1) expression in the skin following UV exposure. 
Interleukin -10, as discussed in section 1.10.3, is an important cytokine in the 
development of Th2 -like immune responses, promoting humoral immunity. IL -10 can 
act on APC, rendering LC tolerogenic and downregulating class II MHC expression 
on macrophages. The importance of IL -10 has been shown in maintenance of 
tolerance in the gut, as IL -10 deficient mice develop inflammatory bowel disease 
(Kuhn et al 1993). 
Induction and expression of IL -10 following high dose UVB was investigated 
by various techniques; immunoperoxidase staining of mouse skin samples and mouse 
skin cell lines (PAM -212 and B 16), ELISA of skin homogenates, cell line supernatants 
and lysates, and PCR of skin sample homogenates. 
Intercellular adhesion molecule (ICAM) -1 (CD54) can be expressed on 
keratinocytes. ICAM -1 is the ligand for both leukocyte function associated antigen 
(LFA) -1 (CD 11 aCD 18) and Mac -1 (CD 11bCD 18), which are commonly expressed on 
T cells and cells of the monocyte/ macrophage lineage respectively. Thus, ICAM -1 is 
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important in attraction, and maintenance, of these cells at sites of expression. It is 
proposed that UV may modulate immune responses by altering ICAM -1 expression 
and the subsequent cellular infiltration. It is also possible that UCA, and/or histamine 
(Mitra et al 1993), may affect the level of ICAM -1 expression following irradiation, 
and this has been investigated. 
Finally, TNF -a is implicated in regulation of ICAM -1 expression and in 
migration of LC from the epidermis (see sections 4.8 and 4.9). IL -1ß is also involved 
in LC migration following UVB exposure. Expression of IL -113 and TNF -a mRNA in 
irradiated ears was examined by PCR, following either UVA1 or UVB exposure. 
Samples of irradiated skin, together with supernatants and lysates of cultured cell lines 
or primary epidermal cells were examined for TNF -a protein. 
The aims of these experiments were - 
1. To examine the source(s) of cutaneous IL -10, and its role in suppression of DTH, 
following UVB irradiation of mice. 
2. To examine differences in cytokine gene expression in the skinfollowing either 
UVA1 or UVB exposure of mice. 




The role and source(s) of IL -10 in UVB- mediated immune suppression. 
6.2. The role of IL -10 in UVB and cis -UCA mediated suppression of 
DTH responses. 
These experiments were conducted to examine the role of IL -10 in the 
immunomodulation induced by UVB exposure and cis -UCA application on DTH 
responses. Mice were irradiated with 1500 J /m2 UVB, 4h before injection with 
anti- Th -10. Three days later mice were infected with HSV -1. When the DTH 
response was elicited 10 days later by injecting HSV -1 antigens into the ear pinnae, it 
was found that the DTH response was significantly suppressed by UVB treatment 
(p= 0.001 and p= 0.014, vs. positive controls in individual experiments). 
Suppression was measured at 61% and 59% within individual experiments. 
Suppression was enhanced in mice that had been injected with antibodies to IL -10, to 
91% and 85% respectively. This enhancement was significant in only one UVB 
experiment (p= 0.029, vs. UVB and control serum in experiment 1). This is shown in 
fig. 6.1. In parallel experiments, 100µg cis -UCA was injected subcutaneously into 
groups of mice, and mice injected with anti -IL -10 or control serum 4h later. One hour 
later, HSV -1 infection was established by injecting mice with 5 x 105 pfu HSV -1 
subcutaneously. The DTH response of these mice is also shown in fig. 6.1. In one of 
two experiments, cis -UCA suppressed the DTH response (by 39 %; p= 0.02, 
vs. positive control). Injection of anti -IL -10 4h after cis -UCA exposure increased the 
suppression to 70% and 17 %, although this was not significantly different from 
suppression induced in cis -UCA and control serum treated mice. Therefore, in these 
experiments injection of antibodies to neutralise IL -10 did not reverse UVB or 
cis -UCA mediated suppression of the DTH response to HSV. This suggests that 
IL -10 does not play a role in UVB- mediated suppression of DTH to HSV. 
The antibodies against IL -10 used in this experiments were used in preliminary 
studies to investigate immunoperoxidase staining of cells for IL -10 expression, and 
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although not used for later investigations, did result in staining of IL -10. The SXC -1 
clone secretes rat anti -mouse IL -10 (Mosmann et al 1990), and has previously been 
shown to have neutralising effects on IL -10 (Rivas and Ullrich, 1992; Rivas and 
Ullrich, 1994). 
6.3. IL -10 in the serum of UVB irradiated mice. 
C3H/HeN mice were irradiated with 7 MED (10 kJ /m2) UVB on the shaved 
backs and serum collected at daily intervals thereafter. IL -10 content of the sera was 
measured by ELISA, as described in section 2.3.3. As can be seen in fig. 6.2, IL -10 
protein was detectable at all times. IL -10 dropped from levels found constitutively in 
these mice by 1 day, but then peaked between 3 and 4 days following UVB exposure. 
IL -10 protein level was at its highest in serum taken 7 days after irradiation. The drop 
one day following UVB exposure may be due to IL -10 secreting cells being removed 
from the circulation, such as recruitment of macrophages (Kang et al 1994) or T cells 
(Di Nuzzo et al 1998) to irradiated sites. The peak at day 3 -4 correlates with the time at 
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Figure 6.1. UVB or cis -UCA suppressed the DTH response to HSV -1, and this was not restored by 
neutralising IL -10 antibodies. Mice (n =8) were irradiated with 1500 J /m2 UVB, and injected with anti - 
IL-10 or control serum (0.1% BSA) 4h later, 3 days before HSV -1 infection. Mice were injected 
subcutaneously with the 100µg cis -UCA 5h before, and injected with anti -IL -10 or control serum lh 
before, HSV -1 infection. Mice were infected by subcutaneous injection with 5 x 105 HSV pfu. DTH 
was elicited 10 days later by injecting 2 x 105 pfu inactivated HSV into the pinnae of each ear. 
Increases in ear thickness were measured 24 hours later. Pre- and post -challenge measurements of ear 
thickness were made and the mean increase in ear thickness used as a measure of the DTH response. 
Results are expressed mean ± SEM for each group. Significant differences between the positive 
control and treated groups were determined by Student's t -test; *= p <0.05 and * *= p< 0.01, vs. 
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Figure 6.2. IL -10 is present in the serum of UVB irradiated mice. Mice were irradiated with 10 
kJ /m2 and sera collected from 2 mice at various times after exposure. IL -10 content was measured 
by ELISA, as described in section 2.3.3. 
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The actual source of IL -10 within irradiated skin is the subject of great debate, 
with potential candidates including keratinocytes (Rivas and Ullrich, 1992), 
melanocytes (Teunissen et al 1997), T cells and macrophages (Kang et al 1994). 
Experiments were conducted to try and establish sources of IL -10 in UVB- irradiated 
mouse skin. 
6.4. IL -10 protein expression in skin samples from UVB exposed 
mice. 
Mice were irradiated with 3 or 5 MED UVB on their back skin, one day after 
shaving. Samples of dorsal skin were taken at various times following exposure, and 
were homogenised as described in section 2.3.1. ELISA of supernatants from skin 
homogenates were inconsistent in the concentration of IL -10 /g skin (wet weight) 
recovered, but commonly showed increased IL -10 within the first 24h following 
irradiation. A representative experiment is shown in fig. 6.3. This result suggests that 
IL -10 is released by cells resident to the skin following UVB irradiation, as the time of 
increased expression is too early for infiltrating cells to participate. Furthermore, 
IL -10 protein expression returns to control values after 24h, a time at which 
macrophages are beginning to appear in the epidermis (Hammerberg et al 1996). 
6.5. IL -10 protein expression by UVB irradiated cells. 
PAM -212 cells stained positively for IL -10 before UVB irradiation, and it was 
difficult to tell whether the staining became more intense following irradiation with 10 
mJ /cm2 UVB (see fig. 6.4). The staining appeared to become more focused around 
the nucleus. 
B 16 cells stained were very intensely, even with isotype control antibody. 
Attempts to stain B16 cells by using a longer hydrogen peroxide/ methanol incubation, 
to block endogenous peroxidase, did not significantly reduce the background staining. 
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Quantitative analysis of IL -10 production by cells were also performed by 
ELISA. Epidermal cell suspensions were prepared as described in section 2.1.3. 
Cells were seeded at a density of 1.5 x 106 cells/ well and irradiated with scaled doses 
of UVB (as described in section 2.1.5). Culture supernatants were collected, and cell 
lysates prepared (as described in section 2.3.2). ELISA of supernatants taken from 
epidermal cell suspensions 24h after irradiation suggested that IL -10 was secreted by 
these cells at a concentration of around 200 pg from 1.5 x 106 cells. In vitro irradiation 
had no discernible effect on the amount of IL -10 secreted, at doses up to 20 mJ /cm2. 
ELISA of culture supernatants indicated that IL -10 was not secreted by 
PAM -212 (fig. 6.5) or B16 (fig. 6.6) cells following UVB exposure, at doses up to 20 
mJ /cm2. Concentrations of IL -10 in cell lysates were very inconsistent, but suggested 
that IL -10 was unaltered within 24h of UVB exposure, by doses up to 20 mJ /cm2. 
There was a decline in IL -10 within PAM -212 cells 48h after UVB irradiation, and this 
appeared to be dose -dependent. 
UVB doses up to 20 mJ /cm2 did not significantly alter viability of either cell 
line (PAM -212 and B 16), so the decline in recoverable intracellular IL -10 could not be 
attributed to a drop in viable cell numbers. 
6.6. IL -10 protein in by cell lines cultured with UCA isomers. 
Untreated PAM -212 cells stained positively for IL -10 (see fig. 6.4). IL -10 
staining increased in the cytoplasm, and became more focused around the nucleus, 
after 6h incubation with 10 µg/m1 cis -UCA (shown in fig. 6.7). Incubation with 10 
µg/ml trans -UCA had no effect on IL -10. In experiments using 6h incubation with 
100 µg/ml UCA, there was no discernible difference between IL -10 staining in 
cis -UCA or trans -UCA incubated PAM -212 (see fig. 6.7). When PAM -212 were 
incubated with 100 µg /m1 cis -UCA for 24h, there was increased cytoplasmic staining 
for IL -10 (see fig. 6.7). 
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Development of immunostaining by a technique other than peroxidase, such as 
use of fluorescent antibodies, would prevent some of the difficulties encountered 
during these experiments. The skin produces large quantities of endogenous 
peroxidase, particularly following UVB exposure. For example, peroxidase is 
produced during melanogenesis (Okun, 1996). 
From the experiments described here, there does not appear to be a clear 
stereo -specificity with regard to stimulation of IL -10 expression by UCA. Cis -UCA 
appeared to be a slightly better stimulus than trans -UCA. It should be noted that 
despite the use of a cell line (PAM -212), not all cells stained positively for IL -10 
expression. A similar pattern was observed following UVB irradiation. 
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Figure 6.3. IL -10 protein is induced in the skin after 5 MED UVB. Mice (n= 3) were shaved on 
their dorsal surfaces and irradiated with 5 MED UVB. Skin samples were processed to extract IL -10 
as described in section 2.3.1. IL -10 concentrations were determined by ELISA, as described in 
section 2.3.3. Results are shown as mean ± sem, of 3 samples, for each point. *=p < 0.05, 





Figure 6.4. IL -10 staining in PAM -212 cells following UVB irradiation. The top panel shows cells 
which were not irradiated and the bottom panel shows cells which were stained 24h after irradiation 
with UVB (both magnifications are x 125; cells incubated with negative control antibody were not 
stained). 
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Figure 6.5. IL -10 in lysates or culture supernatants from of PAM -212 cells. 1.5 x 106 PAM -212 
cells were seeded per well, 24 -well plates, and irradiated with scaled doses of UVB. Lysates (open) and 
supernatants (closed) were collected 24h (left) or 48h (right) after irradiation and IL -10 content 





Figure 6.6. IL -10 in lysates or the culture supernatants from B16 cells. 1.5 x 106 B16 cells were 
seeded per well, 24 -well plates, and irradiated with scaled doses of UVB. Lysates (open) and 
supernatants (closed) were collected 24h after irradiation and IL -10 content measured by ELISA, as 







Figure 6.7. Immunostaining for IL -10 in PAM -212 cells incubated with UCA. Cells were incubated 
with 10 µg/ml (1) or 100 µg /m1 (3) trans -UCA, and harvested after 6h. Panel 5 shows PAM -212 cells 
incubated with 100 µg/m1 trans -UCA and harvested after 24h. The righthand panels show PAM -212 
cells which were incubated with cis -UCA (10 µg /ml (2) or 100 µg/m1(4) harvested after 6h, and 100 
µg/m1(6) harvested after 24h (all magnifications are x 125; cells incubated with negative control 
antibody were not stained). 
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The source(s) of TNF -a in UVB- irradiated skin. 
TNF -a is implicated in UVB- induced immune suppression, particularly that of 
CH responses (Rivas and Ullrich, 1994). It has been shown that UV- induced DNA 
damage is responsible for expression of TNF -a in mouse and human skin (Kitibel et al 
1998). As mentioned earlier, TNF -a is vital for LC migration and DC accumulation 
following UVB irradiation (see chapters 4 and 5). 
6.7. The induction of TNF -a protein by UVB in murine skin. 
Mice were irradiated on the shaved back with 5 MED UVB. At various times 
thereafter, skin samples were collected, weighed and homogenised ELISA of skin 
homogenates for TNF -a revealed that the concentration was increased immediately 
after irradiation, which took 50 mins to administer (shown in fig. 6.8). TNF -a protein 
was found constitutively at a concentration of around 6000 pg/g skin, but increased to 
15,000 pg/g skin within the irradiation period. The TNF -a concentration peaked at 
20,000 pg /g skin 4h after the end of irradiation. By 8h after irradiation, TNF -a 
concentrations returned to, and remained at, levels comparable to unirradiated mice. 
6.8. The induction of TNF -a protein by UVB irradiation of epidermal 
cells. 
Single cell suspensions of primary epidermal cells were irradiated with various 
doses of UVB. Supernatants and lysates were collected 24h after irradiation, and 
TNF -a content of both measured by ELISA. As found with IL -10, TNF -a 
concentrations in supernatants and lysates were not altered significantly by UVB 
exposure. Concentrations found were 250 ± 30 pg from 1.5 x 106 cells. 
When cell lines were analysed for TNF -a protein following UVB irradiation, 
TNF -a could not be found in supernatants from PAM -212 or B16 cultures. Increasing 
UVB doses reduced TNF -a within cultured cells. TNF -a content of PAM -212 cells 
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Figure 6.8. TNF -a protein is induced in the skin after 5 MED UVB. Mice (n= 3) were irradiated 
with 5 MED UVB. Skin samples were taken at various times after irradiation and processed for 
TNF-a extraction as described in section 2.3.1. TNF -a content was measured by ELISA, as 






Figure 6.9. TNF -a is not released by keratinocytes (PAM -212), but intracellular stores are reduced 
by increasing UVB radiation. Cells were seeded at 1.5 x 106 per well and allowed to monolayer before 
irradiating. Culture medium was replaced with PBS during irradiation, and supernatants or cell lysates 
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Figure 6.10. TNF -a is not released by melanocytes (B 16), but intracellular stores are reduced by 
increasing UVB radiation. Cells were seeded at 1.5 x 106 per well and allowed to monolayer before 
irradiating. Culture medium was replaced with PBS during irradiation, and supernatants or cell lysates 
collected 24h later. TNF -a content of samples was assayed by ELISA, as described in section 2.3.3.. 
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ICAM-1 expression following UVB exposure 
LFA -1 and ICAM -1 are important for regulating the interaction of leucocytes 
and keratinocytes in cutaneous immune responses. Induction of NF-KB, which 
controls ICAM -1 gene expression, can be mediated by TNF -a or reactive oxygen 
intermediates (Jourd'heuil et al 1997). Production of these as a result of UV- radiation 
is a proposed mechanism for altering ICAM -1 expression. Another potential mediator 
is the DNA damage induced by UVB (Krutmann and Grewe, 1995). Experiments 
were conducted to examine whether cis -UCA could also participate in regulation of 
ICAM -1 expression. 
6.9. Effect of UVB irradiation on ICAM -1 expression in irradiated 
skin. 
Immunoperoxidase staining of skin sections derived from C3H/HeN mice 
irradiated with 15 kJ /m2 (10 MED) UVB showed an upregulation of ICAM -1 at 24h 
after exposure (see fig. 6.11). This was most apparent on cells beneath the dermis, 
which lacked ICAM -1 expression before irradiation. There were patches of 
constitutive staining in the epidermis, and these were also increased by UVB exposure. 
6.10. Effect of UVB irradiation on ICAM -1 expression on PAM -212. 
ICAM -1 expression on PAM -212 was investigated by flow cytometry. The 
monoclonal antibody used to detect ICAM -1 expression was titrated against LPS- 
stimulated peritoneal macrophages, and gave positive staining (43 %) at a dilution of 
0.01'mg antibody /ml. DC, purified from lymph nodes by centrifugatin on a 
metrizamide gradient (71% positive, background = 13.3 %) and LNC (41% positive, 
background = 1.6 %) also gave positive staining using this protocol. 
ICAM -1 expression could not be induced on PAM -212 by TNF -a alone, as 
background staining with isotype control antibody gave similar flow cytometry profiles 
to PAM -212 cells stained with anti -ICAM -1. Varying the concentration of cis -UCA, 
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trans -UCA, histamine, or their combinations, also failed to alter ICAM -1 staining 
above that of isotype control stained cells. This experiment was repeated 16 times and 
an enhancement in ICAM -1 staining did not occur. 
It was possible that the treatment of the cultured cells, such as the method of 
removal from flasks destroyed the epitope on ICAM -1 which the monoclonal antibody 
recognised. The cells used as positive controls for ICAM -1 staining were relatively 
non -adherent, so not normally subjected to trypsinisation. However, when positive 
control cells were treated with trypsin and then analysed for ICAM -1 expression, the 
flow cytometry profile was unchanged. Additionally, when PAM -212 cells were 
removed mechanically from plates, flow cytometry profiles were not altered. 
Trypsinisation was not therefore responsible for any loss of staining. 
198 
 
' .1,. . ' r.; . 
Figure 6.11. Expression of ICAM -1 in mouse skin irradiated with 10 MED UVB. C3H/HeN mice 
were irradiated with 10 MED UVB (15 kJ /m2), and skin collected 24h later. Sections were stained 
with anti- ICAM -1 antibody and developed with DAB as described in section 2.3.4. Areas of ICAM -1 
expression are shown in brown. The top panel shows ICAM -1 staining in normal skin and the bottom 
panel shows ICAM -1 staining in irradiated skin. 
Establishing the polymerase chain reaction (PCR) technique. 
Due to the observation that IL -10 and TNF -a protein were reduced by UVB 
irradiation, but were not detectable in supernatants, it was decided to investigate 
cytokine mRNA expression. This potentially allows a better examination of the effects 
of irradiation, as it indicates the potential to produce protein, and removes the 
involvement of any pre -made cytokine stores. 
6.11. RNA isolation. 
Experiments to investigate the effect of UVR or UCA exposure on cytokine 
mRNA expression were carried out in a wide variety of cell types. Initial problems 
with isolation and purity of extracted RNA samples were overcome by adopting an SV 
RNA isolation system, which was quicker, gave a better yield and proved more 
consistent than the phenol/chloroform RNA isolation technique used initially. 
6.12. Establishing optimal MgC12 concentration. 
Optimal MgC12 concentrations in the PCR mix for each cell type and each 
cytokine were established. Pooled samples from each cell type were subjected to PCR 
for the cytokine under investigation over a MC12 concentration range, using a standard 
cycle number of 40. This cycle number was used as products were likely to plateau 
using a greater cycle number, due to exhaustion of DNA polymerase and/or other PCR 
reagents. Products were resolved on 1.5% agarose gels containing ethidium bromide, 
allowing visualisation under a UV lamp. The MgCl2 concentration which resulted in 
the brightest product upon development was determined as the optimum for the 
particular cell type and cytokine under analysis, and this concentration was used for all 
similar, subsequent PCR reactions (the conditions for PCR are shown in table 2.1). 
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6.13. Establishing an optimal cycle number for each cytokine. 
The results of PCR cycle experiments are shown in fig. 6.12 for RNA derived 
from cultured cell lines. The optimal cycle number was 33 for TNF -a, 33 for IL -10 
and 38 for I3-actin. 
Positive controls were subjected to PCR reactions over a range of cycle 
numbers, using radioactively labelled primers. Positive controls consisted of ears 
from mice which had been contact sensitised with Ox, then CH elicited by ear 
challenge with 1% Ox. Ears were taken and RNA extracted 24h after challenge. 
Radioactive products were resolved on 12% polyacrylamide gels, and samples 
developed by autoradiograph. The raw volume (the arbitrary figure derived by 
computer analysis of the autoradiograph, see section 2.5.5) for each product was 
calculated, and the optimal cycle number derived from the linear region of the plot to 
ensure that the PCR reaction for each cytokine was not saturated. The results of PCR 
cycle experiments are shown in fig. 6.13 for RNA derived from mouse ears. The 
optimal cycle number was 33 for TNF -a, 33 for IL -113, 38 for IL -10, 28 for 1FN -y 
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Figure 6.12. Linearity of PCR product accumulation with increasing cycle number, for RNA from 
cell lines. RNA was extracted from PAM -212 or B16 cells as described in section 2.5.1, and 
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Figure 6.13. Linearity of PCR product accumulation with increasing cycle number, for RNA from 
mouse ears. RNA was extracted from mouse ears as described in section 2.5.1. Mice were either 
untreated (untreat), or contact sensitised with Ox and CH elicited by challenge on the ear. Ears were 
collected 24h later to identify cytokine mRNA expression (Ox group). RNA was amplified for the 
relevant cytokine over a range of cycle numbers. 
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Investigating the effects of UVR on mRNA expression in a variety of 
skin cells. 
6.14. Effect of UVA1 exposure on mRNA expression of TNF -a and 
IL -113 in skin. 
Mice were irradiated with 1 MED UVA1, and ears collected at various times 
thereafter. RNA was extracted from mouse ears as described in section 2.5.1, and 
amplified for IL-10 or TNF -a. Samples within individual experiments were run in 
duplicate and normalised against 0-actin, where a value of 1= (cytokine): 0-actin, in 
unirradiated samples. After 1 MED UVA1 exposure, TNF -a mRNA showed no 
significant alteration from constitutive levels, at up to 48h after UVA1 exposure (see 
fig. 6.14). Points shown before Oh represent constitutive expression levels in 
unirradiated ears, which were collected just before irradiation. IL -1ß mRNA was very 
inconsistent in ears exposed to UVA1, but there was upregulation 24h after the end of 
irradiation (shown in fig. 6.14). IL -10 mRNA was only detectable in small amounts at 
96h after irradiation (not shown). UVA1 may not upregulate TNF -a expression, and 
this would support the earlier fmding that UVA1 induced accumulation of DC within 
DLN is not dependent upon TNF -a (see section 5.4). 
6.15. Effect of UVB exposure on mRNA expression of TNF -a and 
IL -113 in skin. 
After 1 MED UVB, TNF -a mRNA was transiently upregulated, peaking 4h 
after irradiation (a 5 -fold increase from unirradiated ears) and remaining increased at 8h 
(around 3- fold). One day after irradiation, TNF -a mRNA expression had returned to 
constitutive levels, but increased once more at 48h after UVB exposure. This is 
shown in fig. 6.15. IL -10 mRNA expression was also upregulated by 5 -fold over 
unirradiated ears 4h after exposure, and returned to constitutive levels by 8h. As with 
TNF -a mRNA expression, IL-10 mRNA was increased 48h after irradiation (see 
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fig. 6.15). IL -10 mRNA expression was upregulated within an hour of UVB 
irradiation, and continued to rise until a peak at 24h. After 24h, expression was 
slightly reduced but remained elevated from that found in unirradiated ears, even by 
96h after UVB exposure (see fig. 6.16). This indicates that UVB has the ability to 
promote expression of mRNA for the cytokines critical for LC migration. In addition 
to this, UVB increases the potential of irradiated sites to create a microenvironment 
favourable for Th2 -like cytokine producing cells. 
6.16. Effect of UVA1, followed by UVB, exposure on mRNA 
expression in skin. 
Reeve and colleagues have shown that mice irradiated with UVA are partially 
protected against the immunosuppressive effects of subsequent UVB irradiation 
(Reeve et al 1998), apparently via IFN -y (Reeve et al 1999). As UVA1 did not protect 
LC from depletion from the epidermis mediated by UVB, the effects of this dual UV 
regimen were investigated at the mRNA level. 
Mice were irradiated with 1 MED UVA1 followed immediately by 1 MED 
UVB, and ears collected at various times thereafter. RNA was amplified for IL -lß or 
TNF -a. Samples were run in duplicate and normalised against F3- actin, where a value 
of 1= (cytokine): 13- actin, in unirradiated samples. TNF -a mRNA was reduced from 
constitutive levels immediately after the irradiation period, and remained suppressed 
throughout the timecourse studied (until 48h after exposure) (see fig. 6.17). IL -113 
mRNA expression was transiently upregulated 24h after the end of irradiation, in ears 
exposed to UVA1 followed by UVB (shown in fig 6.18). These results would 
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Figure 6.14. A comparison of IL -113 and TNF -a mRNA expression in the ears of UVA1 irradiated 
mice. Mice were irradiated with 1 MED UVA1, and ears collected at various times thereafter. RNA 
was extracted from mouse ears as described in section 2.5.1, and amplified for IL -113 (left) or TNF -a 
(right). Results are represented as the mean ± SEM, for 3 individual experiments. Samples within 
individual experiments were run in duplicate and normalised against 13- actin, where a value of 1= 
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Figure 6.15. A comparison of IL -113 and TNF -a mRNA expression in the ears of UVB irradiated 
mice. Mice were irradiated with 1 MED UVB, and ears collected at various times thereafter. RNA 
was extracted from mouse ears as described in section 2.5.1, and amplified for IL -113 (left) or TNF -a 
(right). Results are represented as the mean ± SEM, for 3 individual experiments. Samples within 
individual experiments were run in duplicate and normalised against 13- actin, where a value of 1= 
(cytokine): (3- actin, in unirradiated samples. 
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Figure 6.16. IL -10 mRNA expression in mouse ears irradiated with 1 MED UVB. Mice were 
irradiated with 1 MED UVB, and ears collected at various times thereafter. RNA was extracted from 
mouse ears as described in section 2.5.1, and amplified for IL -10. Results are represented as the mean 
± SD, with samples run in duplicate. IL -10 was not consistently found in unirradiated mouse skin. 
Therefore, samples were normalised against 13- actin, where a value of 1= (cytokine): (3- actin, in 
samples taken 24h after irradiation. Results of 2 individual experiments are shown. Early expression 




















Figure 6.17. Cytokine mRNA expression after I MED UVA1 followed immediately by 1 MED 
UVB. Mice were irradiated with 1 MED UVA1 followed immediately by 1 MED UVB, and ears 
collected at various times thereafter. RNA was extracted from mouse ears as described in section 
2.5.1, and amplified for TNF-a (left) or IL-113 (right). Results are represented as the mean ± SD, 
with samples run in duplicate. Samples were normalised against 13-actin, where a value of 




Source(s) of IL -10 in irradiated skin 
IL -10 is believed to play a major role in suppression of immune responses 
following UVB irradiation (Ullrich, 1995). In experiments by Rivas and Ullrich 
(1992), injecting UVB irradiated mice with antibodies against IL -10 partially inhibited 
immunosuppression of DTH responses. Mice were irradiated with 15 kJ /m' UVB and 
sensitised with alloantigen 5 days later, with DTH elicited a futher 7 days later. The 
dose of UVB used suppressed the DTH response in C3H/HeN mice by 84 %. Mice 
which were injected with monoclonal anti -IL -10 antibodies 4 and 24h after UVB 
irradiation had a DTH response which was suppressed by 42% compared to positive 
control mice (Rivas and Ullrich, 1992). In another study, mice lacking expression of 
IL -10 (IL -10 targetted; IL-10T mice) were completely resistant to the 
immunosuppressive effects of UVB on DTH to alloantigens (BALB /c spleen cells) 
(Beissert et al 1996). 
In the experiments reported in section 6.2, injection of antibodies against IL -10 
did not reverse UVB- or cis -UCA mediated suppression of the DTH response to 
HSV -1. Mice which were injected with anti -IL -10 actually exhibited increased 
suppression of DTH compared to mice injected with control serum, following UVB 
irradiation. 
It may be that the lack of a second injection, 24h after UVB irradiation or 
cis -UCA application in the experiments in section 6.2 prevented complete 
neutralisation of IL -10. It is of interest that complete lack of IL -10, such as in IL -10T 
mice, completely abrogated the immunosuppressive effects of UVB upon DTH 
responses (Beissert et al 1996). In the experiments of Rivas and Ullrich, injection of 
anti -IL -10 4 and 24h after a highly immunosuppressive UVB dose only halved the 
degree of immunosuppression observed (84% reduced to 42% immunosuppression of 
DTH to alloantigen) (Rivas and Ullrich, 1992). It may be that IL -10 has to be 
neutralised over a longer period following UVB exposure. This idea is further 
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supported by experiments investigating IL -10 concentrations in sera from irradiated 
mice. 
IL -10 was detectable by ELISA in sera of mice irradiated with 7 MED (10 
kJ /m2) UVB. This peaked at 3 -4 days after exposure. This finding is in agreement 
with the timecourse Beissert and colleagues found for IL -10 protein in the serum of 
C57BL /6 mice exposed to 30 kJ /m2 UVB (Beissert et al 1996). A quicker, more 
transient timecourse which peaked at 36h and cleared by 72h, was observed by Rivas 
and Ullrich, following exposure of C3H/HeN mice to a 15 kJ /m2 UVB dose (Rivas 
and Ullrich, 1994). Local and systemic immune suppression following UVB 
exposure exhibit different kinetics. Local suppression can be observed immediately 
and up to 48h if C57BL /6 mice are sensitised through the irradiated site. If mice are 
sensitised through an unirradiated site, a lag period of 3 days is required before 
systemic suppression is observable (Hammerberg et al 1996). In experiments by 
Horio and Miyauchi, systemic suppression of CH following UVB irradiation was 
maximal when sensitisation occured 3 days after exposure (Miyauchi and Horio, 
1995). 
Alterations in cytokine profiles were not apparent during the induction phase of 
CH (see section 3.9), but there appeared to be a bias towards Th2 -like cytokine 
production at the elicitation phase (see section 3.7). As mentioned previously, the 
cytokine microenvironment in which an antigen is encountered is important in directing 
the subsequent immune response. Further experiments investigated the production, 
and potential sources, of the Th2 -like cytokine, IL -10, in irradiated skin. 
There are many potential sources of IL -10 within irradiated skin, including 
keratinocytes (Rivas and Ullrich, 1992), melanocytes (Teunissen et al 1997), T cells 
(Ullrich, 1995; Kitajima et al 1996), B cells, mast cells and macrophages (Kang et al 
1994). IL -10 production by murine keratinocytes is generally accepted. Depletion 
studies have shown keratinocytes to be the main source of IL -10 mRNA after 
sensitisation with contact allergens (Enk and Katz, 1992b). Although keratinocytes 
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synthesize small amounts of IL -10 mRNA, the protein may remain inside the cells 
(Kang et al 1994). Teunissen and colleagues (1997) found that IL -10 mRNA was 
only detectable in pure melanocyte cultures, but not in pure cultures of primary 
keratinocytes, following stimulation with phorbol myristate acid (PMA), IFN -y or 
UVB. This was not translated to detectable levels of protein however. Thus, the effect 
of UVB exposure on IL -10 protein in keratinocytes (PAM -212) or melanocytes (B 16) 
was investigated. 
PAM -212 cells stained positively for IL -10 before UVB irradiation (described 
in section 6.4). Staining became more focussed around the nucleus following 
irradiation. Shreedhar and colleagues interpreted this as a sign of de novo synthesis 
(Shreedhar et al 1998), but it could also be a sign of apoptosis, with packaging of 
cellular material. ELISA of cell lysates indicated that IL -10 content of PAM -212 cells 
was unaffected 24h after UVB irradiation, and cell viability was unaltered. IL -10 
content of PAM -212 cells was reduced in a dose -dependent manner by 48h after 
irradiation. ELISA of culture supernatants indicated that IL -10 was not secreted by 
PAM -212 or B16 cells upon UVB exposure (at doses up to 20 mJ /cm2). Rivas and 
Ullrich (Rivas and Ullrich, 1992) identified IL -10 in supernatants from PAM -212 cells 
irradiated with 20 mJ /cm2 UVB 24h earlier, as there was a band which reacted with 
anti -IL -10 antibodies on Western blots. In their experiments, IL -10 was not secreted 
by unirradiated PAM -212 cells. One possible reason for this discrepancy may be the 
UVB source. Whilst the studies reported here used a Philips TL -12 lamp, Rivas and 
Ullrich used an FS -40 lamp, which emits 46% of its energy in the UVA waveband 
(Goéttsch et al 1998). Any, or the degree of, contamination by UVA wavelengths may 
have a critical role in the levels of IL -10 detected. Grewe et al. found that UVB or 
UVA1 caused a time- and dose -dependent induction of IL -10 mRNA expression in, 
and protein secretion by, long -term cultured human keratinocytes. UVA1 was a 
stronger inducer than UVB, by a factor of 2 (Grewe et al 1995). 
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B16 cells stained very intensely upon development of immunoperoxidase 
staining for IL -10, even when isotype control antibody was used. As peroxide is an 
important factor in melanogenesis, attempts to stain B16 cells in this way required a 
longer H202 /methanol step to block endogenous peroxide. It may however have been 
better to have used a different means of development, such as immunofluorescence. 
Concentrations of IL -10 in B16 cell lysates, measured by ELISA, were very 
inconsistent between experiments, but again these results suggested that IL -10 was 
unaltered by doses up to 20 mJ /cm2. 
Goodman and colleagues used keratinocytes as accessory cells in stimulating 
T cell responses (Goodman et al 1994). There was a specific defect in T cell IFN -y 
production, whereas IL -2 and IL -4 were induced at levels comparable to those seen 
when professional APC were used as accessory cells. This was not due to 
non -productive CD28 engagement, as stimulation of this pathway with monoclonal 
antibodies did not induce IFN -y production in keratinocyte supported cultures. IL -2 
was increased 10 -fold in these cultures, demonstrating a specific deficiency in IFN -y 
as opposed to failure to respond to CD28 signalling. RT -PCR revealed that 
keratinocytes produced little or no mRNA for IL -12 compared with professional APC, 
and addition of IL -12 to cultures restored IFN -y production. As IL -10 is directly 
implicated in reducing cytokine production by Thl -like cells (de Waal Malefyt et al 
1992; Moore et al 1993; Howard and O'Garra, 1992), this is in agreement with a 
potential role for keratinocyte derived IL -10 in altering immune responses following 
UVB irradiation. 
As mentioned above, Grewe et al. examined the effect of UV exposure cultured 
human keratinocytes. In addition to the effects of UVA or UVB exposure, IL -10 
production was increased 2 -3 fold when keratinocytes were cultured in high Cat+ 
medium (Grewe et al 1995). Neither addition of TNF -a or IL -la to unirradiated cells, 
or addition of neutralising antibodies to TNF -a or IL -1 a to UVB irradiated cells, 
altered the level of IL -10 produced. Similarly, modulation of eicosanoid production by 
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adding PGE2, or disturbing cyclo -oxygenase activity by indomethacin, did not affect 
IL -10 production. 
Source(s) of TNF -a in irradiated skin 
TNF -a is needed to keep LC alive in culture, whereas without 
keratinocyte- derived cytokines the cells rapidly involute and die. TNF -a does not have 
any effects on the maturational state of LC, and freshly isolated epidermal cells express 
TNF -a mRNA (Koch et al 1990). 
The concentration of TNF -a protein within samples of mouse skin exposed to 
5 MED UVB, was investigated. There was an increase immediately after irradiation 
(which took 50 mins to administer). Levels were increased 2 -fold over those found 
constitutively, and peaked at 20µg TNF -a per gram of skin, 4h after the end of 
irradiation. By 8h after UVB exposure, TNF -a protein within the skin had returned to 
constitutive levels. In a previous experiment (described in section 4.9), TNF -a was 
injected into the ears at a dose of 1000 U/ ear to induce LC migration. This 
concentration increased the LC migration induced by 1 MED UVB alone. 
Analysis of cultured cells was carried out to determine the source of TNF -a in 
irradiated skin. In supernatants from PAM -212 and B16 cells, TNF -a was not 
detectable either constitutively or 24h after irradiation with any dose of UVB up to 20 
mJ /cm2. However, TNF -a was detectable in lysates of unirradiated cells. Analysis of 
lysates 24h after irradiation revealed that TNF -a was lost from both PAM -212 and 
B16 cells in a dose -dependent manner. This reduction in TNF -a was more marked for 
PAM -212 cells than B16 cells (see figs. 6.11 and 6.12). 
Walsh investigated the human sunburn response, both in vitro and in vivo 
(Walsh, 1995). UVB resulted in rapid degranulation of mast cells, with a 
consequential release of TNF -a. This was accompanied by expression of the 
TNF- inducible adhesion molecules, ELAM -1 and ICAM -1, on the cutaneous 
epithelium 2h later, which peaked between 4 and 6h later. This effect could be blocked 
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by the mast cell inhibitor, disodium cromoglycate. Keratinocytes contributed 
minimally to the TNF -a released. Twice as much TNF -a was released when dermal 
explants were irradiated, indicating that removal of the epidermis, and thereby 
protective granules, augmented the effect. In the experiment described in section 6.9, 
ICAM -1 expression was detected in small patches in the stratum corneum of 
unirradiated mice. Expression was upregulated in these areas following irradiation of 
C3H/HeN mice with 10 MED UVB. There was no expression of ICAM -1 expression 
in the dermis of unirradiated skin, but ICAM -1 was induced following a 10 MED UVB 
exposure. 
LFA -1 and ICAM -1 are important for regulating the interaction of leucocytes 
and keratinocytes in cutaneous immune responses. ICAM -1 gene expression is 
controlled by nuclear factor (NF)-KB, which is inducible by TNF -a. Induction of 
NF -KB by reactive oxygen intermediates (Jourd'heuil et al 1997), produced as a result 
of UV- radiation, is a proposed mechanism for altering ICAM -1 expression. Another 
potential mediator is the DNA damage induced by UVB (Krutmann and Grewe, 1995). 
TNF -a is implicated in DNA damage following UVB exposure, as injection of 
antibodies against TNF -a reduced DNA fragmentation, and caused a significant, but 
incomplete, reduction in sunburn cell formation (Schwarz et al 1995). Experiments 
were conducted to examine whether cis -UCA could also participate in regulation of 
ICAM -1 expression. 
Experiments by Mitra and colleagues (1993) indicated that UCA, and/or 
histamine, may play a role in determining the level of ICAM -1 expression following 
irradiation. Incubation of primary human keratinocytes with TNF -a induced ICAM -1 
expression by 48h of culture. Addition of irradiated UCA resulted in ICAM -1 
expression increased from that induced by TNF -a alone. Cis -UCA, even above 
physiological levels, could not augment phorbol 12- myristate 13- acetate (TPA) 
induced synthesis of either TNF -a mRNA expression in, or protein secretion from, 
keratinocytes (Redondo et al 1996). 
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In in vitro experiments, PAM -212 cells did not appear to express ICAM -1 on 
their surface, despite incubation with TNF -a (see section 6.10). One difference in the 
treatment of positive control cells (LPS- stimulated peritoneal macrophages, DC or 
LNC) and the PAM -212 cells to be studied was in harvesting of the cells. PAM -212 
form a monolayer during culture, making it necessary to remove them enzymatically. 
A detrimental effect of trypsin/ versene harvesting on ICAM -1 expression was 
discounted by removing cells from the monolayer by a mechanical method. Analysis 
of cells harvested by this technique yielded similar results. Corver et al. investigated 
the effect of monolayer dissociation with trypsin/EDTA on 3 ovarian carcinoma cell 
lines, and found one of these to have decreased, but still detectable, ICAM -1 
expression as a result (Corver et al 1995). In another study, tryptic dissociation of 
monolayered cells caused loss of CD44 expression, but not ICAM -1, using 13 ovarian 
carcinoma cell lines and 2 mesothelial cell lines (Gardner et al 1995). Therefore, it is 
unlikely that dissociation of the PAM -212 monolayer by trypsin depletes ICAM -1 from 
the cell surface. 
Interestingly, Kashihara -Sawami et al. found that ICAM -1 was increased on 
keratinocytes grown in low calcium medium, which correlated with basal cell keratin 
K5 expression (Kashihara- Sawami and Norris, 1992). This is supported by the 
observation that increased TNF -a was released upon irradiation of dermal explants 
(Walsh, 1995). Immunostaining of skin sections from irradiated mice suggested that 
ICAM -1 was induced under the dermis (see section 6.9). Thus, the 
differentiation / developmental status of the cell may play a role in keratinocyte ICAM -1 
expression, and this could explain why ICAM -1 is undetectable on PAM -212. 
Additionally, ICAM -1 expression on basal keratinocytes was induced by 
intracutaneous injection of tuberculin- purified protein derivative (PPD) to elicit DTH in 
humans, but was not significantly induced by UVB treatment (Norris et al 1991). 
The timing of investigation of ICAM -1 expression following UV irradiation on 
keratinocytes may also be critical. Norris and colleagues (1990) found that UVR had a 
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biphasic effect on ICAM -1 expression on human keratinocytes, with a downregulation 
preceding an upregulation. In experiments by Krutmann and colleagues (1990), in 
vitro irradiation of human keratinocytes prior to stimulation with TNF -a inhibited 
ICAM -1 upregulation in a dose -dependent manner. UVB irradiation did not affect the 
low constitutive ICAM -1 expression of KB cells (epidermoid carcinoma cells) within a 
24h incubation period. Further studies by the same group revealed that UVB exposure 
of keratinocytes inhibited ICAM -1 upregulation in response to either TNF -a or IFN -y. 
Restoration of responsiveness to TNF -a required at least a 24h recovery period 
(Krutmann et al 1992a). There was a significant increase in ICAM -1 expression 48h 
after irradiation. In experiments by Norris et al (1990), UVR inhibited keratinocyte 
ICAM -1 expression induced by IFN -y, 24h after irradiation. However, UVR induced 
expression to greater levels than IFN -y alone by 48, 72 and 96h of culture, and 
enhanced the upregulation induced by IFN -y. 
In an ICAM -1 transgenic mouse model, with gene expression under control of 
the basal keratin K14 (Williams and Kupper, 1994), CH responses were not 
potentiated as expected, and CD45+ leukocyte infiltration was not increased at ICAM -1 
expression sites. These points argue that ICAM -1 expression on keratinocytes may 
not play a key role in UV- induced immunomodulation in murine models, or at the very 
least, cannot act on its own. 
An attempt was made to compare expression of IL -1 ß and TNF -a mRNA in the 
ears of mice irradiated with either 1 MED UVA1 or 1 MED UVB. These cytokines are 
central to LC migration, and contrasting effects of UVA1 and UVB on LC migration 
have been shown in chapter 4. A true comparison of timings was very difficult due to 
the different power outputs of the respective lamps. The dose used throughout the 
experiments was assessed physiologically, and represented 1 MED for either lamp. 
Whilst it took only 10 mins to administer 1 MED broad -band UVB (1440 Jim), it took 
approximately 3h to administer 1 MED UVA1 (500 kJ /m2). Attempts to reduce the 
administration time for 1 MED UVA1 involved reducing the tube to target distance. 
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However, this caused overheating and proved detrimental to the health of the irradiated 
mice. The overheating problem was reduced by placing a fan in the exposure room, 
but temperature was only controllable by placing the lamp further away from the mice. 
As such, any timings are taken from the end -point of 1 MED UVA1 irradiation. If the 
irradiation time had been cut short, mice would have received a dose of less than 1 
MED. 
The timecourse for TNF -a mRNA induction by UVB radiation (section 6.15) 
correlated to that found for protein expresion in irradiated skin (see fig. 6.8). Both 
showed an early (4h) and transient peak in expression, before returning to constitutive 
levels. TNF -a mRNA expression was increased 5 -fold, whilst protein was increased 
2 -fold. IL -lß mRNA expression was similarly upregulated by approximately 5 -fold 
over expression in unirradiated skin samples, by 4h after UVB irradiation. Expression 
quickly reverted to constitutive levels before rising again at 48h after exposure. 
IL -10 mRNA expression was upregulated within an hour of UVB irradiation, 
and continued to rise until a peak at 24h (see fig. 6.16). IL -10 protein in irradiated 
skin peaked at 8h after UVB exposure, and had returned to constitutive levels by 24h 
(see fig. 6.3). 
TNF -a expression was not altered from constitutive levels at any time after 
exposure to 1 MED UVA1 (see fig. 6.14). IL-113 mRNA expression was inconsistent 
in UVA1 irradiated skin, but showed an increase by 24h after the end of exposure. 
Therefore, UVA1 does not induce expression of both cytokines shown to be critical 
for LC migration (Kimber et al 1998). 
In mice which were exposed to both UVA1 and UVB, TNF -a mRNA 
expression was downregulated. IL-113 was increased at 24h, and had returned to 
constitutive levels at 48h, after exposure (see fig. 6.17). This dual exposure regimen 
appears to prevent (TNF -a) or delay (1L-113) the signals necessary for LC migration, 
and this may explain the photoprotective effect seen by others (Reeve et al 1999). 
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However, it should be noted that LC migration and accumulation of DC do occur in 
these mice (see figs. 4.4, 4.5 and 5.4 respectively). 
TNF -a mRNA was minimally increased by 8h after UVB exposure of human 
skin (2.5 MED), and reached a maximum by 24h. Timecourses were not taken 
beyond the 24h timepoint. No alteration was seen in ICAM -1 or VCAM -1 expression, 
although E- selectin was increased from 4h onwards, reaching maximal levels at 24h 
(Strickland et al 1997). 
In agreement with the results in sections 6.14 and 6.15, there is evidence that 
UVB irradiation induces TNF -a production in the human epidermis, but that UVA1 
irradiation does not (Skov et al 1998a). 3 MED UVB led to a rapid increase in TNF -a 
concentration in suction -blister fluid, which was maximal 6h after exposure. UVA1 
caused a slight decrease. Both UV regimens led to a slight increase in IL -10 and cis - 
UCA, although this was larger with UVB (Skov et al 1998a). As mentioned in section 
1.9.2, IL -6 expression can be induced by IL -1. Kirnbauer et al. reported that UVB, 
but not UVA, induced IL -6 production from human epidermal cells (Kirnbauer et al 
1989). They therefore supply circumstantial data that UVA does not alter IL -1 
expression to a significant degree. 
In experiments by Enk and Katz, there was enhanced expression of TNF -a, 
IL -10, IL-la and even IL-113 mRNA, in epidermal cell suspensions prepared 4h after 
injection of IL-1 ß in vivo. Addition of IL-113 to keratinocytes (derived by washing 
non - adherent cells from epidermal cell cultures) resulted in increased TNF -a and 
IL -10, with a less pronounced increase of IL -la (Enk and Katz, 1995). 
Supernatants of highly enriched cultured LC display IL -1 and TNF -a, but not 
IL -4 or IFN -y activities. Cell mixing experiments to investigate the role of 
contaminating keratinocytes showed that IL -1 and TNF -a were predominantly derived 
from these keratinocytes. PCR revealed that IL -1 ß transcripts were limited to LC 
(Schreiber et al 1992). 
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Throughout the UVB timecourse there was a gradual increase in IL -113 mRNA 
above constitutive levels, and this may correlate with replenishment of LC. As IL -113 
and TNF -a are involved in LC migration, a quick upregulation following UVB 
exposure may have been anticipated. Both cytokine mRNAs were transiently 
upregulated 4h, and TNF -a protein was upregulated 8h, following UVB exposure. 
UVA1 did not induce an upregulation of TNF -a mRNA expression within irradiated 
skin, and UVA1 did not result in LC depletion. These results therefore suggest a 
mechanism for this. 
IL-10 - mRNA upregulated at 1h 
peak at 24h 
above constitutive until 96h 
upregulated at 96h 
IL -10 - protein peak at 8h nd 
constitutive at 24h 
TNF -a - mRNA peak at 4h 
constitutive at 24h 
upregulated at 48h 
? small peak at 4h 
TNF -a - protein peak at 4h nd 
constitutive at 24h 
Table 6.1. The effects of UVB and UVAL on IL -10 and TNF -a at the mRNA and 
protein levels. nd= not done. 
221 
6.19. Criticisms of experimental design and suggestions for further 
work 
The UV doses used in the experiments described herein were equivalent on the 
basis of erythemal activity, and have been shown to be immunosuppressive (El -Ghorr 
and Norval, 1999). However, UVAI is less efficient at UCA photoisomerisation than 
UVB. A 1 MED UVA1 exposure results in 17 %, whereas 1 MED UVB results in 
over 40 %, cis -UCA formation. The LC depletion observed with UVB was 
dose -dependent, and at 360 J /m2 UVB no significant reduction in LC numbers could 
be detected. Cis -UCA formation is around 20% at this dose (El -Ghorr and Norval, 
1999). Therefore, there may be a threshold percentage cis -UCA at which LC depletion 
is mediated. 
Now that the optimal times for cytokine upregulation following irradiation have 
been identified, it would be interesting to investigate the effect of varying UV doses 
upon expression. Additionally, the effect of topical apllication of UCA isomers can 
now be examined. It would be of interest to establish if there is a maximum threshold 
for inducing cytokine expression, particularly with reference to the cytokines involved 
in inducing LC migration. 
The PCR technique can also be applied to investigate cytokine mRNA 
expression within the skin at various points of the CH response, in mice irradiated 
before sensitisation or not. This would appear to be critical, as UVB did not alter 
cytokine secretion from DLNC of mice following contact sensitisation, but did so after 
elicitation of the CH response (see chapter 3). Experiments by Garssen and coworkers 
(1999) indicate that mRNA expression for 1FN -7 is downregulated in spleen cell 
populations following secondary stimulation. It would be of interest to examine if 
selection of T helper cell profiles occurs within sites of elicitation which have 
previously been irradiated, and if so, at what time. This could have major implications 
upon the potential of an irradiated site to elicit a CH response comparable to responses 
in unirradiated animals. 
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Development of immunostaining by a technique other than peroxidase, such as 
use of fluorescent antibodies, has to be undertaken. Alternatively, use of a melanocyte 
cell line which does not produce as much endogenous peroxidase as B16 may facilitate 
immunoperoxidase staining. Peroxidase is produced during melanogenesis, so in cell 




The preceding chapters have detailed UV mediated effects on a variety of 
immune parameters. These included suppression of immune responses by UVB, via 
effects on LC within the epidermis and changes in DC frequency within DLN, and the 
subsequent cytokine profiles of DLN during both contact sensitisation and elicitation of 
CH. The molecular signals involved in altering these immune parameters within the 
skin were examined. Some of the findings of this study are summarised in table 7.1. 
7.1. The effects of UVR on cytokines involved in LC migration. 
Kimber and colleagues have postulated that topical application of a contact 
sensitiser leads to quick release of IL -10 within the cutaneous site, which in turn 
induces TNF -a secretion. The two cytokines then induce LC migration to the DLN 
(Kimber et al 1998). Supernatants of highly enriched cultured LC display IL -1 and 
TNF -a. Cell mixing experiments to investigate the role of contaminating keratinocytes 
showed that TNF -a was predominantly derived from this cell type. PCR revealed that 
IL -10 transcripts were limited to LC (Schreiber et al 1992). Injection of anti -IL -10 into 
the skin prior to TNCB treatment completely prevented sensitisation to this chemical 
(Enk et al 1993a). IL -10 deficient mice require greater concentrations of contact 
sensitiser than their wild -type counterparts in order to mount CH responses upon 
challenge (Shornick et al 1996). When DLNC from wild -type mice contact sensitised 
with 0.1% TNCB were incubated with haptenated spleen cells in vitro, antigen specific 
proliferation could be detected. When DLNC from IL -10 deficient mice contact 
sensitised with 0.1% TNCB were incubated with haptenated spleen cells, there was no 
antigen specific proliferation (Shornick et al 1996). Intradermal injection of TNF -a 
224 
results in a decrease of LC numbers in the epidermis (Cumberbatch et al 1997a), and in 
a dose- and time -dependent accumulation of DC (Cumberbatch and Kimber, 1992). 
The efficiency of skin sensitisation is similarly reduced, with impaired CH responses 
in anti -TNF -a treatred mice compared to mice treated with control serum. These 
effects were only detected when TNF -a was inhibited at the time of sensitisation, as 
injection of anti -TNF -a 18h after contact sensitisation was without effect 
(Cumberbatch and Kimber, 1995). Mice lacking the p75 TNF -a receptor have 
reduced LC migration and CH responses (Wang et al 1997). Therefore, if UVR can 
initiate transcription of the IL -113 and/or TNF -a gene(s), it may result in migration of 
LC from the epidermis. Presentation of antigen subsequently encountered through the 
irradiated site may thereby be altered, or diminished, via the absence of LC within the 
epidermis. 
Contrasting effects of UVA1 and UVB on LC migration have been shown in 
chapter 4. IL -113 mRNA expression was upregulated by 4h following UVB exposure, 
quickly reverted to around constitutive levels before rising again 48h after exposure. 
Induction of TNF -a mRNA expression by UVB radiation (section 6.15) correlated to 
increased protein expresion in skin irradiated with 5 MED (see fig. 6.8). 
Following UVA1 exposure, IL -113 mRNA expression showed an increase not 
earlier than 24h, and TNF -a mRNA expression was not altered form constitutive 
expression levels. 
In summary, UVB irradiation results in early induction (within 4h) of IL -113 
and TNF -a mRNA expression in mouse skin. UVA1 does not cause upregulation of 
IL -1ß until 24h after exposure, and has does not consistently alter TNF -a mRNA 
expression. 
In experiments by Enk and Katz, there was enhanced expression of TNF -a, 
IL -10 and even IL -113 mRNA, in epidermal cell suspensions prepared 4h after injection 
of IL -1 ß in vivo. Addition of IL-113 to cultured keratinocytes resulted in increased 
TNF -a and IL -10 (Enk and Katz, 1995). Infiltrating monocyte /macrophage cells 
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could be influenced by the altered microenvironment. Monocyte production of IL -10 
occurs 8 -24h after LPS treatment, and this is dependent on TNF -a (Wanidworanun 
and Strober, 1993). 
In experiments by Hirao and colleagues, together with an increase in IL -1, 
IL -lra was increased markedly following 2 -3 MED of UVR. Following sun -exposure 
the ratio of IL- lra:IL -la in skin increased to over 100, an excess sufficient to block 
IL -la- induced biological responses (Hirao et al 1996). Therefore, although UV 
stimulates an increase in IL -1 levels, with the concomitantly greater rise in IL -lra, UV 
may inhibit the activities of IL -la and suppress inflammatory responses (Norris et al 
1991). 
7.2. LC migration following UVR. 
LC possess a plasma- membrane ATPase, an enzyme which protects LC from 
permeabilization upon exposure to extracellular ATP, whereas keratinocytes and 
macrophages (J774) are susceptible (Girolomoni et al 1992). Loss of ATPase activity 
correlates with an "activated" state, and application of a second contact sensitiser 24h 
after the first resulted in tolerance to the second (Hanua et al 1989). 
Noonan et al. found that ATPase positive cells were reduced 24h after 
irradiating mice on the back with monochromatic UVB (270, 290, 320 nm) (Noonan et 
al 1984). Irradiating with 270 or 290 nm UVB led to a loss of dendrites and a 
decrease in the total epidermal LC. A dose of 320 nm UV that caused 50% systemic 
suppression of CH did not deplete LC. 
In the experiments described in chapter 4, UVB depleted LC from the 
epidermis in a dose -dependent fashion. This depletion in LC numbers was dependent 
on IL-113 and TNF -a, as blocking of either cytokine prevented any alterations normally 
induced by UVB. Following irradiation with 1 MED UVB, LC numbers within the 
epidermis were reduced by 6h, and maximally reduced by 12h. Interestingly, in 
experiments by Cumberbatch and colleagues, LC numbers began to recover 12 -17h 
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after intradermal injection with TNF -a, although numbers were still significantly 
reduced from control values (Cumberbatch et al 1997c). In section 4.9, injection of 
TNF -a into the ears of irradiated mice did not increase LC migration above that in mice 
injected with TNF -a alone. 
The steady -state turnover rate for LC is 7 days (Ghaznawie et al 1999). 
Therefore, a 2 day timespan for repopulation of LC from the 30% reduction induced 
by a 1 MED UVB irradiation is in agreement with this. Recent studies indicate that 
repopulation of LC can occur by cells residing in the hair follicles. Irradiation of 
human skin with 4 MED UVB showed that the hair follicle is a critical reservoir of LC 
(Gilliam et al 1998). Cells deep within the follicle are reasonably protected from UVB, 
which could only penetrate, and induce thymine dimers in, the superficial hair follicle 
opening. LC migrated out of the follicle and into the epidermis 48h, and maximally 
72h, after exposure. These LC exhibited a deficiency in the T cell costimulatory 
molecules, B7.1 and B7.2. 
In the studies of Aubin and colleagues, a continued PUVA regimen led to a 
decrease in ATPase +, Ia+ and Thy -1+ cells in the exposed skin of C3H or BALB /c 
mice. Chronic UVA exposure alone also reduced ATPase +, la +, Thy -1+ cells, but had 
no effect on immune function (Aubin et al 1991). 
As mentioned above, a single, 1 MED UVA1 exposure could not stimulate a 
marked increase in TNF -a expression, and therefore, it may not provide an essential 
signal for LC migration. Similarly, IL -lß was not upregulated at early timepoints 
following UVA1 irradiation. In agreement, UVA1 did not mediate LC depletion from 
the epidermis at up to 96h after exposure. 
UVA- mediated damage to membranes, proteins, DNA or other cell targets is 
predominantly related to oxidative stress. Clement- Lacroix and colleagues found that 
the APC function of cultured LC (measured by MECLR) was dose -dependently 
reduced by direct UVA exposure, at doses up to 20 J /m2 (Clement- Lacroix et al 1996). 
APC function was restored by preventing oxidative damage by overnight incubation of 
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LC with the anti -oxidant vitamin E. UVA1, but not UVB or UVC, induced various 
non -nuclear changes in mammalian cells, including damage to cytoplasmic organelles, 
increased membrane permeability and cell lysis (Beer et al 1993). Polychromatic UV 
light, composed of environmentally relevant wavelengths, was found to disrupt the 
cytoplasmic microtubule complex in a dose -dependent manner. Microtubules were 
disrupted after 3000 Jim' UVA exposure, but not following UVC irradiation (Noonan 
et al 1984). No changes could be seen in the actin microfilaments which stretch across 
the length of control and irradiated cells. 
Therefore, UVA1 may not induce LC migration from the epidermis, but may 
prevent irradiated LC from functioning properly. The cells may become immobilised, 
and not be able to function properly. However, treatment with either UVB or TNF -a 
after UVA1 irradiation did result in migration of LC, and unlike LC after UVB 
exposure, UVA1 exposed LC do upregulate B7, and are capable of stimulating naive 
T cells (Dittmar et al 1999). 
Cis -UCA did deplete LC, but took longer than UVB, with maximal depletion 
24h after topical application. In experiments by Kurimoto and Streilein, LC were 
rounded up and possessed fewer dendrites as early as 5h after an intradermal injection 
of 200µg cis -UCA (Kurimoto and Streilein, 1992). Therefore the discrepancy in the 
time of maximum LC depletion following either UVB irradiation against cis -UCA 
application, may simply be due to the time needed for UCA to absorb and penetrate to 
the target LC within the epidermis. LC depletion following cis -UCA painting was 
similar to UVB in its dependence upon IL -1ß and TNF -a (see sections 4.8 and 4.10). 
Kurimoto and Streilein showed that loss of LC dendrites and suppression of CH could 
be partially restored by intraperitoneal injection of anti -TNF -a antibodies 2h before 
cis -UCA treatment (Kurimoto and Streilein, 1992). These experiments indicate that if 
LC can be retained in the site to be sensitised, CH responses are normal. 
Caution regarding extrapolation of these results across species barriers is 
required. Goettsch and colleagues showed that changes in the morphology of LC 
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within mouse or rat skin were detectable after 3 -9 kJ /m2 UVB, but not in human LC. 
UVB suppressed the function of epidermal cells in the MECLR, with cells from mice 
most susceptible and humans more resistant, with an interspecies effect variation of 
5.5 (Goettsch et al 1998). 
In summary, UVB and cis -UCA deplete LC from the epidermis in mice, and 
this is dependent on IL -113 and TNF -a. UVA1 does not reduce LC numbers within the 
epidermis. 
7.3. UVR and its effects DC accumulation within DLN 
In agreement with UVB depleting LC from the epidermis, there was an 
accumulation of DC within DLN following UVB irradiation (see sections 5.2 and 5.3). 
As with LC migration, this effect was dependent on TNF -a and IL-113 (see figs. 5.3 
and 5.4 respectively). There was an unexpected increase in DC within DLN after 
UVA1 exposure (described in section 5.3). Only antibodies to IL -lß, but not TNF -a, 
prevented an accumulation of DC within DLN following UVA1 (see sections 5.4 and 
5.5). 
There are a number of potential APC within the dermis other than LC, and it is 
possible that UVA1 acts on one or more of these cell types to induce their migration to 
DLN. There is evidence that a second pathway of cutaneous antigen presentation 
exists. Ia+ DC, present in the perivascular region of the mouse dermis, when 
hapten -derivatised, are capable of inducing CH in naive mice (Tse and Cooper, 1990). 
Thus, if UVA1 depleted these cells, it may impair subsequent immune responses. 
Alternatively, there also exists a population of Thy -1 +, Ia cells, exhibiting a dendritic 
morphology, within the murine epidermis. It has been suggested that the ratio of these 
cells to LC influences the intensity of CH (Bigby et al 1987; Sullivan et al 1986). 
Migration of these cells mediated by UVA1 may interfere with immune responses due 
to alterations in the ratio of respective APC within DLN. 
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Moodycliffe et al. (1992) showed that UVB irradiation alone induced DC 
migration to DLN. Neither UCA isomer had an effect on DC numbers within DLN 
(Moodycliffe et al 1992). An antibody to cis -UCA does not prevent the accumulation 
of DC following UVB irradiation (El -Ghorr and Norval, 1995). 
UVB not only alters DC numbers, but can change the antigen presenting ability 
of DC (Young et al 1993; Noonan et al 1988). A time delay for the onset of defective 
APC function was required, as DC taken 3 days after irradiation had normal activity, 
whilst those taken 7 days later were suppressive. DC treated with IL -10 were capable 
of supporting proliferation of, and IFN -y secretion by, both CD4+ and CD8+ T cells in 
an MLR. In contrast, IL -10 markedly inhibited DC driven IFN -y production by 
purified CD4+ or CD8+ T cells. Under the same conditions, macrophage- dependent 
proliferation was strongly inhibited. IL -10 inhibited DC induced production of IFN -y 
by Th 1 clones, and by CD4+ and CD8+ T cells from unprimed mice in a primary 
allogeneic MLR (Macatonia et al 1993). 
In summary, UVB irradiation results in an accumulation of DC within DLN, 
and this is dependent on IL -1ß and TNF -a. UVA1 also causes an IL -113 dependent 
accumulation of DC, but this is not dependent on TNF -a. 
7.4. UVR and its effects on contact sensitisation 
The strength of the proliferative response to the sensitiser correlates with the 
level of sensitisation and the severity of elicitation (Kimber et al 1990a). There 
similarly exists a correlation between the number of DC arriving in DLN 24h after 
sensitisation and the magnitude of the induced proliferation (Kimber et al 1990b; 
Kimber et al 1990c). The proliferative response of DLNC after contact sensitisation 
was suppressed if mice were exposed to UVB before sensitisation (fig. 3.6). The 
local lymph node assay is able to identify at least moderate and strong skin allergens 
(Kimber, 1992). Thus, the depressed proliferative responses observed in these 
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experiments (see fig. 3.9), would indicate that UVB reduces the relative strength of the 
sensitiser. 
In vitro irradiation of epidermal cells and LC with 20 mJ /cm2 UVB led to loss 
of their ability to stimulate Th 1 cell lines, but the cells retained APC function for Th2 
cell lines. Irradiated splenic adherent cells lost APC function for both subsets (Simon 
et al 1990). UVB irradiation of monocytes impaired their ability to stimulate 
proliferation and IFN -y production of Thl cells, whilst retaining normal APC function 
to Th2 cells (Kremer et al 1996). Th0 cell stimulation was also normal, but exhibited a 
preferential suppression of IFN -y production. This was related to decreased 
production of IL -12 p70 protein. IL -10 did not have any effects on anti -CD3 or 
alloantigen- induced LC- dependent T cell proliferation, but production of IL -2 and 
lFN -y. IL -10 pretreated LC did not alter proliferative responses of Th2 -cell clones 
(D10.G4), but were unable to support proliferation of Thl -cell clones (AE7) (Enk et al 
1993b). Chronic activation of both murine CD4+ T cells in the presence of IL -10 gives 
rise to T cells with low proliferative capacity (Groux et al 1997). However, UVB 
irradiation before contact sensitisation did not significantly alter IL -10 or IFN -y 
secretion by DLNC compared with DLNC from unirradiated, contact sensitised mice 
(figs. 3.9 and 3.11 respectively). 
Irradiation of mice led no increase in IFN -y production from DLNC towards 
the end of the culture period (see fig 3.10). Anti -IFN -y did not significantly alter CH 
responses to Ox. This suggests that IFN -y participates in, but is not wholly 
responsible for, the CH response (Thomson et al 1993). IFN -y "'" mice can mount CH 
responses as well as WT mice (C57B1/6). UVB and cis -UCA can suppress CH 
responses in both wild -type (C57B1/6) and IFN -y-'- mice (Reeve et al 1999). 
T cells from naive, or FTTC- sensitised mice, produced less IFN -y and IL -2 in 
response to culture with APC from UV- irradiated mice than in response to APC from 
unirradiated mice (Saijo et al 1996). IL -4 and IL -10 were not detectable unless culture 
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supernatants were concentrated, and were not consistently produced. Culture with 
APC from UV- irradiated mice did not increase Th2 -like cytokine synthesis. 
Injection of anti -IL -12 before sensitisation resulted in a reduced ear swelling 
upon challenge ( Riemann et al 1996). Furthermore, Riemann and colleagues showed 
that when anti -M -12 treated mice were rechallenged, the CH response remained 
minimal, suggesting that tolerance had been induced (Riemann et al 1996). Anti -IL -12 
injection before sensitisation inhibited UVB induced suppression of CH (Schwarz et al 
1996). However, UVB irradiation before sensitisation resulted in increased IL -12 
production by 48h of culture (see fig. 3.10). Schmitt et al observed increased IL -12 
production by LNC from irradiated mice (Schmitt et al 1998). IL -12 production was 
increased in LNC from UVB- irradiated mice compared with LNC from non -irradiated 
mice, as measured by ELISA. DC- enriched populations from the spleens of irradiated 
mice produced significantly less biologically active IL -12 than splenic DC from 
unirradiated mice. 
Antigen induced cytokine production in mice transgenic for IL -12 p40 is 
skewed toward a Th2 profile, with decreased production of IFN -y and increased 
production of IL -4 and IL -10, suppressed DTH responses (Yoshimoto et al 1998). 
The IL -12 ELISA used for analysis of DLNC culture supernatants measured both the 
inducible p40 subunit and the bioactive p70 heterodimer. UVB may increase IL -12 
p40 production by DLNC. Secretion of IL -12 p40, which can bind the IL -12 receptor, 
may interfere with signalling via IL -12 p70 and skew immune responses by this 
antagonistic mechanism. 
There is evidence that exposure to sub -optimal concentrations of skin 
sensitisers may tip the balance between promoting or inhibitory signals in CH (Sy et al 
1977). Accordingly, it was observed that UVB- mediated immune suppression was 
enhanced by using lower challenge concentrations (see section 3.4). LC depletion may 
be a mechanism to reduce the antigenic dose presented to T cells, and may therefore 
cause suppression of T cell responses. 
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In summary, UVB decreases the proliferative response of DLNC following 
contact sensitisation. UVB also appears to increase Thl -like cytokine production, but 
this may be mis- interpreted due to IL -12 p40 induction. IL -10 production by DLNC 
of contact sensitised mice is unaltered by UVB irradiation. 
7.5. UVB and its effects on elicitation of CH responses. 
In these analyses, UVB irradiation before contact sensitisation appeared to 
change the cytokine profile upon CH elicitation. lFN -y and IL -12 were produced in 
culture supernatants of DLNC from mice undergoing a CH response, but were reduced 
in culture supernatants from DLNC of mice which were irradiated before contact 
sensitisation. The profiles were changed to that of a primary response, as cytokine 
production by UVB treated DLNC was similar to that of negative control mice (see 
section 3.7). IL -10 was not detectable at any time during culture. These data support 
the hypothesis that UVB reduces Thl -like immune responses, but not by upregulation 
of Th2 -like responses (Saijo et al 1996). 
Garssen and colleagues have used a similar system to that used in this study, 
with pre- exposure to suberythemal UVB on 4 days prior to sensitisation of BALB /c 
mice with Ox 4 days after the last irradiation. They could not detect IFN -y or IL -4 in 
supernatants taken from DLNC after 24h of culture (Garssen et al 1999). When 
DLNC were stimulated in vitro with conA or Ox coupled to BSA, there was decreased 
production of IFN -y by cells from irradiated animals. Similar results were found by 
PCR, indicating that these effects also occur at the mRNA level. Further investigation 
using picryl chloride (PC1) as the contact sensitiser showed that IFN -y and IL -12 were 
reduced in in vitro stimulated culture supernatants from irradiated mice, but IL -4 
production was unaltered. IL -10 was not detectable in these assays. 
In a secondary immune response, T cells can encounter and be activated by 
antigen at the site of application, as well as in DLN. The cytokine microenvironment 
in which an antigen is encountered is important in directing the subsequent immune 
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response. In experiments by Goodman and colleagues, when keratinocytes were used 
as accessory cells there was a specific defect in T cell IFN -y production, whereas IL -2 
and IL -4 were induced at levels comparable to those seen when professional APC were 
used as accessories (Goodman et al 1994). RT -PCR revealed that keratinocytes 
produced little or no mRNA for IL -12 p40 compared with professional APC, and 
addition of IL -12 to cultures could restore lFN -y production. IL -10 application can 
suppress the upregulation of IFN -y mRNA normally seen in challenged skin (Kondo 
et al 1994). 
In summary, UVB irradiation suppressed CH responses in mice. Production 
of Thl -like cytokines by DLNC was decreased in mice which were irradiated before 
contact sensitisation. 
7.6. UVB effects on the cutaneous microenvironment. 
Injection of IL -10 (1 -214) into the ears of mice 8h before application of TNCB, 
then challenging on the contra -lateral ear 5d later, led to significant inhibition of CH 
(Enk et al 1994). If sensitised to another chemical at a later time, IL -10 treated mice 
were able to respond, indicating that suppression was hapten- specific. Hapten -specific 
anergy could also be observed in the DLNC of IL -10 treated mice. Sensitisation with 
contact allergens induces IL -10 mRNA in murine epidermal cells, detectable at 4h and 
maximal by 12h (Enk and Katz, 1992b). The effector phase of CH can also be 
blocked by IL -10 (Schwarz et al 1994). IL -10 injection decreases the inflammatory 
cell infiltrate, and decreases edema at the dermis compared to mice with a normal CH 
response (Kondo et al 1994). Evidence for the downregulatory role of IL -10 in DTH 
is provided by intraperitoneal injection of the cytokine prior to either the sensitisation 
or elicitation phase. IL -10 injection leads to blocking of both events (Schwarz et al 
1994). IL -10 injection therefore results in similar changes in immune responsiveness 
to UVB irradiation. 
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Mice lacking expression of IL -10 (IL -10T mice) were completely resistant to 
the immunosuppressive effects of UVB on DTH to alloantigens (BALB /c spleen cells) 
(Beissert et al 1996). Mice which were injected with monoclonal anti -IL -10 antibodies 
4 and 24h after UVB irradiation had a DTH response which was suppressed by half as 
much as mice not treated with antibody (Rivas and Ullrich, 1992). In these studies, a 
single injection of antibodies against IL -10 did not reverse UVB- or cis -UCA mediated 
suppression of the DTH response to HSV -1 (see section 6.2). It may be that IL -10 
has to be neutralised for a longer time following irradiation to prevent its activity. This 
would also indicate that it is likely that there are many factors involved in IL -10 
production following UVB exposure, and potentially, many sources. 
Local suppression can be observed immediately and up to 48h if C57BL /6 mice 
are sensitised through the irradiated site. IL -10 mRNA expression was upregulated 
within an hour of UVB irradiation, and continued to rise until a peak at 24h (see 
fig. 6.16). Expression remained elevated above constitutive levels 96h after exposure. 
IL -10 protein in irradiated skin peaked at 8h after UVB exposure, and had returned to 
constitutive levels by 24h (see fig. 6.3). IL -10 was detectable by ELISA in sera of 
mice irradiated with 7 MED UVB, and peaking 3 -4 days after exposure. This finding 
is in agreement with a previous timecourse found for IL -10 protein in the serum of 
C57BL /6 mice exposed to UVB (Beissert et al 1996). If mice are sensitised through 
an unirradiated site, a lag period of 3 days until contact sensitisation is required before 
maximal systemic suppression of CH can be observed (Miyauchi and Horio, 1995; 
Hammerberg et al 1996). 
ELISA of cell lysates indicated that IL -10 content of PAM -212 cells was 
unaffected 24h after UVB irradiation. IL -10 content of PAM -212 cells was reduced in 
a dose -dependent manner by 48h after irradiation, and this was not due to decreased 
cell viability. ELISA of culture supernatants indicated that IL -10 was not secreted by 
PAM -212 or B16 cells upon UVB exposure (at doses up to 20 mJ /cm2). Rivas and 
Ullrich (Rivas and Ullrich, 1992) identified IL -10 in supernatants from PAM -212 cells 
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irradiated with 20 mJ /cm2 UVB 24h earlier, but not in supernatants from unirradiated 
PAM -212 cells. 
UVB may alter the lymphocytes populations within irradiated sites. This may 
be facilitataed by effects on adhesion or costimulatory molecules. CD44 expression on 
LC is important in lymphocyte homing and T cell activation. TNF -a can upregulate 
CD44 expression, whereas IL -10 downregulates expression, both in a 
concentration -dependent manner. When added simultaneously to cultures of LC, the 
two cytokines mutually neutralised each other's activity (Osada et al 1995). As 
discussed above, both TNF -a and IL -10 are present in UVB -irradiated skin samples 
shortly after exposure (see figs. 6.8 and 6.3 respectively). In the experiment described 
in section 6.9, ICAM -1 expression was induced in the subdermal compartment 
following a 10 MED UVB exposure. ICAM -1 gene expression is controlled by 
nuclear factor (NF) -KB. Induction of NF -KB by reactive oxygen intermediates 
(Jourd'heuil et al 1997), or by TNF -a, is a proposed mechanism for altering ICAM -1 
expression. TNF -a is also implicated in DNA damage following UVB exposure, as 
injection of antibodies against TNF -a reduced DNA fragmentation (Schwarz et al 
1995). DNA damage induced by UVB is another potential mediator (Krutmann and 
Grewe, 1995). Cis -UCA, even above physiological levels, could not augment 
phorbol 12- myristate 13- acetate (TPA) induced synthesis of either TNF -a mRNA 
expression in, or protein secretion from, keratinocytes (Redondo et al 1996). 
Norris and colleagues (1990) found that UVR had a biphasic effect on ICAM -1 
expression on human keratinocytes, with a downregulatory effect preceding an 
upregulation. In experiments by Krutmann and colleagues (1990), in vitro irradiation 
of human keratinocytes prior to stimulation with TNF -a inhibited ICAM -1 
upregulation in a dose -dependent manner. Further studies by the same group revealed 
that UVB exposure of keratinocytes inhibited ICAM -1 upregulation in response to 
either TNF -a or IFN -y. Restoration of responsiveness to TNF -a required at least a 
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24h recovery period (Krutmann et al 1992a). There was a significant increase in 
ICAM -1 expression 48h after irradiation. 
In summary, UVB causes an increase in TNF -a and IL -10 protein within 
irradiated sites. These may play a role in altering the cytokine microenvironment for 
subsequent immune responses. 
UV 13 UVA l cis-UC A 
immune suppression CH CH (reported in 1) CH (reported in 2) 
DTH DTH (reported in 1) DTH 
LC depletion YES NO YES 
from epidermis (max. at 12h) (max. at 24h) 
TNF -a dependent, TNF -a dependent, 
EL-1f1 dependent IL-113 dependent 
DC accumulation TNF -a dependent, TNF -a dependent, NONE 
in DLN IL -113 dependent IL -113 dependent (reported in 3) 
cytokine mRNA 
in skin 
TNF-a (peak at 4h) NO TNF-a 
IL-113 (peak at 4h) IL-1(3 (upreg at 24h) 
IL -10 (continued rise) 
Table 7.1. The effects of UVB, UVAL and cis -UCA on the immune parameters 
investigated. 
(1 = El -Ghorr and Norval, 1999, 2 = Kondo et al, 1995, 3 = Moodycliffe et al, 1992). 
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7.7 Summary 
In any response to antigen, there is a chain of events leading to the final 
immunological decision and outcome, which can be clearance, ignorance or 
exacerbation of the disease state. UVB plays a role in this decision making by biasing 
the system and having knock -on effects throughout the subsequent response. 
There is evidence that UVB irradiation induces TNF -a production in the human 
epidermis, but that UVA1 does not (Skov et al 1998a). It is therefore rational to expect 
LC migration following UVB exposure, and this has been identified in this study. 
UVA1 did not cause a decrease in LC frequency within the epidermis. A predominant 
role for TNF -a in human monocyte IL -10 synthesis has been shown (Wanidworanun 
and Strober, 1993). Lymphocytes from UVR exposed mice produce less IL -2 and 
IFN -y, but more IL -4, when activated in vitro by antigen. A similar change could be 
induced when mice were treated with LPS or IL-lß. The ability of IL-113 to alter 
cytokine secretion is not a direct effect, as addition of IL-1p to cultures of 
antigen -primed T cells does not alter cytokine patterns (Araneo et al 1994). 
Leukocytes produce TNF -a and IL-113 in response to stimulation by LPS. LPS is also 
a potent stimuli for IL -lra mRNA expression and release, and upregulation of IL -lra 
has been reported in irradiated skin (Hirao et al 1996). Release of IL -lra can be 
potentiated in the presence of IL -10. IL -10 alone does not increase IL- l ra release, but 
manages to stabilise IL -1 ra mRNA. IL -10 inhibits production of TNF -a, IL-113, and 
IL -8 under the same conditions (Cassatella et al 1994). Similarly, injection of IL -10 
inhibits the mRNA signals for IL-la, IL-113 and TNF -a (Enk et al 1994). 
Contact sensitisation after irradiation resulted in an unresponsiveness to the 
sensitiser upon challenge. A low zone tolerance effect can be mediated by cells other 
than LC (Steinbrink et al 1996). Use of radiolabelled allergen showed that chemicals 
can leave the site of application via local blood vessels, whereas a small fraction of 
allergen remains in the site for days (Macher and Chase, 1969). Timed excision of 
sensitised sites showed that the chemical does not have to become cell associated, and 
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that the escaping chemical established tolerance rather than sensitisation. Loss of LC 
from the irradiated epidermis robs the cutaneous immune system of its primary APC, 
increasing the likelihood of antigen presentation by (an)other cell type(s) and 
facilitating leakage of contact sensitiser into the systemic environment. Additionally, 
any sensitiser encountered at the site will do so in an environment more favourable 
toward Th2 -like immune responses. Interestingly, a recent study has found that IL -4 
inhibits LC migration induced by TNF -a, via downregulation of TNFR2 expression 
(Takayama et al 1999). 
Irradiated epidermal cells and LC lose their ability to stimulate KLH- specific 
Th 1 cell lines, but retain APC function to KLH- specific Th2 cell lines (Simon et al 
1990). When keratinocytes are used as accessory cells there is a specific defect in 
T cell IFN -y production. This is because keratinocytes produce little or no mRNA for 
IL -12 compared with professional APC (Goodman et al 1994). Incubation of 
epidermal cells in cis -, but not trans -UCA completely inhibited antigen presentation in 
a spindle -cell tumour antigen system. Secondary immune responses were also 
affected, as incubation with cis -UCA prior to injecting antigen -pulsed epidermal cells 
into the footpads of immune mice inhibited the DTH response (Beissert et al 1997). 
A proposed mechanism of action leading to immune modulation following 
UVB irradiation is shown in fig. 7.1, based upon the results of this study, and related 
to the findings of other groups. UVB photoisomerises UCA. Cis -UCA, in 
conjunction with another UV- induced 'factor' induces secretion of IL -113. IL-113 in turn 
initiates in TNF -a production and release, with both cytokines inducing LC migration 
from the epidermis (with subsequent accumulation of DC within the DLN). IL -113 and 
TNF -a also contribute to IL -10 synthesis and secretion, either from resident cells or 
infiltrating macrophages, thereby altering the cutaneous microenvironment. IL -10, 
aided by IL -1ra, then downregulates IL -113 and TNF -a expression, making it more 
difficult for presentation of antigens encountered through the site shortly after UVB 
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irradiation. T cells within DLN of irradiated mice appear to be primed in the normal 
fashion however, exhibiting the same cytokine profiles as unirradiated mice, although 
with a lower proliferative response. Upon homing to the site of sensitisation, the cells 
are not fully activated due to the Th2 -like cytokine microenvironment. 
Effects on disaease states 
Clearance 
Ever since Finsen's first recognition that UVR could heal the skin lesions of 
skin tuberculosis (Lupus vulgaris) (Finsen, 1899), phototherapy has operated on a 
largely empirical basis. Narrow -band UVB (311 -312 nm) is as effective as PUVA in 
treatment of psoriasis (Van Weelden et al 1990). The epidermis of psoriasis patients 
contains about 3 times as much UCA as that of normal subjects, and the antigen - 
presenting ability of epidermal cells is reduced during UVB therapy (Gilmour et al 
1993). 
UVB suppressed human ACD both locally and systemically following Ni 
allergy elicitation, whilst UVA exposure had no effect (Sjovall and Christensen, 
1986). In a study by Simons and colleagues, UVB was slightly better at treating 
chronic hand dermatitis than PUVA, although both therapies relieved the condition 
(Simons et al 1997). However, the side -effects, such as erythema and pigmentation, 
were greater following PUVA, and the group recommended that patients be treated 
with UVB initially, then PUVA if this failed. Conversely, UVA1 is a better treatment 
for atopic eczema than UVB (Krutmann et al 1992b; Krutmann et al 1998). 
Graft survival can be prolonged by treating the recipient with UVB or PUVA, 
whereas UVA alone has no effect (Gruner et al 1992). Injection of cis -UCA starting 
on the day of transplantation was able to prolong the survival of allogeneic MHC 
disparate skin grafts in mice. Furthermore, cis -UCA injection delayed the onset of 
acute graft versus- host disease and prevented the lethal disease in 30% of animals 
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(Gruner et al 1992). Acute graft versus- host disease is regarded as a Thl cell 
mediated disease, whereas the milder chronic form is chararcterised by activation of 
CD4+ T cells secreting Th2 -like cytokines (Rus et al 1995; Corsini et al 1995). 
Ignorance 
As has been shown in this study, UVB can prevent sensitisation to contact 
sensitisers. It has also been shown that UVB, and cis -UCA, can prevent DTH 
responses. It is likely that UVB and cis -UCA can also prevent sensitisation to, and 
subsequent recognition of, tumour neoantigens (Streilein et al 1994b). This appears to 
be as a biological side -effect, which has evolved to prevent the immune system 
rejecting sunburned skin containing altered, self -antigens. 
UVB caused a reduction in immunisation rates to DPCP in human volunteers, 
when given 3 days before sensitisation and CH was elicited 3 weeks later. UVA was 
without effect (Skov et at 1997). 
Exacerbation 
Erythemagenic UVR is toxic in the autoimmune disease systemic lupus 
erythematosus (SLE) (McGrath et al 1994; Dov Golan et al 1992). This phenomenon 
may be due to further suppression of already reduced cell- mediated immunity 
(Horwitz, 1972). Tissue damage occurs, and may be due to TNFa production. 
Suppression of NK cells and perturbed regulation of immunoglobulin production 
could also exacerbate the disease. Enhanced binding of autoantibodies to the cell 
membrane of UV- irradiated keratinocytes may perpetuate tissue damage (Dov Golan et 
al 1992). 
UVB could be of particular relevence in HIV patients, where sunlight could 
induce AIDS progression (Vincek, 1995; Wallace and Lasker, 1992). Irradiation of a 
chronically HIV- infected promonocytic cell line (U1) induced elevated reverse 
transcriptase activity and p24 antigen levels in culture supernatants (Stanley et al 
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1989). There was also a time -dependent upregulation in viral antigen after UVB 
exposure. A switch from Thl to Th2 -like cytokine profiles is implicated in disease 
exacerbation (Clerici and Shearer, 1993). However, most published data indicate few, 
if any, adverse affects on HIV -positive individuals following phototherapy (reviewed 
in Adams et al 1996). 
Immune response to intracellular bacteria could also be altered by UVB. The 
lepromin reaction, a cell- mediated immune response to antigens of Mycobacterium 
leprae, is reduced in locally irradiated sites. Irradiation decreases lymphocyte 
infiltration, particularly CD4+ T cells, in and around the induced granuloma (Cestari et 
al 1995). As the granulomatous response limits or suppresses infection, it thus 




















































































































































































































































































































































Applegate LA, Ley RD, Alcalay J and Kripke ML (1989) Identification of the molecular target for the 
suppression of contact hypersensitivity by ultraviolet radiation. J.Exp.Med. 170:1117 -1131. 
Aragane Y, Riemann H, Bhardwaj RS, Schwarz A, Sawada Y, Yamada H, Luger TA, Kubin M, 
Trinchieri G and Schwarz T (1994) IL -12 is expressed and released by human keratinocytes and 
epidermoid carcinoma cell lines. J.Immunol. 153:5366 -5372. 
Aragane Y, Schwarz A, Luger TA, Ariizumi K, Takashima A and Schwarz T (1997) Ultraviolet light 
suppresses IFN- y- induced IL -7 gene expression in murine keratinocytes by interfering with TIN 
regulatory factors. J.Immunol. 158:5393 -5399. 
Aragane Y, Kulms D, Metze D, Wilkes G, Poppelmann B, Luger TA and Schwarz T (1998) 
Ultraviolet light induces apoptosis via direct activation of CD95 (Fas /APO -1) independently of its 
ligand CD95L. J. Cell Biol. 140:171 -182. 
Araneo BA, Dowell T, Moon HB and Daynes RA (1994) Regulation of murine lymphokine 
production in vivo . Ultraviolet radiation exposure depresses IL -2 and enhances IL -4 production by T 
cells through an IL -1- dependent mechanism. J.Invest.Dermatol. 102:197 -204. 
Askenase PW, van Loveren H, Kraeuter -Kops S, Ron Y, Meade R, Theoharides TC, Nordlund JJ, 
Scovern H, Gerhson MD and Ptak W (1983) Defective elicitation of delayed -type hypersensitivity in 
W/Wv and SI/SId mast cell -deficient mice. J.Immunol. 131:2687 -2694. 
Aubin F, Dall'Acqua F and Kripke ML (1991) Local suppression of contact hypersensitivity in mice 
by a new bifunctional psoralen, 4,4', 5'- trimethylazapsoralen, and UVA radiation. J.Invest.Dermatol. 
97:50 -54. 
Austad J and Braathan LR (1985) Effect of UVB on alloactivating and antigen -presenting capacity of 
human epidermal Langerhans' cells. Scand.J.Immunol. 21:417 -423. 
Autier P (1998) Les cancers de la peau et les facteurs d'environment. Revue Medicale de Bruxelles 
19:A346 -350. 
244 
Babu GS, Joshi PC and Viswanathan PN (1998) UVB- induced reduction in biomass and overall 
productivity of cyanobacteria. Biochem.Biophys.Res.Commun. 244:138 -142. 
Bamford RN, Grant AJ, Burton JD, Peters C, Kurys G, Goldman CK, Brennan J, Roessler E and 
Waldmann TA (1994) The interleukin (IL) 2 receptor ß chain is shared by IL -2 and a cytokine, 
provisionally designated IL -T, that stimulates T -cell proliferation and the induction of 
lymphokine- activated killer cells. Proc.Natl.Acad.Sci. USA 91:4940 -4944. 
Basham TY, Nickoloff BJ, Merigan TC and Morhenn VB (1985) Recombinant gamma interferon 
differentially regulates class II antigen expression and biosynthesis on cultured normal human 
keratinocytes. J.Interferon.Res. 5:23 -32. 
Beer JZ, Olvey KM, Miller SA, Thomas DP and Godar DE (1993) Non -nuclear damage and cell lysis 
are induced by UVA, but not UVB or UVC, radiation in three strains of L5178Y cells. 
Photochem. Photobiol. 58:676 -681. 
Beissert S, Hosoi J, Kuhn R, Rajewsky K, Muller W and Granstein RD (1996) Impaired 
immunosuppression response to ultraviolet radiation in interleukin-l0- deficient mice. 
J.Invest.Dermatol. 107:553 -557. 
Beissert S, Mohammad T, Toni H, Lonati A, Yan Z, Morrison H and Granstein RD (1997) 
Regulation of tumor antigen presentation by urocanic acid. J.Immunol. 159:92 -96. 
Bentham G and Aase A (1996) Incidence of malignant melanoma of the skin in Norway, 1955 -1989: 
associations with solar ultraviolet radiation, income and holidays abroad. Int.J.Epidemiol. 25:1132- 
1138. 
Berg DJ, Leach MW, Kuhn R, Rajewsky K, Muller W, Davidson NJ and Rennick D (1995) 
Interleukin 10 but not interleukin 4 is a natural suppressant of cutaneous inflammatory responses. 
J. Exp. Med. 182:99-108. 
Bergmanson JP and Sheldon TM (1997) Ultraviolet radiation revisited. CLAO Journal 23:196 -204. 
Bergstresser PR, Cruz Jr,P.D., Niederkorn JY and Takashima A (1995) Third International Workshop 
on Langerhans Cells: discussion overview. J.Invest.Dermatol. 99:15 -45. 
245 
Berke G (1995) Unlocking the secrets of CTL and NK cells. Immunol.Today 16:343 -346. 
Bigby M, Kwan T and Sy M -S (1987) Ratio of Langerhans cells to Thy -l' dendritic epidermal cells 
influences the intensity of contact hypersensitivity. J.Invest.Dermatol. 89:495 -499. 
Birt DF, Mitchell D, Gold B, Pour P and Pinch HC (1997) Inhibition of ultraviolet light induced 
skin carcinogenesis in SKH -1 mice by apigenin, a plant flavonoid. Anticancer.Res. 17:85 -91. 
Blauvelt A, Asada H, Klaus -Kovtun V, Altman DJ, Lucey DR and Katz SI (1996) Interleukin -15 
mRNA is expressed by human keratinocytes, Langerhans' cells, and blood- derived dendritic cells and is 
downregulated by ultraviolet B radiation. J.Invest.Dermatol. 106:1047 -1052. 
Boonstra A and van Oudenaren A (1998) Modulation of Th1/Th2 by ultraviolet -B irradiation (Abstr). 
Photochem.Photobiol. 67:45S. 
Bos, JD, Das, PK and Kapsenberg, ML. Skin immune system (SIS), Boca Raton:CRC Press, 1997. 
Ed. 2 pp. 9 -16. 
Braverman IM and Keh -Yen A (1992) The periadventitial cell of the cutaneous microvasculature 
known as the veil cell, is the dermal dendrocyte . Clin.Res. 40:A496. 
Buckman SY, Gresham A, Hale P, Hruza G, Anast J, Masferrer J and Pentland AP (1998) COX -2 
expression is induced by UVB exposure in human skin: implications for the development of skin 
cancer. Carcinogenesis 19:723 -729. 
Burke KE, Burford RG, Combs Jr GF, French 1W and Skeffington DR (1992) The effect of topical 
L- selenomethionine on minimal erythema dose of ultraviolet irradiation in humans. 
Photodermatol. Photoimmunol. Photomed. 9:52 -57. 
Burton JD, Bamford RN, Peters C, Grant AJ, Kurys G, Goldman CK, Brennan J, Roessler E and 
Waldmann TA (1994) A lymphokine, provisionally designated interleukin T and produced by a 
human adult T -cell leukemia line, stimulates T -cell proliferation and the induction of 
lymphokine- activated killer cells . Proc.Natl.Acad.Sci. USA 91:4935 -4939. 
Caceres -Dittmar G, Ariizumi K, Xu S, Tapia FJ, Bergstresser PR and Takashima A (1995) Hydrogen 
peroxide mediates UV- induced impairment of antigen presentation in a murine epidermal- derived 
dendritic cell line. Photochem.Photobiol. 62:176 -183. 
246 
Carson WE, Giri JG, Lindemann MJ, Linett ML, Ahdieh M, Paxton R, Anderson D, Eisenmann J, 
Grabstein K and Caligiuri MA (1994) Interleukin (IL) 15 is a novel cytokine that activates human 
natural killer cells via components of the IL -2 receptor. J.Exp.Med. 180:1395 -1403. 
Cassatella MA, Meda L, Gasperini S, Calzetti F and Bonora S (1994) Interleukin 10 (IL -10) 
upregulates IL -1 receptor antagonist production from lipopolysaccharide -stimulated human 
polymorphonuclear leukocytes by delaying mRNA degradation. J.Exp.Med. 179:1695 -1699. 
Cestari TF, Kripke ML, Baptista PL, Bakos L and Bucana CD (1995) Ultraviolet radiation decreases 
the granulamatous response to lepromin in humans. J.Invest.Dermatol. 105:8 -13. 
Chadwick CA, Potten CS, Nikaido O, Matsunaga T, Proby C and Young AR (1995) The detection 
of cyclobutane thymine dimers, (6 -4) photolesions and the Dewar photoisomers in sections of 
UV- irradiated human skin using specific antibodies, and the demonstration of depth penetration effects. 
J.Photochem.Photobiol.B: Biol 28:163-170. 
Chaker MB, Tharp MD and Bergstresser PR (1984) Rodent epidermal Langerhans cells demonstrate 
greater histochemical specificity for ADP than for ATP or AMP. J.Invest.Dermatol. 82:496 -500. 
Chatterjee ML, Agarwal R and Mukhtar H (1996) Ultraviolet B radiation -induced DNA lesions in 
mouse epidermis: an assessment using a novel 32P- postlabelling technique. 
Biochem. Biophys. Res. Commun. 229:590 -595. 
Chu AC, Davenport V and Morris JF (1998) Immunologic protection afforded by sun screens. 
J.Invest.Dermatol. 111:340. 
Clark LC (1985) The epidemiology of selenium and cancer. Fed.Proc. 44:2584 -2589. 
Clement- Lacroix P, Michel L, Moysan A, Morliere P and Dubertret L (1996) UVA- induced immune 
suppression in human skin: protective effect of vitamin E in human epidermal cells in vitro. 
Br. J. Dermatol. 134:77 -84. 
Clerici M and Shearer GM (1993) A Thl -> Th2 switch is a critical step in the etiology of HIV 
infection. Immunol.Today 14:107 -111. 
247 
Coebergh JWW, Neumann HAM, Vrints LW, Van Der Heijden L, Meijer WJ and Verhagen -Teulings 
MTH (1991) Trends in the incidence of non -melanoma skin cancer in the SE Netherlands 1975 -1988: 
a registry based study. Br.J.Dermatol. 125:353 -359. 
Cooper KD, Fox P, Neises G and Katz SI (1985) Effects of ultraviolet radiation on human epidermal 
cell alloantigen presentation: initial depression of Langerhans cell -dependent function is followed by 
the appearance of T6- Dr+ cells that enhance epidermal alloantigen presentation. J.Immunol. 134: 
129 -137. 
Cooper KD, Oberhelman L, Hamilton TA, Baadsgaard O, Terhune M, LeVee G, Anderson T and 
Koren H (1992) UV exposure reduces immunization rates and promotes tolerance to epicutaneous 
antigens in humans: relationship to dose, CD1a -DR+ epidermal macrophage induction, and 
Langerhans cell depletion. Proc.Natl.Acad.Sci.(USA) 89:8497 -8501. 
Corsini E , Bruccoleri A, Marinovich M and Galli CL (1995) In vitro mechanism(s) of 
ultraviolet- induced tumor necrosis factor -alpha release in a human keratinocyte cell line. 
Photodermatol. Photoimmunol. Photomed. 11:112 -118. 
Corver WE, Cornelisse CJ, Hermans J and Fleuren GJ (1995) Limited loss of nine tumor -associated 
surface antigenic determinants after tryptic cell dissociation. Cytometry 19:267 -272. 
Cumberbatch M and Kimber I (1992) Dermal tumour necrosis factor -a induces dendritic cell 
migration to draining lymph nodes, and possibly provides one stimulus for Langerhans' cell 
migration. Immunology 75:257 -263. 
Cumberbatch M and Kimber I (1995) Tumour necrosis factor -a is required for accumulation of 
dendritic cells in draining lymph nodes and for optimal contact sensitisation. Immunology 84:31 -35. 
Cumberbatch M, Dearman RJ and Kimber I (1997a) Langerhans cells require signals from both 
tumour necrosis factor -a and interleukin -113 for migration. Immunology 92:388 -395. 
Cumberbatch M, Dearman RJ and Kimber I (1997b) Interleukin 113 and the stimulation of 
Langerhans cell migration: comparisons with tumour necrosis factor a. Arch.Dermatol.Res. 289: 
277 -284. 
248 
Cumberbatch M, Dearman RJ and Kimber I (1997c) Interleukin 113 and the stimulation of 
Langerhans' cell migration: comparisons with tumour necrosis factor a. Arch.Dermatol.Res. 
289:277 -284. 
D'Aquila RDT, Betchel LJ, Videlaer JA, Eron JJ, Gorczyca P and Kaplan JC (1991) Maximising 
sensitivity and specificity of PCR by pre -amplification heating. Nucleic Acids Res 19:3749. 
D'Eustachio P, Jadidi S, Fuhlbrigge RC, Gray PW and Chaplin DD (1987) Interleukin -la and 13 
genes: linkage on chromosome 2 in the mouse. Immunogenetics 26:339 -343. 
Dai R and Streilein JW (1997) Ultraviolet B- exposed and soluble factor -pre- incubated epidermal 
Langerhans' cells fail to induce contact hypersensitivity and promote DNP- specific tolerance. 
J.Invest.Dermatol. 108:721 -726. 
Damian DL, Halliday GM and Barnetson RStC (1997) Broad -spectrum sunscreens provide greater 
protection against ultraviolet- radiation -induced suppression of contact hypersensitivity to a recall 
antigen in humans. J.Invest.Dermatol. 109:146 -151. 
Damian DL, Halliday GM, Taylor CA and Barnetson RStC (1998) ULtraviolet radiation induced 
suppression of Mantoux reactions in humans. J.Invest.Dermatol. 110:824 -827. 
Davenport V, Morris JF and Chu AC (1998) Immunologic protection afforded by sunscreens in vitro. 
J.Invest.Dermatol. 108:859 -863. 
De Fabo E, Noonan F, Fisher M, Burns J and Kacser H (1983) Further evidence that the 
photoreceptor mediating UV- induced systemic immune suppression is urocanic acid. 
J.Invest.Dermatol. 80:319(Abs). 
De Fabo EC and Noonan FP (1983) Mechanism of immune suppression by ultraviolet irradiation in 
vivo. I. Evidence for the existence of a unique photoreceptor in skin and its role in photoimmunology. 
J. Exp. Med. 157:84-98. 
De Fabo EC, Phillips TM, Chmielinska J and Noonan FP (1999) Altered skin cytokine environment 
after UVB irradiation in UCA- deficient histidinemic C57BL /6- HalEd' mice (Abstr). Adv.Dermatol. 
6:7167 -7168. 
249 
de Fine Olivarius F, Wulf HC, Crosby J and Norval M (1997a) Seasonal variation in urocanic acid 
isomers in human skin. Photochem.Photobiol. 66:119 -123. 
de Fine Olivarius F, Wulf HC, Therkildsen P, Poulsen T, Crosby J and Norval M (1997b) Urocanic 
acid isomers: relation to body site, pigmentation, stratum corneum thickness and photosensitivity. 
Arch. Dermatol. Res. 289:501 -505. 
de Fine Olivarius F, Lock -Anderson J, Gronhoj Larsen F, Wulf HC, Crosby J and Norval M (1998) 
Urocanic acid isomers in patients with basal cell carcinoma and cutaneous malignant melanoma. 
Br. J. Dermatol. 138:986 -992. 
de Fine Olivarius GF, Wulf HC, Crosby J and Norval M (1996) The sunscreening effect of urocanic 
acid. Photodermatol .Photoimmunol.Photomed. 12:95 -99. 
de Waal Malefyt R, Yssel H, Roncarolo M -G, Spits H and de Vries JE (1992) Interleukin -10. 
Curr.Opin.Immunol. 4:312 -320. 
Dearman RJ, Moussavi A, Kemeny DM and Kimber I (1996) Contribution of CD4* and CD8+ T 
lymphocyte subsets to the cytokine secretion patterns induced in mice during sensitization to contact 
and respiratory chemical allergens. Immunology 89:502 -510. 
Deeg HJ, Bazar L, Sigaroudinia M and Cottler -Fox M (1989) Ultraviolet B light inactivates bone 
marrow T lymphocytes but spares hematopoietic precursor cells. Blood 73:369 -371. 
Denkins Y, Fidler IJ and Kripke ML (1989) Exposure of mice to UV -B radiation suppresses the 
delayed hypersensitivity to Candida alicans. Photochem.Photobiol. 49:615 -619. 
Devary Y, Rosette C, DiDonato JA and Karin M (1993) NF -KB activation by ultraviolet light not 
dependent on a nuclear signal. Science 261:1442 -1445. 
Di Nuzzo S, De Rie MA, van der Loos CM, Bos JD and Teunissen MBM (1996) Solar- simulated 
ultraviolet irradiation induces selective influx of CD4+ T lymphocytes in normal human skin. 
Photochem.Photobiol. 64:988 -993. 
Di Nuzzo S, Sylva -Steenland RMR, De Rie MA, Das PK, Bos JD and Teunissen MBM (1998) UVB 
radiation preferentially induces recruitment of memory CD4+ T cells in normal human skin: Long -term 
effect after a single exposure. J.Invest.Dermatol. 110:978 -981. 
250 
Diffey BL and Grice J (1997) The influence of sunscreen type on photoprotection. Br.J.Dermatol. 
137:103 -105. 
DiIulio NA, Xu H and Fairchild RL (1996) Diversion of CD4+ T cell development from regulatory T 
helper to effector T helper cells alters the contact hypersensitivity response. Eur.J.Immunol. 26: 
2606 -2612. 
Dittmar HC, Weiss JM, Termeer CC, Denfeld RW, Wanner MB, Skov L, Barker JNWN, Schopf E, 
Baadsgaard O and Simon JC (1999) In vivo UVA -1 and UVB irradiation differentially perturbs 
antigen -presenting function of human epidermal Langehans cells. J.Invest.Dermatol. 112:322 -325. 
Dov Golan T, Elkon KB, Gharavi AE and Krueger JG (1992) Enhanced membrane binding of 
autoantibodies to cultured keratinocytes of systemic lupus erythematosus patients after ultraviolet 
B /ultraviolet A irradiation. J. Clin.lnvest. 90:1067 -1076. 
Eigler A, Sinha B, Hartmann G and Endres S (1997) Taming TNF: strategies to restrain this 
proinflammatory cytokine. Immunol.Today 18:487 -492. 
El -Ghorr A and Norval M (1995) A monoclonal antibody to cis -urocanic acid prevents the 
ultraviolet- induced changes in Langerhans cells and delayed hypersensitivity responses in mice, 
although not preventing dendritic cell accumulation in lymph nodes draining the site of irradiation and 
contact hypersensitivity responses. J.Invest.Dermatol. 105:264 -268. 
El -Ghorr AA, Norval M, Lappin MB and Crosby JC (1995) The effect of chronic low -dose UVB 
radiation on Langerhans cells, sunburn cells, urocanic acid isomers, contact hypersensitivity and serum 
immunoglobulins in mice. Photochem.Photobiol. 62:326 -332. 
El -Ghorr AA and Norval M (1999) The UV waveband dependencies in mice differ for the suppression 
of contact hypersensitivity, delayed -type hypersensitivity and cis -urocanic acid formation. 
J.Invest.Dermatol. 112:757 -762. 
Enk AH and Katz SI (1992a) Early molecular events in the induction phase of contact sensitivity. 
Proc.Natl.Acad.Sci. USA 89:1398 -1402. 
Enk AH and Katz SI (1992b) Identification and induction of keratinocyte -derived IL -10. J.Immunol. 
149:92 -95. 
251 
Enk AH, Angeloni VL, Udey MC and Katz SI (1993a) An essential role for Langerhans cell- derived 
IL-lß in the initiation of primary immune responses in skin. J.Immunol. 150:3698 -3704. 
Enk AH, Angeloni VL, Udey MC and Katz SI (1993b) Inhibition of Langerhans cell 
antigen -presenting function by IL -10. A role for IL -10 in induction of tolerance. J.Immunol. 
151:2390 -2398. 
Enk AH, Saloga J, Becker D, Mohamadzadeh M and Knop J (1994) Induction of hapten- specific 
tolerance by IL -10 in vivo. J.Exp.Med. 179:1397 -1402. 
Enk AH and Katz SI (1995) Contact sensitivity as a model for T -cell activation in skin. 
J.Invest.Dermatol. 105:80S-83S. 
Ferguson TA, Dube P and Griffith TS (1994) Regulation of contact hypersensitivity by interleukin 
10. J.Exp.Med. 179:1597 -1604. 
Finsen NR. Uber die Bedeutung der chemische Strahlen des Lichtes fur Medicin und Biologie, Leipzig: 
Vogel, 1899 
Fiorentino DF, Zlotnik A, Vieira P, Mosmann TR, Howard M, Moore KW and O'Garra A (1992) 
IL -10 acts on the antigen -presenting cell to inhibit cytokine production by Thl cells. 
J.Invest.Dermatol. 99:71S-73S. 
Fisher MS and Kripke ML (1977) Systemic alteration induced in mice by ultraviolet light irradiation 
and its relationship to ultraviolet carcinogenesis. Proc.Natl.Acad.Sci.USA 74:1688 -1692. 
Forsthuber T, Yip CY and Lehmann PV (1996) Induction of TH1 and TH2 immunity in neonatal 
mice. Science 271:1728 -1730. 
Frederick JE and Snell HE (1988) Ultraviolet radiation levels during the Antarctic spring. Science 
241:438 -440. 
Friedmann PS (1981) Disappearance of epidermal Langerhans cells during PUVA therapy. 
Br.J.Dermatol. 105:219 -221. 
Friedmann PS, White SI, Parker S, Moss C and Matthews JNS (1989) Antigenic stimulation during 
ultraviolet therapy in man does not result in immunological tolerance. Clin.Exp.Immunol. 76:68 -72. 
252 
Fujisawa H, Kondo S, Wang B, Shivji GM and Sauder DN (1996) The role of CD4 molecules in the 
induction phase of còntact hypersensitivity cytokine profiles in the skin and lymph nodes. 
Immunology 89:250 -255. 
Fujisawa H, Wang B, Kondo S, Shivji GM and Sauder DN (1997) Costimulation with ultraviolet B 
and interleukin -1 alpha dramatically increase tumor necrosis factor -alpha production in human dermal 
fibroblasts. J.Int.Cytokine.Res. 17:307 -313. 
Fuller CJ, Faulkner H, Bendich A, Parker RS and Roe DA (1992) Effect of (3- carotene 
supplementation on photosuppression of delayed -type hypersensitivity in normal young men. 
Am. J. Clin. Nutr. 56:684-690. 
Galli SJ and Hammel I (1984) Unequivocal delayed hypersensitivity in mast -cell deficient and biege 
mice. Science 226:710 -713. 
Gardner MJ, Jones LM, Catterall JB and Turner GA (1995) Expression of cell adhesion molecules on 
ovarian tumour cell lines and mesothelial cells, in relation to ovarian cancer metastasis . Can.Letts. 
91:229 -234. 
Garssen J, Buckley TL and van Loveren H (1998) A role for neuropeptides in UVB- induced systemic 
immunosuppression. Photochem.Photobiol. 68:205 -210. 
Garssen J, Vandebriel RJ, de Gruijl FR, Wolvers DAW, Van Dijk M, Fluitman A and van Loveren H 
(1999) UVB exposure- induced systemic modulation of Thl- and Th2- mediated immune responses. 
Immunology 97:506 -514. 
Gasparro FP (1998) Photobiology 101. J.Invest.Dermatol. 110:183. 
Gately MK, Warrier RR, Honasoge S, Carvajal DM, Faherty DA, Connaughton SE, Anderson TD, 
Sarmiento U, Hubbard BR and Murphy K (1991) Administration of recombinant IL -12 to normal 
mice enhances cytolytic lymphocyte activity and induces production of IFN-y in vivo. Int.Immunol. 
6:157 -167. 
Gautam SC, Chikkala NF and Hamilton TA (1992) Anti -inflammatory action of IL -4. Negative 
regulation of contact sensitivity to trinitrochlorobenzene. J.Immunol. 148:1411 -1415. 
253 
Geba GP, Ptak W, Anderson GM, Paliwal V, Ratzlaff RE, Levin J and Askenase PW (1996) 
Delayed -type hypersensitivity in mast cell- deficient mice. Dependence on platelets for expression of 
contact sensitivity. J.Immunol. 157:557 -565. 
Gensler HL, Timmerman BN, Valcic S, Wachter GA, Dorr R, Dvorakova K and Alberts DS (1996) 
Prevention of photocarcinogenesis by topical administration of pure epigallocatechin gallate isolated 
from green tea . Nutr.Cancer. 26:325 -335. 
Gershon RK, Askenase PW and Gershon MD (1975) Requirement for vasoactive amines for 
production of delayed -type hypersensitivity skin reactions. J.Exp.Med. 142:732 -747. 
Ghaznawie M, Papadimitriiou JM and Heenan PJ (1999) The steady -state turnover of murine 
epidermal Langerhans cells. Br.J.Dermatol. 141:57 -61. 
Gibbs NK, Norval M, Traynor NJ, Crosby JC, Lowe G and Johnson BE (1993) Comparative 
potency of broad -band and narrow -band phototherapy sources to induce edema, sunburn cells and 
urocanic acid photoisomerization in hairless mouse skin. Photochemistry & Photobiology 58: 
643 -647. 
Gibbs NK, McCloone PR and Simics E (1997) An action spectrum for urocanic acid isomerisation in 
human skin in vivo. Photochem.Photobiol. 65:103s -104s (Abs). 
Gilliam AC, Kremer IB, Yoshida Y, Stevens SR, Tootell E, Teunissen MBM, Hammerberg C and 
Cooper KD (1998) The human hair follicle: A reservoir of CD40+ B7- deficient Langerhans cellsthat 
repopulate epidermis after UVB exposure. J.Invest.Dermatol. 110:422 -427. 
Gilmour JW, Vestey JP, George S and Norval M (1993a) Effect of phototherapy and urocanic acid 
isomers on natural killer cell function. J.Invest.Dermatol. 101:169 -174. 
Gilmour JW, Vestey JP and Norval M (1993b) The effect of UV therapy on immune function in 
patients with psoriasis. Br.J.Dermatol. 129:28 -38. 
Gimmi CD, Freeman GJ, Gribben JG, Gray G and Nadler LM (1993) Human T -cell clonal anergy is 
induced by antigen presentation in the absence of B7 costimulation. Proc.Natl.Acad.Sci. USA 
90:6586 -6590. 
254 
Girolomoni G, Santantonio ML, Bergstresser PR, Cruz PD,Jr. and Gianetti A (1992) Membrane 
ecto -ATPase on epidermal Langerhans cells. J.Invest.Dermatol. 99:18S -19S. 
Goettsch W, Hurks MHM, Garssen J, Mommaas AM, Slob W, Hoekman J, Pierik F, Roholl PJM 
and van Loveren H (1998) Comparative immunotoxicology of ultraviolet B exposure I. Effects of in 
vitro and in situ ultraviolet B exposure on the functional activity and morphology of Langerhans cells 
in the skin of different species . Br.J.Dermatol. 139:230 -238. 
Goodman RE, Nestle F, Naidu YM, Green JM, Thompson CB, Nickoloff BJ and Turka LA (1994) 
Keratinocyte- derived T cell costimulation induces preferential production of 1L -2 and IL -4 but not 
IFN -y. J.Immunol. 152:5189 -5198. 
Grabstein KH, Eisenmann J, Shanebeck K, Rauch C, Srinivasan S, Fung V, Beers C, Richardson J, 
Schoenborn MA, Ahdieh M, Johnson L, Alderson MR, Watson JD, Anderson DM and Giri JG 
(1994) Cloning of a T cell growth factor that interacts with the b chain of the interleukin -2 receptor. 
Science 264:965 -968. 
Granstein RD, Askari M, Whitaker D and Murphy GF (1987) Epidermal cells in activation of 
suppressor lymphocytes: further characterization. J.Immunol. 138:4055 -4062. 
Grewe M, Gyufko K and Krutmann J (1995) Interleukin -10 production by cultured human 
keratinocytes: regulation by ultraviolet B and ultraviolet Al radiation. J.Invest.Dermatol. 104:3 -6. 
Grewe M, Duvic M, Aragane Y, Schwarz T, Ullrich SE and Krutmann J (1996) Lack of induction of 
IL -10 expression in human keratinocytes (Reply). J.Invest.Dermatol. 106:1330 -1331. 
Groux H, O'Garra A, Bigler M, Rouleau M, Antonenko S, de Vries JE and Roncarolo M -G (1997) A 
CD4+ T -cell subset inhibits antigen -specific T -cell responses and prevents colitis. Nature 389: 
737 -742. 
Gruner S, Diezel W, Stoppe H, Oesterwitz H and Henke W (1992) Inhibition of skin allograft 
rejection and acute graft- versus -host disease by cis -urocanic acid. J.Invest.Dermatol. 98:459 -462. 
Gu Y, Kuida K, Tsutsui H, Ku G, Hsiao K, Fleming MA, Hayashi N, Okamura H, Nakanishi K, 
Kurimoto M, Tanimoto T, Flavell RA, Sato V, Harding MW, Livingston DJ and Su MS (1997) 
Activation of interferon -y inducing factor mediated by interleukin- I ß converting enzyme. Science 
275:206 -209. 
255 
Guckian M, Jones CD, Vestey JP, Cooper EJ, Dawe R, Gibbs NK and Norval M (1995) 
Immunomodulation at the initiation of phototherapy and photochemotherapy. 
Photodermatol. Photoimmunol. Photomed. 11:163 -169. 
Halliday KE and Norval M (1997) The effect of ultraviolet radiation on infectious diseases. 
Rev.Med.Micro. 8:179 -188. 
Hammerberg C, Duraiswamy N and Cooper KD (1996) Temporal correlation between UV radiation 
locally -inducible tolerance and the sequential appearance of dermal, then epidermal, classll MHC` 
CDl lb' monocytic /macrophagic cells. J.Invest.Dermatol. 107:755 -763. 
Handel- Fernandez ME, Kurimoto I, Streilein JW and Vincek V (1999) Genetic mapping and physical 
cloning of UVB susceptibility region in mice. J.Invest.Dermatol. 113:224 -229. 
Hanua D, Fabre M, Schmitt DA, Lepoittevin J -P, Stampf J -L, Grosshans E, Benezra C and Cazenave 
J -P (1989) ATPase and morphologic changes in Langerhans cells induced by epicutaneous application 
of a sensitizing dose of DNFB. J.Invest.Dermatol. 92:689 -694. 
Hart PH, Jones CA, Jones KL, Watson CJ, Santucci I, Spencer LK and Finlay -Jones JJ (1993) 
Cis -urocanic acid stimulates human peripheral blood monocyte prostaglandin E2 productionand 
suppresses indirectly tumor necrosis factor -a. J.Immunol. 150:4514 -4523. 
Hersey P, Haran G, Hasic E and Edwards A (1983) Alteration of T cell subsets and induction of 
suppressor T cell activity in normal subjects after exposure to sunlight. J.Immunol. 31:171 -174. 
Hersey P, MacDonald M, Burns C, Schibeci S, Matthews H and Wilkinson FJ (1987) Analysis of 
the effect of a sunscreen agent on the suppression of natural killer cell activity induced in human 
subjects by radiation from solarium lamps. J.Invest.Dermatol. 88:271 -276. 
Hersey P, Magrath H and Wilkinson F (1993) Development of an in vitro system for the analysis of 
ultraviolet radiation -induced suppression of natural killer cell activity. Photochem.Photobiol. 57: 
279 -284. 
Hirao T, Aoki H, Yoshida T, Sato Y and Kamoda H (1996) Elevation of interleukin 1 receptor 
antagonist in the stratum corneum of sun -exposed and ultraviolet B- irradiated human skin. 
J.Invest.Dermatol. 106:1102 -1107. 
Hogan DJ, To T and Gran L (1989) Risk factors for basal cell carcinoma. Int.J.Dermatol. 28: 
256 
467 -471. 
Holliday MR, Corsini E, Smith S, Basketter DA, Dearman RJ and Kimber I (1997) Differential 
induction of cutaneous TNF -a and IL -6 by topically applied chemicals. Am.J.Contact.Derm. 8: 
158 -164. 
Hollis DE and Scheibner A (1988) Ultrastructural changes in epidermal Langerhans cells and 
melanocytes in response to ultraviolet irradiation, in Australians of Aboriginal and Celtic descent. 
Br.J.Dermatol. 119:21 -31. 
Horwitz DA (1972) Impaired delayed type hypersensitivity in systemic lupus erythematosus. 
Arth ritis. Rheum. 15:353-359. 
Hosoi J, Murphy GF, Egan CL, Lerner EA, Grabbe S, Asahina A and Granstein RD (1993) 
Regulation of Langerhans cell function by nerves containing calcitonin gene -related peptide. Nature 
363:159 -163. 
Houghtaling MA, Kennedy MA, Mohammad T, Tessman I and Morrison H (1996) Photochemistry 
and photobiology of imidazole -4(5)- methylidene malonic acid: An anolog of both E- and Z- urocanic 
acid. Photochem.Photobiol. 64:216 -219. 
Howard M and O'Garra A (1992) Biological properties of interleukin 10. Immunol.Today 13: 
198 -200. 
Howie S, Norval M and Maingay J (1986) Exposure to low -dose ultraviolet radiation suppresses 
delayed -type hypersensitivity to herpes simplex virus in mice. J.Invest.Dermatol. 86:125 -128. 
Hurks HMH, Van der Molen RG, Out -Luiting C, Vermeer B -J, Claas FHJ and Mommaas AM 
(1997) Differential effects of sunscreens on UVB- induced immunomodulation in humans. 
J.Invest. Dermatol. 109:699 -703. 
Hurks MHM, Out -Luiting C, Vermeer BJ, Claas FHJ and Mommaas AM (1995) The action spectra 
for UV- induced suppression of MLR and MECLR show that immunosuppression is mediated by DNA 
damage. Photochem.Photobiol. 62:449 -453. 
257 
Hurks MHM, Out -Luiting C, Van der Molen R, Vermeer BJ, Claas FHJ and Mommaas AM (1997a) 
Differential suppression of the human mixed epidermal cell lymphocyte reaction (MECLR) and mixed 
lymphocyte reaction (MLR) by cis -urocanic acid . Photochem.Photobiol. 65:616 -621. 
Hurks MHM, Out -Luiting C, Vermeer B -J, Claas FHJ and Mommaas AM (1997b) In situ action 
spectra suggest that DNA damage is involved in ultraviolet radiation -induced immunosuppression in 
humans. Photochem.Photobiol. 66:76 -81. 
Inaba K, Schuler G, Witmar MD, Valinsky J, Atassi B and Steinman RM (1986) Immunologic 
properties of purified epidermal Langerhans' cells. Distinct requirements for stimulation of unprimed 
and sensitized T lymphocytes. J.Exp.Med. 164:605 -613. 
Jackson M, Thomson KE, Laker R, Norval M, Hunter JAA and McKenzie RC (1996) Lack of 
induction of IL -10 expression in human keratinocytes. J.Invest.Dermatol. 106:1329- 11330. 
Jaksic A, Finlay -Jones JJ, Watson CJ, Spencer K, Santucci I and Hart PH (1995) Cis -urocanic acid 
synergizes with histamine for increased PGE2 production by human keratinocytes: link to 
indomethacin -inhibitable UVB- induced immunosuppression. Photochem.Photobiol. 61:303 -309. 
Jeevan A and Kripke ML (1989) Alteration of the immune responses to mycobacterium bovis BCG 
in mice exposed chronically to low doses of UV radiation. Cell.Immunol. 145:2087 -2091. 
Jones CD, Barton AK, Crosby J, Norval M and Gibbs NK (1996) Investigating the red shift between 
in vitro and in vivo urocanic acid phoyoisomerization action spectra. Photochem.Photobiol. 63: 
302 -305. 
Jourd'heuil D, Morise Z, Conner EM, Kurose I and Grisham MB (1997) Oxidant -regulation of gene 
expression in the chronically inflamed intestine. Keio.J.Med. 46:10 -15. 
Kammeyer A, Teunissen MBM, Pavel S, De Rie MA and Bos JD (1995) Photoisomerisation 
spectrum of urocanic acid in human skin and in vitro : effects of simulated solar and artificial 
ultraviolet radiation. Br.J.Dermatol. 132:884 -891. 
Kang K, Hammerberg C, Meunier L and Cooper KD (1994) CD11b+ macrophages that infiltrate 
human epidermis after in vivo ultraviolet exposure potently produce IL -10 and represent the major 
secretory source of epidermal IL -10 protein. J.Immunol. 153:5256 -5264. 
258 
Karagas MR (1994) Occurence of cutaneous basal cell and squanous cell malignancies among those 
with a prior history of skin cancer. J.Invest.Dermatol. 102:10S -13S. 
Karre K (1992) MHC gene control of the natural killer system at the level of the target and the host. 
Sem. Can.Biol. 2:295 -309. 
Kashihara -Sawami M and Norris DA (1992) The state of differentiation of cultured human 
keratinocytes determines the level of intercellular adhesion molecule -1 (ICAM -1) expression induced 
by gamma interferon. J.Invest.Dermatol. 98:741 -747. 
Katiyar SK, Elmets CA, Agarwal R and Mukhtar H (1995) Protection against ultraviolet -B 
radiation -induced local and systemic suppression of contact hypersensitivity and edema responses in 
C3H/HeN mice by green tea polyphenols. Photochem.Photobiol. 62:855 -861. 
Kavanagh G, Crosby J and Norval M (1995) Urocanic acid isomers in human skin: analysis of site 
variation. Br.J.Dermatol. 133:728 -731. 
Kelly DA, Walker SL, McGregor JM and Young AR (1993) A single exposure of solar simulated 
radiation suppresses contact hypersensitivity both locally and systemically in humans: quantitative 
studies with high frequency ultrasound. J.Photochem.Photobiol.B: Biol 148:760 -767. 
Kerr RA (1988) Stratosperic ozone is decreasing. Science 239:1489 -1491. 
Kimber I, Bentley AN, Ward RK, Baker D and Turk JL (1990a) Antigen- restricted antigenic 
competition induced by 2, 4- dinitrochlorobenzene: association with depression of lymphocyte 
proliferation. Int.Arch.Allergy.Appl.lmmunol. 91:315 -322. 
Kimber I, Hilton J, Botham PA, Basketter DA, Scholes EW, Miller K, Robbins MC, Harrison PTC, 
Gray TJB and Waite SJ (1990b) The murine local lymph node assay. Results of an inter -laboratory 
trial. Toxicology Letters 55:203 -213. 
Kimber I, Kinnaird A, Peters SW and Mitchell JA (1990c) Correlation between lymphocyte 
proliferative responses and dendritic cell migration in regional lymph nodes following skin painting 
with contact -sensitizing agents. Int.Arch.Allergy.Appl.Immunol. 93:47 -53. 
259 
Kimber I and Dearman RJ (1991) Investigation of lymph node cell proliferation as a possible 
immunological correlate of contact hypersensitivity by different mechanisms. Food. Chem.Toxicol. 
29:125 -129. 
Kimber, I. Contact sensitivity. In: Principles and practice of immunotoxicology, edited by Miller, K., 
Turk, J. and Nicklin, S. Blackwell Scientific Publications, 1992, p. 104 -124. 
Kimber I and Dearman RJ (1997) Cell and molecular biology of chemical allergy. 
Cli.Rev.Allergy.Immunol. 15:145 -168. 
Kimber I, Dearman RJ, Cumberbatch M and Huby RJD (1998) Langerhans cells and chemical 
allergy. Curr.Opin.lmmunol. 10:614 -619. 
Kirnbauer R, Kock A, Krutmann J, Schwarz T, Urbanski A and Luger TA (1989) Different effects of 
UVA and UVB irradiation on epidermal cell -IL 6 expression and release. J.Invest.Dermatol. 
92:459(Abs). 
Kitagaki H, Ono N, Hayakawa T, Watanabe K and Shiohara T (1997) Repeated elicitation of contact 
hypersensitivity in cutaneous cytokine milieu from a T helper cell type 1 to a T helper type 2 profile. 
J.Immunol. 159:2484 -2491. 
Kitajima T, Ariizumi K, Bergstresser PR and Takashima A (1996) Ultraviolet B radiation sensitizes a 
murine epidermal dendritic cell line (XS52) to undergo apoptosis upon antigen presentation to T cells. 
J.Immunol. 157:3312 -3316. 
Kitibel J, Hejmadi V, Alas L, O'Connor A, Sutherland BM and Yarosh D (1998) UV -DNA damage 
in mouse and human cells induces the expression of tumor necrosis factor a. Photochem.Photobiol. 
67:541 -546. 
Ko CB, Walton S, Keczes K, Bury HPR and Nicholson C (1994) The emerging epidemic of skin 
cancer. Br.J.Dermatol. 130:269 -272. 
Kobata T, Ikeda H, Ohnishi Y, Urushibara N, Nakata SO, Takahashi TA and Sekiguchi S (1993) 
Ultraviolet irradiation inhibits killer -target cell interaction. Vox.Sang. 65:25 -31. 
260 
Koch F, Heufler C, Kämpgen E, Schneeweiss D, Böck G and Schuler G (1990) Tumor necrosis 
factor a maintains the viability of murine epidermal Langerhans cells in culture, but in contrast to 
granulocyte /macrophage colony- stimulating factor, without inducing their functional maturation. 
J. Exp. Med. 171:159 -171. 
Kohno K, Kataoka J, Ohtsuki T, Suemoto Y, Okamoto I, Usui M, Ikeda M and Kurimoto M (1997) 
TN-y inducing factor (IGIF) is a costimulatory factor on the activation of Thl but not Th2 cells and 
exerts its effect independently of IL -12. J.Immunol. 158:1541 -1550. 
Kondo S, McKenzie RC and Sauder DN (1994) Interleukin -10 inhibits the elicitation phase of 
allergic contact hypersensitivity. J.Invest.Dermatol. 103:811 -814. 
Kondo S, Sauder DN, McKenzie RC, Fujisawa H, Shivja GM, El -Ghorr AA and Norval M (1995) 
The role of cis -urocanic acid in UVB- induced suppression of contact hypersensitivity. Immunol.Lett. 
48:181 -186 
Kreider JW and Schmoyer ME (1975) Spontaneous maturation and differentiation of B16 melanoma 
cells in culture. J.Nat.Cancer.Inst. 55:641 -647. 
Kremer IB, Bos JD and Teunissen MBM (1995) Reduced antigen -presenting function of human 
Epstein -Barr virus (EBV) -B cells and monocytes after UVB radiation is accompanied by decreased 
expression of B7, intercellular adhesion molecule -1 (ICAM -1) and LFA -3. Clin.Exp.Immunol. 
101:461 -467. 
Kremer IB, Hilkens CMU, Sylva- Steenland RMR, Koomen CW, Kapsenberg ML, Bos JD and 
Teunissen MBM (1996) Reduced IL -12 production by monocytes upon ultraviolet -B irradiation 
selectively limits activation of T helper -1 cells. J.Immunol. 157:1913 -1918. 
Kremer IB, Sylva- Steenland RMR, Bos JD and Teunissen MBM (1997) Despite the presence of 
UVB- induced DNA damage, HLA -DR+ cells from ex vivo UVB- exposed human skin are able to 
migrate and show no impaired allostimulatory capacity. J.Invest.Dermatol. 109:626 -631. 
Krien PM and Moyal D (1994) Sunscreens with broad -spectrum absorption decrease the trans to cis 
photoisomerisation of urocanic acid in the human stratum corneum after multiple UV light exposures. 
Photochem. Photobiol. 60:280 -287. 
Kripke ML, Thorn RM, Lill PH, Civin CI, Pazmino NH and Fisher MS (1979) Further 
characterization of immunological unresponsiveness induced in mice by ultraviolet radiation. 
Transplantation 28:212 -217. 
261 
Kripke ML, Cox PA, Alas LG and Yarosh DB (1992) Pyrimidine dimers in DNA initiate systemic 
immunosuppression in UV- irradiated mice. Proc.Natl.Acad.Sci. USA 89:7516 -7520. 
Krutmann J, Kock A, Schauer E, Parlow F, Moller A, Kapp A, Forster E, Schopf E and Luger TA 
(1990) Tumor necrosis factor 13 and ultraviolet radiation are potent regulators of human keratinocyte 
ICAM- 1 expression. J.Invest.Dermatol. 95:127 -131. 
Krutmann J, Czech W, Parlow F, Trefzer U, Kapp A, Schopf E and Luger TA (1992) Ultraviolet 
radiation effects on human keratinocyte ICAM -1 expression; UV- induced inhibition of 
cytokine- induced ICAM -1 mRNA expression is transient, differentailly restored for IFNy versus 
TNFa, and followed by ICAM -1 induction via a TNFa -like pathway. J.Invest.Dermatol. 98:923 -928. 
Krutmann J and Grewe M (1995) Involvement of cytokines, DNA damage, and reactive oxygen 
intermediates in ultraviolet radiation- induced modulation of intercellular adhesion molecule -1 
expression. J.Invest.Dermatol. 105:675 -70S. 
Kuhn R, Lohler J, Rennick D, Rajewski K and Muller W (1993) Interleukin -10 deficient mice 
develop chronic enterocolitis. Cell 75:263 -274. 
Kurimoto I and Streilein JW (1992) Deleterious effects of cis -urocanic acid and UVB radiation on 
Langerhans cells and on induction of contact hypersensitivity are mediated by tumor necrosis 
factor -alpha. J.Invest.Dermatol. 99:69S -70S. 
Larsen CP, Steinman RM, Witmer -Pack M, Hankins DF, Morris PJ and Austyn JM (1990) 
Migration and maturation of Langerhans cells in skin transplants and explants. J.Exp.Med. 172: 
1483 -1493. 
Lavker R and Kaidbey K (1997) The spectral dependence for UVA- induced cumulative damage in 
human skin. J.Invest.Dermatol. 108:17 -21. 
Lin AN and Carter DM (1986) Skin cancer in the elderly. Dermatol.Clin. 4:467 -471. 
Locksley RM (1993) Interleukin 12 in host defense against microbial pathogens. 
Proc.Natl.Acad.Sci. USA 90:5879 -5880. 
Long NC, Otterness I, Kunkel SL, Vander AJ and Kluger MJ (1990) Roles of interleukin 1(3 and 
tumour necrosis factor in lipopolysaccharide fever in rats. Am.J.Physiol. 259:R724 -R728. 
262 
Longstreth J, de Gruijl FR, Kripke ML, Abseck S, Arnold F, Slaper HI, Velders G, Takizawa Y and 
van der Leun JC (1998) Health risks. J.Photochem.Photobiol.B: Biol 46:20-39. 
Lowy A, Tominga A, Drebin JA, Takaoki M, Benecerraf B and Greene MI (1983) Identification of an 
I -J+ antigen -presenting cell required for third order suppressor cell activation. J.Exp.Med. 157: 
353 -358. 
Lucke TW, Hole DJ and Mackie RM (1997) An audit of the completeness of non -mealnoma skin 
cancer registration in Greater Glasgow. Br.J.Dermatol. 137:761 -763. 
Macatonia SE (1986) Dendritic cells and the initiation of contact sensitivity to fluorescein 
isothiocyanate. Immunology 59:509 -514. 
Macatonia SE, Doherty TM, Knight SC and O'Garra A (1993) Differential effect of IL -10 on dendritic 
cell- induced T cell proliferation and IFN -y production. J.Immunol. 150:3755 -3765. 
Macher E and Chase MW (1969) Studies on the sensitization of animals with simple chemical 
compounds. XII. The influence of excision of allergenic depots on onset of delayed hypersensitivity 
and tolerance. J.Exp.Med. 129:103 -121. 
MacNeill IB, Elwood JM, Miller D and Mao Y (1995) Trends in mortality from melanoma in Canada 
and prediction of future rates. Statistics in Medicine 14:821 -839. 
Madronich S, McKenzie RL, Bjorn LO and Caldwell MM (1998) Changes in biologically active 
ultraviolet radiation reaching the earth's surface. Journal of Photochemistry & Photobiology. 
B - Biology 46:5 -19. 
Madronich S and de Gruijl FR (1992) Stratospheric ozone depletion between 1979 and 1992: 
implications for biologically active ultraviolet -B radiation and non -melanoma skin cancer incidence. 
Lymphokine & Cytokine Research 11:87 -93. 
Marks R (1995) An overview of skin cancers. Cancer 75:607 -612. 
Matsui MS, Wang N and DeLeo VA (1996) Ultraviolet radiation B induces differentiation and protein 
kinase C in normal human epidermal keratinocytes. Photodermatol .Photoimmunol.Photomed. 
12:103 -108. 
263 
Matta JL, Nazario CM, Armstrong RA and Navas J (1998) Epidemiological trends of melanoma in 
Puerto Rico from 1975 -1991. Boletin - Asociacion Medica de Puerto Rico 90:8 -11. 
Mattner F, Fischer S, Guckes S, Jin S, Kaulen H, Schmitt E, Rude E and Germann T (1993) The 
interleukin -12 subunit p40 specifically inhibits effects of the interleukin -12 heterodimer. 
Eur.J.Immunol. 23:2202 -2208. 
Mauri C, Williams RO, Walmsley M and Feldman M (1996) Relationship between Thl /Th2 
cytokine patterns and the arthritogenic response in collagen- induced arthritis. Eur.J.Immunol. 
26:1511 -1518. 
McGrath Jr,H., Bell JM and Haycock JW (1994) Fluorescent light activates the immunomodulator 
cis -urocanic acid in vitro : implications for patients with systemic lupus erythematosus. 
Annals. Rheum. Diseases. 53:396 -399. 
McIntyre KW, Stepan GJ, Benjamin WR, Plocinski JM, Kaffka KL, Campden CA, Chizzonite RA 
and Kilian PL (1991) Inhibition of interleukin -1 (IL -1) binding and bioactivity in vitro and 
modulation of acute inflammation in vivo by IL -1 receptor antagonist and anti -IL -1 receptor 
monoclonal antibody. J.Exp.Med. 173:931 -939. 
Meunier L, Bata -Csorgo Z and Cooper KD (1995) In human dermis, ultraviolet radiation induces 
expansion of a CD36' CD11b' CD1- macrophage subset by infiltration and proliferation; CD1' 
Langerhans -like dendritic antigen -presenting cells are concomitantly depleted. J.Invest.Dermatol. 
105:782 -788. 
Micaleff MJ, Ohtsuki T, Kohno K, Tanabe F, Ushio S, Namba M, Tanimoto T, Torigoe K, Fujii M, 
Ikeda M, Fukuda S and Kurimoto M (1996) Interferon -y- inducing factor enhances T helper 1 cytokine 
production by stimulated human T cells: synergism with interleukin -12 for interferon -y production . 
Eur.J.Immunol. 26:1647 -1651. 
Middleton E and Kandaswami C (1992) Effects of flavonoids on immune and inflammatory cell 
functions. Biochem.Pharmacol. 43:1167 -1179. 
Mitra RS, Shimizu Y and Nickoloff BJ (1993) Histamine and cis -urocanic acid augment tumour 
necrosis factor -alpha mediated induction of keratinocyte intercellular adhesion molecule -1 expression. 
J. Cell. Physiol. 156:348 -357. 
264 
Miura S, Kulka M, Smith CC, Imakafu S, Burnett JW and Aurelian L (1994) Cutaneous ultraviolet 
radiation inhibits herpes simplex virus -induced lymphoproliferation in latently infected subjects. 
Clin.Immuno.Immunopath. 72:62 -69. 
Miyauchi H and Horio T (1995) Ultraviolet B- induced local immunosuppression of contact 
hypersensitivity is modulated by ultraviolet irradiation and hapten application. J.Invest.Dermatol. 
104:364 -369. 
Mohamadzadeh M, Takashima A, Dougherty I, Knop J, Bergstresser PR and Cruz Jr,P.D. (1995) 
Ultraviolet B radiation up- regulates the expression of IL -15 in human skin. J.Immunol. 155: 
4492 -4496. 
Mohammad T, Morrison H and HogenEsch H (1999) Urocanic acid photochemistry and 
photobiology. Photochem.Photobiol. 69:115 -135. 
Moodycliffe AM, Kimber I and Norval M (1992) The effect of ultraviolet B irradiation and urocanic 
acid isomers on dendritic cell migration. Immunology 77:394 -399. 
Moodycliffe AM, Kimber I and Norval M (1994) Role of tumour necrosis factor -a in ultraviolet B 
light induced dendritic cell migration and suppression of contact hypersensitivity. Immunology 81: 
79 -84. 
Moore KW, O'Garra A, de Waal Malefyt R, Vieira P and Mosmann TR (1993) Interleukin -10. 
Annu.Rev.Immunol. 11:165 -190. 
Moseley H and Mackie RM (1997) Ultraviolet B radiation was increased at ground level in Scotland 
during a period of ozone depletion. Br.J.Dermatol. 137:101 -102. 
Mosmann TR, Schumacher JH, Fiorentino DF, Leverah J, Moore KW and Bond MW (1990) 
Isolation of monoclonal antibodies specific for IL -4, I1 -5, IL -6 and a new Th2- specific cytokine 
(IL -10), cytokine synthesis inhibitory factor, by using a solid phase radioimmunosorbent assay. 
J.Immunol. 145:2938 -2945. 
Mosmann TR, Schumacher JH, Street NF, Budd R, O'Garra A, Fong TAT, Bond MW, Moore KWM, 
Sher A and Fiorentino DF (1991) Diversity of cytokine synthesis and function of mouse CD4' T 
cells. Immunol. Re v. 123:209 -229. 
265 
Mosmann TR and Sad S (1996) The expanding universe of T -cell subsets: Thl, Th2 and more. 
Immunol.Today 17:138 -146. 
Muller G, Saloga J, Germann T, Bellinghausen I, Mohamadzadeh M, Knop J and Enk AH (1994a) 
Identification and induction of human keratinocyte- derived IL -12. J.Clin.Invest. 94:1799 -1805. 
Muller HK, Bucana CD, Kripke ML, Cox PA, Saijo S and Strickland FM (1994b) Ultraviolet 
irradiation of murine skin alters cluster formation between lymph node dendritic cells and specific T 
lymphocytes. Cell.Immunol. 157:263 -276. 
Nickoloff BJ, Fivenson DP, Kunkel SL, Strieter RM and Turka LA (1994) Keratinocyte 
interleukin -10 expression is upregulated in tape- stripped skin, poison ivy dermatitis, and Sezary 
syndrome, but not in psoriatic plaques. Clin.Immuno.Immunopath. 73:63 -68. 
Nickoloff BJ and Turka LA (1994) Immunological functions of non -profesional antigen -presenting 
cells: new insights from studies of T -cell interactions with keratinocytes. Immunol.Today 15: 
464 -469. 
Niizeki H and Streilein JW (1997) Hapten -specific tolerance induced by acute, low -dose ultraviolet B 
radiation of skin is mediated via interleukin -10. J.Invest.Dermatol. 109:25 -30. 
Nishigori C, Yarosh DB, Donawho C and Kripke ML (1996a) The immune system in ultraviolet 
carcinogenesis. J.Invest.Dermatol.Symp.Proc. 1:143 -146. 
Nishigori C, Yarosh DB, Ullrich SE, Vink AA, Bucana CD, Roza L and Kripke ML (1996b) 
Evidence that DNA damage triggers interleukin 10 cytokine production in UV- irradiated murine 
keratinocytes. Proc.Natl.Acad.Sci.USA 93:10354- 10359. 
Noonan FP, Kripke ML, Pederson GM and Greene MI (1981) Suppression of contact 
hypersensitivity in mice by ultraviolet irradiation is associated with defective antigen presentation. 
Immunology 43:527 -533. 
Noonan FP, Bucana C, Sauder DN and De Fabo EC (1984) Mechanism of systemic immune 
suppression by UV radiation in vivo. H. The UV effects on number and morphology of epidermal 
Langerhans cells and the UV- induced suppression of contact hypersensitivity have different wavelength 
dependencies. J.Immunol. 132:2408 -2416. 
266 
Noonan FP, De Fabo EC and Morrison H (1988) Cis -urocanic acid, a product formed by ultraviolet B 
irradiation of the skin, initiates an antigen presentation defect in splenic dendritic cells in vivo. 
J.Invest. Dermatol. 90:92 -99. 
Noonan FP and De Fabo EC (1992) Immunosuppression by ultraviolet B radiation: initiation by 
urocanic acid. Immunol.Today 13:250 -254. 
Norris DA, Lyons MB, Middleton MH, Yohn JJ and Kashihara -Sawami M (1990) Ultraviolet 
radiation can either suppress or induce expression of intercellular adhesion molecule 1 (ICAM -1) on 
the surface of cultured human keratinocytes. J.Invest.Dermatol. 95:132 -138. 
Norris P, Poston RN, Thomas DS, Thornhill M, Hawk J and Haskard DO (1991) The expression of 
endothelial leukocyte adhesion molecule -1 (ELAM -1), intercellular adhesion molecule -1 (ICAM -1), 
and vascular cell adhesion molecule -1 (VCAM -I) in experimental cutaneous inflammation: A 
comparison of ultraviolet B erythema and delayed hypersensitivity. J.Invest.Dermatol. 96:763 -770. 
Norval M, McIntyre CR, Simpson TJ, Howie SEM and Bardshiri E (1988) Quantification of 
urocanic acid isomers in murine skin during development and after irradiation with ultraviolet B light. 
Photodermatology 5:179 -186. 
Norval M, Simpson TJ, Bardshiri E and Howie SEM (1989a) Urocanic acid analogues and the 
suppression of the delayed type hypersensitivity response to Herpes Simplex virus. 
Photochem. Photobiol. 49:633 -639. 
Norval M, Simpson TJ and Ross JA (1989b) Urocanic acid and immunosuppression. 
Photochem. Photobiol. 50:267 -275. 
Norval M, Gibbs NK and Gilmour J (1995) The role of urocanic acid in UV- induced 
immunosuppression: Recent advances (1992- 1994). Photochem.Photobiol. 62:209 -217. 
O'Connor A, Nishigori C, Yarosh D, Alas L, Kitibel J, Burley L, Cox P, Bucana C, Ullrich S and 
Kripke M (1996) DNA double strand breaks in epidermal cells cause immune suppression in vivo and 
cytokine production in vitro. J.Immunol. 157:271 -278. 
Okun MR (1996) The role of peroxidase in mammalian melanogenesis: a review. 
Physiol. Chemi. Phys. Medical. NMR. 28:91 -100. 
267 
Openshaw P, Murphy EE, Hosken NA, Maino V, Davis K, Murphy K and O'Garra A (1995) 
Heterogeneity of intracellular cytokine synthesis at the single -cell level in polarized T helper 1 and T 
helper 2 populations. J.Exp.Med. 182:1357 -1367. 
Osada A, Nakashima H, Furue M and Tamaki K (1995) Up- regulation of CD44 expression by tumor 
necrosis factor -a is neutralized by interleukin -10 in Langerhans cells. J.Invest.Dermatol. 105: 
124 -127. 
Oxholm A, Oxholm P, Staberg B and Bendtzen K (1988) Immunohistological detection of 
interleukin 1 -like molecules and tumur necrosis factor in human epidermis before and after 
UVB- irradiation in vivo. Br.J.Dermatol. 118:369 -376. 
Pentland AP and Mahoney MG (1990) Keratinocyte prostaglandin synthesis is enhanced by IL -1. 
J.Invest.Dermatol. 94:43 -46. 
Picut CA, Cha Soo Lee VMD, Dougherty EP, Anderson KL and Lewis RM (1988) 
Immunostimulatory capabilities of highly enriched Langerhans cells in vitro. J.Invest.Dermatol. 
90:201 -206. 
Polla L, Margolis R, Goulston C, Parrish JA and Granstein RD (1986) Enhancement of the 
elicitation phase of the murine contact hypersensitivity response by prior exposure to local radiation. 
J.Invest.Dermatol. 86:13 -17. 
Price AA, Cumberbatch M, Kimber I and Ager A (1997) c.ç integrins are required for Langerhans cell 
migration from the epidermis. J.Exp.Med. 186:1725 -1735. 
Ptak W, Geba GP and Askenase PW (1991) Initiation of delayed -type hypersensitivity by low -doses 
of monoclonal IgE antibody. Mediation by serotonin and inhibition by histamine. J.Immunol. 
146:3929 -3936. 
Rafferty TS, McKenzie RC, Hunter JAA and et al (1998) Differential expression of selenoproteins 
by human skin cells and protection by selenium from ultraviolet B radiation -induced cell death. 
Biochem.J. 332:231 -236. 
Rattis F -M, Péguet -Navarro J, Courtellemont P, Redziniak G and Schmitt D (1995) In vitro effects 
of ultraviolet B radiation on human Langerhans cell antigen -presenting function. Cell.Immunol. 
164:65 -72. 
268 
Redondo P, Garcia -Foncillas J, Cuevillas F, Espana A and Quintanilla E (1996) Effects of low 
concentrations of cis- and trans -urocanic acid on cytokine elaboration by keratinocytes . 
Photodermatol. Photoimmunol. Photomed. 12:237 -243. 
Reeve VE, Bosnic M, Boehn -Wilcox C and Cope RB (1995) Pyridoxine supplementation protects 
mice from suppression of contact hypersensitivity induced by 2- acetyl -4- tetrahydroxybutylimidazole 
(THI), ultraviolet B radiation (280- 320nm), or cis -urocanic acid. Am.J.Clin.Nutr. 61:571 -576. 
Reeve VE, Bosnic M, Boehm -Wilcox C, Nishimura N and Ley RD (1998) Ultraviolet A radiation 
(320- 400nm) protects hairless mice from immunosuppression induced by ultraviolet B radiation 
(280- 320nm) or cis -urocanic acid. Int.Arch.Allergy.lmmunol. 115:316 -322. 
Reeve VE, Bosnic M and Nishimura N (1999) Interferon -y is involved in photoimmunoprotection by 
UVA (320- 400nm) radiation in mice. J.Invest.Dermatol. 112:945 -950. 
Reeve VE and Tyrell RM (1999) Heme oxygenase indcution mediates the photoimmunoprotective 
activity of UVA radiation in the mouse. Proc.Natl.Acad.Sci. USA 96:9317 -9321. 
Reinhold U, Biltz H, Bayer W and Schmidt KH (1989) Serum selenium levels in patients with 
malignant melanoma. Acta. Derm. Venereol. (Stockh). 69:132 -136. 
Rhodes LE, O'Farrell S, Jackson MJ and Friedmann PS (1994) Dietary fish -oil supplementation in 
humans reduces UVB- erythemal sensitivity but increases epidermal lipid peroxidation. 
J.Invest.Dermatol. 103:151 -154. 
Rhodes LE, Durham BH, Fraser WD and Friedmann PS (1995) Dietary fish oil reduces basal and 
ultraviolet B- generated PGEZ levels in skin and increases the threshold to provocation of polymorphic 
light eruption . J.Invest.Dermatol. 105:532 -535. 
Ried C, Michel G, Beetz A, Kemeny L and Ruzicka T (1994) Lack of induction of IL -10 in human 
keratinocytes by inflammatory cytokines and UVB. J.Invest.Dermatol. 103:433(Abs). 
Riemann H, Schwarz A, Grabbe S, Aragane Y, Luger TA, Wysocka M, Kubin M, Trinchieri G and 
Schwarz T (1996) Neutralization of IL -12 in vivo prevents induction of contact hypersensitivity and 
induces hapten- specific tolerance. J.Immunol. 156:1799 -1803. 
269 
Rink L and Kirchner H (1996) Recent progress in the tumor necrosis factor -a field. 
Int.Arch.Allergy.Immunol. 111:199 -209. 
Rivas JM and Ullrich SE (1992) Systemic suppression of delayed -type hypersensitivity by 
supernatants from UV- irradiated keratinocytes. An essential role for keratinocyte -derived IL -10. 
J.Immunol. 149:3865 -3871. 
Rivas JM and Ullrich SE (1994) The role of IL -4, IL -10, and TNF -a in the immune suppression 
induced by ultraviolet radiation. J.Leuk.Biol. 56:769 -775. 
Robinson D, Shibuyi K, Mui A, Zonin F, Murphy E, Sana T, Hartley SB, Menon S, Kastelian R, 
Bazan F and O'Garra A (1997) IGIF does not drive Thl development but synergizes with IL -12 for 
interferon -gamma production and activates IRAK and NFKB. Immunity 7:571 -581. 
Romagnani S (1991) Human Thl and Th2 subsets: doubt no more. Immunol.Today 12:256 -257. 
Romagnani S (1997) The Thl/Th2 paradigm. Immunol.Today 18:263 -266. 
Rosette C and Karin M (1996) Ultraviolet light and osmotic stress: activation of the JNK cascade 
through multiple growth factor and cytokine receptors. Science 274:1194 -1197. 
Rus V, Svetic A, Nguyen P, Gause WC and Via CS (1995) Kinetics of Thl and Th2 cytokine 
production during the early course of acute and chronic murine graft- versus -host disease. Regulatory 
role of donor CD8' T cells. J.Immunol. 155:2396 -2406. 
Saijo S, Kodari E, Kripke ML and Strickland FM (1996) UVB irradiation decreases the magnitude of 
the Thl response to hapten but does not increase the Th2 response. 
Photodermatol. Photoimmunol. Photomed. 12:145 -153. 
Sato' K, Taguchi H, Maeda T, Minami H, Asada Y, Watanabe Y and Yoshikawa K (1995) The 
primary cytotoxicity in ultraviolet -A- irradiated riboflavin solution is derived from hydrogen peroxide. 
J.Invest.Dermatol. 105:608 -612. 
Saunders, RD, Cridland, NA and Kowalczuk, CI. Animal and Human responses to UVA and UVB 
National Radiological Protection Board, NRPB -R297. 
270 
Schater B, Lederman MM, LeVine MJ and Ellner JJ (1983) Ultraviolet radiation inhibits human 
natural killer activity and lymphocyte proliferation. J.Immunol. 130:2484 -2487. 
Schmitt DA, Owen- Schaub L and Ullrich SE (1995) Effect of IL -12 on immune suppression and 
suppressor cell induction by ultraviolet light. J.Immunol. 154:5114 -5120. 
Schmitt DA, Shreedhar V and Ullrich SE (1998) Inhibition of IL -12 by dendritic cells in response to 
UVB radiation (Abstr) . Photochem.Photobiol. 67:49S. 
Schreiber S, Kilgus O, Payer E, Kutil R, Elbe A, Mueller C and Stingl G (1992) Cytokine pattern 
of Langerhans' cells isolated from murine epidermal cell cultures. J.Immunol. 149:3525 -3534. 
Schwarz A, Grabbe S, Riemann H, Aragane Y, Simon M, Manon S, Andrade S, Luger TA, Zlotnik A 
and Schwartz T (1994) In vivo effects of interleukin -10 on contact hypersensitivity and delayed -type 
hypersensitivity reactions. J. Invest.Dermatol. 103:211 -216. 
Schwarz A, Bhardwaj R, Aragane Y, Mahnke K, Riemann H, Metze D, Luger TA and Schwarz T 
(1995) Ultraviolet -B- induced apoptosis of keratinocytes: evidence for partial involvement of tumor 
necrosis factor -a in the formation of sunburn cells. J.Invest.Dermatol. 104:922 -927. 
Schwarz A, Grabbe S, Aragane Y, Sandkuhl K, Riemann H, Luger TA, Kubin M, Trinchieri G and 
Schwarz T (1996) Interleukin -12 prevents ultraviolet B- induced local immunosuppression and 
overcomes UVB- induced tolerance. J. Invest.Dermatol. 106:1187 -1191. 
Schwarz A, Grabbe S, Mahnke K, Riemann H, Luger TA, Wysocka M, Trinchieri G and Schwarz T 
(1998) Interleukin 12 breaks ultraviolet light induced immunosuppression by affecting CDS+ rather 
than CD4+ T cells. J.Invest.Dermatol. 110:272 -276. 
Schwarz T (1998) UV light affects cell membrane and cytoplasmic targets. 
J.Photochem.Photobiol.B: Biol 44:91-96. 
Serre I, Cano JP, Picot M -C, Meynadier J and Meunier L (1997) Immunosuppression induced by 
acute solar -simulated ultraviolet exposure in humans: prevention by a sunscreen with a sun protection 
factor of 15 and high UVA protection. J.Am.Acad.Dermatol. 37:187 -194. 
271 
Shibaki A, Ohkawara A and Cooper KD (1995) Differential extracellular signalling via FcyR and 
FMLP in functionally distinct antigen -presenting cell susets: Ultraviolet- induced epidermal 
macrophages versus Langerhans cells. J.Invest.Dermatol. 105:383 -387. 
Shornick LP, De Togni P, Mariathasan S, Goellner J, Strauss -Schoenberger J, Kan RW, Ferguson 
TA and Chaplin DD (1996) Mice deficient in IL -113 manifest impaired contact hypersensitivity to 
trinitrochlorobenzene. J.Exp.Med. 183:1427 -1436. 
Shreedhar V, Giese T, Sung VW and Ullrich SE (1998) A cytokine cascade including prostaglandin 
E2, IL -4, and IL -10 is responsible for UV- induced systemic immune suppression. J.Immunol. 
160:3783 -3789. 
Simon JC, Cruz Jr,P.D., Bergstresser PR and Tigelaar RE (1990) Low dose ultraviolet B- irradiated 
Langerhans' cells preferentially activate CD4+ cells of the T helper 2 subset. J.Immunol. 145: 
2087 -2091. 
Simon JC, Tigelaar RE, Bergstresser PR, Edelbaum D and Cruz Jr,P.D. (1991) Ultraviolet B 
radiation converts Langerhans cells from immunogenic to tolerogenic antigen -presenting cells. 
Induction of specific clonal anergy in CD4+ T helper 1 cells. J.Immunol. 146:485 -491. 
Simon MM, Aragane Y, Schwarz A, Luger TA and Schwarz T (1994) UVB light induces nuclear 
factor KB (NF -KB) activity independently from chromosomal DNA damage in cell -free cytosolic 
extracts. J. Invest.Dermatol. 102:422 -427. 
Sjovall P and Christensen OB (1986) Local and systemic effect of ultraviolet irradiation (UVB and 
UVA) on human allergic contact dermatitis. Acta Derm.Venereol.(Stockh). 66:290 -294. 
Skov L, Hansen H, Barker JNWN, Simon JC and Baadsgaard O (1997) Contrasting effects of 
ultraviolet -A and ultraviolet -B exposure on induction of contact sensitivity in human skin. 
Clin. Exp.Immunol. 107:585 -588. 
Skov L, Hansen H, Allen M, Villadsen L, Norval M, Barker JNWN, Simon J and Baadsgaard O 
(1998a) Contrasting effects of ultraviolet Al and ultraviolet B exposure on the induction of tumour 
necrosis factor -a in human skin. Br.J.Dermatol. 138:216 -220. 
272 
Skov L, Hansen H, Dittmar HC, Barker JNWN and Baadsgaard O (1998b) Susceptibility to effects of 
UVB irradiation on induction of contact sensitivity, relevance of number and function of Langerhans 
cells and epidermal macrophages. Photochem.Photobiol. 67:714 -719. 
Slaper H, Velders GJ, Daniel JS, de Gruijl FR and van der Leun JC (1996) Estimates of ozone 
depletion and skin cancer incidence to examine the Vienna Convention achievements. Nature 384: 
256 -258. 
Sontag Y, Garssen J, de Gruijl FR, van der Leun JC, van Vloten WA and van Loveren H (1994) 
Ultraviolet radiation -induced impairment of the early initiating and to late effector phases of contact 
hypersensitivity to picrylchloride: regulation by different mechanisms. J.Invest.Dermatol. 102: 
923 -927. 
Steinbrink K, Kolde G, Sorg C and Macher E (1996) Induction of low zone tolerance to contact 
allergens in mice does not require functional Langerhans cells. J.Invest.Dermatol. 107:243 -247. 
Stenberg C and Larko 0 (1985) Sunscreen application and its importance for the sun protection 
factor. Arch.Dermatol. 121:1400 -1403. 
Stevens SR, Shibaki A, Meunier L and Cooper KD (1995) Suppressor T cell- activating macrophages 
in ultraviolet -irradiated human skin induce a novel, TGF -f3- dependent deficient IL -2ra expression. 
J.Imm unol. 155:5601 -5607. 
Stevens SR, Tarry- Lehmann M and Cooper KD (1998) Distinct cytokine use and production by T 
cells after activation by Langerhans cells versus macrophages infiltrating UV- irradiated epidermis. 
J. Invest.Dermatol. 110:490(Abs). 
Stoll S, Muller G, Kurimoto M, Saloga J, Tanimoto T, Yamauchi H, Okamura H, Knop J and Enk 
AH (1997) Production of IL -18 (IFN -y- inducing factor) messenger RNA and functional protein by 
murine keratinocytes. J.Immunol. 159:298 -302. 
Streilein JW and Bergstresser PR (1988) Genetic basis of ultraviolet -B effects on contact 
hypersensitivity. Immunogenetics 27:252 -258. 
Streilein JW (1993) Sunlight and skin- associated lymphoid tissues (SALT): If UVB is the trigger and 
TNFa is the mediator, what is the message? . J.Invest.Dermatol. 100:47S -52S. 
273 
Streilein JW, Taylor JR, Vincek V, Kurimoto I, Richardson J, Tie C, Medema J -P and Golomb C 
(1994a) Relationship between ultraviolet radiation -induced immunosuppression and carcinogenesis. 
J.Invest.Dermatol. 103:107S-111S. 
Streilein JW, Taylor JR, Vincek V, Kurimoto I, Shimizu T, Tie C and Golomb C (1994b) Immune 
surveillance and sunlight- induced skin cancer. Immunol.Today 15:174 -179. 
Strickland I, Rhodes LE, Flanagan BF and Friedmann PS (1997) TNF -a and IL -8 are upregulated in 
the epidermis of normal human skin after UVB exposure: correlation with neutrophil accumulation and 
E- selectin expresion. J. Invest. Dermatol. 108:763 -768. 
Strickland PT (1986) Photocarcinogenesis by near -ultraviolet (UVA) radiation in Sencar mice. 
J.Invest.Dermatol. 87:272 -275. 
Sullivan S, Bergstresser PR, Tigelaar RE and Streilein JW (1986) Induction and regulation of contact 
hypersensitivity by resident, bone -marrow -derived, dendritic epidermal cells: Langerhans cells and 
Thy -1+ epidermal cells. J.Immunol. 137:2460- 2892467. 
Sutherland BM, Harber LC and Kochevar IE (1980) Pyridimine dimer formation and repair in human 
skin. Cancer Res. 40:3181 -3185. 
Sy M -S, Miller SD and Claman HN (1977) Immune suppression with supraoptimal doses of antigen 
in contact sensitivity. I. Demonstration of suppressor cells and their sensitivity to cyclophosphamide. 
J. I mm un o 1. 119:240-244. 
Tagaya Y, Bamford RN, DeFilippis AP and Waldmann TA (1996) IL -15: A pleiotropic cytokine with 
diverse receptor /signaling pathways whose expression is controlled at multiple levels. Immunity 
4:329 -336. 
Takayama K, Yokozeki H, Ghoreishi M, Satoch T, Katayama I, Umeda T and Nishioka K (1999) 
IL -4 inhibits the migration of human Langerhans cells through downregulation of TNF receptor II 
expression. J.Invest.Dermatol. 113:541 -546. 
Takeda K, Tsutsui H, Yoshimoto T, Adachi O, Yoshida N, Kishimoto T, Okamura H, Nakanishi K 
and Akira S (1998) Defective NK cell activity and Thl response in IL -18- deficient mice. Immunity 
8:383 -390. 
274 
Tang J -M, Dunner Jr,K., Kripke ML and Bucana C (1992) Characteristics of antigen -presenting cells 
involved in contact sensitization of normal and UV- irradiated mice. J.Invest.Dermatol. 99:20S -22S. 
Teunissen MBM, Sylva- Steenland RMR and Bos JD (1993) Effect of low -dose ultraviolet -B radiation 
on the function of human T lymphocytes in vitro. Clin.Exp.Immunol. 94:208 -213. 
Teunissen MBM, Koomen CW, de Waal Malefyt R and Bos JD (1994) Inability of human 
keratinocytes to synthesize interleukin -10. J.Invest.Dermatol. 102:632(Abs). 
Teunissen MBM, Koomen CW, Jansen J, de Waal Malefyt R, Schmitt E, Van den Wijngaard RMJGJ, 
Das PK and Bos JD (1997) In contrast to their murine counterparts, normal human keratinocytes and 
human epidermoid cell lines A431 and HaCaT fail to express IL -10 mRNA and protein. 
Clin.Exp.Immunol. 107:213-223. 
Thomas WR and Schrader JW (1983) Delayed hypersensitivity in mast -cell- deficient mice. 
J.Immunol. 130:2565 -2567. 
Thomson JA, Troutt AB and Kelso A (1993) Contact sensitization to oxazolone: involvement of 
both interferon -y and interleukin -4 in oxazolone- specific Ig and T -cell responses. Immunology 
78:185 -192. 
Tie C, Golomb C, Taylor JR and Streilein JW (1995) Suppressive and enhancing effects of 
ultraviolet B radiation on expression of contact hypersensitivity in man. J.Invest.Dermatol. 104: 
18 -22. 
Tilg H, Dinarello CA and Mier JW (1997) IL -6 and APPs: anti -inflammatory and 
immunosuppressive mediators. Immunol.Today 18:428 -432. 
Toda K, Miyauchi Y, Nesumi N, Konishi J and Imamura S (1986) UVB/PUVA- induced suppression 
of hùman natural killer activity is reduced by superoxide dismutase and/or interleukin 2 in vitro. 
J.Invest.Dermatol. 86:519 -522. 
Toews GB, Bergstresser PR and Streilein JW (1980) Epidermal Langerhans cell density determines 
whether contact hypersensitivity or unresponsiveness follows skin painting with DNFB. J.Immunol. 
124:445 -453. 
275 
Trefzer U, Brockhaus M, Lotscher H, Parlow F, Budnik A, Grewe M, Christoph H, Kapp A, Schopf 
E and Luger TA (1993) The 55 -kD tumor necrosis factor receptor on human keratinocytes is regulated 
by tumor necrosis factor -alpha and by ultraviolet B radiation . J.Clin.Invest. 92:462 -470. 
Trinchieri G, Matsumato- Kobayashi M, Clark SC, Seehra J, London L and Perussia B (1984) 
Response of resting human peripheral blood natural killer cells to interleukin 2. J.Exp.Med. 
160:1147 -1169. 
Trinchieri G (1989) Biology of natural killer cells. Adv.Immunol. 47:187 -376. 
Trinchieri G (1993) Interleukin -12 and its role in the generation of Thl cells. Immunol.Today 
14:335 -338. 
Trinchieri G (1994) Interleukin -12 and its role in the generation of Thl cells. Immunol.Today 
14:335 -338. 
Tse Y and Cooper KD (1990) Cutaneous dermal Ia` cells are capable of initiating delayed type 
hypersensitivity responses. J. Invest.Dermatol. 94:267 -272. 
Tsuji RF, Geba GP, Wang Y, Kawamoto K, Matis LA and Askenase PW (1997) Required early 
complement activation in contact sensitivity with generation of local CS- dependent chemotactic 
activity, and late T cell interferon y: a possible initiating role of B cells. J.Exp.Med. 186:1015 -1026. 
Ullrich SE (1994) Mechanism involved in the systemic suppression of antigen -presenting cell 
function by UV irradiation. Keratinocyte- derived IL -10 modulates antigen- presenting cell function of 
splenic adherent cells. J.Immunol. 152:3410 -3416. 
Ullrich SE (1995) The role of epidermal cytokines in the generation of cutaneous immune reactions 
and ultraviolet radiation -induced immune suppression. Photochem.Photobiol. 62:389 -401. 
Ullrich SE (1999) The role of cytokines in UV- induced systemic immune suppression (Abstr). 
Photochem.Photobiol. 69:58S. 
Urbanski A, Schwarz T, Neuner P, Krutman J, Kirnbauer R, Kock A and Luger TA (1990) 
Ultraviolet light induces increased circulating interleukin -6 in humans. J.Invest.Dermatol. 94: 
808 -811. 
276 
Ushio S, Namba M, Okura T, Hattori K, Nukada Y, Akita K, Tanabe F, Konishi K, Micaleff M, 
Fujii M, Torigoe K, Tanimoto T, Fukuda S, Ikeda M, Okamura H and Kurimoto M (1996) Cloning 
of the cDNA for human IFN -y- inducing factor, expression in Escherichia coli, and studies on the 
biologic activities of the protein . J.Immunol. 156:4274 -4279. 
Valerie K, Delers A, Bruck C, Thiriart C, Rosenberg H, Debouck C and Rosenberg M (1988) 
Activation of human immunodeficiency virus type 1 by DNA damage in human cells . Nature 
333:78 -81. 
van Loveren H, Meade R and Askenase PW (1983) An early component of delayed -type 
hypersensitivity mediated by T cells and mast cells. J.Exp.Med. 157:1604 -1617. 
van Loveren H and Askensase PW (1984) Delayed -type hypersensitivity is mediated by a sequence of 
two different T cell populations. J.Immunol. 133:2397 -2401. 
van Loveren H, Kato K, Meade R, Green DR, Horowitz M, Ptak W and Askenase PW (1984a) 
Characterization of two different Ly -1+ T cell populations that mediate delayed -type hypersensitivity. 
J.Immunol. 133:2402 -2411. 
van Loveren H, Kato K, Ratzlaff RE, Meade R, Ptak W and Askenase PW (1984b) Use of 
micrometers and calipers to measure various components of delayed -type hypersensitivity ear swelling 
reactions in mice. J.Imm.Meths 67:311 -319. 
Van Praag MCG, Mulder AA, Claas FHJ, Vermeer B -J and Mommaas AM (1994) Long -term 
ultraviolet B- induced impairment of Langerhans cell function: an immunoelectron microscopic study. 
Clin.Exp.Immunol. 95:73 -77. 
Vandebriel RJ, Da Weger RA, Los G, van Loveren H, Wiegers GJ, Oude Weernink PA and Den Otter 
W (1989) Two specific T cell factors that initiate immune responses in murine allograft systems. A 
comparison of biologic functions. J.Immunol. 143:66 -73. 
Vermeer M, Schmieder GJ, Yoshikawa T, van den Berg JW, Metzman MS, Taylor JR and Streilein 
JW (1991) Effects of ultraviolet B light on cutaneous immune responses of humans with deeply 
pigmented skin. J.Invest.Dermatol. 97:729 -734. 
Vincek V (1995) Sunlight induced progression of AIDS. Med.Hypotheses. 44:119 -123. 
277 
Vink AA, Strickland FM, Bucana C, Cox PA, Roza L, Yarosh DB and Kripke ML (1996a) 
Localization of DNA damage and its role in altered antigen -presenting cell function in 
ultraviolet -irradiated mice. J.Exp.Med. 183:1491 -1500. 
Vink AA, Yarosh DB and Kripke ML (1996b) Chromophore for UV- induced immunosuppression: 
DNA. Photochem.Photobiol. 63:383 -386. 
Vink AA, Moodycliffe AM, Shreedhar V, Ullrich SE, Roza L, Yarosh DB and Kripke ML (1997) 
The inhibition of antigen -presenting activity of dendritic cells resulting from UV irradiation of murine 
skin is restored by in vitro photorepair of cyclobutane dimers. Proc.Natl.Acad.Sci. USA 94: 
5255 -5260. 
Vogelmann AM, Ackerman TP and Turco RP (1992) Enhancements in biologically effective 
ultraviolet radiation following volcanic eruptions. Nature 359:47 -49. 
Wallace BM and Lasker JS (1992) Awakenings...UV light and HIV gene activation. Science 
257:1211 -1212. 
Walsh LJ (1995) Ultraviolet B irradiation of skin induces mast cell degranulation and release of 
tumour necrosis factor -a. Immunol.Cell.Biol. 73:226 -233. 
Wang B, Fujisawa H, Zhuang L, Kondo S, Shivji GM, Kim CS, Mak TW and Sauder DN (1997) 
Depressed Langerhans cell migration and reduced contact hypersensitivity response in mice lacking 
TNF receptor p75. J.Immunol. 159:6148 -6155. 
Wang B, Amerio P and Sauder DN (1999) Role of cytokines in epidermal Langerhans cell migration. 
J.Leuk.Biol. 66:33-39. 
Wanidworanun C and Strober W (1993) Predominant role of tumor necrosis factor -a in human 
monocyte IL -10 synthesis. J.Immunol. 151:6853 -6861. 
Webb SE, Pollard JW and Jones GE (1996) Direct observation and quantification of macrophage 
chemoattraction to the growth factor CSF -1. J. Cell. Science 109:793 -803. 
Webber LJ, Whang E and De Fabo EC (1997) The effects of UVA -I (340- 400nm), UVA -II 
(320- 340nm) and UVA -I +II on the photoisomerisation of urocanic acid in vivo. 
Photochem.Photobiol. 66:484 -492. 
278 
Weigle WO and Romball CG (1997) CD4+ T -cell subsets and cytokines involved in peripheral 
tolerance. Immunol.Today 18:533 -538. 
Weitzen ML and Bonavida B (1984) Mechanism of inhibition of human natural killer activity by 
ultraviolet radiation. J.Immunol. 133:3128 -3132. 
Whitmore SE and Morison WL (1995) Prevention of UVB- induced immunosuppression in humans 
by a high sun protection factor sunscreen. Arch.Dermatol.Res. 131:1128 -1133. 
Wilkinson PC and Liew FY (1995) Chemoattraction of human blood T lymphocytes by 
interleukin -15. J. Exp. Med. 181:1255 -1259. 
Williams IR and Kupper TS (1994) Epidermal expression of intercellular adhesion molecule 1 is not 
a primary inducer of cutaneous inflammation in transgenic mice. Proc.Natl.Acad.Sci. USA 91: 
9710 -9714. 
Wolf P and Kripke ML (1998) Immunologic protection afforded by sunscreens beyond designated sun 
pprotection factors? J.Invest.Dermatol. 110:184. 
Yoshikawa T, Rae V, Bruins -Slot W, Van den Berg J -W, Taylor JR and Streilein JW (1990) 
Susceptibility to effects of UVB radiation on induction of contact hypersensitivity as a risk factor for 
skin cancer in humans. J.Invest.Dermatol. 95:530 -536. 
Yoshikawa T and Streilein JW (1990) Genetic basis of the effects of ultraviolet light B on cutaneous 
immunity. Evidence that polymorphism at the Tnfa and Lps loci governs suseptibility. 
Immunogenetics 32:398 -405. 
Yoshimoto T, Wang C -R, Yoneto T, Waki S, Sunaga S, Komagata Y, Mitsuyama M, Miyazaki J -I 
and Nariuchi H (1998) Reduced T helper 1 responses in IL -12 p40 transgenic mice. J.Immunol. 
160:588 -594. 
Young AR, Chadwick CA, Harrison GI, Nikiado O, Ramsden J and Potten CS (1998) The similarity 
of action spectra for thymine dimers in human epidermis and erythema suggests the DNA is the 
chromophore for erythema . J.Invest.Dermatol. 111:982 -988. 
279 
Young JW, Baggers J and Soergel SA (1993) High -dose UV -B radiation alters human dendritic cells 
costimulatory activity but does not allow dendritic cells to tolerize T lymphocytes to alloantigen in 
vitro. Blood 81:2987 -2997. 
Yuen KS and Halliday GM (1997) a- tocopherol, an inhibitor of epidermal lipid peroxidation, 
prevents ultraviolet radiation from suppressing the skin immune system. Photochem.Photobiol. 
65:587 -592. 
Yuspa SH, Hawley- Nelson PA, Burke RL, Pachl C, Berman PW and Laskky LA (1980) A survey of 
transformation markers in differentiating epidermal cell lines in culture. Cancer Res. 40:4694 -4703. 
Zamansky GB and Chou I -N (1987) Environmental wavelengths of ultraviolet light induce 
cytoskeletal damage. J. Invest.Dermatol. 89:603 -606. 
280 
Publications arising from this thesis 
1. Duthie MS, Kimber I and Norval M (1999) The effects of ultraviolet radiation on 
the human immune system. British Journal of Dermatology, 140:995 -1009. 
2. Duthie MS, Dearman RJ, Kimber I and Norval M (1998) Ultraviolet B irradiation 
of mice enhances IL -12 p40 production in lymph node cells (Abstr.). Immunology, 
95:1255. 
(presented at BSI Annual Congress, Harrogate, UK; 1 -4 December, 1998). 
3. Duthie MS, Dearman RJ, Kimber I and Norval M (1999) Differential effects of 
UVA1 and UVB radiation on Langerhans cell migration (Abstr.). Journal of 
Photochemistry and Photobiology B: Biology (in press). 
(presented at European Society for Photobiology (ESP) conference, Granada, Spain; 3 -8 September, 
1999). 
4. Duthie MS, Dearman RJ, Kimber I and Norval M (1999) Differential effects of 
UVA and UVB on Langerhans cell migration (to be submitted for publication) 
Presentations 
Differential effects of UVA and UVB on Langerhans cell migration - presented at Skin Biology Club, 
Falkirk, UK (May, 1999) 
Departmental seminar, presented at Department of Medical Microbiology, Edinburgh, 
UK (June, 1999) 
281 
0P166 ULTRAVIOLET -B IRRADIATION OF MICE ENHANCES IL -12 p40 PRODUCTION IN LYMPH NODE CELLS 
MS Duthie. RI Dearman', I Kimber 1 and M Norval 
Medical Microbiology. University of Edinburgh Medical School. 
Edinburgh EH8 9AG. and 1Zeneca Central Toxicology Laboratory. 
Macclesfield SK104TJ. 
Ultraviolet t.UVI -B irradiation suppresses cell- mediated immune 
responses to antigens encountered subsequently through the exposed site. 
It has been suggested that UV -B mediates these effects by blocking the 
induction of ThI -like cytokine responses. In the present study C3HIHeN 
mice were irradiated with 2 minimum erythema] doses of UV -B prior to 
contact sensitisation on their ears with 1% oxazolone; conditions which 
resulted in approximately 50% suppression of contact hypersensitivity. 
The auricular lymph nodes draining the irradiated sensitised site were 
excised and the lymph node cells cultured in vitro for 120 h with 
measurement of cytokine production by ELISA. UV -B irradiation 
caused no change in IL -10 or IFN -r secretion compared with the 
unirradiated group However exposure resulted in a significant increase 
in IL -12 p40 production by 48 h. These data indicate that UV -B 
irradiation enhances synthesis of IL -12 by lymph node cells while not 
affecting Th2 cytokine production. How these changes relate to the 
immunosuppression induced by UV -B exposure remains uncertain as 
yet. 
Abstract presented at British Society for Immunology (BSI) Annual 
Congress, Harrogate, 
UK; 1 -4 December, 1998. 
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DIFFERENTIAL EFFECTS OF UVA AND UVB ON 
LANGERHANS CELL MIGRATION. 
MS Duthie, RJ Dearman' , I Kimber' . and M Norval 
Dept. of Medical Microbiology. University of Edinburgh Medical 
School, Edinburgh. UK. I Astra- Zeneca Central Toxicology 
Laboratory. Macclesfield, UK. 
Time- courses for the reduction of Langerhans cells numbers in the 
epidermis of mice following exposure to UVA or UVB irradiation, 
or skin painting with cis -urocanic acid (UCA). have been 
established. Using doses which suppressed delayed hypersensitivity 
in all cases. both L: VB and cis -UCA resulted in a reduction of 
Langerhans cell numbers within 24h of exposure, whereas UVA had 
no effect (at up to 72h). Furthermore. UVA did not exert any 
protection against the UVB- mediated depletion in Langerhans cell 
numbers. The reduction in Langerhans cells following both UVB 
and cis -UCA exposure could be blocked by pre -treatment of mice 
with neutralising antibodies to either IL -lß or TNF -a. UVB 
irradiation has been shown to cause an increase in dendritic cell 
numbers in lymph nodes draining irradiated sites. UVA irradiation 
also caused an increase. However. pre- treatment with anti -TNT-a 
blocked this effect following UVB exposure, but did not alter the 
UVA- mediated increase. These results indicate that UVB induces 
Langerhans cell migration from the epidermis, possibly via UCA 
isomerisation and subsequent secretion of TNF -a and IL- l ß. UVA 
may act through a different mechanism and may target another 
cutaneous antigen presenting cell type. possibly dermal dendritic 
cells. 
Abstract presented at European Society for Photobiology (ESP) conference, Granada, 
Spain; 3 -8 September, 1999. 
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ABSTRACT 
The UVB- and UVA1 (340 -400 nm)- induced migration of Langerhans cells (LC) 
from the epidermis and accumulation of dendritic cells (DC) in the lymph nodes 
draining the exposed skin site of C3H/HeN mice have been investigated. One 
minimum erythemal dose (MED) of UVB (1.5 kJ /m2) and of UVA1 (500 kJ /m2) 
were chosen, amounts which had been shown previously to suppress delayed 
hypersensitivity (DTH). UVB irradiation resulted in a reduction in epidermal LC 
numbers which was most apparent 12 h after exposure, but, in contrast, UVA1 had 
no significant effect up till 72 h after exposure. UVA 1 did not exert any protection 
against the UVB- mediated depletion in LC numbers. The reduction in LC following 
UVB exposure could be prevented by treatment of the mice with neutralising 
antibodies to either tumor necrosis factor (TNF) -a or interleukin (IL)-f3 2 h before 
irradiation. It was known already that exposure to UVB caused an increase in the 
number of dendritic cells (DC) in the lymph nodes draining the irradiated skin site. 
In the present study we have shown that UVA1 had a similar effect. Pre -treatment of 
the mice with neutralising antibodies to IL -1ß substantially inhibited the increase 
after both UV regimens. However TNF -a antibodies only affected the UVB- induced 
increase and did not alter the increase in DC numbers following UVA1 exposure. 
These results indicate that UVB causes the migration of LC from the epidermis and 
an accumulation of DC in the draining lymph nodes by a mechanism that involves 
both TNF -a and IL -113. UVA1, on the other hand, does not cause LC migration from 
the epidermis and the UVA1- induced accumulation of DC in the draining lymph 
nodes requires IL -113, but not TNF -a. Therefore it is likely that UVA1 may act 
through a different mechanism from UVB and may target a cutaneous antigen 
presenting cell other than LC, such as the dermal DC. 
INTRODUCTION 
In the course of a normal cutaneous immune response, Langerhans cells (LC), the 
major antigen presenting cells of the epidermis, internalise and process antigen, and, 
in response to changes in the local cytokine milieu, they migrate to the draining 
lymph node. During the migration in the afferent lymphatics, LC mature, as revealed 
by the altered expression of various adhesions and co- stimulatory molecules. Once 
in the paracortical region of the lymph node, where they are known as dendritic cells 
(DC), they present antigen peptides to specific T cells, which are then stimulated to 
proliferate and to produce a particular cytokine profile. The key migratory signals 
are believed to be provided in an autocrine fashion by interleukin (IL)-113, and in a 
paracrine fashion by tumor necrosis factor (TNF) -a (Kimber et al, 1998; Wang et al, 
1999). LC express only the type 2 (p75) TNF -a receptor, and mice deficient in 
expression of this receptor demonstrate significantly impaired LC migration (Wang 
et al, 1997). Blocking of TNF -a activity by neutralising antibodies revealed that 
TNF -a acts early in the response, as injection of the antibodies prior to contact 
sensitisation, but not 18 h after, inhibited the sensitisation phase and the subsequent 
contact hypersensitivity (CH) on challenge (Cumberbatch and Kimber, 1995). IL -Iß 
is produced solely by LC in the normal mouse epidermis, and its synthesis is 
enhanced by topical exposure to chemical allergens (Enk and Katz, 1992). 
Intradermal injection of IL -113 stimulates LC migration from the epidermis, but at a 
slower rate than that induced by injection of TNF -a (Cumberbatch et al, 1997a). 
Therefore it is believed that IL -10 acts as the initial signal to upregulate TNF -a 
production and release from keratinocytes, and delivers an autocrine signal for LC 
migration simultaneously (Kimber et al, 1998). 
UV radiation is divided into three wavebands: UVC (200 -280 nm), UVB (280- 
315 nm) and UVA (315 -400 nm), further divided into UVA1 (340 -400 nm) and 
UVA2 (315 -340 nm). It is recognised that UVB exposure can suppress cell - 
mediated immune responses to a variety of antigens, including contact sensitisers 
British Journal of Dermatology 1999; 140: 995 -1009. 
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Summary The adverse outcome of increased ultraviolet (UV) irradiation on human health is currently of 
concern. While many experiments have been carried out in rodent models, fewer have been designed 
to test the effects of UV exposure in human subjects. This review concentrates on the modulations 
induced in the human immune system by UV, and outlines changes in antigen presentation by 
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As well as links with skin cancer, ultraviolet (UV) irradia- 
tion causes alterations in immune functions. While the 
mechanisms of these effects have been widely investigated 
in inbred mouse strains, and to some extent in rats, ethical 
and practical considerations have meant that relatively 
few human studies have been conducted. 
W radiation can be divided into three categories, 
dependent on wavelength: UVC, 200 -280 nm; UVB, 
280 -315 nm; UVA, 315 -400 nm. Stratospheric ozone 
effectively blocks wavelengths shorter than 290 nm, 
together with 70 -90% of UVB. Between 1970 and 
1987, a substantial decrease in the protective ozone 
layer occurred,1"2 with a resultant increase in the 
amount of UVB reaching the Earth's surface, which 
was particularly apparent over Antarctica. In spite of 
this change, it is difficult to determine if there is a global 
trend towards increasing UVB levels over populated 
regions of the world, due to the relatively short time - 
span of the measurements. However, life- styles have 
altered in recent decades, leading to increased personal 
exposure to UV in many cases. Such factors include 
more leisure time, `sunshine' holidays, the use of sun - 
beds for cosmetic tanning, the wearing of minimal 
Clothing outdoors and the insufficient use of sunscreens. 
In addition, phototherapy is used more frequently for 
the treatment of a number of medical conditions such as 
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psoriasis and acute graft- versus -host disease. Finally, 
some industrial UV exposure can occur, as is the case 
with welding arcs or tungsten halogen lamps. 
Most of the UV which irradiates human skin is 
absorbed by the epidermis, with transmission of the 
longer wavelengths only into the dermis. Most experi- 
ments thus far have concentrated on the UVB waveband 
which is regarded as the most important in mediating 
immunosuppression. However, there is growing interest 
in the effects of UVA3 and in solar -simulated radiation. It 
is believed that UV acts by initiating a cascade of events 
in the skin starting with absorption by a chromophore 
or chromophores locally and ending in immuno- 
modulation. Among the first changes, membrane 
damage, induction of cytoplasmic transcription factors, 
DNA damage and isomerization of urocanic acid 
(UCA)4'3 appear to play important parts. Alterations 
in antigen -presenting cell populations occur, so that 
antigens encountered through UV- exposed skin are 
presented differently, or not at all, from those encoun- 
tered through normal skin. Changes at the molecular 
level are induced so that intercellular and intracellular 
signalling mechanisms are modified, and the local 
microenvironment becomes more favourable to the 
development of T- helper (Th) 2 -like immune responses. 
These effects can be demonstrated not only at a local level 
but, at least in rodent models, at distant sites also, result- 
ing in antigen -specific systemic immunosuppression. 
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Cellular aspects of ultraviolet radiation 
Several studies have indicated that UV irradiation of 
human subjects generally leads to the downregulation 
of delayed hypersensitivity, considered as an important 
measure of T -cell function. The first two of these involve 
suppression of already established responses. Mork and 
Austad6 reported that 70% of their patients with aller- 
gic chronic dermatitis were treated successfully with 
suberythemal UVB, and the situation was maintained if 
UVB was given once weekly thereafter. Similarly, expo- 
sure to suberythemal UVB four times weekly over a 
3 -week period was sufficient to suppress the contact 
hypersensitivity (CH) response to nickel in nickel - 
sensitive individuals.' This effect was limited to the 
UVB wavelengths, as UVA did not alter the patch -test 
scores. In contrast, Tie et al.8 found that subjects sensi- 
tized through normal skin and challenged via UVB- 
exposed skin, exhibited enhanced CH. 
Using carefully graded doses of sensitizer (1- chloro- 
2,4-dinitrobenzene, DNCB), Friedmann et a1.9 showed 
that therapy with both broadband UVB and psoralen 
plus UVA (PUVA) induced impairment of CH in about 
70% of patients with psoriasis. The sensitizer was 
applied approximately half -way through the therapy 
and the elicitation occurred 4 weeks after the cessation 
of therapy. Subjects who were not sensitized successfully 
during treatment were resensitized at a later date, and 
no evidence for tolerance was obtained in either the 
UVB or the PUVA group. 
Following exposure of a small area of skin to 144 mJ/ 
cm2 UVB on each of 4 consecutive days, a protocol 
which reduces Langerhans cell numbers in the epidermis 
from 565 to 17/mm2, 40% of volunteers demonstrated 
suppressed CH responses to DNCB applied epicuta- 
neously at the site of exposure, followed by challenge 
at a distant unirradiated site.10 In parallel with mouse 
studies, these subjects were designated as UVB suscep- 
tible and the others, in whom the extent of the CH 
response was unaltered by the UV exposure, were 
termed UVB resistant. It was also found that 92% of 
skin cancer patients fall into the UVB- susceptible 
category,10 and therefore UVB- induced suppression of 
CH may act as a risk factor /indicator for skin cancers. 
However, it should be noted that the proportion of black 
people with the UVB- susceptible trait is similar to that in 
Caucasians, despite the significantly lower incidence of 
skin cancer in this population," although this could be 
attributed to the protective effects of melanin preventing 
significant DNA damage. Skov et al.12 also reported that 
56% of human subjects exhibited suppressed CH 
responses following 3 minimal erythema doses (lamps) 
of UVB and sensitization on the irradiated site. 
Tolerance was not induced in the unresponsive indivi- 
duals. Interestingly, tests to assess Langerhans cell 
(CD1a+ HLA -DR +) and macrophage (CD1a- TEA_ 
DR +) numbers and the ability of epidermal cells to 
activate autologous T cells following irradiation 
revealed no differences between the UVB- susceptible 
and UVB- resistant individuals. Thus, susceptibility to 
UVB cannot be correlated easily with these local changes 
in epidermal antigen -presenting cell populations or 
functions. 
The clear division into UVB susceptible and UVB 
resistant has not been confirmed in all studies. Cooper 
et al.13 reported that almost all subjects had a reduced 
ability to respond to DNCB if the sensitizer was applied 
to the irradiated site. The downregulation was dose 
dependent to some extent as the lowest exposure used 
(0.75 MED of UVB daily for 4 days to a small area of 
skin) induced non -responsiveness in 68% of individuals 
while the highest (2 MED of UVB daily for 4 days) 
induced non -responsiveness in 95% of individuals. 
The most susceptible people exhibited tolerance to 
DNCB on repeated challenge with the sensitizer. There 
was a modest suppression in CH if the DNCB was applied 
at a distant unirradiated site after 4 MED UVB was given 
as a single dose. There may be a wavelength dependence 
in the local immunosuppressive effect, as exposure to 
UVA did not alter the induction of CH in any subject.14 
Another study has demonstrated that solar -simulated 
UV exposure, corresponding to 3 MED, followed by 
sensitization on the irradiated site, led to suppressed 
CH responses in 50% of subjects.15 However, in con- 
trast, Kelly et a1.16 found that solar -simulated radiation 
was highly immunosuppressive in all subjects tested. A 
single exposure of a small area of skin to 3 MED was 
followed by sensitization with DNCB on the irradiated 
site and diphenylcyclopropenone on a distant site, and 
elicitation with both sensitizers occurred 3 weeks later. 
The CH response was completely suppressed locally in 
100% of individuals and systemically in 83% of indivi- 
duals. A dose of radiation of this magnitude is of 
biological relevance as it would be experienced within 
1 h at noon in the summer in the U.K. 
It is difficult at this time to draw definite conclusions 
from these rather disparate observations. However, it is 
clear that, in all studies, at least a proportion of human 
subjects exhibit suppressed CH if the sensitizer is applied 
to the irradiated site. The effect is more marked if small 
quantities of sensitizer are used. UV- induced tolerance 
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observed, and the contribution of different wavelengths 
within the UV spectrum is uncertain at present. 
Antigen - presenting function 
The primary antigen -presenting cells in the epidermis 
are the Langerhans cells, which form a network of 
dendritic cells. Following contact with antigen, they 
internalize and process it, with changes in local cyto- 
kine production leading to their migration to the drain- 
ing lymph node. During migration via the afferent 
lymph, Langerhans cells mature, as revealed by the 
altered expression of various adhesion and costimula- 
tory molecules. Once in the paracortical region of the 
lymph node, they present processed antigenic peptides 
to specific T cells, which are stimulated to proliferate 
and produce a particular cytokine profile. It is apparent 
that disruption of Langerhans cells could be a funda- 
mental component of UV- mediated immunosuppres- 
sion, either by incorrect, inappropriate or inefficient 
antigen presentation. Alternatively, depletion or 
apoptosis of Langerhans cells could lead to antigen 
presentation by another cell type. 
Several studies have examined Langerhans cell num- 
bers and morphology within human skin following UV 
exposure, two of which have been outlined above.1012 
Photochemotherapy (PUVA) for skin conditions such as 
psoriasis altered Langerhans cell morphology after a 
single exposure, with loss of fine dendritic processes.17 
Repeated exposures led to a progressive reduction in 
numbers, to 10% after seven treatments. By this time, 
the remaining cells were elongated, with coarse den - 
drites. Langerhans cells were detectable in, or under, the 
basal layer, suggesting migration out of the epidermis, 
or the preferential survival of cells positioned deeper in 
the skin. An Australian study showed that UV acts 
differently on the Langerhans cells of people of different 
racial origins.18 Whereas Langerhans cells were 
depleted by apoptosis in the darker skin of Aboriginal 
or Asian Australians, cells in those of Celtic descent died 
due to membrane disruption and organelle damage.18 
Absolute numbers were less drastically reduced in black 
people, and returned to normal levels more quickly. 
The effect of low -dose, long -term UVB (300 -500 J/ 
m2 initially, three times weekly for 4 weeks) on the 
function of Langerhans cells was investigated in skin 
blisters /biopsies from healthy volunteers, and showed 
a marked suppression of the mixed epidermal cell 
lymphocyte reaction (MECLR).19 MECLR is used as a 
measure of immune responsiveness; epidermal cells act 
as stimulators to induce proliferation of allogeneic 
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peripheral blood responder cells. The reduction in 
MECLR was not paralleled by changes in Langerhans 
cell numbers or in HLA class II expression. Further- 
more, the Langerhans cells appeared ultrastructurally 
normal.19 It is unlikely that low -dose UVB alters these 
cells at a phenotypic or structural level, but it could alter 
membrane motility,20 thereby decreasing the efficiency 
of antigen presentation, or of antigen internalization 
and processing. 
Further in vitro investigations of human Langerhans 
cell function showed a UVB dose -dependent decrease of 
T -cell proliferation in the MECLR.21 Responses by both 
CD4 + and CD8 + T cells were inhibited by UVB- treated 
Langerhans cells. Supernatants from irradiated cells did 
not inhibit the proliferation induced by unirradiated 
control Langerhans cells, suggesting that immuno- 
suppression is not mediated by soluble factors, as indi- 
cated by murine models.2223 Addition of interleukin 
11-1ß or IL -2 did not reverse the defective 
Langerhans cell function.21 Phenotypic analysis indi- 
cated that UVB did not alter levels of expression or the 
percentage of cells displaying HLA -DR. However, 
cultured Langerhans cells were less sensitive to UVB 
exposure than fresh cells. Cultured Langerhans cells 
express higher levels of the costimulatory molecules 
intercellular adhesion molecule (ICAM) -1 (CD54), B7 
and leucocyte function -associated antigen 3. UVB may 
therefore exert an immunosuppressive effect by prevent- 
ing accessory function development, a phenomenon 
seen with blood dendritic cells.24 Again, this could be 
related to cytoskeletal damage25 and /or decreased 
mobility of surface antigens.20 
Epidermal cells obtained from suction blisters of 
human skin after exposure in vivo to varying doses of 
UV exhibited altered capacities to stimulate T cells. 
Epidermal cells were pulsed with purified antigen, 
either immediately or 24 h following UV treatment, 
and their ability to induce T -cell proliferation assessed. 
A dose -dependent reduction of activating ability was 
found,26 and could be mimicked by pretreatment of 
epidermal cells to deplete HLA -DR + cells. As Langer- 
hans cells are the only DR + cells resident in normal 
human epidermis, it is likely that changes in these cells 
account for these observations. Cell death was limited to 
DR - keratinocytes, and was not related to the responses 
obtained.26 
UV also causes changes in intercellular signalling. In 
vitro stimulation by epidermal cells obtained from both 
UV- exposed and normal control skin induced a greater 
than 1000 -fold increase in mRNA for the T -cell growth 
factor, IL -2, in allogeneic CD4 + T cells. However, the 
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mRNA for the IL -2 receptor a -chain (IL -2Ra, CD25) 
was upregulated only upon stimulation by normal, 
unirradiated epidermal cells.27 At the protein level, 
CD2 5 expression on T cells was increased within 48 h 
of incubation with normal epidermal cells, but was not 
altered by incubation with irradiated epidermal cells. 
Treatment with antibodies to transforming growth 
factor (TGF) -ß restored the ability of the UV- exposed 
epidermal cells to upregulate CD25. Thus, the altered 
immune response after UV exposure seems to be due in 
part to TGF -13 released by epidermal cells post -UV, 
initiating an altered early CD4 + T -cell gene expression, 
which is characterized by the deficient IL -2Ra expres- 
sion.27 Furthermore, T cells stimulated by UV- exposed 
epidermal cells had altered growth factor utilization 
and cytokine production patterns.28 T cells cultured 
with control epidermal cells utilized IL-2, IL-7 and IL-15 
for growth, and produced predominantly interferon 
(IFN) -y. Those stimulated with UV- exposed epidermal 
cells used IL -4 for growth, and more cells produced IL -4 
and /or IL -5 compared with controls. 
Monocytes leave the circulation by binding to the 
endothelial leucocyte adhesion molecule (ELAM) -1. 
This is induced on the vascular endothelium in the 
proximity of a UV- irradiated site, or after injection with 
purified protein derivative (PPD), which elicits delayed - 
type hypersensitivity (DTH).29 ELAM -1 was first 
detectable at 6 h, and maximally at 24 h, in both 
cases. Infiltration by macrophages into the treated site 
had a similar time course. By 3 days, however, ELAM -1 
was more strongly expressed in DTH sites than in 
UV exposed skin. This difference may be due to local 
cytokine activity. Thus, following UV, ELAM -1 could act 
by recruiting antigen -presenting macrophages, tem- 
porarily replacing the Langerhans cells which had 
migrated from the skin. Other adhesion molecules 
induced by intradermal injection of PPD to elicit 
DTH, such as vascular cell adhesion molecule 
(VCAM) -1 and ICAM -1, were unaltered in UV- exposed 
skin.29 
Investigation of epidermal cell suspensions, derived 
from skin which had been subjected to erythemogenic 
UVB each day for 4 days, showed a doubling in numbers 
of CD3 6+ macrophages compared with unirradiated 
controls.30 This increase correlated with the recovery, 
and enhancement, of MECLR responses.3o,31 In situ 
immunohistochemistry and flow cytometry of cell sus- 
pensions revealed that UV radiation induced not only 
infiltration of CD3 6 + monocyte /macrophage cells into 
the epidermis, but also expansion of the dermal macro- 
phage subset, which is phenotypically identical.32 
T cells 
While aspects of T -cell immunity have been outlined 
above in the context of hypersensitivity responses, the 
effects of UV on T -cell numbers are worthy of considera- 
tion. Changes in circulating T -cell subsets as a result of 
exposure are controversial and, indeed, it is possible that 
such modulations are only transient. Thus, for example, 
Gilmour et aí.33 found no significant changes in the 
percentages of blood CD3 +, CD4 + or CD8 + cells 
during and after broadband UVB phototherapy or 
PUVA. In contrast, exposure of people to the mid -day 
sun for 1 h /day for 12 days during the spring in Sydney, 
Australia, led to a small but significant decrease in the 
number of peripheral T cells.34 Circulating CD4 + cell 
numbers declined markedly, while CD8 + cells 
increased. The reduction in the CD4 /CD8 ratio was 
not completely restored even 2 weeks postexposure. 
The decrease in peripheral CD4 + T cells might be 
accounted for by migration into irradiated sites. 
Limited studies have examined T -cell subsets in UV- 
exposed skin. Biopsies showed an initial decrease, or 
depletion, of intraepidermal T cells within 2 days of a 
single erythemal UV dose of solar -simulated light.35 
Dermal T cells increased by 24 h and were maximal at 
48 h. One week after the irradiation, the migration into 
the epidermis of CD3 + T cells, expressing CD4 but not 
CD8, could be detected. These cells were almost exclu- 
sively of the memory phenotype (CD45R0 +), and 
lacked expression of the activation markers HLA -DR, 
VIA -1 and 1L -2R.36 Thus, the cutaneous CD4 /CD8 ratio 
may be increased following UV exposure. The time course 
of the T -cell infiltration into the epidermis and dermis 
was UV dose dependent. One explanation for the initial 
loss of cutaneous T cells may be phototoxicity. It has been 
shown that T cells are hypersensitive to UV compared 
with keratinocytes,37 monocytes38 and B cells.39 
Natural killer cells 
Natural killer (NK) cells are major histocompatibility 
complex (MHC)- unrestricted cells which are part of the 
innate immune system, important in the recognition 
and lysis of both virally infected cells and tumour cells. 
They also play a part in the development of Thl -like 
immune responses via the release of IFN -y. 
UV radiation causes a dose -dependent inhibition of 
NK cell activity.4o'41 In vitro exposure demonstrated that 
NK activity and lymphocyte proliferation, in response to 
mitogen, were inhibited to the same extent. Both effects 
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nucleic acid acting as the main chromphore,42 
although there is also evidence for the involvement of 
UCA (see section below). The dose required for 50% 
inhibition of NK cell activity at 300 nm was only 3 mJ/ 
02, equivalent to about 12 min of mid -day exposure to 
the sun in a temperate climate during summer. 
Although these experiments were conducted in vitro, 
which would eliminate the absorptive properties of the 
skin, it is likely that environmental UV exposure might 
be sufficient to inhibit NK cell function.4 
°'42 As UV 
penetration through skin layers, assessed by thymine 
dimer formation, shows a very small decline of 2.5 % per 
cell layer at 300 nm,43 at this wavelength the amount of 
radiation required to inhibit NK cell activity is within 
that reaching the dermis and capillaries. In addition, it 
has been calculated that when the greater proportion of 
UVA in solar radiation and its greater penetration into 
the skin are taken into account, UVA may have an 
equivalent immunosuppressive effect to that of UVB on 
NK cell activity.44 
In vivo studies utilizing solarium exposure as a source 
of W have concluded that NK cell function is reduced 
during the course of tanning.34 This suppression was 
particularly significant 2 weeks after the last treatment. 
Circulating NK cell numbers were also decreased, 
although the correlation between the numbers and 
function was not absolute. Measurement of NK cell 
activity after various UV therapies, used for the treat- 
ment of psoriasis, showed depression during and 
4weeks after the irradiation course.45 The precise 
timing and extent of the downregulation varied between 
the groups (PUVA, broadband UVB, narrowband UVB) 
and may be related to dose. No change in circulating NK 
cell numbers was reported.45 
UV radiation does not prevent NK cells recognizing 
and binding to their target cells but acts at the apoptotic 
or lysis stage. NK cells, exposed to ÜV in vitro, were 
induced spontaneously to release cytotoxic factors, 
detectable within 30 min of exposure.40 In agreement 
with this is the observation that superoxide dismutase 
(SOD), an antioxidant which scavenges superoxide 
anions, reversed the UV- induced suppression in NK 
cell activity.45 IL -2 also reversed the suppression and 
acted synergistically with SOD. Thus, UV may induce 
NK cells to produce reactive oxygen species, resulting in 
a less efficient killing of target cells. 
In association with a decrease in NK cell activity, a 
similar decrease in NK- associated cytokines might be 
expected as a result of UV radiation. As NK cells are a 
potent, although not the only source of IFN -y,4° UV 
could bias the systemic immune system away from 
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cellular immune responses. Induction of suppressive 
monocyte /macrophage cells, T cells and their related 
cytokines, as well as prostaglandin release, could then 
play a part in exacerbating the downregulation in NK 
cell activity. 
Molecular aspects of ultraviolet radiation 
Urocanic acid 
UCA is formed by the enzyme histidine ammonia -lyase 
during keratinization. It is found naturally as the trans - 
isomer within the stratum corneum and is a major 
absorber of UV in the skin. On UV irradiation, trans -UCA 
isomerizes to cis -UCA in a dose -dependent fashion until 
the stationary state is reached when approximately 
equal quantities of the two isomers are present. It 
takes approximately 2 weeks for the cis -UCA to return 
to a baseline level. The isomerization is efficient between 
305 and 341 nm (i.e. in both the UVB and UVA wave- 
bands) in Caucasian skin47 and has a maximum at 
290 -310 nm.48 The percentage of cis -UCA in suction 
blister fluid 24 h after 3 MED of either UVB or UVA1 
(340 -400 nm) is increased over that found in fluid from 
unirradiated skin.49 The elevated percentage of cis -UCA 
in suction blister fluid seems to be maintained for 
several weeks following irradiation.33 There is a large 
interindividual variation in UCA concentration but little 
difference between body sites within one person.50'51 
There is no correlation between the total UCA concen- 
tration and skin type, degree of pigmentation, MIED or 
stratum corneum thickness.50'51 A study of seasonal 
variation in UCA isomers in human skin showed that 
the total UCA content was lower in the summer months 
in all six body sites tested, of which some were normally 
exposed and others not exposed to sun.52 The percen- 
tage of cis -UCA was close to the maximum obtainable 
during the summer months, except in the buttocks, and 
it decreased to below 7% in the winter months in all 
body sites apart from the forehead. A recent study of 
patients who had been treated for basal cell carcinoma 
and malignant melanoma concluded that there was no 
difference in the absolute content of UCA isomers 
between the skin of the two cancer groups and 
normal controls.53 Irradiating these subjects with a 
single test UV dose resulted in a relatively higher 
production of cis -UCA in both cancer groups compared 
with the controls. The significance of this change, if any, 
is not known at present. 
UCA was regarded initially as a potential sunscreen 
but tests to evaluate its sun protection factor (SPF) have 
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shown that this is not the case. Addition of trans -UCA to 
human skin in amounts about 200 times greater than 
those occurring naturally afforded a SPF of only 1. 58.54 
Rodent experiments have suggested that cis -UCA can 
initiate at least some of the events leading to UV- induced 
immunosuppression (see reviews55,56) and the pioneer- 
ing work of De Fabo and Noonan showed that the 
wavelength dependency of suppression of CH by UV 
has a similar action spectrum to the absorption spec- 
trum of UCA.4'5 Evidence to corroborate this view in 
human subjects is obviously not easy. cis -UCA has been 
shown to suppress human NK cell activity in a dose - 
dependent manner in vitro, while trans -UCA had little 
effect.45 However, no correlation was found between the 
percentage of cis -UCA in the skin and the suppression in 
NK cell activity induced by narrowband UVB therapy in 
individuals with psoriasis.57 If human epidermal cells 
were treated with cis -UCA in vitro before testing their 
activity as stimulator cells in a MECLR, a 20% suppres- 
sion resulted.58 The downregulation was increased to 
2 7% by incubation of the epidermal cells with cis -UCA 
for 3 -6 days before testing. trans -UCA had no such 
effect. In addition, cis -UCA did not alter a mixed lym- 
phocyte reaction if present throughout the culture 
period.S8 Thus, a partial downregulation in human 
epidermal antigen -presenting activity could be attribu- 
ted to cis -UCA. A further potential in vivo mechanism of 
action of cis -UCA includes the stimulation of prosta- 
glandin E2 (PGE2) production, which has been reported 
in vitro from human peripheral blood monocytes59 and 
keratinocytes.6° 
DNA damage 
As is the case with cis -UCA, rodent models suggest that 
DNA damage is a critical event in UV- induced immuno- 
suppression (see review61). Evidence to support this 
view is limited in human subjects. Hurks et aí.62 
showed that the in vitro action spectrum for the sup- 
pression in the MECLR is associated with UV- induced 
DNA damage. This study was recently extended to 
investigate the action spectra at four wavelengths for 
the induction of thymine dimers, which represent the 
largest subclass of cyclobutyl pyrimidine dimers, and 
the suppression in the MECLR following in situ irradia- 
tion of small pieces of human skin.63 The two action 
spectra had close similarities with a high sensitivity at 
254, 297 and 302 nm, then a steep decline to 312 nm. 
However, with such large gaps in the wavelengths 
studied and no information regarding UVA wave- 
lengths, more information is required. 
Cytokine induction 
UV induces changes in epidermal cytokine profiles, 
involving both pro -inflammatory and anti -inflammatory 
cytokines, from a wide range of cell types. 
Interleukin -1. Keratinocytes are known to be a rich 
source of IL -1, which stimulates prostaglandin synthesis 
by many cell types.64 IL -1 was shown to be present in 
the stratum corneum of normal human skin, but not in 
the basal layer. After UVB exposure, IL -1 appeared in 
the basal cell layer, and was increased in the more 
exterior regions.65 Together with this increase in IL-1, 
IL -1 receptor antagonist (IL -1ra) was increased 
markedly following 2 -3 MED of UV.66 IL-lra is 
reportedly induced during keratinocyte differentiation, 
a known effect of UV radiation or sun exposure.67 The 
ratio of IL -lra: IL -la in sun -exposed skin was over 100, 
an excess sufficient to block IL -la- induced 
biological responses.66 In un- exposed skin, the ratio 
was about 8, which was too low to block activity. 
Therefore, although UV stimulates an increase in IL-1 
levels, with the concomitantly greater rise in IL -lra, UV 
may actually inhibit the activities of IL-la and 
suppress an inflammatory response. The adhesion 
molecule VCAM -1 is known to be upregulated on 
endothelial cells by IL -1, but is unaltered by UV 
exposure.29 
Tumour necrosis factor -a. Studies in mouse models 
suggest that susceptibility to UVB- induced immuno- 
suppression is partly controlled by the Tnf locus,68 
Tumour necrosis factor (TNF) -a is involved in 
Langerhans cell migration from the skin,69 and induc- 
tion of this cytokine could lead to altered, or diminished, 
antigen presentation, via Langerhans cell depletion. 
TNF -a is strongly implicated in the inflammatory 
response to UVB exposure. Skov et al.49 found that 
irradiating human skin with 3 MED of UVB led to a 
rapid increase in TNF -a protein in suction blister fluid, 
which was maximal at 6 h following exposure. Interest- 
ingly, exposure to 3 MED UVAl resulted in a slight 
decrease in TNF -a at 6 h.49 
Conflicting data are reported on the role of UVB- 
induced TNF -a in the upregulation of E- selectin. Strickland 
et aí.70 found E- selectin expression on dermal blood 
vessels proximal to the exposed site by 4 h, before 
TNF -a could be detected. Walsh71 studied the `sunburn 
response, finding that mast cells degranulated upon 
exposure to 3 MED, releasing stores of intracellular 
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expression on cutaneous endothelium by 2 h. Keratino- 
cytes contributed minimally to this effect, which could 
be blocked with the mast cell inhibitor disodium 
cromoglycate.71 TNF -a is further implicated in sunburn 
cell formation by in vitro studies, as antibodies to TNF -a 
reduce UV- induced apoptosis in human keratinocytes, 
although not completely. 
72 
UVB exposure (200 J /m2) stimulates a similar quan- 
tity of TNF -a from cultured human dermal fibroblasts as 
does IL -la. However, the two treatments synergize to 
give a 30 -40 -fold increase in TNF -a, mirrored by 
mRNA expression.73 As UVB is capable of inducing 
IL-la directly, and as incident UVB can penetrate to 
the dermis, a TNF -a cascade could be initiated in this 
site.73 In vitro studies using a human keratinocyte cell 
line showed that blockade of IL -la activities 
with monoclonal antibodies also resulted in a partial 
inhi -bition of TNF -a release, supporting an autocrine 
role for IL -la in TNF -a release.74 Antioxidants have a 
similar effect in inducing TNF -a secretion.74 DNA 
damage is implicated in TNF -a gene expression follow- 
ing UVB exposure.75 cis -UCA, even above physiological 
levels, could not augment phorbol 1 2-myristate 13- 
acetate- induced synthesis of either TNF -a mRNA 
or protein in keratinocytes.76 Interestingly, UVB 
mimics the TNF -a- induced modulation of the p55 
TNF surface receptor on keratinocytes, and mRNA 
expression via a TNF -a- mediated autocrine regulatory 
pathway.77 
Interleukin 6. IL -1 is a potent inducer of IL -6, a cytokine 
which is detectable in serum 1 -3 h after 2 -4 MED 
whole -body UV exposure of human subjects.78.79 IL -6 
has a wide range of effects, including fever induction 
and the synthesis of acute phase proteins. Like IL -1, it is 
known to be produced by keratinocytes and Langerhans 
cells. Although initially regarded as a proinflammatory 
cytokine, recent evidence suggests a significant anti- 
c inflammatory, and even an immunomodulatory, role for 
IL-6. It can elicit the release of adrenocorticotrophic 
hormone from the central nervous system, increasing 
synthesis of glucocorticoids in the adrenal gland.80 In 
turn, these suppress IL -1 and TNF -a synthesis. It is also 
suggested that IL -6 induces the soluble form of the TNF 
receptor, p55.80 Elevations in IL -6 correlate well with 
UV-induced fever courses, and precede increases in 
acute phase proteins such as C- reactive protein.79 C- 
reactive protein induced by 11-6 promotes synthesis of 
five- to 10 -fold greater quantities of IL -lra compared 
with IL-lß from peripheral blood mononuclear cells.80 
Antibodies to IL -6 inhibit this in a dose -dependent 
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manner. Irradiation of long -term cultured epidermal 
cells shows that IL -6 production is attributable to UVB 
wavelengths, with UVA having no effect.78 Whether 
IL -6 production is mediated directly by UVB, and /or via 
IL -1 or other mediators in vivo is unresolved. 
Interleukin 10. With the apparent deviation toward a 
Th2 -like cytokine response following UVB exposure, it is 
natural to hypothesize a central role for IL -10 in UVB- 
induced immunosuppression. IL-10 exhibits antagonis- 
tic effects towards IFN -y, inducing downregulation of 
MHC class II expression, and therefore antigen presen- 
tation, on macrophages.81 It suppresses cytokine 
synthesis when Thl T -cell clones, or NK cells, are 
activated by IL -2 and accessory cells in an antigen 
non -specific manner. Furthermore, while down - 
regulating inflammatory cytokines,ß2 11-10 can 
upregulate IL -lra expression and secretion.83 IL -10 
could thereby play a key part in the production of 
`split -tolerance'. 
There is strong evidence for this in the mouse following 
UVB exposure, especially for the participation of keratino - 
cyte- derived 1L -10.23 Human studies present a less clear 
picture, with some groups finding both keratinocyte- 
derived IL-10 mRNA and secreted protein,84'85 some 
finding mRNA without protein secretion,86 and others 
finding neither mRNA87'88 nor protein.89'90 
After exposure of small areas of human skin sites to 3 
MED UVB or UVA1, Skov et al. found that IL -10 protein 
was slightly increased in suction blister fluid taken 24 h 
later. This increase was only significant following UVB 
irradiation.49 Kang et x1.86 argue that IL -10 within UV- 
exposed human skin is secreted from infiltrating 
CD11b+ macrophages rather than resident CDllb- 
keratinocytes. Langerhans cells and UV- induced macro- 
phages respond differently to inflammatory stimuli.91 
The infiltrating macrophages preferentially activate 
suppressor CD4 + T cells,91 and secrete high levels of 
IL -10. UV- induced macrophages could thereby favour 
development of Th2 -like suppressor cells. Although 
keratinocytes synthesize small amounts of IL -10 
mRNA, the protein may remain inside the cells. 
Teunissen et al.89 performed exhaustive studies on 
normal human keratinocytes from 40 donors and 
were unable to detect any IL -10 mRNA or protein 
following UVB irradiation. Examination of two human 
cell lines (A341, HaCaT) gave similar results. IL -10 
mRNA within melanocytes was detected, without 
protein secretion. Therefore, the positive findings from 
other groups84'8 5 may be due to melanocyte contamin- 
ation. Teunissen et aí.ß9 also performed whole body 
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irradiations (1.5 MED), and were unable to detect 
alterations in serum IL -10 levels outwith the 24 -h 
biphasic temporal pattern of controls. It is difficult to 
reconcile this result with a major role for macrophage - 
derived IL-10 in systemic immunosuppression in 
human subjects. 
Interleukin 12. As 11-12 is regarded as the key cytokine 
in directing cell -mediated immune responses, via 
generation of Thl cells92'93 and enhancement of NK 
cell activity,94 regulation of this cytokine is also central 
to UV- induced immunosuppression. There is evidence 
for this in various mouse models.9596 IL -12 p35 chain 
mRNA is expressed constitutively by human keratino - 
cytes, and upon contact sensitization, p40 mRNA is 
rapidly expressed.97 IL -12 protein is detectable in 
concentrated epidermal cell supernatants, and is readily 
detectable in keratinocyte cell line supernatants 
following stimulation with phorbol- 12,13- dibutyrate.98 
Anti -IL -12 treatment of haptenated human epidermal 
cells causes a 50% reduction in allogeneic T -cell 
proliferation assays.97 UVB irradiation of human 
peripheral blood monocytes, before using them in 
antigen -presenting cell- dependent T -cell stimulation 
assays, resulted in a selective inhibition of antigen 
presentation to established human Thl clones.99 
While proliferation and IFN--y production by Thl 
clones was inhibited in a dose -dependent manner, 
normal proliferative activity and cytokine production 
were maintained in Th2 clones. Perhaps most interest- 
ingly, while the proliferative responses of Th0 clones 
were normal, there was a preferential suppression of 
IFN--y production, skewing cytokine profiles towards 
those of Th2 clones.99 These studies indicate the way 
that resident dermal and /or infiltrating macrophages 
may behave at irradiated sites. 
Interleukin 15. IL -15 has the ability to stimulate growth 
of both CD4 + and CD8 + T -cell subsets,'°° to generate 
lymphokine- activated killer cells101,102 and to act as a 
chemokine for T cells.103 Conflicting data have 
been reported regarding IL-15 after UV exposure. 
Mohamadzadeh etal.104 found that 11 -15 mRNA was 
constitutively expressed in the human dermis, but was 
absent in the epidermis. Upon UV exposure, IL -15 
mRNA was enhanced in dermal sheets and induced in 
the epidermis. Expression was traced to HLA -DR - cells, 
predominantly keratinocytes, but not to HLA -DR + 
cells, probably Langerhans cells. Immunoblot analysis 
revealed that IL-15 protein secretion in cultured 
keratinocytes was enhanced by UVB. In contrast, 
Blauvelt et a1.105 detected constitutive IL -15 mRNA 
expression in freshly isolated human keratinocytes 
and Langerhans cells, and this was downregulated by 
UVB exposure in a dose- and time -dependent manner. 
One important difference between the experimental 
protocols used by these groups is that Mohamadzadeh 
et a1.104 irradiated intact epidermal and dermal sheets, 
whereas Blauvelt et al.'°5 irradiated after segregation of 
cell types. Doses of 2001/m2 UVB were found to be toxic 
in vitro, but gave optimal IL -15 mRNA expression in situ. 
This may imply that 11-15 expression is under the 
control of other intercellular UV- inducible factors found 
within the skin, but which cannot act in culture. IL-15 
mRNA appears to be regulated at post -transcriptional 
levels,106 and is not necessarily related to protein secre- 
tion. Macrophages can also produce IL- 15,107 and if 
recruited locally as a result of UV irradiation, could be 
another source of this cytokine. IL -15 could play an 
important part in regulating the local cytokine micro - 
environment at UV- exposed sites, aiding the outgrowth 
of suppressor T cells. 
The sources and various interactions of some of these 




As sunscreens prevent classical sunburn, i.e. erythema, 
it would be anticipated that they would also protect 
against UV- induced immunosuppression. The easiest 
way to reduce UCA photoisomerization is to decrease 
the intensity of incident light, and the rate of cis -UCA 
formation is reduced by topical application of 
sunscreens.108 This is limited to broad -spectrum (i.e. 
filtering out both UVB and UVA), highly protective 
sunscreens however. cis -UCA formation is inversely 
related to the SPF, with protection against isomerization 
exceeding the SPF values by a factor of greater than 10. 
After multiple exposures, the protective effect of classi- 
cal UVB filters is lost, with only those blocking both UVA 
and UVB retaining activity against photoisomeriza- 
tion.108 Thus, sunscreens which prevent sunburn may 
protect against at least one mechanism (cis -UCA) of 
immunosuppression, with the degree of protection 
determined by the nature of the sunscreen. 
Attempts to develop systems to assess the immune 
protection factor of sunscreens, in comparison with 
their SPFs, have resulted in much discussion.' °9 -112 
Davenport et al. used breast tissue explants as a source 
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Figure 1. A potential mechanism by which 
ultraviolet (UV) radiation may alter the 
cellular and cytokine components of the 
human epidermis, resulting in 
immunosuppression. IL, interleukin; TNFa, 
tumour necrosis factor -a; UCA, urocanic 
acid; PGE2, prostaglandin E2; KC, 
keratinocyte; LAK, lymphokine- activated 
cell; LC, Langerhans cell; MC, melanocyte; 
Mph, monocyte /macrophage; NK, natural 
killer cell; released by /acting upon 
(- -., weakly); , migration; 1, 
blocking; 1/1, increased /decreased. 








LCs to draining lymph node, 
with altered ability to present antigen 
of epidermal cells for MECLR experiments, finding that 
the reduction in the elicited response was prevented by 
application of various sunscreens.109 The degree of 
protection is debatable, and may not exceed the 
SPE111 Application of a high protection sunscreen 
(SPF 29) was found to prevent the UVB- induced sup- 
pression of both the primary allergic reaction, and CH 
elicitation, to DNCB.113 Broad- spectrum sunscreens 
stopped the immunosuppression of CH to a recall 
antigen (nickel) when applied before solar -simulated 
irradiation (suberythemal, once a day for 5 days). 
There was only a slight protective effect afforded by a 
narrowband sunscreen.114 
Application of sunscreens prevented infiltration of 
CD36 + macrophages into irradiated sites when an 
erythemogenic, 4 -day UVB exposure protocol was 
used.30 The influx of these cells is closely correlated 
with the modulation of MECLR responses. However, 
when a suberythemogenic, 4 -week protocol was 
employed, suppression of MECLR was not altered by 
sunscreen application.30 
Multiple, low -dose exposures to UV in solaria 
decreased both NK cell function and numbers,34 a 
phenomenon which was not prevented by sunscreen 
application.115 The sunscreens used in these studies 
did not block UVA wavelengths. Other immunological 
properties, such as immunoglobulin production, mea- 
sured in pokeweed mitogen -stimulated cultures of B and 
Tcells, and DTH, remained depressed.115 A decrease in 
the circulating CD4:CD8 ratio, with a rise in the per- 
centage of CD8 + cells, still occurred. As prevention of 
UV-induced immunosuppression appears dependent on 
the nature of the sunscreens, caution regarding their 
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damage such as erythema could encourage longer 
exposure, unwittingly enhancing damage to the 
immune system. Behaviour regarding sunscreen appli- 
cation is also vitally important, as studies show they are 
commonly used in insufficient amounts116 and volumes 
below those at which the commercial SPF is calculated. 
Diet 
Various food components, including flavonoids,117 
green tea polyphenols, silymarin and pyridoxine, can 
influence the immune system, and when they are either 
fed or topically applied to irradiated mice, skin cancer 
incidence,118,119 pyrimidine dimer formation120 and 
immune suppression121,122 are reduced. Pyridoxine- 
supplemented feed also reduces the suppression of CH 
after cis -UCA painting in mice.121 
There is more circumstantial evidence for the influence 
of dietary components in UV- induced immunosuppression 
in humans. Melanoma patients have decreased levels of 
selenium in their sera, compared with healthy indivi- 
duals.123 Selenium is important in inducing free radical 
scavenging systems, and it is postulated that decreased 
levels increase susceptibility to various cancers.124 Topi- 
cal L- selenomethionine application leads to an increased 
M D 125 Rafferty et a1.126 have shown recently that 
sodium selenite and selenomethionine supplementation 
protects human keratinocytes and melanocytes in vitro 
from UVB- induced cell death. It has been hypothesized 
that an antioxidant -rich diet will protect against 
UV- induced free radical formation within the skin 
and subsequent cell membrane damage. During 
the course of a 3 -6 month diet including fish oil 
supplements, rich in w -3 fatty acids, the MED rose 
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progressively for each volunteer, but decreased within 
10 weeks of termination.127 The total fatty acid content 
within the epidermis rose from 1.8% to 24.2 %, and was 
accompanied by thiobarbituric acid -reactive sub- 
stances, indicating lipid peroxidation in irradiated 
skin. Thus, w -3 fatty acids decrease UVB erythemal 
sensitivity but increase susceptibility of the skin to 
lipid peroxidation.127 In another fish oil supplementa- 
tion study, the MED was again shown to increase, with a 
concomitant decrease in PGE2 levels.128 Reduced PGE2 
may be due to w -3 fatty acid interference at more than 
one step. The w -3 fatty acids may compete with the 
more common w -6 fatty acids for metabolism of cyclooxy- 
genase, or for release from cell membranes by phospho- 
lipases. It is also suggested that w -3 fatty acids can act as 
an oxidizable buffer, reducing free radical damage to 
more essential structures. 
Another antioxidant, vitamin E, offers partial protection 
against the UVA- induced decrease in the ability of human 
Langerhans cells to present antigen.129 These data imply, 
but do not confirm, a role for oxidative stress in the 
immunosuppressive effects of UVA. In one single -diet 
study, it was found that 13-carotene prevented UV- induced 
suppression of DTH (measured by a Multitest CMI kit, 
incorporating seven different test antigens) after 10 weeks, 
compared with that in volunteers fed a placebo diet.13o 
Discussion 
UV appears to be able to influence immune responses at 
multiple levels. By altering the appearance, function 
and numbers of Langerhans cells, UV can change the 
cell type by which antigen is presented. ELAM -1 is 
induced on vascular endothelium after ÚV,29 facilitating 
a monocytic infiltration at the exposed site. Macro- 
phages could subsequently present antigen in a less 
efficient manner compared with Langerhans cells. In 
races with darker skin, Langerhans cells are not 
depleted as markedly, and return to basal levels more 
quickly,18 than in Caucasians. Therefore, such indivi- 
duals may be less immunosuppressed, and this may 
contribute to the lower incidence of skin cancer in black 
people. One difficulty with this theory is the role of 
IL -10. If Teunissen et al. are correct in their belief that 
melanocytes are the main source of IL -10,89 greater 
immunosuppressive effects in more melanized skin 
might be expected. 
Long -term, low -dose UVB does not deplete Langer- 
hans cell numbers, but may act at a cytoskeletal level25 
to prevent efficient antigen presentation, by altering 
processing, phagocytosis or migration. This appears to 
be mediated by blocking the expression of costimulatory 
molecules.24 UV may alter the local cytokine milieu, by 
exerting effects on various cell types. There appears to 
be an initial burst of bioactive IL -1 from keratinocytes, 
promoting an inflammatory response. UVB- induced 
IL -1 and cyclooxygenase may initiate prostaglandin 
synthesis.131 Either UVB directly, or via the action of 
IL -1, induces IL -6 release and the characteristic post -UV 
exposure fever. The inflammatory response may be 
downregulated by UV- or IL -6- induced production of 
IL -lra, with its subsequent release rendering IL -1 inac- 
tive. This is supported by the observation that VCAM -1, 
which can be induced by IL -1, is not upregulated on 
vascular endothelium after UV exposure.29 
The precise role, and source, of IL -10 in an UV- 
irradiated site remain to be elucidated. It is conceivable 
that melanocytes release small amounts upon exposure, 
and this could bias the site towards a Th2 -like response 
in the event of an immunological challenge. This could 
also be achieved by prevention of IL -12 upregulation, 
and could explain the suppression of CH responses. 
Alternatively, a similar mechanism involving the recently 
discovered cytokine IL- 18132.133 may have a role. This effect 
could be enhanced by damage to Langerhans cells. Mem- 
brane perturbation of Langerhans cells in pale skin may 
be an important step in macrophage activation, result- 
ing in further IL -10 secretion. In black skins, apoptosis 
of Langerhans cells may prevent this enhancement, and 
could explain why black people are not more immuno- 
suppressed than white people. Also, TNF -a is an inducer 
of IL-10 mRNA expression,134 and may be of relevance to 
infiltrating monocyte /macrophage cells. 
Although IL -15 release after UV exposure is another 
controversial area, it is perhaps more conceivable that 
IL -15 is induced,104 rather than downregulated,los 
after UV. IL -15 could then play an important part in 
attracting T cells into the exposed site, a phenomenon 
observed over time. Initial decreases in T -cell numbers 
may be due to phototoxic effects. The delay in recruit- 
ment could also be accounted for if macrophages were 
the major source of 11-15. T -cell recruitment would 
then be determined by macrophage infiltration kinetics. 
IL -15 may also be important in the inhibition of NK 
cells, by promoting their development into lymphokine- 
activated killer cells. These may quickly become 
exhausted, with decreased cytotoxic properties. Alter- 
natively, prostaglandin generated by membrane damage 
may suppress NK cell activity. 135136 Loss of NK cells 
would also deprive the immune system of a key source of 
cytokines which promote cell- mediated immunity. 
Isomerization of trans -UCA to cis -UCA has also been 
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shown to be an important result of UV exposure. cis - 
UCA can directly suppress NK cell activity in a dose - 
dependent manner,45 as well as delay the onset of acute 
graft- versus -host disease.137 This latter fact suggests 
that cis -UCA can act directly or indirectly on a cellular 
source to promote Th2 -like cytokine production (or at 
least inhibit Thl -like cytokines). This is further sup- 
ported by exacerbation of systemic lupus erythemato- 
sus, an antibody- mediated disease, by cis- UCA.138 DNA 
damage may contribute more to immunosuppression by 
shorter UVB wavelengths, as indicated by the marked 
fall in thymine dimer formation, and in situ MECLR 
suppression, between 302 and 312 nm.63 Repair of 
pyrimidine dimers does not fully restore CH responses 
in mice,139 indicating that although DNA damage 
appears to be important, it is not wholly responsible 
for UV- induced immunosuppression. This is supported 
by the fact that humans have the capacity for rapidly 
repairing cyclobutyl pyrimidine dimers by a photo - 
reactive enzyme,140 but can still be immunosuppressed 10 
upon UV irradiation. Various studies have shown that 
blocking of cis -UCA or DNA damage prevent UV- induced 
immunosuppression, and it may be that the two do not 
act by mutually exclusive mechanisms. 
The effects of UV radiation on the human immune 
system are extremely complicated and highlight the 
complexity involved in mounting an immune response. 
There seems to be no single definitive, primary action, 
but rather a complex series of events initiated simulta- 13 
neously, or in quick succession, after irradiation. Many 
of the processes may be redundant, making dissection of 
events extremely difficult. Attempts to compare mouse 
and human data are being made, and give some 
indication of the relative risks of UV radiation.141,142 
Photohnmunology is a recent addition to the field of 
immunology, with its relevance to disease and infectious 
states being poorly understood. While reduction of 
stratospheric ozone has been relatively well documented 
and is now being remedied, its potential effects on 
health are only beginning to be appreciated.143 Further 
study is essential to provide guidance regarding 'safe' 
levels of UV exposure, and to develop more effective 
protective measures. In addition, innovative vaccination 
regimens suggest that transcutaneous vaccinations may 18 
be possible in the near future,144,145 making investigations 
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(reviewed in Beissert and Schwarz, 1999). One mechanism may be through effects 
on LC at the irradiated sites. It is known that UVB irradiation leads to a reduction in 
LC numbers at the exposed site, with a loss of dendritic processes in the ones which 
remain (Toews et al, 1980; Aberer et al , 1981; Lynch et al, 1981). 
We have demonstrated that UVB irradiation results in the accumulation of DC in 
the lymph nodes draining the irradiated sites (Moodycliffe et al, 1992). TNF -a was 
found to be a key cytokine in this response as treatment of mice with TNF -a 
antibodies before irradiation blocked the UVB- induced increase (Moodycliffe et al, 
1994). A similar accumulation has been reported following contact sensitisation, 
with inhibition by TNF -a antibodies (Cumberbatch and Kimber, 1995; 
Cumberbatch et al,1997b). 
In previous studies we have shown that irradiation of C3H/HeN mice with either 
UVB or UVA1 can suppress both the CH response, using oxazolone as the skin 
sensitiser, and the delayed type hypersensitivity (DTH) response, using an infectious 
model with herpes simplex virus (El -Ghorr and Norval, 1999). However, the doses 
required to exert such immunomodulatory effects were found to differ markedly. For 
CH, significant downregulation occurred with a dose of 500 kJ /m2 UVA1 
(equivalent to 1 minimal erythemal dose, MED) or higher, and a dose of 5 kJ /m2 
UVB (equivalent to 3.3 MED) or higher. For DTH, significant downregulation 
occurred with a dose of 1 kJ /m2 UVA1 or higher, and a dose of 0.1 kJ /m2 UVB or 
higher. These results indicate that different mediators and pathways may be involved 
in the immunomodulatory cascade, initiated by UV absorbance in the skin, which 
depend on the waveband of the irradiation as well as on the immune parameter 
involved. In addition some recent evidence demonstrates that waveband interactions 
may occurs. For example irradiation with total UVA before UVB partially protected 
mice from the suppression of CH responses induced by UVB (Reeve et al, 1998, 
Reeve et al, 1999). 
The aim of the present study was to investigate whether UVA1 irradiation induces 
a loss of LC from the epidermis of C3H/HeN mice and an accumulation of DC in the 
lymph nodes draining the exposed skin sites, as has been reported for UVB. Doses 
of UVA1 and UVB were chosen which are equivalent in terms of the induction of 
erythema at 1 MED each. The roles of TNF -a and IL-1I3 in these processes were 
identified by neutralising experiments using antibodies to each cytokine, injected 
prior to the UVA1 and UVB irradiation. 
MATERIALS AND METHODS 
Mice 
Female C3H/HeN mice, aged 6 -8 weeks, were obtained from the specific 
pathogen -free animal breeding facility in the Medical Microbiology Transgenic Unit, 
University of Edinburgh. Mice were age- matched to within one week in individual 
experiments. 
UV sources and irradiation of mice 
Two Philips TL -12 lamps with an output range of 270 -350 nm, peak 305 nm, 
emitting 80 mW /cm2 were used as the broadband UVB source. One MED for the 
C3H/HeN mice was 5 kJ /m2. The UVA1 exposure was from a Dr Hoenle Bluelight 
lamp, emitting 38.58 W /m2. Wavelengths below 340 nm were filtered out by 
passage through a 1 cm depth of cation X (provided by Dr F. de Gruijl, University of 
Utrecht) in distilled water at a concentration of 0.1 mg /ml, contained in a perspex 
tray. One MED for the C3H/HeN mice was 500 kJ /m2. The output of both sources 
was determined using a filtered photodiode meter, calibrated against measurements 
made with a UV- visible apectroradiometer (model 742, Optronic Laboratories) 
across the spectral range 250 -450 nm, with a tube to target distance of 16 cm. The 
spectroradiometer was calibrated against tungsten halogen and deuterium standard 
sources which are calibrated by the UK National Physics Laboratory (Teddington, 
UK). 
Mice were UVB- irradiated in a perspex box with a maximum of 4 per box. Due 
to the length of exposure needed for the UVAl, mice were first anaesthesised by 
intraperitoneal injection of 150 µl sterile distilled water containing 1.67 mg /ml 
Hyponorm (Janssen Pharmaceutical, Oxford, UK) and 0.83 mg /ml Hyponovel 
(Roche, Welwyn Garden City, UK). They were then spread out in perspex boxes for 
irradiation to reduce shielding by littermates. Control mice for the UVAl 
experiments were anaesthesised but not irradiated. 
Epidermal LC numbers 
Mice were exposed to UVB or UVAl or not irradiated, as detailed above. In 
experiments examining the neutralising effects of TNF - and IL -113 antibodies, 20 
ug of each antibody (both goat immunoglobulins prepared after immunisation with 
mouse recombinant proteins, R &D Systems, Abingdon, UK) was injected 
intraperitoneally in a 100 µl volume 2 h before irradiation. Control mice, both 
irradiated and unirradiated, were injected with the same volume of normal goat 
serum at the same time. Mouse ears were collected into phosphate buffered saline at 
various times after irradiation and split with foceps. Epidermal sheets from the 
dorsal surface only were prepared and stained for ATPase, using ADP as substrate, 
as a marker for LC (Chaker et al, 1984). Sheets were mounted in 50% glyerol under 
a glass cover slip and the number of ATPase+ cells counted in 10 fields per sheet (1 
field = 0.1 mm2), with a minimum of 4 sheets per group. Results are shown as the 
mean ± SEM. Significant differences between the relevant control and the 
experimental groups were calculated by Student's t -test. 
DC enrichment and counting 
The method outlined in Moodycliffe et al (1993) was used. In brief, the auricular 
lymph nodes were collected from groups of 8 -12 mice 24 h after irradiation. In some 
experiments the mice were pretreated with TNF -a or IL -113 antibodies 2 h before the 
exposure, as detailed above. The lymph nodes from each group were pooled and 
single cell suspension prepared by rubbing through a 200 -mesh steel gauze (J. 
Staniar and Co., Manchester, UK). The cells were washed and suspended in 8 ml 
RPMI -1640 containing 100 I.U. /ml penicillin, 200 mg /ml streptomycin, 2 mM L- 
glutamine, 100 µg /ml gentamicin, 10 pg /ml fungizone, 25 mM HEPES buffer and 
10% heat -inactivated foetal calf serum (all Flow Laboratories, Irvine, UK) [RPMI- 
FCS]. The cell suspension was gently underlaid with 2 ml 14.5% w/v metrizamide 
(Nygaard, Oslo, Norway) and centrifuged at 600 g for 20 min at room temperature. 
The DC- enriched population was removed from the interface and washed twice in 
RPMI -FCS. The pellet was resuspended in RPMI -FCS and the DC counted by 
morphological analysis in the light microscope. DC were counted in three separate 
fields and the results shown are the means of these counts. 
RESULTS 
Irradiation with 1 MED UVA1 does not deplete epidermal LC, whereas UVB 
causes a dose -dependent depletion 
The frequency of epidermal cells was assessed as a function of ATPase+ cells in 
epidermal sheets prepared from the dorsal ear skin of C3H/HeN mice. Data pooled 
from 17 independent experiments revealed that the number of LC in untreated 
(naive) skin was 384 ± 11.5 per mm2 (mean ± SEM). Twenty -four h after exposure 
to 1 MED UVAl, there was no change in the number or the morphology of the LC. 
In contrast, irradiation with 1 MED UVB reduced the LC numbers significantly. The 
results of 4 individual experiments are shown in Table 1, and demonstrate a mean 
drop in epidermal LC numbers of approximately 28 %. The LC remaining in the 
epidermis after UVB exposure were rounded and had fewer dendritic processes than 
in the unirradiated controls. Two smaller doses of UVB were used in comparison 
with the 1 MED dose. When the LC were counted 24 h later, the numbers fell by 
39.4% after 1 MED (p <0.01 v. unirradiated control), by 23 % after 0.5 MED (p<0.05 
v. unirradiated control) and by 7.6% after 0.25 MED (no significant change), 
demonstrating that LC migration induced by UVB exposure is dose -dependent. 
It has been reported that irradiating mice with UVA1 before UVB led to a partial 
reversal of the immunosuppressive effects of UVB on CH (Reeve et al, 1999). To 
determine whether such a combination altered LC numbers in the epidermis, mice 
were irradiated with 1 MED UVA1 followed by 1 MED UVB. At 24 h the LC 
numbers were depleted to levels comparable with those achieved by UVB alone 
(UVA +UVB 192.5 per mm2 ± 19.8, UVB 200 ± 15.9, unirradiated control 329 ± 
17.6 in one experiment; and UVA +UVB 219 ± 16.5, UVB 256 ± 23.6, unirradiated 
control 329 ± 18.8 in a second independent experiment). 
The timecourse for LC depletion following UVB irradiation 
The numbers of LC in the epidermis at various times after exposure to 1 MED 
UVB were examined and the results are shown in Figure la. There was maximal 
depletion at 12 h, followed by a steady recovery back to the resting levels. The LC 
were rounded and had fewer dendrites at 12 h, but the morphology recovered to 
normal as the numbers of LC increased. In a second experiment, a 6 h time point 
was included and a significant reduction in LC numbers was demonstrated. The fall 
was 32% at 6 h (p <0.05 v. unirradiated) and 45.3% (p <0.01 v. unirradiated control) 
at 12 h. 
LC were also monitored between 6 and 72 h after exposure to 1 MED UVA1 but 
there was no significant reduction at any time (Figure lb). The morphology of the 
LC was unaltered throughout with long dendritic processes clearly visible. 
Neutralisation of TNF -a and IL -1(3 prevents LC depletion after UVB 
irradiation 
The available evidence indicates important roles for TNF -a and 1L-lß in the 
induction of LC migration from the epidermis following contact sensitisation 
(Kimber et al, 1998). Therefore experiments were performed to investigate the 
contribution of these cytokines to the UVB- induced reduction in LC numbers. 
Neutralising goat immunoglobulins against either murine TNF -a or IL -10 were 
injected intraperitoneally into mice 2 h prior to UVB irradiation. Control animals 
were injected with normal goat serum before exposure. The results of 2 independent 
experiments are shown in Figure 2a for anti -TNF -a, and in Figure 2b for anti- IL -lß. 
First, the antibodies themselves did not alter LC numbers significantly in 
unirradiated animals compared with those injected with normal goat serum. Second, 
the UVB -irradiated group injected with the normal goat serum showed a significant 
reduction in LC numbers compared with the unirradiated group also injected with the 
normal goat serum (a decrease of 32% and 41% for the TNF -a experiments in Figure 
2a, and 31% and 26% for the IL -lß experiments in Figure 2b). Third, there was no 
significant reduction in LC numbers in the mice pretreated with the cytokine 
antibodies before irradiation compared with unirradiated animals pretreated with the 
same antibody (7.3% and 9% for the TNF -a experiments in Figure 2a, and 2% and 
0% for the IL-1E3 experiments in Figure 2b), and the morphology of the LC was no 
different from that in the unirradiated animals. On the basis of these results, it is 
concluded that TNF -a and IL-lß are both critical cytokines in the migration of LC 
from the epidermis following UVB exposure. 
UVA1 and UVB exposure lead to the accumulation of DC in the lymph nodes 
draining the irradiated sites 
We have shown previously that UVB irradiation causes the accumulation of DC 
in lymph nodes draining the exposed skin site (Moodycliffe et al, 1992). Similar 
experiments were conducted to corroborate this finding and to investigate whether 
UVA1 also induces such an increase in DC in the draining lymph nodes (DLN). 
Mice were exposed to 1 MED UVB or UVA1, and the auricular lymph nodes 
draining the ears collected 24 h later. Control mice were not irradiated. The DC in 
the lymph nodes were counted following enrichment on a metrizamide gradient and 
the results of 4 independent experiments are shown in Table 2. The DC numbers per 
lymph node were increased by both UV regimens by approximately two -fold. 
Neutralisation of TNF -a prevents the UVB- induced, but not the UVA1- induced, 
accumulation of DC in DLN 
An important role for TNF -a in DC accumulation induced by UVB exposure had 
been revealed in a previous study (Moodycliffe et al, 1994). The results in Figure 3a 
for one representative experiment substantiate this finding. There was a 123% 
increase in DC numbers in UVB -irradiated mice compared with unirradiated 
controls, and this was reduced to 36% in animals pretreated with TNF -a antibodies 
compared with unirradiated controls given the same antibodies. 
However, for UVA1 the finding were quite different and are also shown in Figure 
3a. There was a 248% increase in DC numbers in UVA1- irradiated mice, and a 
236% increase in animals pretreated with TNF -a antibodies compared with 
unirradiated controls, also given the TNF -a antibodies. Thus, as the TNF -a 
antibodies did not affect substantially the increase in DC numbers following 
exposure, a major role for this cytokine in UVA1- induced DC accumulation is not 
indicated. 
Neutralisation of IL -10 prevents both the UVB and the UVAI- induced 
accumulation of DC in DLN 
As Il -113 was shown to have a significant effect on the migration of LC from the 
skin, a similar approach to that just described for TNF -a was employed but using IL- 
113 antibodies. The results of such an experiment are shown in Figure 3b. It was 
found that the IL -113 antibodies, injected 2 h prior to either UVB or UVA1 exposure, 
substantially inhibited the accumulation of DC in the DLN. The antibody itself 
reduced the number of DC slightly compared with mice injected with normal goat 
serum. UVB exposure induced a 103% increase in DC numbers, and UVA1 a 74% 
increase. In both cases, the IL -113 antibodies prevented this accumulation almost 
completely and to a similar extent. 
DISCUSSION 
Under normal circumstances, LC represent the major antigen presenting cells of 
the epidermis and their numbers and morphology are assessed most frequently by Ia 
or ATPase staining of epidermal sheets. Both methods give the same results using 
the C3H/HeN strain of mouse (Aubin et al, 1991). One mechanism whereby UV 
radiation results in a modulation of immune responses is thought to be by trafficking 
of a proportion of LC from the epidermis. The ones that remain show abnormal 
morphology and have a reduced capacity for antigen presentation. Most studies in 
this area have used broadband UVB sources or solar simulated irradiation, and the 
contribution of the UVA waveband to this process is not well defined. Limited 
information indicates that the effect on LC may be wavelength dependent. Noonan 
et al (1984) reported that irradiation at 270 and 290 nm resulted in a decrease in 
epidermal LC numbers with associated changes in dendrites, but this did not happen 
at 320 nm. Similarly, using monochromatic light, Obata and Tagmani (1.985) found 
that UVA from 320 -400 nm was almost ineffective in reducing LC numbers: 
wavelengths shorter than 300 nm were the most efficient. Previously we reported 
that a single dose of 40 kJ /m2 UVA did not result in a significant reduction in LC 
numbers 24 h later (El -Ghorr et al, 1994). However Aubin et al (1991) demonstrated 
that chronic UVA exposure (10 kJ /m2, 3 times weekly for 4 weeks) reduced the 
number of ATPase+ cells in the epidermis of C3H/HeN mice by approximately 45% 
compared with unirradiated controls. 
In the present study UVB was found to reduce epidermal LC numbers, while 
UVAl did not (Table 1 and Figure 1). The doses from the two lamps were 
equivalent in terms of erythema. This parameter was chosen as it has been suggested 
that the action spectrum for LC depletion from the epidermis is similar to that of the 
induction of erythema (Obata and Tagmani, 1985). We had shown previously that 
DTH responses could be suppressed by either of the UV doses used, and CH 
responses by the UVA1 dose but a 3.3 -fold higher dose of UVB was required (El- 
Ghorr and Norval, 1999). Therefore no correlation is apparent between the 
migration of LC from the epidermis and the UV- induced modulation of DTH or CH. 
This has also been indicated elsewhere. For example, Noonan et al (1984) found no 
loss in epidermal LC following exposure at 320 nm, even at doses which caused 50% 
suppression of CH, and the chronic UVA irradiation protocol used by Aubin et al 
(1991) which resulted in a considerable loss of LC did not alter CH responses. It is 
interesting to note that low zone tolerance to contact sensitisers can be mediated 
without LC migration (Steinbrink et al, 1996). 
Previously the importance of TNF -a in inducing LC migration from the epidermis 
was demonstrated (Moodycliffe et al, 1994). This result was corroborated in the 
present study (Figure 2) and, by pretreatment of mice with IL-113 antibodies prior to 
UVB exposure which restored the LC numbers to the level found in unirradiated 
controls (Figure 2), a role for IL -113 was also established. These two cytokines are 
critical in LC movement during the early phase of contact sensitisation (Kimber et al, 
1998), together with the downregulation of E- cadherin, expressed on the LC surface 
(Schwarzenberger and Udey, 1996). 
The induction of TNF -a may be wavelength dependent. Skov et al (1998) found 
that irradiating human skin with 3 MED UVB led to a rapid increae in TNF -a 
protein in suction blister fluid, maximal at 6 h after exposure. However UVA1 
resulted in a slight decrease at 6 h. Furthermore in mice carrying a chloramphenicol 
acetyl transferase reporter transgene bearing the entire TNF -a promoter, UVA1 did 
not induce the expression of TNF -a in skin, in contrast to UVB (de Kossodo et al, 
1995). DNA damage, occurring at predominantly dipyrimidine sites and including 
the formation of cyclobutane pyrimidine dimers, may be the initiating factor for 
TNF -a gene expression following UVB irradiation (Kitibel et al, 1998). Other types 
of DNA damage, mainly oxidative forms, are found at longer wavelengths which 
may not be appropriate for the induction of TNF -a. Such a situation has been 
described recently for another UV- induced cytokine, IL -6. The wavelength 
dependence for IL -6 expression in keratinocytes was found to match the spectra for 
both DNA absorption and cyclobutane pyrimidine dimer formation (Petit -Frere et al, 
1998). For example at 365 nm, approximately one -thousandth of the quantity of IL -6 
was produced compared with the same dose but at 302 nm. 
Although IL -113 is known to be essential for contact sensitisation in the mouse and 
to cause LC depletion from the epidermis (Cumberbatch et al, 1997a), little 
information is available regarding the wavelength and the timing of its induction by 
UV. In one study of human subjects, IL -1(3 was detected at elevated concentrations 
in suction blister exudates at 15 h after 3 MED solar simulated radiation, an increase 
which was sustained for at least the next 72 h (Barr et al, 1999). 
In agreement with previous studies (Moodycliffe et al, 1992 and 1994), we 
detected an accumulation of DC in the lymph nodes draining the irradiated skin site 
following UVB exposure (Table 2). This was dependent on TNF -a and IL -113 as 
neutralisation of either cytokine inhibited the increase in numbers (Figure 3). 
Perhaps surprisingly, given the lack of effect of UVA1 on the epidermal LC 
numbers, exposure to this waveband also resulted in an accumulation of DC in the 
DLN (Table 2). A similar role for IL -10 in UVA1- as in UVB -induced accumulation 
was indicated. In contrast to the situation with UVB, TNF -a did not appear to be 
involved after UVA1 exposure as TNF -a antibodies failed to alter substantially the 
increase in DC (Figure 3). 
Therefore UVA1 irradiation may not lead to a significant upregulation in TNF -a 
expression in the epidermis, with the lack of LC migration as a consequence. 
However, as DC still accumulate in the DLN after UVA1, the source of DC must be 
other than the LC. It is possible that they originate in the dermis. DC are found in 
the papillary dermis of normal skin and are considered to be migrating LC, either 
precursors on their way to the epidermis or mature cells on their way to the DLN. In 
addition the dermis contains other subsets of DC, with one in the mouse showing a 
LC -like phenotype (Duraiswamy et al, 1994). An inflammatory infiltrate consisting 
of lymphocytes and macrophages is found around the vessels of the upper and mid - 
dermis following UVA1 irradiation (Lavker and Kaidbey, 1997), indicating that 
cellular changes are induced by this waveband in the dermis. TNF -a is neither 
chemotactic nor chemokinetic for macrophages (Webb et al, 1996), so blocking of its 
activity is unlikely to alter this response. The same may be true for the dermal DC 
moving from the skin to the DLN, in response to UVA1. In addition DC from 
different sites may express different adhesion molecules and the ones on dermal DC 
may render the cells susceptible to IL-113-induced, but not to TNF -a- induced 
migration. 
In summary, we have shown that 1 MED UVB irradiation causes the migration of 
epidermal LC and the accumulation of DC in lymph nodes draining the exposed skin 
site. TNF -a and IL-1 3 are mediators at both of these stages. One MED UVA1 does 
not cause the migration of epidermal LC but DC still accumulate in the DLN, an 
effect which involves IL -113 but not TNF -a. 
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LEGENDS FOR FIGURES 
Figure 1. The timecourse for ATPase+ cells in murine epidermis following 
irradiation with 1 MED UVB (a) or 1 MED UVA 1 (b). Four epidermal sheets from 
the ears of each group were prepared and stained for ATPase. Ten fields were 
counted per individual sheet. Results are shown as the mean ± SEM for each 
timepoint, with 0 h representing the number in unirradiated animals. *= p <0.05 and 
* *= p<0.01 v. unirradiated. 
Figure 2. The roles of TNF -a and IL -1(3 in UVB- mediated LC depletion from the 
epidermis. Mice were injected with normal goat serum (NGS) or TNF -a antibodies 
(a) or IL -10 antibodies (b) 2 h before 1 MED UVB irradiation. Four epidermal sheet 
from the ears of each group were prepared and stained for ATPase activity. 
* *= p<0.01 v. unirradiated, §= p <0.05 and § §= p <0.01 v. the same treatment with the 
cytokine antibody. 
Figure 3. The roles of TNF -a (a) and IL-lß (b) in DC accumulation in lymph nodes 
following 1 MED UVB or UVA1 irradiation. Mice were injected with normal goat 
serum (NGS) or TNF -a antibodies (a) or IL -10 antibodies (b) 2 h before irradiating. 
Auricular lymph nodes were collected 24 h later, and the DC counted following 
enrichment. 
Ex i eriment unirradiated UVB % chane UVA % chan e 
1 374 ± 16.6 263 ± 8.7 -29.7 ( *) 351 ± 11.6 -6.1 
2 329 ± 17.6 200 ± 15.9 -39.2 ( *) 301 ± 21.4 -8.5 
3 329 ± 18.8 256 ± 23.6 -22.2 ( *) 355 ± 53.3 +7.9 
4 430 ± 9.9 346 ± 4.3 -19.5 ( *) 432 ± 19.5 +0.5 
Table 1. UVB induces a reduction in LC, but UVA1 does not. Mice were either unirradiated, or received either 1 
MED UVB or 1 MED UVA 1. Ears were collected and stained for ATPase activity 24h later. In individual 
experiments, 4 epidermal sheets were prepared each group. Ten fields were counted per individual sheet. Results 
from 4 individual experiments are shown as mean ± sem, and percentage change from control values. 
*= p< 0.05, vs. control. 
Ex eriment DC/restin LN UVB % chan e UVA1 % chan e 
1 1067 2186 +105 1857 +74 
2 997 2136 +114 1929 +93 
3 992 2214 +123 3450 +248 
4 1923 4149 +116 3606 +88 
Table 2. UVA1 and UVB irradiation induce an accumulation of DC in DLN. Mice were given a 1 MED 
exposure of either UVB or UVA1, and DLN collected 24h later. Control mice were unirradiated. DC were 
enriched on a 14.5% metrizamide gradient before counting. Results from several individual experiments are 
shown as the number of DC per DLN, and the percentage change from their respective control (unirradiated) 
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